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ABSTRACT 
Chapter 1 describes the attempts to synthesize piperidin-2-ones via an 
aza-Michael-Michael annulation, which were unsuccessful. A general route for the 
synthesis of piperidin-2,4-diones from β-keto esters via a Dieckmann cyclisation was 
proposed and five piperidin-2,4-diones with different substituents at positions-5 and -6 
were prepared. An asymmetric route to 1-unsubstituted piperidin-2,4-diones was also 
developed which involved the use of Davies' chiral auxiliary to induce an asymmetric 
Michael addition. 
Chapter 2 describes a new approach to the synthesis of codeine. The piperidin-4-one 
ring was prepared by a Dieckmann cyclisation; a Robinson annulation was performed 
to construct the cyclohexenone ring and the key bicyclic intermediate was made. 
However, attempts to prepare the corresponding benzomorphan via a Grewe 
cyclisation of the α,β-unsaturated ketone were not successful. Synthesis of various 
2,3-disubstituted piperidin-4-ones using the same strategy as the codeine synthesis was 
attempted; six different piperidin-4-ones with alkyl and aryl substituents at the 
2-position were prepared. 
Chapter 3 describes the attempts to synthesize 1,2-dihydropyrrol-3-ones employing the 
same strategy used to make piperidin-4-ones in Chapter 2. Seven different diester 
intermediates were successfully prepared but attempts for Dieckman cyclisation failed. 
The focus was changed to prepare 5-substituted pyrrolidin-3-ones by the protocol used 
to make piperidin-2,4-diones in chapter 1 and four pyrrolidin-3-ones were made. 
Enantioselective syntheses using the Davies' chiral auxiliary were attempted and 
enantiopure 5-methylpyrrolidin-3-one was prepared. 
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ABBREVIATIONS 
Ac     acetyl 
Ar     aryl 
Bn     benzyl 
Boc     tert-butoxycarbonyl 
br     broad 
n-Bu    n-butyl 
t-Bu     tert-butyl 
campSO3H   camphorsulfonic acid 
CAN    cerium(IV) ammonium nitrate 
d     doublet 
DBS    dibenzosuberylamine 
DCC    dicyclohexylcarbodiimide 
DCE    1,2-dichloroethane  
DCM    dichloromethane 
dd     doublet of doublets 
ddd     doublet of doublet of doublets  
de     diastereoisomeric excess 
DIPEA    diisopropylethylamine 
DMAP    4-(dimethylamino)pyridine 
DMF    dimethylformamide 
DMPU    1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMS    dimethyl sulfide 
DMSO    dimethyl sulfoxide  
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dt     doublet of triplets 
EDC    1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EI     electron impact 
ee     enantiomeric excess 
eq     equivalent 
ESI     electrospray ionisation 
Et     ethyl 
EWG    electron-withdrawing group 
GABA    γ-aminobutyric acid 
gem     geminal 
h     hour 
HIV     human immunodeficiency virus 
HOBt    1-hydroxybenzotriazole 
HRMS    high resolution mass spectroscopy 
Hz     hertz 
IR     infra red 
J     coupling constant 
KHMDS    potassium hexamethyldisilazide 
L     ligand 
LDA    lithium diisopropylamine 
m     meta 
m     multiplet 
M     molar 
Me     methyl 
 7 
 
min     minute 
mL     millilitre 
mp     melting point 
Ms     methanesulfonyl 
MVK    methyl vinyl ketone 
m/z     mass-to-charge ratio 
μL     microlitre 
NaHMDS   sodium hexamethyldisilazide 
NBS    N-bromosuccinimide 
NDMBA    1,3-dimethylbarbituric acid 
NMO    N-methylmorpholine-N-oxide 
NMR    nuclear magnetic resonance 
o     ortho 
p     para 
PG     protecting group 
Ph     phenyl 
PMP    pentamethylpiperidine 
Pr     propyl 
i-Pr     isopropyl 
q     quartet 
R     alkyl 
RT     room temperature 
s     singlet 
t     triplet 
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TBAF    tetra n-butylammonium fluoride 
TBS     tert-butyldimethylsilyl 
TFA     trifluoroacetic acid 
THF     tetrahydrofuran 
TIPS    triisopropylsilyl 
TLC     thin layer chromatography 
TMS    trimethylsilyl 
TPAP    tetra-n-propylammonium perruthenate 
Ts     p-toluenesulfonyl 
UV     ultraviolet 
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CHAPTER 1 
 
Synthesis of Substituted Piperidin-2,4-diones and 
Related Ring Systems 
 
1.1 Introduction 
The piperidine ring plays an important role in pharmaceutically active compounds and 
is commonly found in natural compounds such as the alkaloids.
1–5
 The oxopiperidines 
such as piperidin-2-ones are also present in natural alkaloids
3–5 
or as a part of various 
biologically active compounds.
6–8
 A scaleable synthetic route to diversely substituted 
piperidines and oxopiperidines, though very important to drug development, is still 
challenging.
9,10
 Enantioselective synthesis of the substituted piperidines is even more 
difficult; although the groups of Meyers,
11
 Marazano,
12
 and Comins,
13
 have made 
progress in the preparation of enantiopure piperidines, there are limitations for the 
types and positions of substituents that can be introduced in the ring. 
Piperidin-2,4-diones are also present in various pharmaceutical compounds,
14–18
 but 
routes to 6-substituted piperidin-2,4-diones are limited.
19 
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N
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O
Adalinine
OMe
OMe
N
H
O
O
Anti-hypogpycaemic agent16 
Figure 1.1 Some substituted piperidin-2,4-diones with biological or pharmaceutical activity 
1.1.1 Retrosynthetic Analysis for Oxo-Piperidines 
Unlike piperidines, straightforward synthetic routes to substituted piperidin-2,4-diones 
are limited.
19
 Retrosynthesis of piperidin-2,4-diones usually involves 3,4-disconnection 
or 1,2-disconnection (Scheme 1.1). The synthetic strategies are usually based on 
δ-amino β-ketoester cyclisation,15,16,20–23 Dieckmann cyclisation,15,24–26 or Blaise 
cyclisation.
27
 For piperidin-2-ones a [4+2] cycloaddition is also feasible. 
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Scheme 1.1 Retrosynthetic analysis of oxopiperidines  
1.1.2 Approaches to the Synthesis of Oxo-piperidines 
(i) [4+2] Cycloaddition to Piperidin-2-ones 
In 2005, Ihara reported a one-pot synthesis of piperidin-2-ones by reaction of an 
electrophilic alkene with an α,β-unsaturated amide in an aza-Michael-Michael 
process,
28,29
 a very powerful method for the synthesis of piperidin-2-ones with 4- and 
6-substitutions. Bicyclic piperidin-2-ones 4 were also synthesized (eq(ii), Scheme 1.2). 
However, only N-substituted piperidin-2-ones could be prepared and it is quite difficult 
to incorporate a 3-substituent. It is suprising that this method has not been advanced 
Chapter 1 
15 
 
since it was first reported in 2005 by Ihara.
29
 Thus, it appeared of interest to exploit the 
Ihara reaction and extend the scope to make various piperidin-2-ones.  
NH
R2
O
R1
R4
EWG
NO
R1
R4
EWG
R3
TBSOTf, Et3N, 
t-BuOH, DCE
Scheme 1.2 A [4+2] annulation to give piperidin-2-ones
R3
R2
+
CO2Me
TBSOTf, Et3N, 
t-BuOH, DCE
+
52%29
(i)
NH
Ph
O
Bn
NO
Bn
TBSOTf, Et3N, 
t-BuOH, DCE
+ Ph
51%29
(ii)
O
O
NHO
Bn
OMe OMe
NO
Bn
CO2Me
4
1
3
2
46:54 E/Z
>99:<1 E/Z
 
(ii) Intramolecular Blaise cyclisation to piperidin-2,4-diones 
In 1991, Meyers reported the asymmetric synthesis of the Corynantheine alkaloids in 
which the piperidin-2,4-dione ring was formed by an intramolecular Blaise reaction.
27
 
An organozinc complex is formed by the reaction of zinc with the bromine alpha to the 
amide to give the alpha-carbon nucleophile which then attacks the nitrile, leading after 
hydrolysis to the piperidin-2,4-dione (Scheme 1.3). The limitations is that there is no 
straightforward synthesis of the precursor α-bromo ester 5.  
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Scheme 1.3 Intramolecular Blaise reaction
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Bn
NC
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NHZnBr
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Bn
N
NH2
O
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N
O
O
Bn
H2O H+
5 6
(iii) δ-Amino β-ketoester cyclisation to piperidin-2,4-diones 
In 2000, Davis reported the asymmetric synthesis of 6-substituted piperidin-2,4-diones 
by a δ-amino β-ketoester cyclisation.23 An asymmetric Michael reaction of the imine 7 
with methyl acetate was induced by the chiral N-sulfinyl group of 7 to afford the 
N-sulfinyl β-phenylalanine 8 (Scheme 1.4). The δ-amino β-ketoester 9 was made by a 
Claisen condensation of the amino ester 8 with methyl acetate in the presence of excess 
NaHMDS.
23
 The chiral auxiliary was removed by the use of TFA and then a δ-amino 
β-ketoester cyclisation was effected under basic conditions to give the 
6-phenylpiperidin-2,4-dione 10. Davis' approach is powerful because enantiopure 
N-unsubstituted piperidin-2,4-diones can be prepared in a few steps. However, it is 
difficult to prepare piperidin-2,4-diones with 3- and/or 5-substitutions by this method. 
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1. TFA, MeOH
2. NaHCO3
90%
Scheme 1.4 δ-Amino β-ketoester cyclisation23  
(iv) Dieckmann cyclisation to piperidin-2,4-diones 
Dieckmann cyclisation is a widely used approach for making substituted 
cyclohexanones and cyclopentanones. This can also be applied to the synthesis of 
oxopiperidines. Using Dieckmann cyclisation to make piperidin-2,4-diones has the 
advantages that the precursor diesters are easily prepared and the reaction conditions 
are usually mild. To our knowledge, there are few enantioselective Dieckmann 
cyclisations that afford 1-unsubstituted piperidin-2,4-diones,
26
 although the 
construction of a bridged piperidin-4-one ring via a diastereoselective Dieckmann 
reaction has been described.
30 
1.1.3 Background of Dieckmann Cyclisation 
Dieckmann cyclisation is an intramolecular Claisen condensation reaction; the 
mechanism is shown in Scheme 1.5. A base abstracts a proton from the alpha carbon to 
give the enolate of the ester which reacts with another ester, leading via 
addition-elimination to ring formation. Once the alkoxy group is displaced to form a 
ketone, a base abstracts the most acidic proton alpha to the ester (marked in diagram) 
to form an enolate and this step is irreversible. After neutralisation, the desired cyclic 
Chapter 1 
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keto ester is formed.  
MeO
OMe
O
O
H H Na
MeO
OMe
O
ONa
H
MeO ONa
OMe
O
OMe
O
O
H
OMe
O
ONa
OMe
O
O
-NaOMe Na
H   quench
Scheme 1.5 Mechanism of Dieckmann cyclisation
n
n
n n
n
n
OMe
OMe
α
 
Dieckmann cyclisation has also been used to synthesize piperidin-2-one rings. The 
amine nitrogen must usually be protected. For the synthesis of piperidin-2,4-diones, 
although most use protected amides for the Dieckmann cyclisation, there are some 
cases of unprotected amides affording N-unsubstituted piperidin-2,4-diones.
24,31,32
  
N
H
O
MeO2C CO2Me
13
N
H
O
O
14
N
R
MeO2C CO2Me
11
N
R
O
12
MeO2C
MeO2C
base
base
Scheme 1.6 Representative Dieckmann cyclisations giving 4-oxopiperidines 
Although Dieckmann cyclisation is widely used to construct cyclopentane rings, there 
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are only around twenty examples using the reaction to prepare pyrrolidin-3-ones 
16.
33–36
 Few of them afford 5-substitution
37
 or proceed enantioselectively
38
 (Scheme 
1.7). 
N
R
MeO2C
CO2Me
15 16
base
Scheme 1.7 Dieckmann cyclisation to pyrrolidin-3-ones
N
R
O
MeO2C
R1O
O
O
N
O OR2
Bn
O
R1O
O
O
O
N
O
Bn
t-BuOK (1.5 eq)
THF, -78 oC, 3 h38
17 18
 
In 1961, Becker showed that enamino esters 19 are also substrates for Dieckmann 
cyclisations, and afford 5,6-dihydro-3-methoxy-4-pyridones 20.
39
 Sodium methoxide 
deprotonates the amine group to give an imine enolate (Scheme 1.8) which then 
participates in a Dieckmann cyclisation to give 5,6-dihydro-3-methoxy-4-pyridones 20. 
N
H
N
H
CO2MeMeO2C CO2Me
O
N
MeO2C
O
OMe
N
MeO2C
ONa
OMe
NaH
-MeOH
NaOMe
19 20
Scheme 1.8 Dieckmann cyclisation of enamino esters 19
OMe
R R
R
R
 
Although it seems that Dieckmann cyclisation of enamino esters 21 to give 
1,2-dihydropyrrol-3-ones 22 is feasible and convenient, to our knowledge only 
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Cambon
35
 attempted to do so and reported that 21 did not undergo a Dieckmann 
cyclisation to give 1,2-dihydropyrrol-3-ones 22. 
N
MeO2C
CO2Me
21 22
base
Scheme 1.9 Dieckmann cyclisation to 1,2-dihydropyrrol-3-ones 22
N
O
R2
R3
R4
CO2Me
R4R2
R3
R1 R1
 
1.1.4 Preparation of β-Amino Esters 
The main objective of this section is the synthesis of 5,6-disubstituted 
piperidin-2,4-diones 23 by a Dieckmann cyclisation approach; the retrosynthetic plan 
is shown in Scheme 1.10. Therefore, an effective preparation of intermediate β-amino 
esters 25 with various R
1
 and R
2
 is required. 
N
H
O
O R2 N
H
O R2
O
OMe
MeO2C
H2N
O
R2
O
OMe
MeO2C
Cl
+
R1 R
1
R1
252423
Scheme 1.10 Retrosynthetic plan of piperidin-2,4-diones 23  
The most convenient way of making β-amino esters 25 is the traditional 
SOCl2-activated esterification of β-amino acids 26 (Scheme 1.11). However, the choice 
of commercially-avaliable β-amino acids 26 is very limited so other methods will 
usually be required for making various β-amino esters 25. 
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H2N R
2
O
OH
R1
26
Scheme 1.11 Esterification of β-amino acids 25
H2N R
2
O
OMe
R1
25
.HCl
SOCl2, MeOH
 
Another method of preparing β-amino esters is by reduction of the corresponding 
vinylogous carbamates 28 (Scheme 1.12), in turn prepared from β-keto esters 27. The 
latter can be prepared from methyl acetoacetate (see Section 1.2.3). Reaction of β-keto 
esters 27 with ammonium acetate gives enamino esters 28 which are then reduced by 
sodium triacetoxyborohydride to afford the desired β-amino esters 25 (Scheme 1.12). 
Many β-amino esters 25 can be prepared by this method which is particularly useful 
when the β-amino acids are unavailable. 
R2
O
OMe
R1
27
Scheme 1.12 Reductive amination of β-keto esters 27
R2 NH2
O
OMe
R1
28
O H2N R
2
O
OMe
R1
25
NH4OAc
NaBH(OAc)3
 
The Blaise reaction is a limited method of preparing β-enamino esters. For example, 
nitriles 29 react with bromo esters 30 to give β-enamino esters 31 which are then 
reduced by sodium borohydride to give β-amino esters 25 (Scheme 1.13).40  
Zinc
Br
CO2MeR
1
+NC R
2
Scheme 1.13 Blaise reaction to β-amino esters 25
3029
H2N
O
OMe
R1
25
NaBH4
NH2
O
OMe
R1
31
R2R
2
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1.1.5 Davies' Chiral Auxiliary Approach for Asymmetric 
Syntheses  
Asymmetric induction is central to the synthesis of chiral compounds. This can be 
achieved by using starting materials from chiral pool (which uses readily avaliable 
enantiopure substrates for the synthesis), or by using a chiral auxiliary or chiral 
catalysts. Davies reported the use of enantiopure α-phenylethylamine as a chiral 
auxiliary in asymmetric Michael addition of the amine 33 to α,β-unsaturated esters 32 
to give enantiopure adducts 34 in over 98% ee (Scheme 1.14).
41–44
 Since both 
enantiomers of α-phenylethylamine are commercially-avaliable and inexpensive, 
Michael adducts 34 can be made with (S,R)- or (R,S)- configuration. This auxiliary can 
be removed by catalytic hydrogenation. 
Ph N
Li
Ph
R
CO2Me
34
33
32
R
CO2Me
NPh
Ph
-78 oC, THF
Scheme 1.14 Chiral auxiliary-induced asymmetric Michael reaction 
Adducts 34 are key building blocks which can be converted to various amine 
derivatives (Scheme 1.15). Hydrogenation of adducts 34 removed both the auxiliary 
and benzyl group to give various β-amino esters 35.41 The benzyl group of 34 was 
removed selectively with the use of CAN by an unknown mechanism
44
 and 
intermediates 36 were then cyclised by a base to afford β-lactams 37.42,43 If R of 
adducts 34 is an ether, treating 34 with a base induced transesterification to give the 
lactone 38.
43
 Since this chiral auxiliary approach is powerful and effective, one of our 
objectives was to exploit and extend this approach for the synthesis of 
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piperidin-2,4-diones enantioselectively. 
34
35
R
CO2Me
NH2
H2, Pd(OH)2/C
MeOH, AcOH
36
R
CO2Me
NHPh N
O
R
Ph
37
0 oC, Et2O
34
O O
N
Ph
Ph
38
TBAF
THF, RT
MeMgBrCAN
MeCN/H2O
34
Scheme 1.15 Applications of enantiopure adducts 3441-44
(i)
(ii)
(iii)
R=TBDMSO
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1.2 Results and Discussion 
1.2.1 Attempted Synthesis of Piperidin-2-ones via a 
Palladium-catalyzed Aza-Michael Reaction 
One method of preparing a piperidin-2-one ring involves a palladium-catalyzed 
aza-Michael reaction followed by a Michael reaction.
28
 The piperidinones can then be 
reduced to afford the corresponding piperidines.
29 
In Ihara’s route, the first step was the 
aza-Michael reaction of an α,β-unsaturated amide with a Michael acceptor, catalyzed 
by Pd(PhCN)2Cl2. In the second step, an intramolecular Michael reaction using 
potassium tert-butoxide formed the ring. This route to piperidin-2-ones appears 
powerful because the aza-Michael reaction takes place under mild conditions and does 
not involve the use of strong bases such as n-butyllithium. The convenience of this 
method of making a piperidinone ring gives it potential in the synthesis of many 
natural products. However the reaction has only been reported by Ihara's group and it is 
not well-established. 
+
Pd(PhCN)2Cl2
Ph
O
Ph
O HN
O
t-BuOKNH2
O
H
N
O
Ph
O Me
Scheme 1.16 Route to piperidin-2-ones
aza-Michael 
   reaction
Michael
 reaction
39 4140 42
 
The proposed route for making piperidin-2-ones 46 is shown in Scheme 1.17. The 
electrophilic alkenes 43 reacted with the α,β-unsaturated amide 44 by the 
palladium-catalyzed aza-Michael reaction and the adducts formed were cyclised by a 
Michael reaction to give 5-methoxypiperidin-2-ones 45 which were then 
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decarboxylated to give the desired piperidin-2-ones 46 with various substituents at 
position-6. Since the limitations for such palladium-catalyzed aza-Michael reaction 
were not fully understood, in our hands they were investigated using various 
α,β-unsaturated amides and alkenes. Secondary amines were employed to see if 
N-substituted piperidin-2-ones could be made by this method. Also, synthesis of 
bicyclic piperidin-2-ones was attempted using cyclohex-2-en-1-one as the electrophilic 
alkene. 
OH2N
R
OMe
O
+
N
H
O
MeO2C
R N
H
OR
Scheme 1.17 Proposed route to 6-substituted piperidin-2-ones 46
44 4645
43
1. Pd(PhCN)2Cl2
2. t-BuOK
5% HCl
 
As stated by Ihara, secondary amides were too bulky to participate in such aza-Michael 
reaction; there were no reactions of the benzylamide 47 with either methyl acrylate or 
cyclohex-2-en-1-one (Table 1.1) in our hands as well.
28
 Coupling of 
1-phenylbut-2-en-1-one (40) with the amide 39 was then attempted since it was 
reported in 85 % yield.
28
 However, only a few milligrams of the desired product were 
isolated in the first time, and no product was isolated when this reaction was repeated. 
Nor was the coupling of the amide 39 and cyclohex-2-en-1-one a successful reaction in 
our hands. Therefore, another strategy for making the piperidinone ring was considered, 
namely aza-Michael-Michael annulation reactions. 
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α,β-Unsaturated amide Electrophile alkene Expected product
HN O
OMe
MeO
O N
OMe
39
O
Table 1.1 Aza-Michael reaction of α,β-unsaturated amides with 
α,β-unsaturated ketones and esters
Table 1.1 Reagents and conditions: Pd(PhCN)2Cl2, neat, 60 
oC, overnight.
47
MeO
O O
48
N
OMe
47
O
49
O
NH2
O
Ph
O
40
Ph
O HN
O
41
50
O
N
H
O
O
51
 
1.2.2 Attempted Synthesis of Piperidin-2-ones via an 
Aza-Michael Michael Annulation Reaction 
Ihara also reported a [4+2] annulation (Scheme 1.18) for the synthesis of the 
piperidin-2-one ring from an electrophilic alkene with an α,β-unsaturated amide. This 
annulation is a powerful reaction since the two bond-forming steps can be carried out 
in one laboratory operation. Although the mechanism has not been examined, it is 
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believed that an aza-Michael reaction occurs first followed by Michael reaction rather 
than two bonds forming simultaneously, since the aza-Michael adduct can be isolated 
in some cases.
29
  
NH
c
O
b
a
+
d
EWG
NO
a
d
EWG
c
b
TBSOTf, Et3N, 
t-BuOH, DCE
Scheme 1.18 A [4+2] annulation to give piperidin-2-ones 
The synthesis of substituted piperidin-2-ones in one operation from an α,β-unsaturated 
amide and a Michael acceptor in the presence of TBSOTf has been described (Scheme 
1.18).
29
 This reaction is sensitive to water and the amount of triethylamine added. To 
make this reaction work, the amount of triethylamine should be within the range of 
0.5-1.0 equivalents.
29
 In our hands, the piperidinone 55 could not be made from the 
benzylamide 52 and methyl acrylate, only the starting material 52 being recovered 
(Table 1.2) even though the solvent 1,2-dichloroethane was dried by molecular sieves 
and the glassware was dried over a naked flame. The benzylamide 47 and 53 were also 
reacted with methyl acrylate, but no desired piperidinones were formed. Therefore, the 
acrylamide 57 was prepared since it was reported to react with cyclohex-2-en-1-one to 
give the piperidin-2-one 59 in 51% yield.
29
 However, in our hands, no annulation 
between 57 and either cyclohex-2-en-1-one or methyl acrylate could be achieved under 
the reported conditions. Since it was difficult to make any progress, a much more 
reliable and well-established Dieckmann cyclisation was used to make piperidinones. 
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α,β-Unsaturated amide Electrophilic alkene Expected product
HN O
R3
R2
47: R1=H, R2=H, R3= OMe
52: R1=H, R2=OMe, R3= OMe
53: R1=OMe, R2=H, R3= OMe
MeO
O N O
R3
R2
MeO
O
54: R1=H, R2=H, R3= OMe
55: R1=H, R2=OMe, R3= OMe
56: R1=OMe, R2=H, R3= OMe
R1 R
1
Ph N
H
Ph
O
57
Bn
NO
CO2Me
Ph
58
57
O
Bn
NO
Ph
59
O
Table 1.2 [4+2] Annulation to piperidin-2-ones
Table 1.2 Reagents and conditions: Et3N (0.7 eq), TBSOTf (1.2 eq),  t-BuOH (0.25 eq), 
ClCH2CH2Cl, RT, overnight.
MeO
O
 
1.2.3 Synthesis of Piperidin-2,4-diones via a Dieckmann 
Cyclisation 
The main objective was to exploit and extend the scope of Dieckmann cyclisation to 
make piperidin-2,4-diones without any N-protective groups. It was desired to develop a 
systematic method to prepare piperidin-2,4-diones with various substitutions at 
positions-2, -3, and -5 in only a few steps. With the ability to construct the ring with 
different substituents, syntheses of natural piperidine-containing compounds could be 
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advanced. 
Our general route began with β-keto esters 60 (Scheme 1.19). Amination of 60 with 
ammonium acetate gave enamines 61 which were then reduced to β-amino esters 62 
upon treatment with sodium triacetoxyborohydride. Acylation of β-amino esters 62 
using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) afforded diesters 63 
which were substrates for Dieckmann cyclisation. When treated with sodium 
methoxide, diesters 63 underwent ring closure and the desired products 65 were 
formed after decarboxylation (modified from Vanotti's synthesis)
15
. 
Piperidin-2,4-diones 65 with different 5- and 6- substitutents were made successfully 
by this route.  
Scheme 1.19 General route to piperidin-2,4-diones 65
N
H
R1O
MeO2C CO2Me
H2N R
1
CO2MeNH4OAc, AcOH
MeCN, H2O
N
H
R1O
O
R2
N
H
R1O
OH
R2
R2
R1 NH2
CO2MeR
2
O R1
CO2MeR
2
MeO2C R
2
65a  R1= Me, R2= H 
65b  R1= n-Pr, R2= H 
65c  R1= Et, R2= Me 
65d  R1= CH2Ph, R
2= Me 
65e  R1= Ph, R2= H  
65f   R1= 3-Pyridyl, R2= H
60 61 62
63 64
reflux
NaBH(OAc)3
NaOMe, MeOH
reflux
MeO2C CO2H
EDC, HOBt
reflux
65
 
The mechanism of EDC-activated acylation of β-amino esters is shown in Scheme 1.20. 
A carboxylate ion attacks the electrophilic carbon of EDC. The adduct formed activates 
the carbonyl carbon for nucleophilic attack from an amide due to the 
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electron-withdrawing effect of EDC. After the formation of an amide bond, EDC 
leaves as an urea byproduct and an amide is formed. EDC is a better coupling agent 
than DCC because the urea byproduct is ionic and remains in the aqueous phase during 
extraction of the product. 
Scheme 1.20 Mechanism of EDC-activated acylation
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The 6-methylpiperidin-2,4-dione 65a was our first target due to its simplicity (Scheme 
1.21). The precusor β-amino ester 68a could be easily prepared in 97% yield from 
methyl 3-aminobutanoic acid using thionyl chloride. Acylation of 68a with methyl 
malonate using DIPEA and EDC gave 69a in moderate yield (procedure modified from 
Weis's synthesis).
45
 The 6-methylpiperidin-2,4-dione 65a was prepared by Dieckmann 
cyclisation and decarboxylation
15
 of the diester 69a in 42% yield over two steps. 
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H2N Me
CO2Me
68a
N
H
MeO
MeO2C CO2Me
2. MeCN, 1% H2O
    reflux, 1 h, 42%
N
H
MeO
O
69a
1. NaOMe (2 eq)
    MeOH, reflux, 1 hMeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 46% 65a
Scheme 1.21 Synthesis of the piperidin-2,4-dione 65a  
The 6-propylpiperidin-2,4-dione 65b was prepared to show that piperidin-2,4-diones 
with different alkyl groups at position-6 could be made from methyl acetoacetate 
(Scheme 1.22). Weiler dianion alkylation is a useful method for addition of an alkyl 
group to the carbon with a less acidic proton by the use of two equivalents of strong 
bases. By this method, the methyl group gamma to the ester of methyl acetoacetate 
could be converted into different R groups and that would become the 6-substituents of 
piperidin-2,4-diones. The β-keto ester 66a was prepared in good yield via a Weiler 
dianion alkylation with ethyl bromide using one equivalent of sodium hydride and one 
equivalent of n-butyllithium.
46
 Reductive amination modified from Shipman 
synthesis
47
 afforded the β-amino ester 68b in 32% yield. Treating 68b with methyl 
malonate and EDC gave the diester 69b (40% yield). The subsequent cyclisation and 
decarboxylation
15
 gave the product 65b in 58%, which was better than that of the 
6-methylpiperidin-2,4-dione 65a (42%). This may be due to the fact that a bulkier 
propyl group constrains the bond rotation of 69b and facilitates Dieckmann cyclisation.  
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NH4OAc (5 eq)
 AcOH (few drops)
Pr NH2
CO2Me
O Pr
CO2Me
66a 67a
PhH, reflux, 3d
O Me
CO2Me
H2N Pr
CO2Me
68b
N
H
PrO
MeO2C CO2Me
2. MeCN, 1% H2O
    reflux, 1 h, 58%
N
H
PrO
O
69b
1. NaOMe (1.3 eq)
    MeOH, reflux, 1 h
MeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 40%
65b
Scheme 1.22 Synthesis of the piperidin-2,4-dione 65b
NaH (1.1 eq), n-BuLi (1.1 eq)
EtBr (1 eq), THF
RT, 3 h, 85%
NaBH4 (2.3 eq)
AcOH, RT, 3 h
32%(over 2 steps)
 
The next targets were 5,6-disubstituted piperidin-2,4-diones. It was desired to 
investigate whether the precursor 66b could be made from methyl acetoacetate 
(Scheme 1.23). Methylation of methyl acetoacetate with mild base K2CO3 gave 70 in 
moderate yield.
48
 However, the newly-added methyl group prevented the formation of 
the Weiler dianion when treated with two equivalents of strong bases and failed to give 
the desired product 66b. Therefore, the order of reactions was changed and the 
intermediate 71 was prepared first. By treating with one equivalent of sodium hydride, 
the most acidic proton alpha to the ester (pKa around 14) of 71 was removed. Then one 
equivalent of n-butyllithium was added to remove the less acidic proton alpha to the 
ketone (pKa around 26, marked in diagram) and a Weiler dianion was formed. 
Alkylation of the dianion with methyl iodide occurred at the more reactive carbon to 
form 66b (Scheme 1.24).
46
 It was found to be a clean reaction with an excellent yield 
(97%). To our suprise, methylation of 71 with K2CO3 gave the desired β-keto ester 66b 
in a much better yield than that of methyl acetoacetate (88% and 46%). Thus, the 
overall yield was over 85%. 
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O Et
CO2Me
71
O Me
CO2Me
NaH (1.1 eq)
n-BuLi (1.1 eq)
MeI (1 eq), THF
RT, 3 h, 97%
70
O Et
CO2MeMe
O Me
CO2MeMe NaH (1.1 eq), n-BuLi (1.1 eq)
MeI (1 eq), THF
RT, 3 h
MeI (1 eq), K2CO3 (1.5 eq)
acetone, 0 oC, 2h, 46%
MeI (1 eq)
K2CO3 (1.5 eq)
acetone, 0 oC, 2h, 88%
66b
Scheme 1.23 Synthesis of the keto ester 66b  
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Scheme 1.24 Mechanism of Weiler dianion methylation
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With the β-keto ester 66b in hand, the 6-ethyl-5-methylpiperidin-2,4-dione 65c was 
prepared according to the general route (Scheme 1.25). Amination with ammonium 
acetate and subsequent reduction with sodium triacetoxyborohydride generated in situ 
(procedure modified from Cohen's synthesis)
49
 gave the β-amino ester 67b (35% over 
two steps) which was then acylated to form the diester 69c in 40% yield. The methyl 
group alpha to the ester found not to affect the subsequent Dieckmann cyclisation and 
decarboxylation
15
 which gave the desired 5,6-disubstituted piperidin-2,4-dione 65c in 
71% yield over two steps. From the NMR spectra of the piperidin-2,4-dione 65c, it was 
found to be a 1:1 mixture of diastereoisomers, as expected. 
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NH4OAc (5 eq)
 AcOH (few drops)
67b
PhH, reflux
3d, 52%
68c
2. MeCN, 1% H2O
    reflux, 1 h, 71%
69c
1. NaOMe (2 eq)
    MeOH, reflux, 1 h
MeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 40%
65c
Scheme 1.25 Synthesis of the piperidin-2,4-dione 65c
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AcOH, RT
3 h , 67%O Et
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By a reductive amination based on Grauert's procedure using TMSCl and zinc dust,
40
 
benzyl cyanide was coupled with methyl 2-bromopropanoate to form the β-amino ester 
68d in 15% yield. This reductive amination is very convenient as the β-amino ester can 
be prepared in one step. However, the yield was poor in our hands so the synthesis of 
other piperidin-2,4-diones followed the original route. The β-amino ester 68d was 
acylated in 67% yield. A benzyl group next to nitrogen was found to be compatible 
with Dieckmann cyclisation; the 5,6-disubstituted piperidin-2,4-dione 65d was isolated 
in 56% yield over two steps (Scheme 1.26). The piperidin-2,4-dione 65d was obtained 
as a 1:1 mixture of diastereoisomers. 
68d
2. MeCN, 1% H2O
    reflux, 1 h, 56%
69d
1. NaOMe (1.3 eq)
    MeOH, reflux, 1 h
MeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 67% 65d
Scheme 1.26 Synthesis of the piperidin-2,4-dione 65d
(i) Zinc (4 eq)
          TMSCl (12 eq)
    DCM, THF
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         3 h, 15%
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Whether the 6-phenylpiperidin-2,4-dione 65e could be prepared by this route was of 
interest. Esterification of commercially-avaliable 3-amino-3-phenylpropionic acid 
using thionyl chloride gave the β-amino ester 68e in 87% yield. Coupling the β-amino 
ester 68e with methyl malonate afforded the diester 69e in good yield. The diester 69e 
was cyclised to give the piperidin-2,4-dione 72 in 70% yield which was then 
decarboxylated
15
 in excellent yield to afford the desired product 65e (Scheme 1.27). 
This showed that piperidin-2,4-diones with another ring (including an aromatic one) 
directly connected could be prepared by this route. 
68e
MeCN, 1% H2O
69e
 NaOMe (1.2 eq)
 MeOH
MeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 75%
65e
Scheme 1.27 Synthesis of the piperidin-2,4-dione 65e
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H
PhO
OH
MeO2C
72
reflux, 1 h, 70%
reflux, 1 h, 95%
 
Since the 6-phenylpiperidin-2,4-dione 65e was prepared in good yield, the final target 
compound would be the 6-pyridin-3-ylpiperidin-2,4-dione 65f because it shares the 
structure of the natural alkaloid anabasine. Claisen condensation of 
commercially-avaliable 3-acetylpiperidine with dimethyl carbonate gave the β-amino 
ester 66c in excellent yield.
50
 66c was then treated with ammonium acetate to give the 
enamine 67c.
51
 However, reduction of the enamine 67c using sodium 
triacetoxyborohydride made in situ gave a complex mixture of products suggesting 
pyridinylenamine is not stable under acidic conditions or the pyridine ring affects the 
enamine reduction (Scheme 1.28). 
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NH4OAc (5 eq)
 AcOH (few drops)
67c
PhH, reflux
3d, 78%
68f
NaBH4 (2.3 eq)
AcOH, RT, 3 h
O
CO2Me
66c
H2N
H2N
CO2Me
N
NN
O
N
Dimethyl carbonate (5 eq)
NaH (3 eq), THF
reflux, 1.5 h, 96%
Scheme 1.28 Attempted reduction of the enamine 68f
MeO2C
 
Another route to the β-amino ester 68f was developed (Scheme 1.29). Knoevenagel 
condensation
52,53
 of commercially-avaliable 3-pyridinecarboxaldehyde with malonic 
acid afforded the β-amino acid 73 which was then treated with thionyl chloride in 
methanol to give the β-amino ester 68f in moderate yield (43% over two steps). The 
β-amino ester 68f was then acylated to give the diester 69f quantitatively. Dieckmann 
cyclisation and subsequent decarboxylation
15
 gave the desired piperidin-2,4-dione 65f 
(molecular ion was identified in the mass spectrum) but it was found to be too 
water-soluble and could not be extracted from the aqueous phase. 
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2. MeCN, 1% H2O
    reflux, 1 h
69f
1. NaOMe (2 eq)
    MeOH, reflux, 1 hMeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 99%
65f
 (could not be isolated)
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Scheme 1.29 Synthesis of the piperidin-2,4-dione 65f
Malonic acid (1 eq)
NH4OAc (2 eq), EtOH
reflux, 6 h
68f
H2N
CO2Me
N
SOCl2 (1.3 eq)
MeOH, 3 h
43% (over 2 steps)
 
The mechanism of Knoevenagel condensation is shown in Scheme 1.30. Ammonia 
attacks the carbonyl carbon of the aldehyde. After proton transfers, a water molecule 
leaves and an iminium ion is formed. Malonic acid is deprotonated and attacks the 
iminium ion to form an adduct. At high temperature, one carboxylic acid leaves as 
carbon dioxide and β-amino acid is formed. 
Scheme 1.30 Mechanism of Knoevenagel condensation
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The piperidin-2,4-dione 65f is ionic at various pH (as shown in Figure 1.2) and cannot 
be extracted into the organic phase. Under acidic conditions, the nitrogen atom of the 
pyridine ring protonates and possesses a positive charge. Whereas under basic 
conditions, the β-keto amide deprotonates to form the enolate and negatively charged. 
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Since it was too difficult to extract the piperidin-2,4-dione 65f from the aqueous phase, 
2-pyridin-3-ylpiperidin-4-one was the next target molecule as it should not form an 
enolate under mild basic conditions lacking a β-amide group. 
N
H
O
O
N
N
H
O
O
N
N
H
O
O
N
H
acidic conditions basic conditions
65f
Figure 1.2 Major forms of the piperidin-2,4-dione 65f depending upon the pH  
In order to solve the solubility problem of oxopiperidines containing a pyridine ring, 
the pyridylpiperidin-4-one 74, rather than the pyridylpiperidin-2,4-dione 65f, became 
the target. Since the pKa of a piperidin-4-one is much higher than a piperidin-2,4-dione, 
the pyridylpiperidin-4-one would not deprotonate to form an enolate under mild basic 
conditions and would be extractable from the aqueous phase (Figure 1.3). 
N
H
O
O
N
N
H
O
O
N
basic conditions
65f
Figure 1.3 Major forms of the piperidin-2,4-dione 65f and the 
piperidin-4-one 74 under mild basic conditions
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The proposed route for making the 2-pyridin-3-ylpiperidin-4-one 74 is shown in 
Scheme 1.31. The β-amino ester 68f was coupled with methyl acrylate by an 
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aza-Michael reaction to give the diester 75 in 73% yield (procedure modified from 
Schlewer's synthesis).
54
 The amine of 75 was then protected by a Boc group in 68% 
yield. However, treating the diester 76 with sodium methoxide resulted in a complex 
mixture of products and the piperidin-4-one 77 could not be isolated from this mixture. 
Owing to these difficulties, attempts to make the 6-pyridin-3ylpiperidinone ring by this 
route were abandoned.   
75
NaOMe (2 eq)
MeOH, reflux, 1 h
MeO2C
Et3N (2 eq), MeOH
RT, 8 h, 73%
77
N
H
MeO2C CO2Me
N
O
N
N
Scheme 1.31 Attempted synthesis of the piperidin-4-one 74
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1.2.4 Attempted Alkylations of Piperidin-2,4-diones at Position-3 
Using the general route of N-acylation-Dieckmann cyclisation (Scheme 1.19), 
piperidin-2,4-diones with different substituents at positions-5 and -6 were made. Our 
next goal would be adding substituents to position-3. Dimethylation of the 
piperidin-2,4-dione 65e with excess methyl iodide and potassium carbonate afforded 
the 3,3-dimethylpiperidin-2,4-dione 78 in 65%. Then, monomethylation of the 
piperidin-2,4-dione 65e using one equivalent of methyl iodide was attempted but only 
the 3,3-dimethylpiperidin-2,4-dione 78 was formed, in 22% yield (Scheme 1.32). One 
possible solution would be the change of the mild base K2CO3 to one equivalent of 
stronger bases such as t-BuOK so as to give 100% enolate conversion of 65e for 
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monomethylation. 
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O
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Me
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N
H
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O
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Me
MeI (3 eq), K2CO3 (3 eq)
acetone, 50 oC, 16 h, 65%
MeI (1 eq), K2CO3 (1.3 eq)
acetone, 50 oC, 16 h, 22%
Scheme 1.32 Alkylations of the piperidin-2,4-dione 65e
NOT
 
Since it was difficult to add a single methyl group to 3-position after the ring formation, 
a possible solution would be methylating at an earlier stage (Scheme 1.33). Methyl 
2-methylmalonate 81 was prepared from commercially-avaliable ethyl 
2-methylmalonate using potassium hydroxide in methanol (55% yield).
55
 The β-amino 
ester 68e was coupled with methyl 2-methylmalonate 81 activated by EDC to give the 
diester 82 in 85% yield. However, Dieckmann cyclisation was not performed when 82 
was treated with sodium methoxide, a complex mixture was formed instead. 
Additionally, 3-methylation of the precusor 72 was attempted which should give 
3-methylpiperidin-2,4-dione 79 after decarboxylation. Methylation using potassium 
carbonate in acetone at 50 
o
C for 16 hours failed and gave complex mixture. Then 
methylation which was modified from Prof. Philip Page's synthesis
56
 was tried. TBAF 
was used as a mild base (1.2 equivalents) and the mixture was stirred at room 
temperature for 16 hours. The 3-methoxy-3-methylpiperidin-2,4-dione 83 was isolated 
in 64% yield and the desired 3-methylpiperidin-2,4-dione 79 could be made if the 
subsequent decarboxylation suceeded. 
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68e 82
 NaOMe (1.2 eq)
 MeOHMeO2C CO2H
EDC (1 eq), HOBt (1.5 eq)
DIPEA (4 eq), DCM
RT, 2 h, 85%
Scheme 1.33 Synthesis of the 3-methoxy-3-methylpiperidin-2,4-dione 83
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Decarboxylation of the 3-methoxy-3-methylpiperidin-2,4-dione 83 was found to be 
very challenging. Several attempts were made including acidic, neutral, and basic 
conditions but none of them were successful (Scheme 1.34). Krapcho 
decarboxylation
57
 by heating 83 with NaCl in DMSO under reflux was tried but the 
piperidin-2,4-dione 83 remained unchanged.  
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N
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85  
Entry Conditions 
1 5% HCl, water, reflux, 2 h 
2 MeCN, 1% H2O, reflux, 3 h 
3 NaCl (1.1 eq), H2O (2 eq), DMSO, reflux, 2 h 
4 LiI (5 eq), pyridine, reflux, 2 h 
Scheme 1.34 Attempted decarboxylation of the piperidin-2,4-dione 83 
The mechanism of Krapcho decarboxylation is shown in Scheme 1.35. A chloride ion 
attacks the carbon of methyl ester via a SN2 reaction and the byproduct chloromethane 
is lost as a gas. Then the carboxylate leaves as a carbon dioxide and the enolate 
converts into a ketone in the presence of water in wet DMSO. The reaction equilibrium 
shifts towards right since the byproducts are both gases and would leave the reaction 
system once formed. 
Scheme 1.35 Mechanism of Krapcho decarboxylation
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Since methoxy ester could not be removed from the piperidin-2,4-dione 83 in our 
hands, routes to the piperidin-2,4-dione 77 using other esters were investigated 
(Scheme 1.36). Synthesis of the allyl ester 89a and the tert-butyl ester 89d were 
attempted because they are more likely to be removed by traditional decarboxylation 
methods. The benzyl ester 89b and the p-methoxybenzyl ester 89c were target 
compounds as well since Prof. Philip Page
56
 showed that related benzyl esters could be 
removed by hydrogenation with palladium on activated carbon. 
Scheme 1.36 Proposed route to the 3-methylpiperidin-2,4-dione 85
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Allyl malonate (90a) was prepared by reacting malonic acid with allyl alcohol 
activated by dicyclohexylcarbodiimide (DCC) in 67% yield.
58
 The β-amino ester 68e 
was coupled with allyl malonate (90a) to give the diester 89a (77% yield). However, 
when the diester 89a was treated with sodium methoxide, transesterification occurred 
along with Dieckmann cyclisation to form the unwanted 
3-methoxycarboxylpiperidin-2,4-dione 72. Therefore, potassium tert-butoxide was 
used instead to prevent transesterification. Suprisingly, the allyl ester was found to be  
too good a leaving group and decarboxylation took place immediately after Dieckmann 
cyclisation to give the piperidin-2,4-dione 65e, so that no allyl ester 91 could be 
Chapter 1 
44 
 
isolated (Scheme 1.37). 
Benzyl malonate (90b) and p-methoxybenzyl malonate (90c) were prepared by 
DCC-activated esterification of malonic acid in 26% and 28% respectively.
59
 Acylation 
of the β-amino ester 68e with 90b and 90c gave the diester 89b (83%) and the diester 
89c (79%) respectively. When they were treated with sodium methoxide, no 
Dieckmann cyclisation occurred. Instead, the dimethoxyester 69e was formed 
(transesterification). Sodium hydride was used to cyclise the diester 89b but 
decarboxylation also occurred to give the piperidin-2,4-dione 65e. Then potassium 
tert-butoxide was used to cyclise the diester 89c, the reaction was performed at room 
temperature to avoid decarboxylation. However, no cyclisation took place and only the 
diester 89c was recovered. 
Esterification of malonic acid afforded tert-butyl malonate (90d) in 75% yield.
58
 The 
β-amino ester 68e was acylated with 90d to give the diester 89d in 80% yield. As for 
the diester 89d, using sodium methoxide caused transesterification to give the 
3-methoxypiperidin-2,4-dione 72 while using potassium tert-butoxide caused 
decarboxylation to give the piperidin-2,4-dione 65e. Since decarboxylation of the 
esters 88 were too rapid, the idea of methylating these esters for making 
3-methylpiperidin-2,4-dione had to be abandoned. 
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N
H
PhO
OH
RO2C
8887
N
H
PhO
RO2C CO2Me
69e
N
H
PhO
MeO2C CO2Me
N
H
PhO
OH
MeO2C
72
N
H
PhO
O
65e  
Entry Cpd R Conditions Product 
1 89a Allyl NaOMe (1.3 eq), MeOH, reflux, 1 h 72 (transesterification) 
2 89a Allyl KOtBu (2 eq), PhMe, 80 oC, 1 h 65e (decarboxylation) 
3 89b Benzyl NaOMe (1.3 eq), MeOH, reflux, 1 h 69e (transesterification) 
4 89b Benzyl NaH (1.2 eq), PhMe, reflux, 2 h 65e (decarboxylation) 
5 89c p-Methoxybenzyl NaOMe (1.3 eq), MeOH, reflux, 1 h 69e (transesterification) 
6 89c p-Methoxybenzyl KOtBu (2 eq), THF, RT, 24 h unchanged 
7 89d tert-Butyl NaOMe (1.3 eq), MeOH, reflux, 1 h 72 (transesterification) 
8 89d tert-Butyl KOtBu (2 eq), PhMe, 80 oC, 1 h 65e (decarboxylation) 
    Scheme 1.37 Attempted formation of piperidin-2,4-dione alkyl esters 88 
In order to avoid the decarboxylation step, which had proved so problematic, a route 
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that gave piperidin-2,4-diones with a 3-methyl group and did not possess an ester 
group after Dieckmann cyclisation was proposed (Scheme 1.38). The β-amino ester 
68e was coupled with propionyl chloride to give the amide 89d in excellent yield. The 
hope was that treatment of the amide 89d with base would lead to sufficient 
α-deprotonation of the amide that a Dieckmann-like cyclisation would occur to give 
the desired 3-methylpiperdin-2,4-dione 77. However, treatment of the amide 89d with 
sodium hydride gave only the azetidin-2-one 93 as the only product in 88% yield. That 
means that the amide nitrogen atom, which was throught to be inert, was in fact 
deprotonated and attacked the ester to form an azetidinone. This may be explained by 
Pearson's hard and soft acids and bases (HSAB) theory that the ester being a hard acid 
prefers the deprotonated amide (hard base) rather than the enolate (soft base) for better 
orbital overlapping. Since attempts to block the amide with an N-Boc protection were 
unsuccessful, the focus was shifted to 3-methylation of chiral piperidin-2,4-diones, as 
discussed in Section 1.2.6. 
68e
92
 NaH (1.5 eq)
 xylene
COCl
Et3N (2.5 eq), DCM
RT, 1 h, 90%
Scheme 1.38 Attempted synthesis of the 3-methylpiperidin-2,4-dione 94
H2N Ph
CO2Me
N
H
PhO
CO2Me
N
H
PhO
O
94
reflux, 1 h, 88%
N
O
O
Ph
93
NOT
 
1.2.5 Enantioselective Synthesis of Piperidin-2,4-diones 
Piperidine alkaloids play a central role in pharmaceutically-active compounds, and 
most of them are optically active. Thus, enantiocontrolled strategies to substituted 
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oxopiperidines would be very useful in drug development. The groups of Meyers, 
Marazano, and Comins,
24
 have made progressed in this area, but their syntheses have 
limitations on the types and positions of substituents that can be introduced in the ring. 
Our goal was to extend to prepare diversely substituted piperidin-2,4-diones 
enantioselectively. 
Davies
60,61
 showed commercially-avaliable (S)-α-methylbenzylamine can act as a 
chiral auxiliary to induce asymmetric aza-Michael reaction of the amine 95 with 
α,β-unsaturated esters 96 to afford adducts 97. The 3,4-dimethoxybenzyl group can 
then be eliminated using cerium(IV) ammonium nitrate (CAN). Thus an 
enantioselective route to piperidin-2,4-diones was proposed using the Davies protocol 
(Scheme 1.39). Once the blocking group was removed using CAN, amines 98 were 
acylated with acid chloride to give diesters 99. Dieckmann cyclisation and subsequent 
decarboxylation afforded the enantiopure piperidin-2,4-diones 101. The Davies' 
auxiliary in 101 was then removed by methanesulfonic acid to give 1-unsubstituted 
piperidin-2,4-diones 102. 
Scheme 1.39 Proposed route to enantiopure piperidin-2,4-diones 102
N RO
ONa
MeO2C
Ph H
N RO
MeO2C
Ph H
CO2Me
HN R
Ph H
CO2Me
5% HCl
N R
Ph H
CO2Me
NH
Ph H
N RO
O
Ph H
N
H
RO
O
OMe
OMe
OMe
OMe
CO2Me
n-BuLi
CAN O
MeO2C
Cl
NaOMe MsOH
base
R
95
96
97 98
99 100 101
102
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The mechanism of asymmetric aza-Michael reaction is shown in Scheme 1.40. The 
amine is deprotonated by n-butyllithium and attacks the α,β-unsaturated esters. Due to 
the bulkness of the phenyl group of the chiral auxiliary, the phenyl group stays away 
from the α,β-unsaturated esters during the nucleophilic addition. The R group of the 
α,β-unsaturated esters stays away from the methyl group of the auxiliary due to steric 
hindrance so the thermodynamically more stable enolate adducts form. As the amine is 
chiral due to the presence of the auxiliary, the adducts formed would also be a single 
enantiomer. After aqueous workup, the enolate converts into an ester and the desired 
enantiopure adducts are formed. 
N
Ph
Me
H
N
Ph
Me
H
OMe OMe
H
R
OMe
OLi
Li
MeOMeO
N
Ph
Me
H
OMe
H
R
OMe
O
MeO
H+
Scheme 1.40 Mechanism of asymmetric aza-Michael reaction
HR
H
OMe
O
 
Reductive amination of 3,4-dimethoxybenzaldehyde with (S)-α-methylbenzylamine 
and sodium borohydride afforded the amine 95 in 97% yield. However, aza-Michael 
reaction of the amine 95 with methyl sorbate (103c) gave the adduct 104 in 19% yield 
only, although was reported in 90% yield by Davies.
60
 Consequently, another blocking 
group was needed (Scheme 1.41). 
An allyl group was then used to block the amine, and could be removed using 
tris(triphenylphosphine)rhodium(I) chloride (Wilkinson's catalyst)
62
 in a later step. 
Allylation of (S)-α-methylbenzylamine using n-butyllithium (1.1 equivalents) and allyl 
bromide (1 equivalent) at room temperature gave the monallylated amine 105 in 86% 
yield. The amine 105 was then coupled with methyl sorbate (103c) by aza-Michael 
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reaction to afford the adduct 106c in 78% yield.  
N
Ph H
CO2Me
NH
Ph H
OMe
OMe
OMe
OMe
CO2Me
NH2
Ph H
CHO
OMe
OMe
(1 eq)
MeOH, 50 oC, 1 h
1.
2. NaBH4, RT, 16 h, 97%
n-BuLi (1.6 eq), THF
-78 oC, 19%
Scheme 1.41 Synthesis of intermediates 104 and 106c via an aza-Michael 
reaction
95
103c
104
N
Ph H
CO2Me
NH
Ph H
CO2Me
NH2
Ph H (1 eq)
n-BuLi (1.1 eq), THF
-78 oC-RT, 16 h, 86%
n-BuLi (1.6 eq), THF
-78 oC, 78%
105
103c
106c
(i)
(ii)
Br
 
Since an allyl group could be efficiently added and removed, our synthetic route was 
modified as shown in Scheme 1.42; six enantiopure piperidin-2,4-diones 110 with 
various 6-substituents were prepared. 
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Scheme 1.42 General route to enantiopure piperidin-2,4-diones 111
N RO
ONa
MeO2C
Ph H
N RO
MeO2C
Ph H
CO2Me
HN R
Ph H
CO2Me
5% HCl
N R
Ph H
CO2Me
NH
Ph H
N RO
O
Ph H
N
H
RO
O
CO2Me
n-BuLi
O
MeO2C
Cl
NaOMe MsOH
Wilkinson's
catalyst
110a R= Me
110b R= i-Pr
110c R= (E)-CH=CHMe
110d R= Cyclohexyl
110e R= Ph 
110f  R= 3-Pyridyl
105
111
110109108
107106
103R
111a R= Me
111c R= (E)-CH=CHMe
111e R= Ph
 
(E)-Methyl but-2-enoate (103a) and methyl trans-cinnamate (103e) were purchased, 
other α,β-unsaturated esters had to be prepared. Methyl sorbate (103c) was prepared 
quantitatively from sorbic acid by TMSCl-activated esterification.
63
 α,β-Unsaturated 
esters 103b, 103d, and 103f were prepared from relevant aldehydes by Wittig reactions 
using carbomethoxymethylene triphenylphosphorane and were obtained in 46%, 73%, 
and 32% respectively (Scheme 1.43).
64–66
 
Chapter 1 
51 
 
Scheme 1.43 Preparation of α,β-unsaturated esters 103
103f
CHO
CO2Me
CO2Me
CO2Me
CO2Me
N
CO2H
CHO
CHO
N
Ph3P=CHCO2Me (1.1 eq)
MeCN, RT, 24 h, 32%
Ph3P=CHCO2Me (1.1 eq)
Ph3P=CHCO2Me (1.1 eq)
PhMe, reflux, 16 h, 73%
DCM, 0 oC, RT, 16 h, 46%
TMSCl (2.4 eq)
MeOH, RT, 16 h, 99%
103d
103c
103b
 
The mechanism of Wittig reaction using a stablized ylide is shown in Scheme 1.44. 
The ylide attacks the carbonyl carbon to form adducts. Since this step is the 
rate-determining step and is reversible, the thermodynamically more stable adducts 
with two bulky groups far from each other form predominantly. Oxygen anion then 
attacks phosphrous cation and oxaphosphetanes are formed. Then, Ph3PO leaves and 
(E)-alkenes are formed. 
Scheme 1.44 Mechanism of Wittig reaction using a stablized ylide
R1 H
O
H
R1
H
CO2R
2Ph3P O
(E)
PPh3
CO2R
2
Slow
Reversible
O PPh3
H
CO2R
2
R1
H
Thermodynamically 
more stable
O PPh3
H
CO2R
2
R1
H
 
The enantiomerically pure tertiary amines 106 were prepared by metalation of the 
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amine 105 using n-butyllithium and reaction with α,β-unsaturated esters 103 at -78 oC 
(Scheme 1.45).
61
 This aza-Michael reaction gave adducts 106a-e in good yield 
(68-90%) and gave the 3-pyridyl adduct 106f in moderate yield (48%). From the 
1
H 
NMR and 
13
C NMR spectra, no opposite diastereoisomers of adducts 106 were 
identified. 
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N R
Ph H
CO2Me
NH
Ph H
CO2Me 105
106103
(1.6 eq)
n-BuLi (1.55 eq), THF
-78 oC, 2 h
R
 
Cpd R yield (%) 
103a Me 85 
103b i-Pr 69 
103c (E)-CH=CHMe 78 
103d Cyclohexyl 68 
103e Ph 90 
103f 3-Pyridyl 48 
Scheme 1.45 Synthesis of tertiary amines 106 via aza-Michael reactions 
The allyl group of adducts 106 was then cleaved by heating under reflux overnight in 
water/acetonitrile mixture in the presence of Wilkinson's catalyst.
67
 The deprotection 
was clean and gave β-amino esters 107 in good yield (53-87%) except the adduct 107f. 
Presumably, the pyridyl group of the adduct 106f interacted with the catalyst, causing 
various side reactions to occur, as indicated by TLC (Scheme 1.46).  
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HN R
Ph H
CO2Me
N R
Ph H
CO2Me
Wilkinson's catalyst (0.05 eq)
107106
15% H2O in MeCN
reflux, 16 h
 
Cpd R yield (%) 
106a Me 87 
106b i-Pr 59 
106c (E)-CH=CHMe 84 
106d Cyclohexyl 53 
106e Ph 76 
106f 3-Pyridyl 0 
Scheme 1.46 Deallylation of tertiary amines 106 using Wilkinson's catalyst 
The mechanism of deallylation of amine 106 using Wilkinson's catalyst is shown in 
Scheme 1.47. Wilkinson's catalsyt catalyzes the isomerization of N-allyl amines to 
enamines.
68,69
 Then the enamines convert to iminium ions which are attacked by a 
water molecule. After proton transfers, the imines are hydrolyzed to aldehydes and the 
amines 106 are deallylated. 
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H
H
O H
+
O
H
H3O+
Scheme 1.47 Mechanism of the deallylation of amines 106 using Wilkinson's catalyst 
As deallylation using Wilkinson's catalyst was not compatible with the presence of a 
pyridyl group, other deallylating agents were investigated. 1,3-Dimethylbarbituric acid 
(NDMBA) with a catalytic amount of tetrakis(triphenylphosphine)palladium(0) was 
found to be an ideal deallylating agent, and gave the β-amino ester 107f in 96% yield 
(procedure modified from Avenoza's synthesis,
70
 Scheme 1.48). Although a small 
amount of catalyst co-ordinated with the product and could not be removed by column 
chromatography, this did not affect the following acylation step and the product would 
be purified. 
HN R
Ph H
CO2Me
N R
Ph H
CO2Me
Pd(PPh3)4 (0.01 eq)
107f106f
NDMBA (2.98 eq), DCM
RT, 3 h, 96%
Scheme 1.48 Deallylation of the tertiary amine 106f
R= 3-Pyridyl
 
Probably owing to the bulkness of the chiral auxiliary, acylation using methyl malonate 
activated by EDC failed and the more reactive acid chloride was needed. β-Amino 
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esters 107 were acylated with methyl malonyl chloride using triethylamine as a base to 
give diesters 108 in fair to high yields (50-94%, Scheme 1.49).  
N RO
MeO2C
Ph H
CO2Me
HN R
Ph H
CO2Me
O
MeO2C
Cl
108107
(1.1 eq)
Et3N (1.3 eq), DCM
0 oC-RT, 1 h
 
Cpd R yield (%) 
107a Me 58 
107b i-Pr 50 
107c (E)-CH=CHMe 94 
107d Cyclohexyl 66 
107e Ph 80 
107f 3-Pyridyl 75 
Scheme 1.49 Synthesis of diesters 108 
Dieckmann cyclisation of diesters 108 by heating under reflux for 1 hour with sodium 
methoxide in methanol gave cyclised products 109. Cyclised products 109c and 109e 
were isolated as the sodium salts in order to confirm the formation of 
piperidin-2,4-dione ring, while others were decarboxylated directly. Decarboxylation 
using either HCl or neutral conditions
15
 worked well to give piperidin-2,4-diones 110 
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in good to excellent yields (70-97% over two steps, Scheme 1.50). 
N RO
MeO2C
Ph H
CO2Me
108
N RO
ONa
MeO2C
Ph H
109
5% HCl, H2O
reflux, 1 h
N RO
O
Ph H
110
NaOMe (1.2 eq)
MeOH, reflux, 1 h
or 1% H2O, MeCN
reflux ,1 h
 
Cpd R Yield (%, over 2 steps) 
108a Me 97 
108b i-Pr 95 
108c (E)-CH=CHMe 70 
108d Cyclohexyl 76 
108e Ph 83 
108f 3-Pyridyl 99 
       Scheme 1.50 Synthesis of piperidin-2,4-diones 110 
The piperidin-2,4-diones 110b, 110d, 110e were selected for the removal of the chiral 
auxiliary by treatment with methanesulfonic acid to give the corresponding 
1-unsubstituted piperidin-2,4-diones 111a, 111c, 111e in moderate yields (42-56%, 
procedure modified from Paik's synthesis,
71
 Scheme 1.51). 
6-Pyridylpiperidin-2,4-dione (111f) would be very water-soluble once the auxiliary was 
removed and could not be extracted from the aqueous phase, as in the Section 1.2.3. 
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6-Methylpiperidin-2,4-dione (111a) was quite polar and would be difficult to purify by 
column chromatography. The 6-propenylpiperidin-2,4-dione 110c should react with 
methanesulfonic acid normally but insufficient quantities prevented this experiment. 
From the above three successful cases, this route was found as a feasible synthesis of 
enantiomerically-pure 1-unsubstituted piperidin-2,4-diones with various substitutions 
at position-6. 
N RO
O
Ph H
N
H
O
O
111b, 111d, 111e
110b,110d,110e
MsOH (0.95 eq)
PhMe, reflux, 3-5 h
R
 
Cpd R yield (%) 
110b i-Pr 48 
110d Cyclohexyl 42 
110e Ph 56 
Scheme 1.51 Deprotection of piperidin-2,4-diones 110b, 110d, 110e 
1.2.6 Alkylations and Reductions of Chiral Piperidin-2,4-diones 
Several attempts were made to introduce a methyl group at position-3 of the achiral 
piperidin-2,4-dione 65e but only dimethylation was achieved, as previously observed 
in Scheme 1.32. With the chiral auxiliary blocking the amide, it may be the right 
substrate for making 3-substituted piperidin-2,4-diones. 
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The piperidin-2,4-dione 110c was methylated twice by reacting with excess methyl 
iodide and potassium carbonate to give the 3,3-dimethylpiperidin-2,4-dione 112 in 
76% yield (Scheme 1.52). As expected, the 3-methylpiperidin-2,4-dione 114 could not 
be made by reacting 110c with one equivalent of methyl iodide and only the 
3,3-dimethylpiperidin-2,4-dione 112 was isolated. 
NO
O
Ph H
110c
MeI (3 eq), K2CO3 (3 eq)
MeOH, 40 oC, 16 h, 76%
NO
O
Ph H
112
Me
Me
Scheme 1.52 Dimethylation of the piperidin-2,4-dione 110c 
Given that the auxiliary also acts as a blocking group of nitrogen, it was hoped that 
Dieckmann cyclisation would now take place, since azetidin-2-one formation, as 
previously observed, could not occur (Scheme 1.53). 
The β-amino ester 107c was acylated with propionyl chloride to give the amide 113 in 
74% (Scheme 1.53) which was then heated under reflux with sodium hydride in xylene 
for 1 hour. Unfortunately, reverse Michael reaction occurred to give the amide 115, and 
not the cyclised product 114. Owing to time limitations, further investigation of 
3-methylation was not undertaken. 
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Scheme 1.53 Attempted synthesis of the 3-methylpiperidin-2,4-dione 114
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O Cl
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NO
Ph H
CO2Me
113
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Ph H
114
Me
(1.2 eq)
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(i)
(ii)
NOT
Stereoselective reduction of chiral piperidin-2,4-diones would be very helpful for drug 
synthesis since 4-hydroxypiperidine motif is commonly found in alkaloids. Reaction of 
the piperidin-2,4-dione 110e with zinc borohydride at room temperature gave the 
enantiomerically-pure 4-hydroxypiperidin-2-one 116 in 43% yield (procedure modified 
from Davis' synthesis,
72
 Scheme 1.54). The 4-hydroxypiperidin-2-one 116 is in 
cis-form since both phenyl and hydroxy groups are equatorial. Szewczyk reported the 
reduction of 116 by lithium aluminium hydride to afford the 4-hydroxypiperidine 117 
in 62% yield.
72
 Therefore, enantiomerically pure 4-hydroxypiperidines can be prepared 
by our general route. 
N
H
O
O
111e
N
H
O
OH
116
N
H
OH
117
Zn(BH4)2 (2.8 eq)
DCM, 0 oC-RT, 20 h, 43%
LiAlH4 (5 eq), THF
-78 oC-RT, 36 h, 62%72
Scheme 1.54 Reduction of the piperidin-2,4-dione 111e
Ph Ph Ph
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1.2.7 Future Work 
Having developed an asymmetric synthesis of 4-hydroxypiperidines, it is of interest to 
make (-)-4-hydroxyanabasine using this route. As 1-unsubstituted 
6-pyridylpiperidin-2,4-diones are very water-soluble, it was planned to reduce the 
piperidin-2,4-dione 110f to the 4-hydroxypiperidine 119 and then remove the auxiliary 
to give (-)-4-hydroxyanabasine (Scheme 1.55). 
(-)-Anabasine could also be synthesized as shown in Scheme 1.54. The 
piperidin-2,4-dione 110f would react with 1,2-ethanedithiol to give the corresponding 
thioketal which would be reduced by Raney nickel to give the piperidin-2-one 120.
23
 
Subsequent amide reduction by lithium aluminium hydride and auxiliary removal 
should give enantiomerically pure anabasine.  
110f
N
H
OH
(-)-4-Hydroxyanabasine
Scheme 1.55 Synthesis of (-)-anabasine and its derivative
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1.3 Conclusions  
Syntheses of piperidin-2-ones via a palladium-catalyzed aza-Michael reaction of 
α,β-unsaturated amides with Michael acceptors were attempted but none of them were 
successful. Aza-Michael-Michael annulation reported by Ihara
29
 was also employed for 
making such ring but it failed as well.  
Then a route for preparing piperidin-2,4-diones involved a Dieckmann cyclisation was 
proposed (Scheme 1.19). Piperidin-2,4-diones with various substituents at positions-5 
and -6 were prepared by this method. Dimethylation at position-3 could be achieved 
but introduction of a single methyl group at that position failed. 
An asymmetric route to 1-unsubstituted piperidin-2,4-diones using a chiral auxiliary 
was also developed (Scheme 1.42). Dimethylation at position-3 was in good yield but 
monomethylation at that position was not achieved. Reduction of piperidin-2,4-diones 
gave enantiomerically-pure 4-hydroxypiperidin-2-ones which would be useful for drug 
development. In future, it is hoped to make anabasine and related compounds by this 
synthetic route. 
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1.4 Experimental  
All moisture-sensitive reactions were performed under a nitrogen atmosphere and the 
glassware was pre-dried in an oven (130 
o
C). Evaporation refers to the removal of 
solvent under reduced pressure. Melting points were measured by a microscope 
hot-stage Electrothermal 9100 apparatus and are uncorrected. Infra-red (IR) spectra 
were recorded on a Perkin-Elmer PE-983 spectrophotometer; absorptions are quoted in 
wavenumbers (νmax in cm
-1
). 
1
H NMR spectra were recorded on a Bruker AC300 (300 
MHz) spectrometer or a Bruker AMX 500 (125 MHz) spectrometer; data are reported 
in parts per million (δ). Coupling constants (J) are given in Hertz (Hz). The following 
abbreviations were used in signal assignments: singlet (s), broad singlet (br s), doublet 
(d), triplet (t), quartet (q), and multiplet (m). 
13
C NMR spectra were recorded on a 
Bruker AC300 (300 MHz) spectrometer or a Bruker AMX 500 (125 MHz) 
spectrometer; data are reported in parts per million (δ), with CHCl3 as an internal 
standard. Mass spectra were recorded on a VG7070H mass spectrometer with Finigan 
Incos II data system at University College London. Thin-layer chromatography was 
performed on Merck 0.2 mm aluminium-backed silica gel 60 F254 plates and visualized 
by ultra violet light (254 nm) or staining with potassium permanganate with 
subsequent heating. Flash column chromatography was performed using Merck 
0.040-0.063 mm, 230-400 mesh silica gel. Temperatures below 0 
o
C were obtained 
from various mixtures of water, salt and ice, acetone and dry ice. 
General procedure 1 for amidation 
A solution of acryloyl chloride (1.1 equiv) in dichloromethane was added to a 250 mL 
round-bottom flask equipped with a pressure-equalizing dropping funnel. The solution 
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was then cooled to -15 
o
C in an ethylene glycol/dry ice bath. The dropping funnel was 
charged with a solution of amines (1 equiv) and triethylamine in dichloromethane. This 
solution was added dropwise to the acid chloride solution over 25 min, stirred for 30 
min more at -15 
o
C, and slowly warmed to ambient temperature over 1.5 h. The 
mixture was then poured into an aqueous sodium hydroxide and extracted by 
dichloromethane. The combined organic layers were dried (MgSO4), and evaporated. 
General procedure 2a for amidation to diesters 
To a stirred solution of β-amino esters (1 equiv) in dichloromethane at 0 oC under 
nitrogen, anhydrous 1-hydroxybenzotriazole (1.5 equiv) and 
N,N-diisopropylethylamine (4 equiv) were added. Methyl malonate (3 equiv) in 
dichloromethane was added dropwise. 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (1 equiv) was added 
and the mixture was then allowed to warm to room temperature and stirred for 2 h. 
Saturated aqueous sodium hydrogen carbonate was added. The aqueous layer was 
extracted with ethyl acetate and the combined organic layers were washed with brine, 
dried (MgSO4) and evaporated. 
General procedure 2b for amidation to diesters 
To a stirred solution of β-amino esters (1 equiv) in dichloromethane at 0 oC under 
nitrogen, triethylamine (1.3 equivl) and methyl 3-chloro-3-oxopropanoate (1.2 equiv) 
were added. The mixture was then allowed to warm to room temperature and stirred 
for 1 h. The mixture was diluted with dichloromethane and washed with saturated 
aqueous sodium hydrogen carbonate. The aqueous layer was extracted with 
dichloromethane and the combined organic layers were dried (MgSO4) and evaporated. 
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General procedure 3 for Dieckmann cyclisation  
To a stirred solution of diesters (1 equiv) in methanol at room temperature under 
nitrogen, sodium methoxide in methanol (1.2 equiv) was added. The mixture was then 
heated under reflux for 1 h. The mixture was allowed to cool to room temperature, then 
acidifed with 1M hydrochloric acid to around pH 6. The aqueous phase was extracted 
with dichloromethane, dried (MgSO4), and evaporated. The oily residue was added to 
1% water in acetonitrile and the mixture was heated under reflux for 1 h. The mixture 
was allowed to cool to room temperature and evaporated 
General procedure 4 for Michael addition 
To a stirred solution of amines (1.6 equiv) in anhydrous THF at -78 
o
C under nitrogen, 
n-butyllithium (1.55 equiv) was added dropwise via syringe. The mixture was stirred at 
-78 
o
C for a further 30 min. A solution of α,β-unsaturated esters (1 equiv) in anhydrous 
THF was added dropwise via syringe at -78 
o
C and the mixture was stirred for further 3 
h at the same temperature. The mixture was quenched with aqueous saturated 
ammonium chloride and was allowed to warm to room temperature over 15 min. 
Evaporation gave a pale yellow liquid which was partitioned between dichloromethane 
and aqueous 10% citric acid. The aqueous layer was extracted with dichloromethane 
and the combined organic layers were washed with saturated aqueous sodium 
hydrogen carbonate and then brine, dried (MgSO4), and evaporated. 
General procedure 5 for deallylation 
To a stirred solution of β-amino esters (1 equiv) in acetonitrile/water (85:15) at room 
temperature, tris(triphenylphosphine)rhodium(I) chloride (Wilkinson’s catalyst) (5 
mol%) was added in one portion. The mixture was then heated under reflux for 16 h. 
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The mixture was allowed to cool to room temperature and extracted with 
dichloromethane. The combined organic layers were dried (MgSO4) and evaporated. 
(E)-But-2-enamide (39)
73 
O
NH2 
0.880 Aqueous ammonia (9 mL, 0.313 mol) was cooled in an ice bath. Methyl acrylate 
(3 mL, 31.3 mmol) was added dropwise over 5 min. The white solid was filtered and 
recrystallized from deionized water to give 39 (1.91 g, 72%) as white microprisms, mp 
150-152 
o
C (lit.
 74
 mp 155-156 
o
C); IR νmax 3322 (N-H), 3151 (N-H), 1674 (amide 
C=O), 1610, 1407, 1142, 662 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 6.87 (1H, dq, J= 
17.7, 7.8 Hz, =CHCH3) 5.86 (1H, dq, J= 17.7, 1.7 Hz, =CHCO) 5.45 (1H, s, NH) 1.88 
(3H, dd, J= 7.8, 1.7 Hz, CH3CH=). 
(E)-1-Phenylbut-2-en-1-one (40)
73 
O
Ph  
Aluminium chloride (freshly ground, 1.84 g, 13.7 mmol) was added to benzene (6.67 
mL). The mixture was stirred vigorously while (E)-crotonyl chloride (1.03 mL, 10.8 
mmol) was added dropwise over 5 min. The mixture was stirred for further 15 min, and 
then poured into a mixture of ice (33 mL) and hydrochloric acid (17 mL, 2M). The 
mixture was extracted with diethyl ether (2 x 10 mL), washed with sodium hydroxide 
(10 mL, 4M), dried (MgSO4), and evaporated. The resulting yellow oil was purified by 
distillation to give 40 as colourless oil (0.65 g, 42%), bp 120 
o
C/760 mmHg (lit.
 75
 bp 
90-95 
o
C/2.0 mmHg); Rf 0.76 (30% ethyl acetate/hexane); IR νmax 2972 (C-H), 1668 
(ketone C=O), 1621 (C=C), 1446, 1293, 1217, 963, 756, 689 cm
-1
; 
1
H NMR (300 MHz, 
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CDCl3) δ 7.94-7.91 (2H, m, Ph) 7.73-7.53 (1H, m, Ph) 7.49-7.46 (2H, m, Ph) 7.08 (1H, 
dq, J= 19.5, 6.6 Hz, =CHCH3) 6.88 (1H, dd, J= 19.5 ,0.5 Hz, =CHCO) 2.00 (3H, dd, 
J= 6.6, 0.5 Hz, CH3CH=).  
 (2E)-N-[(4-Methoxyphenyl)methyl]but-2-enamide (47)
 
HN
OMe
O
 
Following general procedure 1, reaction of crotonyl chloride (1.31 mL, 11.8 mmol) in 
dichloromethane (45 mL), 4-methoxybenzylamine (1.43 mL, 10.9 mmol) and 
triethylamine (1.53 mL) in dichloromethane (45 mL) gave a pale yellow solid that was 
triturated with cyclohexane (4 x 55 mL) to give 47 (1.79 g, 80%) as white microprisms, 
mp 115-117 
o
C; Rf 0.82 (ethyl acetate), IR νmax (solution in CHCl3) 3284 (N-H), 2835 
(C-H), 1668 (amide C=O), 1620, 1418, 1252, 1225 cm
-1
; 
1
H NMR (300 MHz, CDCl3) 
δ 7.26 (1H, s, Ph) 7.22 (2H, d, J= 8.6 Hz, Ph) 6.86 (2H, d, J= 8.6 Hz, Ph) 6.87 (1H, dq, 
J= 15.2, 6.9 Hz, =CHCH3) 5.78 (1H, dq, J= 15.2, 1.6 Hz, =CHCO) 5.60 (1H, br d, J= 
5.6 Hz, NH) 4.43 (2H, d, J= 5.6 Hz, CH2Ar) 3.79 (3H, s, OCH3) 1.85 (3H, dd, J= 6.9, 
1.6 Hz, CH3CH=); 
13
C NMR (300 MHz, CDCl3) δ 165.7 (CONH) 159.1 (ArCOCH3) 
140.2 (=CHCH3) 130.5 (=CHCO) 129.2 (ArC) 124.9 (ArC) 114.1 (ArC) 55.3(CH3O) 
43.1 (CH2Ar) 17.7 (CH3CH=); m/z (Cl+) 228 (100%, M+Na
+
), 174 (5%, M
+
-OMe); 
HRMS C12H15NO2Na calcd. 228.1000, found 228.1011. 
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(2E)-N-[(3,4-Dimethoxyphenyl)methyl]but-2-enamide (52)                                                                  
NH
OMe
OMe
O
 
Following general procedure 1, reaction of crotonyl chloride (0.26 mL, 2.71 mmol) in 
dichloromethane (12 mL), veratrylamine (0.44 mL, 3.03 mmol) and triethylamine 
(0.42 mL) in dichloromethane (12 mL) gave a pale yellow solid that was triturated with 
cyclohexane (4 x 55 mL) to give 52 (0.39 g, 61%) as white microprisms, mp 71-75 
o
C; 
Rf 0.52 (ethyl acetate); IR νmax 3280 (N-H), 2835 (C-H), 1669 (amide C=O), 1626, 
1419, 1262, 1225 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.41 (1H, s, Ph) 7.00 (1H, dq, 
J= 15.2, 6.9 Hz, =CHCH3) 6.90-6.79 (2H, m, Ph) 5.80 (1H, dq, J= 15.2, 1.6 Hz, 
=CHCO) 5.65 (1H, br d, J= 5.7 Hz, NH) 4.44 (2H, d, J= 5.7 Hz, CH2Ar) 3.87 (6H, s, 2 
x OCH3) 1.89 (3H, dd, J= 6.9, 1.6 Hz, CH3CH=); 
13
C NMR (300 MHz, CDCl3) δ 165.8 
(CONH) 149.1 (ArCOCH3) 148.5 (ArCOCH3) 140.3 (=CHCH3) 130.9 (ArCCH2) 
124.9 (=CHCO) 120.2 (ArC) 111.3 (ArC) 111.2 (ArC) 55.9 (CH3O) 55.9 (CH3O) 43.4 
(CH2Ar) 17.7 (CH3CH=). 
(2E)-N-[(2,4-Dimethoxyphenyl)methyl]but-2-enamide (53)
 
HN
OMe
O
MeO  
Following general procedure 1, reaction of crotonyl chloride (0.31 mL, 2.64 mmol) in 
dichloromethane (12 mL), 2,4-dimethoxybenzylamine (0.45 mL, 3.00 mmol) and 
Chapter 1 
69 
 
triethylamine (0.42 mL) in dichloromethane (12 mL) gave a pale yellow solid that was 
triturated with cyclohexane (4 x 55 mL) to give 53 (0.55 g, 88%) as white microprisms, 
mp 132-132.6 
o
C; Rf 0.70 (ethyl acetate), IR νmax 3283 (N-H), 2835 (C-H), 1668 
(amide C=O), 1613, 1419, 1262, 1222 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.21 (1H, d, 
J= 8.1 Hz, Ph) 6.91-6.76 (1H, m, Ph) 6.45 (1H, s, Ph) 6.42 (1H, dq, J= 15.5, 1.9 Hz, 
=CHCH3) 5.88 (1H, br d, J= 5.8 Hz, NH) 5.76 (1H, dq, J= 15.5, 5.4 Hz, =CHCO) 4.42 
(2H, d, J= 5.8 Hz, CH2Ar) 3.86 (3H, s, OCH3) 3.83 (3H, s, OCH3) 1.83 (3H, dd, J= 5.4, 
1.9 Hz, CH3CH=); 
13
C NMR (300 MHz, CDCl3) δ 165.5 (CONH) 160.5 (ArCOCH3) 
158.6 (ArCOCH3) 139.6 (=CHCH3) 130.7 (ArCCH2) 125.3 (=CHCO) 119.0 (ArC) 
104.0 (ArC) 98.6 (ArC) 55.4 (CH3O) 55.4 (CH3O) 38.8 (CH2Ar) 17.7 (CH3CH=); m/z 
(Cl+) 235 (25%, M
+
), 220 (5%, M
+
-CH3), 166 (8%, M
+
-CH3CHCHCO), 151 (100%, 
M
+
-CH3CHCHCONH), 98 (4%, M
+
-CH3CHCHCONHCH2); HRMS C13H17NO3 calcd. 
235.1203, found 235.1208. 
(E)-3-Phenylprop-2-enoyl chloride (122)
76 
O
Cl
 
trans-Cinnamic acid (1.00 g, 7.46 mmol) was added in a 25 mL round-bottom flask 
and dissolved in toluene (10 mL) under nitrogen. Then thionyl chloride (0.75 mL, 10.3 
mmol) was added and the mixture was heated under reflux for 2 h. The pale yellow 
liquid was evaporated to give 122 (quantitative) as white microprisms, mp 35-36 °C 
(lit.
 77
 mp 35-37 °C); Rf 0.60 (ethyl acetate); IR νmax 2942 (C-H), 1689 (acid chloride 
C=O), 1631 (C=C), 1264, 731, 703 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.85 (1H, d, 
J= 16.0 Hz, =CHAr) 7.57-7.51 (2H, m, Ph) 7.50-7.44 (2H, m, Ph) 7.41-7.23 (1H, m, 
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Ph) 6.60 (1H, d, J= 16.0 Hz, =CHCO).  
(E)-N-Benzyl-3-phenylpro-2-enamide (57)
78 
O
N
H
 
Benzylamine (1.72 mL, 15.8 mmol) was stirred vigorously in crushed ice while 
3-phenylpro-2-enoyl chloride (1.31 g, 7.89 mmol) was being added dropwise. The 
reaction mixture was then filtered and washed with distilled water (15 mL). 
Recrystallization from methanol gave white microprisms of 57 (1.32 g, 70%), mp 
106-109 
o
C (lit.
 79
 106-108 
o
C); Rf 0.30 (ethyl acetate); IR νmax 3275 (N-H), 2925 
(C-H), 1656 (amide C=O), 1617 (C=C), 1536, 1220, 977, 732, 698 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) δ 7.69 (1H, d, J= 15.7 Hz, =CHAr) 7.50-7.49 (2H, m, Ph) 7.37-7.26 (8H, 
m, Ph) 6.41 (1H, d, J= 15.7 Hz, =CHCO) 5.88 (1H, br d, J= 5.7 Hz, NH) 4.59 (2H, d, 
J= 5.7 Hz, CH2Ar). 
Methyl 2-methyl-3-oxobutanoate (70)
48 
OMe
O O  
To a stirred mixture of methyl acetoacetate (1 mL, 9.26 mmol) and methyl iodide (0.58 
mL, 9.26 mmol) in acetone (3 mL), potassium carbonate (1.91 g, 13.89 mmol) was 
added slowly at 0 
o
C and the mixture was stirred for 2 h at 0 
o
C and then stirred at 
room temperature for 16 h. Diethyl ether (10 mL) was added and the mixture was 
filtered. The filtrate was washed with brine (5 mL), dried (Na2SO4), and evaporated. 
The resulting pale yellow oil was purified by flash chromatography (10% ethyl 
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acetate/hexane) to give 70 (0.53 g, 46%) as a colourless oil, Rf 0.18 (15% ethyl 
acetate/hexane); IR νmax 2955 (C-H), 1740 (ketone C=O), 1708 (ester C=O), 1457, 
1166, 1084, 878, 670 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.74 (3H, s, OCH3) 3.52 (1H, 
q, J= 7.5 Hz, CHCH3) 2.24 (3H, s, CH3CO) 1.33 (3H, d, J= 7.5 Hz, CH3CHCO);
13
C 
NMR (300 MHz, CDCl3) δ 203.6 (COCH3) 171.0 (COOCH3) 53.4 (CHCOO) 52.4 
(OCH3) 28.4 (CH3CH) 12.8 (CH3CO). 
Methyl 3-oxopentanoate (71)
46 
OMe
O O  
To a stirred solution of sodium hydride (2.05 g, 0.102 mol, 60% in mineral oil, washed 
with petroleum ether and THF) in THF (75 mL) at 0 °C, methyl acetoacetate (5 mL, 
46.4 mmol) was added dropwise. The mixture was cooled to -20 °C after stirring at 0 
°C for 10 min. n-Butyllithium (20.5 mL, 2.5 M, 50.9 mmol) was added over 10 min 
and the mixture was stirred at -20 °C for 5 min. Methyl iodide (2.9 mL, 46.6 mmol) 
was added dropwise and the mixture was stirred at room temperature for 3 h. The 
mixture was then poured to saturated ammonium chloride solution (50 mL), extracted 
with diethyl ether (3 x 50 mL), dried (MgSO4), and evaporated to give 71 (5.84 g, 97%) 
as a pale yellow oil, 
1
H NMR (300 MHz, CDCl3) δ 3.73 (3H, s, OCH3) 3.46 (2H, s, 
CH2CO2CH3) 2.57 (2H, t, J= 7.2 Hz, CH2CH3) 1.08 (3H, t, J= 7.2 Hz, CH3CH2). 
Methyl 3-oxohexanoate (66a)
46 
OMe
O O  
To a stirred solution of sodium hydride (4.10 g, 0.102 mol, 60% in mineral oil, washed 
with petroleum ether and THF) in THF (150 mL) at 0 °C, methyl acetoacetate (10 mL, 
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92.8 mmol) was added dropwise. The mixture was cooled to -20 °C after stirring at 0 
°C for 10 min. n-Butyllithium (41 mL, 0.102 mol, 2.5 M) was added over 10 min and 
the mixture was stirred at -20 °C for 5 min. Bromoethane (7 mL, 93.1 mmol) was 
added dropwise and the mixture was stirred at room temperature for 3 h. The mixture 
was then poured to saturated ammonium chloride solution (100 mL), extracted with 
diethyl ether (3 x 100 mL), dried (MgSO4), and evaporated. The resulting orange solid 
was purified by distillation (105 °C/1.6 mmbar) to give 66a (11.33 g, 85%) as a 
colourless oil, IR νmax 2923 (C-H), 1752 (ketone C=O), 1736 (ester C=O), 1438, 1319, 
1261, 1163 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.72 (3H, s, OCH3) 3.46 (2H, s, 
CH2CO2CH3) 2.51 (2H, t, J= 7.2 Hz, CH2CH2CH3) 1.62 (2H, qt, J= 7.4, 7.2 Hz, 
CH2CH3) 0.92 (3H, t, J= 7.4 Hz, CH3CH2);
 13
C NMR (300 MHz, CDCl3) δ 202.7 
(COCH2) 167.7 (COOCH3) 52.3 (OCH3) 49.0 (CH2COOCH3) 44.9 (CH2COCH2)) 16.9 
(CH2CH3) 13.5 (CH3CH2). 
Methyl 2-methyl-3-oxopentanoate (66b)
 
OMe
O O  
To a stirred mixture of methyl 3-oxopentanoate (1.00 g, 7.68 mmol) and methyl iodide 
(0.48 mL, 7.68 mmol) in acetone (10 mL), potassium carbonate (1.60 g, 11.52 mmol) 
was added slowly at 0 
o
C and the mixture was stirred for 2 h at 0 
o
C and then stirred at 
room temperature for 16 h. Diethyl ether (20 mL) was added and the mixture was 
filtered. The filtrate was washed with brine (5 mL), dried (Na2SO4), and evaporated to 
give 66b (0.98 g, 88%) as a yellow oil, IR νmax 2955 (C-H), 1742 (ketone C=O), 1707 
(ester C=O), 1598, 1456, 1260, 1147 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.72 (3H, s, 
OCH3) 3.54 (1H, q, J= 7.7 Hz, CHCH3) 2.54 (2H, d, J= 3.2 Hz, CH2CO) 1.34 (3H, d, 
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J= 7.7 Hz, CH3CHCO) 1.08 (3H, t, J= 3.2 Hz, CH3CH2); 
13
C NMR (300 MHz, CDCl3) 
δ 206.4 (COCH2) 171.1 (COOCH3) 52.4 (CHCOO) 52.4 (OCH3) 34.7 (CH2CO) 12.9 
(CH3CH) 7.7 (CH3CH2). 
Methyl 3-oxo-3-(pyridin-3-yl)propanoate (66c)
50 
OMe
OH O
N
10
11
12
13
14
15
16
17
18
OMe
O O
N
1
2
3
4
5
6
7
8
9
 
To a stirred solution of sodium hydride (9.90 g, 0.246 mol, 60% in mineral oil, washed 
with petroleum ether and THF) in THF (60 mL), dimethyl carbonate (14.7 g, 0.423 mol) 
was added. The mixture was heated under reflux for 10 min. 3-Acetylpyridine (9.90 g, 
81.7 mmol) in THF (24 mL) was added over 15 min and the mixture was heated under 
reflux for 1.5 h. The mixture was then poured to ice water (100 mL) and neutralized by 
1M hydrochloric acid. The mixture was then extracted with ethyl acetate (3 x 100 mL), 
dried (MgSO4), and evaporated. The resulting yellow oil was purified by flash 
chromatography (30% ethyl acetate/hexane) to give 66c (14.1 g, 96%) as yellow 
microprisms, mp 72-73 
o
C (lit.
80 
73-74 
o
C); Rf 0.17 (30% ethyl acetate/hexane); IR νmax 
3315 (O-H), 2955 (C-H), 1738 (seter C=O), 1687 (alkenyl C=C), 1625, 1585, 1270, 
1209, 987, 801, 701 cm
-1
; 
1
H NMR (300 MHz, CDCl3) (2:1 keto-enol mixture) δ 8.85 
(1H, d, J= 1.9 Hz, C1H) 8.67 (1H, d, J= 1.9 Hz, C10H) 8.49-8.48 (1H, m, C5H) 
8.38-8.34 (1H, m, C14H) 7.96-7.92 (1H, m, C3H) 7.75-7.73 (1H, m, C12H) 7.17-7.13 
(1H, m, C4H) 7.05-7.03 (1H, m, C13H) 3.72 (3H, s, OCH3) 5.44 (1H, s, C16H) 3.85 (2H, 
s, C7H) 3.48 (3H, s, C18H) 3.44 (3H, s, C9H);
 13
C NMR (300 MHz, CDCl3) δ 191.5 (C6) 
172.8 (C15) 168.5 (C18) 167.2 (C9) 153.7 (C1) 151.6 (C10) 149.7 (C5) 147.1 (C13) 135.6 
(C3) 133.2 (C12) 131.1 (C2) 128.8 (C11) 123.5 (C4) 123.2 (C13) 88.1 (C16) 52.2 (C9) 51.4 
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(C18) 45.4 (C7); m/z (Cl+) 180 (100%, M+H
+
); HRMS C9H10NO3 calcd. 180.0655, 
found 180.0658. 
Methyl 3-amino-2-methylpent-2-enoate (67b)
 
OMe
NH2 O  
To a stirred solution of methyl 2-methyl-3-oxopentanoate (0.98 g, 6.77 mmol) in 
benzene (50 mL), ammonium acetate (2.60 g, 33.76 mmol) and a few drops of acetic 
acid were added. The mixture was heated under reflux for 3 d with the azeotropic 
removal of water. The mixture was allowed to cool to room temperature, then diluted 
with ethyl acetate (50 mL), washed with saturated aqueous sodium hydrogen carbonate 
(15 mL), dried (Na2SO4), and evaporated to give 67b (0.51 g, 52%) as an orange oil, 
IR νmax 3303 (N-H), 2924 (C-H), 1744 (ester C=O), 1656 (alkenyl C=C), 1610, 1462, 
1161 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.72 (3H, s, OCH3) 2.25 (2H, q, J= 7.6 Hz, 
CH2CH3) 1.75 (3H, s, CH3CCOO) 1.15 (3H, t, J= 7.6 Hz, CH3CH2); m/z (Cl+) 144 
(65%, M+H
+
); HRMS C7H14NO2 calcd. 144.1025, found 144.1019. 
Methyl 3-amino-3-(pyridin-3-yl)propenoate (67c)
51 
OMe
NH2 O
N
1
2
3
4
5
6
7
8
 
To a stirred solution of methyl 3-oxo-3-(pyridin-3-yl)propanoate (1.89 g, 10.57 mmol) 
in benzene (40 mL), ammonium acetate (4.07 g, 52.84 mmol) and a few drops of acetic 
acid were added. The mixture was heated under reflux for 3 d with the azeotropic 
removal of water. The mixture was allowed to cool to room temperature, then diluted 
with ethyl acetate (30 mL), washed with saturated aqueous sodium hydrogen carbonate 
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(5 mL), dried (Na2SO4), and evaporated to give 67c (1.46 g, 78%) as yellow 
microprisms, mp 112-114 
o
C; IR νmax 3396 (N-H), 3301 (N-H), 2955 (C-H), 1664 
(ester C=O), 1620 (alkenyl C=C), 1559, 1475, 1312, 1171, 793, 712 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) δ 8.67-8.62 (1H, m, C1H) 8.52-8.47 (1H, m, C5H) 7.77-7.71 (1H, m, 
C3H) 7.26-7.19 (1H, m, C4H) 4.82 (1H, s, =CHCOO) 3.59 (3H, s, OCH3);
 13
C NMR 
(500 MHz, CDCl3) δ 170.4 (C8) 157.5 (C6) 151.3 (C1) 147.5 (C5) 133.9 (C3) 133.5 (C2) 
123.6 (C4) 85.6 (C7) 50.6 (C8). 
Methyl 3-aminobutanoate hydrochloride (68a)
 
H2N
CO2Me.HCl
 
To a stirred solution of methyl 3-aminobutanoic acid (4.80 g, 46.5 mmol) in methanol 
(80 mL) in a salt-ice bath, thionyl chloride (7 mL, 96.5 mmol) was added dropwise via 
an addition funnel. The resulting solution was heated under reflux for 3 h. The mixture 
was then concentrated and washed with hot hexane to give 68a (6.93 g, 97%) as a 
yellow oil, IR νmax 3397 (N-H), 2917 (C-H), 1716 (ester C=O), 1611 (C=C), 1497, 
1439, 1188, 1103, 1005 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.38 (3H, br s, NH2) 
3.82-3.80 (1H, m, CHCH3) 3.69 (3H, s, OCH3) 2.98 (1H, dd, J= 15.8, 5.0 Hz, CH2CH) 
2.76 (1H, dd, J= 15.8, 5.0 Hz, CH2CH) 1.51 (3H, d, J= 4.9 Hz, CH3CH2);
 13
C NMR 
(300 MHz, CDCl3) δ 171.1 (COOCH3) 52.4 (OCH3) 45.1 (CHNH) 38.1 (CH2COOCH3) 
18.6 (CH3CH2). 
Methyl 3-aminohexanoate (68b)
 
OMe
NH2 O  
To a stirred solution of methyl 3-oxohexanoate (11.21 g, 77.7 mmol) in benzene (160 
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mL), ammonium acetate (30 g, 0.388 mol) and a few drops of acetic acid were added. 
The mixture was heated under reflux for 3 d with the azeotropic removal of water. The 
mixture was allowed to cool to room temperature, then diluted with ethyl acetate (150 
mL), washed with saturated aqueous sodium hydrogen carbonate (15 mL), dried 
(Na2SO4), and evaporated to give β-enamino ester as a pale orange oil. Sodium 
borohydride (7.15 g, 189 mmol) was added portion wise to a stirred solution of glacial 
acetic acid (200 mL) whilst the temperature was maintained at around 20 °C. The 
mixture was then stirred for 30 min until there was no hydrogen gas evolved. The 
β-enamino ester was then added in one portion and the mixture was stirred at room 
temperature for 3 h. The acetic acid was removed in vacuo and the residue was 
dissolved in ethyl acetate (100 mL). The mixture was extracted with water (4 x 100 
mL), and the pH of the aqueous phase was adjusted to pH 12 by potassium carbonate. 
The mixture was extracted with chloroform (3 x 150 mL) and the combined organic 
layers were dried (MgSO4), and evaporated to give 68b (3.61 g, 32%) as an orange oil, 
IR νmax 3272 (N-H), 2957 (C-H), 1736 (ester C=O), 1553, 1436, 1379, 1174 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 3.73 (3H, s, OCH3) 3.20-3.16 (1H, m CHNH2) 2.46 (1H, 
dd, J= 15.7, 3.9 Hz, CH2COOCH3) 2.25 (1H, dd, J= 15.7, 9.0 Hz, CH2COOCH3) 2.03 
(2H, br s, NH2) 1.36-1.33 (4H, m, CH2CH3 + CH2CH2CH3) 0.91 (3H, t, J= 2.5 Hz, 
CH3CH2);
 13
C NMR (300 MHz, CDCl3) δ 173.1 (COOCH3) 51.5 (OCH3) 48.0 
(CHNH2) 42.3 (CH2COOCH3) 39.7 (CH2CH2CH3) 19.2 (CH2CH3) 14.0 (CH3CH2). 
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Methyl 3-amino-2-methylpentanoate (68c)
 
OMe
NH2 O  
Sodium borohydride (0.64 g, 16.8 mmol) was added portion wise to a stirred solution 
of glacial acetic acid (11 mL) whilst the temperature was maintained at around 20 °C. 
The mixture was then stirred for 30 min until there was no hydrogen gas evolved. 
Methyl 3-amino-2-methylpent-2-enoate (0.93 g, 6.47 mmol) was then added in one 
portion and the mixture was stirred at room temperature for 3 h. The acetic acid was 
removed in vacuo and the residue was dissolved in ethyl acetate (10 mL). The mixture 
was extracted with water (4 x 10 mL), and the pH of the aqueous phase was adjusted to 
pH 12 by potassium carbonate. The mixture was extracted with chloroform (3 x 15 mL) 
and the combined organic layers were dried (MgSO4), and evaporated to give 68c (0.63 
g, 67%) as an orange oil, IR νmax 3321 (N-H), 2961 (C-H), 1731 (ester C=O), 1569, 
1457, 1402, 1198, 975 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (1:1 mixture of 
diastereoisomers) δ 3.67 (3H, s, OCH3) 3.66 (3H, s, OCH3) 2.90-2.43 (2H, m CHNH2 
+ CHCOOCH3) 1.53 (2H, br s, NH2) 1.42-1.16 (2H, m, CH2CH3) 1.14-1.11 (3H, m, 
CH3CH) 0.96-0.90 (3H, m, CH3CH2). 
Methyl 3-amino-2-methyl-4-phenylbutanoate (68d)
 
OMe
NH2 O
Ph
 
To a stirred mixture of zinc dust (2.60 g, 39.28 mmol) in dichloromethane (13 mL) 
under nitrogen, trimethylsilylchloride (0.26 ml, 0.109 mol) was added. The mixture 
was stirred for 30 min at room temperature. Tetrahydrofuran (8 mL) was added and the 
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mixture was heated to 42 
o
C. A mixture of benzyl cyanide (1.00 g, 8.54 mmol) and 
methyl 2-bromopropanoate (2.85 g, 17.07 mmol) was added to the mixture and was 
heated under reflux for 2 h. The mixture was left to cool down and filtered. Sodium 
borohydride (0.60 g, 15.37 mmol) and ethanol (2.5 mL) was added cautiously to the 
filtrate and the mixture was stirred for 3 h. Hydrochloric acid (9 mL, 2M) was then 
added and the aqueous layer was extracted with dichloromethane (2 x 10 ml). The 
combined organic layers were dried (MgSO4) and evaporated. The oily residue was 
diluted with toluene (4 mL) and alkalized with concentrated ammonia (3 ml). The 
aqueous phase was then extracted with toluene (2 x 4 mL), dried (MgSO4) and 
evaporated. The resulting oil was purified by flash chromatography (20% ethyl 
acetate/hexane) to give 68d (0.27 g, 15%) as a yellow oil, Rf 0.75 (30% ethyl 
acetate/hexane); IR νmax 3368 (N-H), 2948 (C-H), 1726 (ester C=O), 1664, 1453, 1166, 
740 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (1:1 mixture of diastereoisomers) δ 7.38-7.30 
(5H, m, Ph) 3.69 (3H, s, OCH3) 3.40-3.21 (1H, m CHNH2) 2.92-2.73 (1H, m, 
CHCOOCH3) 2.60-2.40 (2H, m, CH2Ar) 1.65 (2H, br s, NH2) 1.26-1.18 (3H, m, 
CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 176.1 (COOCH3) 175.9 (COOCH3) 139.1 
(ArC) 139.1 (ArC) 129.4 (ArC) 129.3 (ArC) 129.1 (ArC) 128.6 (ArC) 126.5 (ArC) 
55.5 (CHNH2) 54.4 (CHNH2) 51.7 (OCH3) 51.6 (OCH3) 45.7 (CHCOOCH3) 44.6 
(CHCOOCH3) 41.8 (CH2Ar) 41.6 (CH2Ar) 14.5 (CH3CH) 11.7 (CH3CH). 
Methyl 3-amino-3-phenylpropanoate hydrochloride (68e) 
Ph OMe.HCl
NH2 O
 
To a stirred solution of 3-amino-3-phenylpropionic acid (6.00 g, 36.0 mmol) in 
methanol (150 mL) in a salt-ice bath, thionyl chloride (18 mL, 0.24 mol) was added 
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dropwise via an addition funnel. The resulting solution was stirred at room temperature 
for 24 h. Diethyl ether (150 mL) was added and the solution was left to crystallize. The 
microprisms were filtered, washed with diethyl ether to give 68e (6.82 g, 87%) as 
white microprisms, mp 143-144 
o
C (lit.
81
 145-147 
o
C); IR νmax 3351 (N-H), 3215 
(N-H), 2952 (C-H), 1734 (ester C=O), 1650 (C=C), 1498, 1456, 1214, 762, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.43-7.19 (5H, m, Ph) 4.43 (1H, t, J= 5.9 Hz, CHNH2) 
3.68 (3H, s, OCH3) 2.80 (2H, d, J= 5.9 Hz, CH2COO) 1.77 (2H, br s, NH);
 13
C NMR 
(500 MHz, CD4OD) δ 170.0 (COOCH3) 135.4 (ArC) 129.4 (ArC) 129.2 (ArC) 127.6 
(ArC) 52.3 (CHNH2) 52.3 (OCH3) 38.5 (CH2COO). 
Methyl 3-amino-3-(pyridin-3-yl)propanoate (68f)
53 
OMe
NH2 O
N
1 2
3
4
5
 
To a stirred solution of 3-pyridinecarboxaldehyde (8.24 g, 76.8 mmol) in ethanol (15 
mL), malonic acid (8.00 g, 76.8 mmol) and ammonium acetate (12.00 g, 0.156 mol) 
were added. The mixture was heated under reflux for 6 h and was then filtered, 
redissolved in methanol (150 mL) and cooled to 0 
o
C. Thionyl chloride (2.7 mL, 99.8 
mmol) was added dropwise, stirred at 0 
o
C for 30 mins and at room temperature for 3 h. 
The mixture was then heated under reflux for 1 h. Diethyl ether (200 mL) was added 
and the precipitate was filtered to give 68f (5.42 g, 43%) as white microprisms, mp 
202-205 
o
C (lit.
82
 197-199 
o
C); IR νmax 3296 (N-H), 2953 (C-H), 1737 (ester C=O), 
1657 (C=C), 1516, 1248, 1168, 701 cm
-1
; 
1
H NMR (500 MHz, D2O) δ 8.55-8.53 (1H, 
m, C1H) 8.50-8.50 (1H, m, C5H) 7.91-7.89 (1H, m, C3H) 7.49-7.46 (1H, m, C4H) 4.74 
(1H, dd, J= 7.9 , 6.6 Hz, CHNH2) 2.88 (1H, dd, J= 16.3 , 7.9 Hz, CH2CH) 2.80 (1H, dd, 
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J= 16.3 , 6.6 Hz, CH2CH);
 13
C NMR (300 MHz, CDCl3) δ 170.9 (COOCH3) 149.3 (C1) 
147.8 (C5) 134.8 (C2) 134.4 (C3) 123.8 (C4) 52.2 (CH3O) 48.3 (CHNH) 38.5 
(CH2COO). 
Methyl 3-(2-methoxycarbonylacetylamino)butanoate (69a)
 
HN
CO2Me
OMe
O O
 
Following general procedure 2a, reaction of methyl 3-aminobutanoate hydrochloride 
(0.50 g, 3.30 mmol) in dichloromethane (7 mL), 1-hydroxybenzotriazole (0.66 g, 4.9 
mmol), N,N-diisopropylethylamine (2.3 mL, 13.0 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.59 g, 3.30 mmol), 
and methyl malonate (1.52 g, 9.80 mmol) in dichloromethane (10 mL) gave a pale 
yellow solid that was purified by flash chromatography (60% ethyl acetate/hexane) to 
give 69a (0.33 g, 46%) as a yellow gum, Rf 0.33 (75% ethyl acetate/hexane); IR νmax 
3293 (N-H), 2956 (C-H), 1730 (ketone C=O), 1650 (amide C=O), 1545, 1436, 1196, 
1015, 569 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.26 (1H, br s, NH) 4.48-4.25 (1H, m, 
CHCH2CO2CH3) 3.63 (3H, s, OCH3) 3.58 (3H, s, OCH3) 3.19 (2H, s, CH2CON) 
2.51-2.36 (2H, m, CH2CHN) 1.13 (3H, d, J= 6.7 Hz, CH3CHN);
 13
C NMR (500 MHz, 
CDCl3) δ 171.7 (COOCH3) 169.4 (COOCH3) 164.3 (CON) 52.3 (OCH3) 51.6 (OCH3) 
42.2 (CHCH2CO2Me) 41.3 (CH2CON)) 39.8 (CH2CHN) 19.8 (CH3CH); m/z (Cl+) 218 
(100%, M+H
+
); HRMS C9H16NO5 calcd. 218.1023, found 218.1022. 
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Methyl 3-(2-methoxycarbonylacetylamino)hexanoate (69b)
 
HN
CO2Me
OMe
O O
 
Following general procedure 2a, reaction of methyl 3-aminohexanoate (0.47 g, 3.30 
mmol) in dichloromethane (7 mL), 1-hydroxybenzotriazole (0.66 g, 4.90 mmol), 
N,N-diisopropylethylamine (2.3 mL, 13.0 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.59 g, 3.30 mmol), 
and methyl malonate (1.52 g, 9.80 mmol) in dichloromethane (10 mL) gave a pale 
yellow solid that was purified by flash chromatography (55% ethyl acetate/hexane) to 
give 69b (0.32 g, 40%) as a colourless gum, Rf 0.44 (75% ethyl acetate/hexane); IR 
νmax 3292 (N-H), 2956 (C-H), 1734 (ester C=O), 1649 (amide C=O), 1545, 1436, 1169, 
1015, 573 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.22 (1H, br s, NH) 4.52-4.24 (1H, m, 
CHCH2CO2CH3) 3.74 (3H, s, OCH3) 3.69 (3H, s, OCH3) 3.31 (2H, s, CH2CON) 
2.56-2.54 (2H, m, CH2CO2CH3) 1.56-1.49 (2H, m, CH2CH2CH3) 1.39-1.32 (2H, m, 
CH2CH3) 0.91 (3H, d, J= 7.3 Hz, CH3CH2);
 13
C NMR (300 MHz, CDCl3) δ 172.1 
(COOCH3) 169.7 (COOCH3) 164.3 (CON) 52.4 (OCH3) 51.7 (OCH3) 46.0 
(CHCH2CO2CH3) 41.2 (CH2COOCH3) 38.4 (CH2CH2CH3) 36.1 (CH2CON) 19.3 
(CH2CH3) 13.8 (CH3CH2); m/z (Cl+) 246 (100%, M+H
+
); HRMS C11H20NO5 calcd. 
246.1336, found 246.1332. 
Methyl 3-(2-methoxycarbonylacetylamino)-2-methylpentanoate (69c)
 
HN
CO2Me
OMe
O O
 
Following general procedure 2b, reaction of methyl 3-amino-2-methylpentanoate (0.30 
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g, 2.07 mmol), triethylamine (0.38 mL, 2.70 mmol), and methyl 
3-chloro-3-oxopropanoate (0.27 mL, 2.48 mmol) in dichloromethane (8 mL) gave a 
pale yellow oil that was purified by flash chromatography (40% ethyl acetate/hexane) 
to give 69c (0.20 g, 40%) as a pale yellow oil, Rf 0.56 (75% ethyl acetate/hexane); 
1
H 
NMR (300 MHz, CDCl3) (mixture of diastereoisomers) δ 7.49-7.20 (1H, m, NH) 
4.23-4.11 (1H, m, CHCH2CH3) 3.75 (3H, s, OCH3) 3.74 (3H, s, OCH3) 3.69 (3H, s, 
OCH3) 3.66 (3H, s, OCH3) 3.34-3.30 (2H, m, CH2CON) 2.71-2.64 (1H, m, CHCH3) 
1.61-1.55 (2H, m, CH2CH3) 1.16 (3H, d, J= 11.1 Hz, CH3CH) 1.15 (3H, d, J= 7.2 Hz, 
CH3CH) 0.92 (3H, t, J= 7.2 Hz, CH3CH2);
 13
C NMR (300 MHz, CDCl3) δ 175.7 
(COOCH3) 174.8 (COOCH3) 169.6 (COOCH3) 169.3 (COOCH3) 165.0 (CONH) 164.8 
(CONH) 52.8 (OCH3) 52.7 (OCH3) 52.4 (OCH3) 52.3 (OCH3) 51.7 (CHNH) 48.6 
(CHNH) 43.3 (CHCOOCH3) 42.0 (CHCOOCH3) 41.5 (CH2COOCH3) 41.2 
(CH2COOCH3) 26.4 (CH2CH3) 24.7 (CH2CH3) 14.7 (CH3CH) 12.8 (CH3CH) 10.6 
(CH3CH2); m/z (Cl+) 246 (100%, M+H
+
); HRMS C11H20NO5 calcd. 246.1342, found 
246.1345. 
Methyl 3-(2-methoxycarbonylacetylamino)-2-methyl-4-phenylbutanoate (69d)
 
HN
CO2Me
OMe
O O
Ph
 
Following general procedure 2b, reaction of methyl 
3-amino-2-methyl-4-phenylbutanoate (0.13 g, 0.60 mmol), N,N-diisopropylethylamine 
(0.21 mL, 1.21 mmol), and methyl 3-chloro-3-oxopropanoate (0.10 mL, 0.90 mmol) in 
dichloromethane (4 mL) gave a pale yellow oil that was purified by flash 
chromatography (40% ethyl acetate/hexane) to give 69d (0.13 g, 67%) as a colourless 
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oil, Rf 0.83 (75% ethyl acetate/hexane); IR νmax 3301 (N-H), 2953 (C-H), 1733 (ester 
C=O), 1657 (amide C=O), 1554, 1436, 1165, 701 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
(mixture of diastereoisomers) δ 7.29-7.16 (5H, m, Ph) 4.51-4.13 (1H, m, CHCH2Ph) 
3.72 (3H, s, OCH3) 3.66 (3H, s, OCH3) 3.27-3.12 (2H, m, CH2CON) 2.84-2.67 (2H, m, 
CH2Ph + CHCH3) 1.22-1.18 (3H, m, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 175.9 
(COOCH3) 174.8 (COOCH3) 169.8 (COOCH3) 169.4 (COOCH3) 164.8 (CONH) 164.3 
(CONH) 137.8 (ArC) 137.6 (ArC) 129.3 (ArC) 129.2 (ArC) 128.5 (ArC) 128.4 (ArC) 
126.7 (ArC) 126.6 (ArC) 53.1 (OCH3) 52.4 (OCH3) 52.3 (OCH3) 51.9 (OCH3) 42.9 
(CHNH) 42.6 (CHNH) 41.5 (CHCOOCH3) 41.0 (CHCOOCH3) 40.7 (CH2Ar) 39.9 
(CH2Ar) 37.8 (CH2COOCH3) 37.8 (CH2COOCH3) 13.2 (CH3CH) 12.9 (CH3CH). 
Methyl 3-(2-methoxycarbonylacetylamino)-3-phenylpropanoate (69e)
 
HN
CO2Me
Ph
OMe
O O
 
Following general procedure 2a, reaction of methyl 3-amino-3-phenylpropanoate (0.65 
g, 3.00 mmol) in dichloromethane (6 mL), 1-hydroxybenzotriazole (0.61 g, 4.50 mmol), 
N,N-diisopropylethylamine (2.1 mL, 12.0 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.55 g, 3.00 mmol), 
and methyl malonate (1.40 g, 9.00 mmol) in dichloromethane (8 mL) gave a pale 
yellow solid that was purified by flash chromatography (40% ethyl acetate/hexane) to 
give 69e (0.63 g, 75%) as white microprisms, mp 67-69 
o
C (lit.
45
 65 
o
C); Rf 0.50 (75% 
ethyl acetate/hexane); IR νmax 3293 (N-H), 2954 (C-H), 1734 (ester C=O), 1649 (amide 
C=O), 1540, 1435, 1270, 1158, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (presence of 
rotamers) δ 7.94 (1H, d, J= 8.4 Hz, NH) 7.39-7.16 (5H, m, Ph) 5.39-5.35 (1H, m, 
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CHCH2CO2Me) 3.64 (3H, s, OCH3) 3.53 (3H, s, OCH3) 3.23 (2H, s, CH2CON) 
2.87-2.82 (1H, m, CH2CHN) 2.77-2.73 (1H, m, CH2CHN);
 13
C NMR (500 MHz, 
CDCl3) δ 171.2 (COOCH3) 169.4 (COOCH3) 164.6 (CON) 140.5 (ArC) 128.5 (ArC) 
127.8 (ArC) 126.6 (ArC) 52.1 (CHCH2CO2Me) 50.7 (OCH3) 50.0 (OCH3) 41.6 
(CH2CON)) 40.4 (CH2CHN); m/z (Cl+) 280 (98%, M+H
+
); HRMS C14H18NO5 calcd. 
280.1180, found 280.1176. 
Methyl 3-(2-methoxycarbonylacetylamino)-4-(pyridin-3-yl)butanoate (69f)
 
HN
CO2Me
OMe
O
N
O
 
Following general procedure 2b, reaction of methyl 
3-amino-3-(pyridin-3-yl)propanoate (0.50 g, 1.98 mmol), N,N-diisopropylethylamine 
(1.4 mL, 7.93 mmol), and methyl 3-chloro-3-oxopropanoate (0.32 mL, 2.98 mmol) in 
dichloromethane (12 mL) gave a pale yellow oil that was purified by flash 
chromatography (50% ethyl acetate/hexane) to give 69f (0.55 g, 99%) as a yellow oil, 
Rf 0.08 (75% ethyl acetate/hexane); IR νmax 3273 (N-H), 2954 (C-H), 1733 (ester C=O), 
1656 (amide C=O), 1546, 1481, 1166, 713 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (mixture 
of rotamers) δ 8.67 (1H, s, aryl) 8.57-8.49 (1H, m, aryl) 7.64-7.55 (1H, m, aryl) 
7.26-7.18 (1H, m, aryl) 5.38 (1H, dd, J= 6.4, 5.3 Hz, CHNH) 3.67 (3H, s, OCH3) 3.53 
(3H, s, OCH3) 3.26 (2H, s, CH2CON) 2.86 (1H, dd, J= 16.0, 6.4 Hz, CH2CH) 2.79 (1H, 
dd, J= 16.0, 5.3 Hz, CH2CH);
 13
C NMR (500 MHz, CDCl3) δ 170.8 (COOCH3) 169.3 
(COOCH3) 164.8 (CONH) 148.8 (ArC) 148.1 (ArC) 136.2 (ArC) 134.4 (ArC) 123.6 
(ArC) 123.3 (ArC) 52.5 (OCH3) 52.0 (OCH3) 47.9 (CHNH) 41.3 (CH2CONH) 39.6 
(CH2CH). 
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3-Methoxy-6-phenylpiperidine-2,4-dione (72)
 
HN
O
OH
1 2
3
4
5
6
CO2Me
7 8
Ph  
To a stirred solution of methyl 3-(2-methoxycarbonylacetylamino)-3-phenylpropanoate 
(1.40 g, 5.01 mmol) in methanol (15 mL) at room temperature under nitrogen, sodium 
methoxide in methanol (3.1 mL, 6.02 mmol, 1.97 M) was added. The mixture was then 
heated under reflux for 2 h. The mixture was allowed to cool to room temperature, then 
diluted with diethyl ether and filtered. The white precipitate was dissolved in water, 
which was then acidified to pH 2-3 by 1M hydrochloric acid. The product was then 
extracted into ethyl acetate (3 x 20 mL) and the combined organic layers were washed 
with brine (10 mL), dried (MgSO4) and evaporated to give 72 (0.86 g, 70%) as white 
microprisms, mp 122-125 
o
C (lit.
24
 128-130 
o
C); Rf 0.26 (5% methanol/chloroform); 
IR νmax 3311 (O-H), 2952 (C-H), 1713 (ester C=O), 1638 (amide C=O), 1571, 1448, 
1265, 730, 697 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.27-7.14 (5H, m, Ph) 6.22 (1H, br 
s, NH) 4.64 (1H, t, J= 7.5 Hz, C6H) 3.68 (3H, s, OCH3) 2.81 (2H, d, J= 7.5 Hz, C5H); 
13
C NMR (500 MHz, CDCl3) δ 183.5 (C4) 172.0 (C7) 164.8 (C2) 139.6 (ArC) 129.1 
(ArC) 128.7 (ArC) 126.5 (ArC) 97.4 (C3) 52.7 (C8) 52.3 (C5) 37.8 (C6). 
6-Methylpiperidine-2,4-dione (65a)
 
HN
O
O 
Following general procedure 3, reaction of methyl 
3-(2-methoxycarbonylacetylamino)butanoate (0.30 g, 1.38 mmol) in methanol (2.0 
mL), and sodium methoxide in methanol (1.5 mL, 2.76 mmol, 1.84 M) gave 65a (74 
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mg, 42%) as a yellow microprism, mp 115-118 
o
C; IR νmax 3217 (N-H), 2968 (C-H), 
1726 (ketone C=O), 1663 (amide C=O), 1445, 1331, 1198, 742, 556 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 3.98-3.77 (1H, m, CHCH3) 3.26 (1H, d, J= 19.8 Hz, CH2CON) 
3.19 (1H, d, J= 19.8 Hz, CH2CON) 2.64 (1H, dd, J= 16.4, 3.9 Hz, CH2CHNH) 2.30 
(1H, dd, J= 16.4, 9.6 Hz, CH2CHNH) 1.30 (3H, d, J= 6.5 Hz, CH3CH);
 13
C NMR (500 
MHz, CDCl3) δ 203.4 (COCH2) 169.8(CONH) 47.0 (CHCH3) 46.2 (CH2CONH) 44.6 
(CH2CH) 21.3 (CH3CH); m/z (Cl+) 128 (100%, M+H
+
); HRMS C6H10NO2 calcd. 
128.0711, found 128.0714. 
6-Propylpiperidine-2,4-dione (65b)
 
HN
O
OPr  
Following general procedure 3, reaction of methyl 
3-(2-methoxycarbonylacetylamino)hexanoate (0.17 g, 0.70 mmol) in methanol (1.0 
mL), and sodium methoxide in methanol (0.54 mL, 1.05 mmol, 2.00 M) gave 65b (63 
mg, 58%) as white microprisms, mp 112-116 
o
C; IR νmax 3249 (N-H), 2925 (C-H), 
1736 (ketone C=O), 1664 (amide C=O), 1516, 1302, 1172 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 3.65 (1H, m, CHNH) 3.25 (2H, m, CH2CON) 2.68-2.64 (1H, m, 
CH2CHCH2CH2) 2.37-2.29 (1H, m, CH2CHCH2CH2) 1.50-1.22 (4H, m CH2CH3 + 
CH2CH2CH3) 0.93 (3H, m, CH3CH2);
 13
C NMR (500 MHz, CDCl3) δ 208.0 (COCH2) 
176.1 (CONH) 36.9 (CH2COCH2CONH) 34.0 (CH2CONH) 29.7 (CHNH) 21.1 
(CH2CH2CH3) 18.4 (CH2CH3) 13.9 (CH3CH2); m/z (Cl+) 156 (35%, M+H
+
); HRMS 
C8H14NO2 calcd. 156.1025, found 156.1022. 
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6-Ethyl-5-methylpiperidine-2,4-dione (65c)
 
HN
O
OEt
 
Following general procedure 3, reaction of methyl 
3-(2-methoxycarbonylacetylamino)-2-methylpentanoate (0.12 g, 0.48 mmol) in 
methanol (3.0 mL), and sodium methoxide in methanol (0.53 mL, 0.92 mmol, 1.74 M) 
gave 65c (53 mg, 71%) as a yellow oil, Rf 0.08 (75% ethyl acetate/hexane); IR νmax 
3280 (N-H), 2925 (C-H), 1725 (ketone C=O), 1661 (amide C=O), 1458, 1343, 1203 
cm
-1
; 
1
H NMR (300 MHz, CDCl3) (mixture of diastereoisomers) δ 7.95 (1H, br s, NH) 
7.79 (1H, br s, NH) 3.75-3.69 (1H, m, CHCH2CH3) 3.22 (2H, m, CH2CON) 2.67-2.63 
(1H, m, CHCH3) 2.41-2.36 (1H, m, CHCH3) 1.73-1.70 (2H, m, CH2CH3) 1.59-1.52 
(2H, m, CH2CH3) 1.19-1.05 (3H, m, CH3CH) 0.99-0.83 (3H, m, CH3CH2);
 13
C NMR 
(300 MHz, CDCl3) δ 205.7 (COCH) 170.0 (CONH) 55.6 (CHCH3) 54.5 (CHCH3) 46.4 
(CHNH) 46.4 (CHNH) 46.0 (CH2CO) 41.0 (CH2Ar) 26.2 (CH2CH3) 24.4 (CH2CH3) 
11.6 (CH3CH2) 10.1 (CH3CH2) 10.0 (CH3CH) 8.5 (CH3CH); m/z (Cl+) 156 (100%, 
M+H
+
); HRMS C8H14NO2 calcd. 156.2023, found 156.2021. 
6-Benzyl-5-methylpiperidine-2,4-dione (65d)
 
HN
O
OBn
 
Following general procedure 3, reaction of methyl 
3-(2-methoxycarbonylacetylamino)-2-methyl-4-phenylbutanoate (0.09 g, 0.30 mmol) 
in methanol (1.2 mL), and sodium methoxide in methanol (0.2 mL, 0.38 mmol, 1.97 M) 
gave 65d (36 mg, 56%) as a yellow oil, IR νmax 3245 (N-H), 2923 (C-H), 1721 (ketone 
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C=O), 1661 (amide C=O), 1454, 1345, 1209, 702 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
(mixture of diastereoisomers) δ 7.63-7.19 (5H, m, Ph) 3.92-3.83 (1H, m, CHCH2Ph) 
3.27-3.13 (2H, m, CH2CON) 2.90 (1H, m, CHCH3) 2.65-2.61 (1H, m, CH2Ph) 
2.51-2.46 (1H, m, CH2Ph) 1.28-1.25 (3H, m, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 
204.8 (COCH) 204.7 (COCH) 169.2 (CONH) 168.4 (CONH) 136.0 (ArC) 135.5 (ArC) 
129.5 (ArC) 129.4 (ArC) 129.3 (ArC) 129.1 (ArC) 127.7 (ArC) 127.4 (ArC) 55.8 
(CHCH3) 54.5 (CHCH3) 47.4 (CHNH) 46.6 (CHNH) 46.1 (CH2CO) 46.1 (CH2CO) 
41.0 (CH2Ar) 37.9 (CH2Ar) 12.1(CH3CH) 10.5 (CH3CH); m/z (Cl+) 218 (100%, 
M+H
+
); HRMS C13H16NO2 calcd. 218.1181, found 218.1189. 
6-Phenylpiperidine-2,4-dione (65e)
15 
HN
O
OPh
1 2 3
4
5
6
 
3-Methoxy-6-phenylpiperidine-2,4-dione (0.31 g, 1.25 mmol) was added to 1% water 
in acetonitrile (6 mL). The mixture was heated under reflux for 2 h. The mixture was 
allowed to cool to room temperature and evaporated. The residue was purified by flash 
chromatography (1% methanol/chloroform) to give 65e (0.25 g, 95%) as white 
microprisms, mp 160-163 
o
C (lit.
83
 167-169 
o
C); Rf 0.26 (5% methanol/chloroform); 
IR νmax 3248 (N-H), 2927 (C-H), 1722 (ketone C=O), 1664 (amide C=O), 1374, 762, 
699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.47-7.28 (5H, m, Ph) 6.87 (1H, br s, NH) 
4.80 (1H, dd, J= 8.7, 4.5 Hz, C6H) 3.34 (2H, s, C3H) 2.88 (1H, dd, J= 16.0, 4.5 Hz, 
C5H) 2.87 (1H, dd, J= 16.0, 8.7 Hz, C5H);
 13
C NMR (500 MHz, CDCl3) δ 202.3 (C4) 
169.0 (C2) 139.3 (ArC) 129.4 (ArC) 128.9 (ArC) 126.0 (ArC) 52.9 (C5) 47.2 (C3) 47.0 
(C6); m/z (Cl+) 190 (95%, M+H
+
); HRMS C11H12NO2 calcd. 190.0863, found 
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190.0859.  
Methyl 3-(2-methoxycarbonylethylamino)-3-(pyridin-3-yl)propanoate (75)
 
HN
CO2Me
CO2Me
N 1
23
4
5  
To methyl 3-amino-3-(pyridin-3-yl)propanoate hydrochloride (0.60 g, 2.38 mmol) in 
methanol (6 mL) was added methyl acrylate (0.24 mL, 2.62 mmol) and triethylamine 
(0.7 mL). The mixture was stirred for 8 h at room temperature. The mixture was 
concentrated in vacuo and was then diluted with water (5 mL), acidied with 1M 
hydrochloric acid to pH 4, and washed with ethyl acetate (2 x 10 mL). The aqueous 
phase was then neutralized by saturated sodium bicarbonate solution, extracted with 
ethyl acetate (2 x 10 mL), washed with water (2 x 5 mL), dried (MgSO4) and 
evaporated to give 75 (0.46 g, 73%,) as a yellow oil, IR νmax 3310 (N-H), 2953 (C-H), 
1728 (ester C=O), 1434, 1168, 1123, 1024, 715 cm
-1
;
 1
H NMR (500 MHz, CDCl3) δ 
8.60-8.50 (2H, m, C1H + C5H) 7.84-7.82 (1H, m, C3H) 7.28-7.26 (1H, m, C4H) 
4.12-4.10 (1H, m, CHCH2COO) 3.66 (3H, s, OCH3) 3.64 (3H, s, OCH3) 2.72-2.61 (4H, 
m, CH2NH + CH2CH) 2.46-2.44 (2H, m, CH2CH2NH) 1.95 (1H, br s, NH);
 13
C NMR 
(500 MHz, CDCl3) δ 173.0 (COOCH3) 171.6 (COOCH3) 149.2 (C1) 149.2 (C5) 137.9 
(C2) 134.6 (C3) 123.7 (C4) 57.2 (CHCH2) 51.8 (CH3O) 51.7 (CH3O) 42.7 (CH2CH) 
42.5 (CH2NH) 34.5 (CH2CH2NH). 
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Methyl 3-[(tert-butoxycarbonyl)- 
(2-methoxycarbonylethyl)amino]-3-(pyridin-3-yl)propanoate (76)
 
BocN
CO2Me
CO2Me
N 1
23
4
5  
To methyl 3-(2-methoxycarbonylethylamino)-3-(pyridin-3-yl)propanoate (0.30 g, 1.13 
mmol) in dichloromethane (3 mL) was added di-tert-butyl dicarbonate (0.29 mL, 1.24 
mmol). The mixture was stirred for 16 h at room temperature. The mixture was 
concentrated in vacuo. The residue was then diluted with water (5 mL), acidied with 
1M hydrochloric acid to pH 4, and washed with ethyl acetate (2 x 10 mL). The aqueous 
phase was then neutralized by saturated sodium bicarbonate solution, extracted with 
ethyl acetate (2 x 10 mL), washed with water (2 x 5 mL), dried (MgSO4) and 
evaporated. The resulting oil was purified by flash chromatography (50% ethyl 
acetate/hexane) to give 76 (0.25 g, 68%) as a colourless oil, Rf 0.58 (75% ethyl 
acetate/hexane);
 1
H NMR (500 MHz, CDCl3) δ 8.57-8.51 (2H, m, C1H + C5H) 
7.70-7.64 (1H, m, C3H) 7.53-7.51 (1H, m, C4H) 5.53-5.58 (1H, m, CHCH2COO) 3.68 
(3H, s, OCH3) 3.61 (3H, s, OCH3) 3.39 (2H, m, CH2CH2N) 3.31-3.01 (2H, m, CH2CH) 
2.54-2.52 (2H, m, CH2N) 1.44 (9H, s, (CH3)3C);
 13
C NMR (500 MHz, CDCl3) δ 172.1 
(COOCH3) 171.0 (COOCH3) 149.0 (C1) 149.2 (C5) 123.5 (C4) 52.1 (CHCH2) 52.0 
(CH3O) 51.7 (CH3O) 28.4 ((CH3)3C). 
3,3-Dimethyl-6-phenylpiperidine-2,4-dione (78)
 
HN
O
OPh
1 2
3
4
5
6
7
8
 
To 6-phenylpiperidine-2,4-dione (0.12 g, 0.61 mmol) in acetone (3 mL) was added 
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potassium carbonate (0.25 g, 1.84 mmol) and iodomethane (0.11 ml, 1.84 mmol). The 
mixture was stirred at 50 
o
C for 16 h. The solution was filtered and the filtrate was 
evaporated. The resulting yellow solid was purified by flash chromatography (60% 
ethyl acetate/hexane) to give 78 (0.09 g, 65%) as white microprisms, mp 165-168 
o
C 
(lit.
84 
168-169 
o
C); Rf 0.72 (ethyl acetate); IR νmax 3199 (N-H), 2978 (C-H), 1714 (ester 
C=O), 1649 (amide C=O), 1463, 1400, 1325, 768, 700 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.60-7.26 (5H, m, Ph) 6.60 (1H, br s, NH) 4.71 (1H, dd, J= 4.7, 2.5 Hz, C6H) 
2.91 (1H, dd, J= 15.5, 4.7 Hz, C5H) 2.84 (1H, dd, J= 15.5, 2.5 Hz, C5H) 1.39 (3H, s, 
C7H) 1.38 (3H, s, C8H);
 13
C NMR (300 MHz, CDCl3) δ 208.2 (C4) 175.8 (C2) 140.0 
(ArC) 129.3 (ArC) 128.8 (ArC) 126.0 (ArC) 52.1 (C5) 52.0 (C3) 45.3 (C6) 23.1 (C7) 
22.8 (C8). 
Methyl 2-methylmalonate potassium salt (81)
55 
KO OMe
O O
 
To a stirred solution of diethyl 2-methylmalonate (5.00 g, 28.7 mmol) in methanol (100 
mL), potassium hydroxide (2.50 g, 44.6 mmol) was added. The mixture was then 
stirred at room temperature for 16 h and concentrated in vacuo. The residue was 
washed with diethyl ether (2 x 30 mL) to give 81 (2.00 g, 55%) as white microprisms, 
IR νmax 2924 (C-H), 1716 (ester C=O), 1457, 1166, 1085, 877 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) δ 6.56 (1H, br s, OH) 3.76 (3H, s, OCH3) 3.40 (1H, q, J= 7.2 Hz, CHCO) 
1.45 (3H, d, J= 7.2 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 175.0 (COOCH3) 
170.7 (COOH) 52.7 (OCH3) 45.8 (CHCH3) 13.5 (CH3CH). 
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Methyl 3-(2-methoxycarbonylpropionylamino)-3-phenylpropanoate (82)
 
HN
CO2MePh
OMe
O O
 
Following general procedure 2a, reaction of methyl 3-amino-3-phenylpropanoate (0.50 
g, 2.32 mmol) in dichloromethane (6 mL), 1-hydroxybenzotriazole (0.47 g, 3.48 mmol), 
N,N-diisopropylethylamine (1.7 mL, 9.30 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.43 g, 2.32 mmol), 
and methyl 2-methylmalonate (0.92 g, 6.95 mmol) in dichloromethane (8 mL) gave a 
pale yellow oil that was purified by flash chromatography (40% ethyl acetate/hexane) 
to give 82 (0.57 g, 85%) as white microprisms, mp 59-62 
o
C; Rf 0.80 (75% ethyl 
acetate/hexane); IR νmax 3297 (N-H), 2962 (C-H), 1734 (ester C=O), 1649 (amide 
C=O), 1538, 1435, 1165, 915, 699 cm
-1
; 
1
H NMR (300 MHz, CDCl3) (1:1 mixture of 
diastereoisomers) δ 7.55 (1H, br d, J= 7.8 Hz, NH) 7.35-7.23 (5H, m, Ph) 5.45-5.37 
(1H, m, CHCH2CO2CH3) 3.75 (3H, s, OCH3) 3.73 (3H, s, OCH3) 3.61 (3H, s, OCH3) 
3.39-3.30 (1H, m, CHCON) 2.95-2.79 (2H, m, CH2CHN) 1.29-1.20 (3H, m, CH3CH);
 
13
C NMR (300 MHz, CDCl3) δ 172.6 (COOCH3) 172.4 (COOCH3) 171.5 (COOCH3) 
171.4 (COOCH3) 168.2 (CON) 140.3 (ArC) 128.8 (ArC) 128.7 (ArC) 127.7 (ArC) 
127.6 (ArC) 126.2 (ArC) 126.1 (ArC) 52.6 (CHCH2CO2CH3) 51.9 (OCH3) 49.7 (OCH3) 
46.8 (CHCON) 46.7 (CHCON) 40.0 (CH2CHN) 39.9 (CH2CHN) 14.9 (CH3CH) 14.7 
(CH3CH). 
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3-Methoxy-3-methyl-6-phenylpiperidine-2,4-dione (83)
 
HN
O
OPh
1 2
3
4
5
6
CO2Me
7 8
9
 
To 3-methoxy-6-phenylpiperidine-2,4-dione (0.16 g, 0.64 mmol) in THF (2 mL) was 
added tetrabutylammonium fluoride (0.8 mL, 1M in THF) and iodomethane (0.08 mL, 
1.28 mmol). The mixture was stirred at room temperature for 24 h. The solution was 
neutralized with 1M hydrochloric acid and extracted with chloroform. After 
evaporation, the resulting yellow oil was purified by flash chromatography (55% ethyl 
acetate/hexane) to give 83 (0.11 g, 64%) as white microprisms, Rf 0.83 (ethyl acetate); 
1
H NMR (300 MHz, CDCl3) (1:1 mixtures of diastereoisomers) δ 7.47-7.21 (5H, m, Ph) 
6.60 (1H, br s, NH) 4.82-4.49 (1H, m, C6H) 4.69-4.64 (1H, m, C6H) 3.69 (3H, s, C7H) 
3.64 (3H, s, C7H) 3.04-2.90 (2H, m, C5H) 2.82-2.73 (2H, m, C5H) 1.57 (3H, s, C9H) 
1.51 (3H, s, C9H);
 13
C NMR (300 MHz, CDCl3) δ 201.7 (C4) 201.6 (C4) 170.3 (C2) 
169.6 (C2) 167.5 (C7) 167.5 (C7) 139.3 (ArC) 139.2 (ArC) 129.4 (ArC) 129.3 (ArC) 
129.0 (ArC) 128.9 (ArC) 126.2 (ArC) 126.1 (ArC) 63.8 (C3) 63.7 (C3) 53.5 (C8) 53.4 
(C8) 52.4 (C5) 52.0 (C5) 45.7 (C6) 45.7 (C6) 18.3 (C9) 18.3 (C9); m/z (Cl+) 262 (100%, 
M+H
+
); HRMS C14H16NO4 calcd. 262.1074, found 262.1067. 
Methyl malonate potassium salt (123)
 
KO OMe
O O
 
To a stirred solution of ethyl malonate (1.84 g, 11.5 mmol) in methanol (60 mL), 
potassium hydroxide (1.00 g, 17.8 mmol) was added. The mixture was then stirred at 
room temperature for 16 h and concentrated in vacuo. The residue was washed with 
Chapter 1 
94 
 
diethyl ether (2 x 30 mL) to give 123 (1.49 g, 84%) as white microprisms, mp 206-210 
o
C (lit.
85
 204-207 
o
C); IR νmax 2959 (C-H), 1726 (ester C=O), 1594, 1401, 1287, 1227, 
1147, 1023, 875, 700, 611, 569 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 3.67 (3H, s, OCH3) 
3.16 (2H, s, CH2COO);
 13
C NMR (500 MHz, D2O) δ 174.6 (COOK) 172.3 (COOCH3) 
52.9 (OCH3) 44.7 (CH2COO). 
Allyl malonate (90a)
86 
HO O
O O
 
To a stirred solution of malonic acid (5.20 g, 50 mmol) and allyl alcohol (6.8 mL, 100 
mmol) in acetonitrile (150 mL), dicyclohexylcarbodiimide (11.35 g, 11.0 mmol) in 
acetonitrile (50 mL) was added dropwise. The mixture was stirred at room temperature 
for 30 min. The mixture was then filtered and concentrated. The residue was 
redissolved in diethyl ether (250 mL) and extracted with saturated sodium bicarbonate 
solution (2 x 100 mL). The aqueous phase was then acidified with 1M hydrochloric 
acid to pH 1, extracted with ethyl acetate (2 x 200 mL), dried (MgSO4), and evaporated 
to give 90a (4.83 g, 67%) as an orange oil, IR νmax 3400 (N-H), 2952 (C-H), 1713 
(ester C=O), 1649 (C=C), 1412, 1149, 989, 929 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
5.96-5.88 (1H, m, CH=CH2) 5.36 (1H, dd, J= 17.2, 8.5 Hz, CH2=CHCH2O) 5.28 (1H, 
dd, J= 17.2, 10.4 Hz, CH2=CHCH2O) 4.68 (1H, d, J= 5.8 Hz, CH2O) 3.47 (2H, s, 
CH2COO);
 13
C NMR (500 MHz, CDCl3) δ 171.6  (COOH) 166.4 (COOCH2) 131.3 
(CHCH2) 119.2 (CH2CHCH2O) 66.5 (CH2O) 40.9 (CH2COO). 
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Benzyl malonate (90b)
 
HO O
O O  
To a stirred solution of malonic acid (2.08 g, 20.0 mmol) and benzyl alcohol (1.08 g, 
10.0 mmol) in ethyl acetate (20 mL) at -10 °C, dicyclohexylcarbodiimide (2.06 g, 10.0 
mmol) in ethyl acetate (4 mL) was added dropwise. The mixture was stirred at room 
temperature for 16 h. The mixture was then filtered. The filtrate was washed with water 
(20 mL) and extracted with saturated sodium bicarbonate solution (3 x 20 mL). The 
aqueous phase was then acidified with 4M hydrochloric acid, extracted with ethyl 
acetate (3 x 20 mL), dried (MgSO4), and evaporated to give 90b (1.08 g, 26%) as a 
yellow oil, IR νmax 3201 (O-H), 2948 (C-H), 1714 (ester C=O), 1318, 1146, 986, 736, 
695 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.11 (1H, br s, OH) 7.61-7.21 (5H, m, Ph) 
5.21 (2H, s, CH2Ar) 3.48 (2H, s, CH2CO2H);
 13
C NMR (500 MHz, CDCl3) δ 171.1 
(COOH) 166.8 (COOCH2) 135.1 (ArC) 128.7 (ArC) 128.6 (ArC) 127.3 (ArC) 67.7 
(CH2Ar) 41.3 (CH2COO). 
4-Methoxybenzyl malonate (90c)
59 
HO O
O O
OMe
 
To a stirred solution of malonic acid (2.08 g, 20.0 mmol) and 4-methoxybenzyl alcohol 
(1.38 g, 10.0 mmol) in ethyl acetate (20 mL) at -10 °C, dicyclohexylcarbodiimide (2.06 
g, 10.0 mmol) in ethyl acetate (4 mL) was added dropwise. The mixture was stirred at 
room temperature for 16 h. The mixture was then filtered. The filtrate was washed with 
water (20 mL) and extracted with saturated sodium bicarbonate solution (3 x 20 mL). 
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The aqueous phase was then acidified with 4M hydrochloric acid, extracted with ethyl 
acetate (3 x 20 mL), dried (MgSO4), and evaporated. The resulting yellow solid was 
recrystallised from toluene to give 90c (1.23 g, 28%) as white microprisms, mp 72-75 
o
C (lit.
59
 78 
o
C); IR νmax 3351 (N-H), 2957 (C-H), 1715 (ester C=O), 1612 (C=C), 1514, 
1243, 1147, 1029, 816, 517 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.18-7.13 (2H, m, Ph) 
6.74-6.72 (2H, m, Ph) 5.10 (2H, s, CH2Ar) 3.81 (3H, s, OCH3) 3.42 (2H, s, CH2CO2H);
 
13
C NMR (500 MHz, CDCl3) δ 171.0 (COOH) 167.0 (COOCH2) 160.0 (ArC) 130.4 
(ArC) 127.1 (ArC) 114.1 (ArC) 67.6 (CH2Ar) 55.4 (OCH3) 40.7 (CH2COO); m/z (Cl+) 
224 (5%, M+H
+
); HRMS C11H12O5 calcd. 224.0685, found 224.0683. 
tert-Butyl malonate (90d)
58 
HO OtBu
O O
 
To a stirred solution of malonic acid (1.04 g, 10.0 mmol) and tert-butanol (1.48 g, 20.0 
mmol) in acetonitrile (50 mL), dicyclohexylcarbodiimide (2.27 g, 11.0 mmol) in 
acetonitrile (10 mL) was added dropwise. The mixture was stirred at room temperature 
for 30 min. The mixture was then filtered and concentrated. The residue was 
redissolved in diethyl ether (20 mL) and extracted with saturated sodium bicarbonate 
solution (3 x 20 mL). The aqueous phase was then acidified with 1M hydrochloric acid 
to pH 1, extracted with ethyl acetate (3 x 20 mL), dried (MgSO4), and evaporated to 
give 90d (1.31 g, 75%) as a colourless oil, IR νmax 3220 (O-H), 2980 (C-H), 1712 
(ester C=O), 1369, 1327, 1140, 835 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 3.30 (2H, s, 
CH2COO) 1.49 (9H, s, (CH3)3C);
 13
C NMR (500 MHz, CDCl3) δ 83.6 (C(CH3)3) 41.1 
(CH2COO) 28.0 ((CH3)3C). 
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Methyl 3-[2-(allyloxycarbonyl)acetylamino]-3-phenylpropanoate (89a)
 
HN
CO2Me
Ph
O
O O
 
Following general procedure 2a, reaction of methyl 3-amino-3-phenylpropanoate 
hydrochloride (1.00 g, 4.65 mmol) in dichloromethane (13 mL), 
1-hydroxybenzotriazole (0.94 g, 7.00 mmol), N,N-diisopropylethylamine (3.6 mL, 
20.90 mmol), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.85 g, 
4.65 mmol), and allyl malonate (2.00 g, 13.94 mmol) in dichloromethane (13 mL) gave 
a pale yellow solid that was purified by flash chromatography (50% ethyl 
acetate/hexane) to give 89a (1.09 g, 77%) as a colourless oil, Rf 0.75 (75% ethyl 
acetate/hexane); 
1
H NMR (500 MHz, CDCl3) δ 8.01 (1H, br d, J= 7.9 Hz, NH) 
7.34-7.25 (5H, m, Ph) 5.92-5.91 (1H, m, =CHCH2O) 5.46-5.45 (1H, m, 
CHCH2CO2CH3) 5.33 (1H, ddd, J= 17.2, 7.8, 1.4 Hz, CH2=CHCH2O) 5.27 (1H, ddd, 
J= 17.2, 11.6, 1.4 Hz, CH2=CHCH2O) 4.66-4.64 (1H, m, CH2O) 3.62 (3H, s, OCH3) 
3.37 (2H, s, CH2CONH) 2.92-2.87 (1H, m, CH2CHN) 2.86-2.85 (1H, m, CH2CHN);
 
13
C NMR (500 MHz, CDCl3) δ 171.3 (COOCH3) 169.0 (COOCH2) 164.2 (CON) 140.3 
(ArC) 131.4 (CHCH2O) 128.8 (ArC) 127.8 (ArC) 126.3 (ArC) 119.3 (CH2CHCH2O) 
66.2 (CH2O) 51.9 (OCH3) 49.8 (CHCH2CO2Me) 41.3 (CH2CHN) 40.2 (CH2CON); 
m/z (Cl+) 306 (100%, M+H
+
); HRMS C16H20NO5 calcd. 306.1342, found 306.1343. 
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Methyl 3-[2-(4-methoxybenzyloxycarbonyl)acetylamino]-3-phenylpropanoate 
(89b)
 
HN
CO2Me
Ph
O
O O
OMe 
Following general procedure 2a, reaction of methyl 3-amino-3-phenylpropanoate 
hydrochloride (0.48 g, 2.23 mmol) in dichloromethane (7 mL), 1-hydroxybenzotriazole 
(0.45 g, 3.40 mmol), N,N-diisopropylethylamine (1.6 mL, 8.90 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.41 g, 2.20 mmol), 
and 4-methoxybenzyl malonate (1.00 g, 4.46 mmol) in dichloromethane (6 mL) gave a 
pale yellow solid that was purified by flash chromatography (60% ethyl acetate/hexane) 
to give 89b (0.68 g, 79%) as a yellow oil, Rf 0.76 (75% ethyl acetate/hexane); IR νmax 
3295 (N-H), 2953 (C-H), 1732 (ester C=O), 1649 (amide C=O), 1514, 1244, 1152, 
1029, 823, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.98 (1H, br d, J= 7.7 Hz, NH) 
7.50-7.26 (7H, m, Ph) 6.90-6.88 (2H, m, Ph) 5.47-5.42 (1H, m, CHCH2CO2CH3) 5.12 
(2H, s, CH2Ar) 3.81 (3H, s, OCH3) 3.63 (3H, s, OCH3) 3.36 (2H, s, CH2CON) 2.96 
(1H, dd, J= 15.7, 4.6 Hz, CH2CHN) 2.82 (1H, dd, J= 15.7, 6.2 Hz, CH2CHN);
 13
C 
NMR (500 MHz, CDCl3) δ 171.9 (COOCH3) 169.2 (COOCH2) 164.2 (CON) 160.0 
(ArC) 140.3 (ArC) 130.4 (ArC) 128.8 (ArC) 127.7 (ArC) 127.2 (ArC) 126.3 (ArC) 
114.1 (ArC) 67.3 (CH2Ar) 55.4 (OCH3) 51.9 (OCH3) 49.9 (CHCH2CO2CH3) 41.4 
(CH2CHN) 40.2 (CH2CON). 
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Methyl 3-(2-tert-butoxycarbonyacetylamino)-3-phenylpropanoate (89c)
 
HN
CO2Me
Ph
OtBu
O O
 
Following general procedure 2a, reaction of methyl 3-amino-3-phenylpropanoate 
hydrochloride (0.48 g, 2.23 mmol) in dichloromethane (7 mL), 1-hydroxybenzotriazole 
(0.45 g, 3.40 mmol), N,N-diisopropylethylamine (1.6 mL, 8.90 mmol), 
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.41 g, 2.20 mmol), 
and tert-butyl malonate (0.78 g, 4.50 mmol) in dichloromethane (6 mL) gave a pale 
yellow solid that was purified by flash chromatography (50% ethyl acetate/hexane) to 
give 89c (0.57 g, 80%) as white microprisms, mp 60-62 
o
C; Rf 0.87 (75% ethyl 
acetate/hexane); IR νmax 3293 (N-H), 2979 (C-H), 1730 (ester C=O), 1649 (amide 
C=O), 1539, 1367, 1256, 1143, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.93 (1H, br d, 
J= 8.3 Hz, NH) 7.26-7.16 (5H, m, Ph) 5.41-5.37 (1H, m, CHCH2CO2CH3) 3.68 (3H, s, 
OCH3) 3.19 (2H, s, CH2CON) 2.87 (1H, dd, J= 15.6, 6.5 Hz, CH2CHN) 2.77 (1H, dd, 
J= 15.6, 4.8 Hz, CH2CHN) 1.40 (9H, s, (CH3)3C);
 13
C NMR (500 MHz, CDCl3) δ 
171.1 (COOCH3) 168.2 (COOCC) 165.0 (CON) 140.6 (ArC) 128.9 (ArC) 127.6 (ArC) 
126.4 (ArC) 82.3 (C(CH3)3) 51.7 (CHCH2CO2CH3) 49.8 (OCH3) 42.6 (CH2CON) 40.3 
(CH2CHN) 28.0 ((CH3)3C). 
Methyl 3-phenyl-3-propionylaminopropanoate (89d)
 
HN
CO2MePh
O
 
To a stirred solution of methyl 3-amino-3-phenylpropanoate hydrochloride (0.50 g, 
2.32 mmol) in dichloromethane (8 mL) at 0 
o
C under nitrogen, triethylamine (0.78 mL, 
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5.58 mmol) and 1-chloro-1-oxopropane (0.27 mL, 3.02 mmol) was added. The mixture 
was then allowed to warm to room temperature and stirred for 1 h. The mixture was 
diluted with dichloromethane (30 mL) and washed with saturated aqueous sodium 
hydrogen carbonate (10 mL). The aqueous layer was extracted with dichloromethane 
(2 x 10 mL) and the combined organic layers were dried (MgSO4) and evaporated. The 
resulting pale yellow oil was purified by flash chromatography (60% ethyl 
acetate/hexane) to give 89d (0.49 g, 90%) as white microprisms, mp 60-64 
o
C; Rf 0.18 
(50% ethyl acetate/hexane); IR νmax 3280 (N-H), 2951 (C-H), 1736 (ester C=O), 1643 
(amide C=O), 1536, 1435, 1230, 1164, 761, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.29-7.16 (5H, m, Ph) 7.01 (1H, br d, J= 8.2 Hz, NH) 5.42-5.22 (1H, m, CHPh) 3.55 
(3H, s, OCH3) 2.86 (1H, dd, J= 15.6, 4.7 Hz, CH2CHN) 2.75 (1H, dd, J= 15.6, 6.5 Hz, 
CH2CHN) 2.14 (2H, q, J= 7.6 Hz, CH2CON) 1.09 (3H, t, J= 7.6 Hz, CH3CH2CO);
 13
C 
NMR (300 MHz, CDCl3) δ 173.3 (COOCH3) 171.6 (CONH) 140.9 (ArC) 128.6 (ArC) 
127.5 (ArC) 126.3 (ArC) 51.7 (OCH3) 49.5 (CHPh) 40.0 (CH2COO) 29.6 (CH2CON) 
9.8 (CH3CH2CON). 
 (S)-(3,4-Dimethoxybenzyl)-(1-phenylethyl)amine (95)
87 
OMe
OMe
N
H
 
(S)-1-Phenylethylamine (4.6 mL, 35.5 mmol) was added at 50 
o
C in a thin stream to a 
solution of 3,4-dimethoxybenzaldehyde (6.00 g, 36.0 mmol) in methanol (21.4 mL). 
The mixture was stirred for 1 h at the same temperature. Then sodium borohydride 
(0.81 g, 37.8 mmol) was added to the mixture at 25 
o
C and was stirred for 16 h. The 
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mixture was extracted by toluene (2 x 60 mL) and evaporated to give 95 (8.89 g, 97%) 
as a colourless oil, Rf 0.44 (ethyl acetate); IR νmax 3211 (N-H), 2958 (C-H), 1611 
(C=C), 1587, 1504, 1437, 1286, 1154, 1132, 760, 699 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.60-7.31 (3H, m, Ph) 7.28-7.17 (2H, m, Ph) 6.86-6.80 (3H, m, Ph) 3.88 (3H, 
s, OCH3) 3.84 (3H, s, OCH3) 3.80 (1H, q, J= 6.6 Hz, CHAr) 3.68 (1H, d, J= 17.3 Hz, 
CH2Ar) 3.60 (1H, d, J= 17.3 Hz, CH2Ar) 1.69 (1H, s, NH) 1.31 (3H, d, J= 6.6 Hz, 
CH3CH); 
13
C NMR (300 MHz, CDCl3) δ 148.9 (ArC) 148.0 (ArC) 145.7 ArC) 133.4 
(ArC) 128.5 (ArC) 127.0 (ArC) 126.7 (ArC) 120.2 (ArC) 111.5 (ArC) 111.1 (ArC) 
57.5 (CH2NH) 55.9 (CH3O) 55.8 (CH3O) 51.5 (CHAr) 21.5 (CH3CH). 
(R)-Methyl 3-{(3,4-dimethoxybenzyl)-[(1S)-1-phenylethyl]amino}hex-4-enoate 
(104)
43 
MeO2C
N Ph
OMe
OMe
 
Following general procedure 4, reaction of (S)-(3,4-dimethoxybenzyl) 
(1-phenylethyl)amine (2.79 g, 10.3 mmol) in anhydrous THF (10 mL), n-butyllithium 
(1.6 M in hexanes, 6.2 mL, 9.95 mmol), and (E,E)-methyl hexa-2,4-dienoate (0.81 g, 
6.42 mmol) in anhydrous THF (10 mL) gave a pale yellow oil that was purified by 
flash chromatography (20% ethyl acetate/hexane) to give 104 (0.49 g, 19%) as a pale 
yellow oil, Rf 0.54 (30% ethyl acetate/hexane); IR νmax 2935 (C-H), 1734 (ester C=O), 
1512, 1449, 1260, 1133, 1027, 970, 765, 699 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.60-7.12 (5H, m, Ph) 6.91 (1H, s, Ph) 6.79 (2H, q, J= 8.3 Hz, Ph) 5.64-5.48 (2H, m, 
CH=CHCHN + CH=CHCH3) 4.00 (1H, q, J= 6.7 Hz, CHAr) 3.86 (3H, s, OCH3) 3.81 
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(3H, s, OCH3) 3.78 (1H, dd, J= 7.3 Hz, CHCH2CO2CH3) 3.71 (1H, d, J= 14.3 Hz, 
CH2Ar) 3.44 (1H, d, J= 8.2, 7.3 Hz, CH2Ar) 3.44 (3H, s, CH3OOC) 2.53 (2H, dd, J= 
14.6, 8.2 Hz, CH2CO2CH3) 2.28 (2H, dd, J= 14.6, 7.3 Hz, CH2CO2CH3) 1.71 (3H, d, 
J= 4.9 Hz, CH3CH=CH) 1.38 (3H, d, J= 6.7 Hz, CH3CHAr). 
(S)-(1-Phenylethyl)(prop-2-enyl)amine (105)
88 
Ph N
H  
To a solution of (S)-1-phenylethylamine (6.06 g, 60.0 mmol) in anhydrous THF (150 
mL) at -78 
o
C under nitrogen, n-butyllithium (1.6 M in hexanes, 41.3 mL, 66.0 mmol) 
and allyl bromide (6.8 mL, 62.0 mmol) was added dropwise via syringe. The solution 
was stirred at -78 
o
C for 3 h and at room temperature for 15 h. The mixture was 
quenched with water (20 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic layers were dried (Na2SO4), and evaporated. The resulting pale 
yellow oil was purified by flash chromatography (30% ethyl acetate/hexane) to give 
105 (8.27 g, 86%) as a pale yellow oil, Rf 0.55 (50% ethyl acetate/hexane); IR νmax 
3062 (N-H), 2972 (C-H), 1642 (C=C), 1449, 1119, 993, 914, 756, 698 cm
-1
; [α]25D = 
-50.2 (c 0.98, CH2Cl2) (lit.
89
 [α]25D = -58.8 c 1.04, CH2Cl2); 
1
H NMR (300 MHz, 
CDCl3) δ 7.36-7.08 (5H, m, Ph) 5.96-5.82 (1H, m, CH=CH2) 5.15-5.05 (2H, m, 
CH2=CHCH2NH) 3.80 (1H, q, J= 6.6 Hz, CHCH3) 3.10 (2H, d, J= 5.9 Hz, CH2CH=) 
1.51 (1H, br s, NH) 1.36 (3H, d, J= 6.6 Hz, CH3CH); 
13
C NMR (500 MHz, CDCl3) δ 
145.6 (ArC) 137.1 (CHCH2) 128.5 (ArC) 127.2(ArC) 126.7 (ArC) 115.8 (CHCH2) 
57.6 (CHPh) 50.3 (CH2NH) 24.3 (CH3CH).  
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(E)-Methyl 4-methylpent-2-enoate (103b)
64 
OMe
O
 
Isobutyraldehyde (2 mL, 22.0 mmol) was added dropwise to a solution of 
carbomethoxymethylene triphenylphosphorane (6.44 g, 25.2 mmol) in 
dichloromethane (20 mL) at 0 
o
C. The mixture was stirred for 16 h at room temperature, 
then evaporated. Hexane (20 mL) was added and the solid was filtered off. The filtrate 
was evaporated to give 103b (1.30 g, 46%) as a colourless oil, IR νmax 2961 (C-H), 
1721 (ester C=O), 1656 (alkenyl C=C), 1436, 1287, 1168, 982, 723, 541 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 6.95 (1H, dd, J= 15.0, 6.7 Hz, CH=CHCOO) 5.77 (1H, dd, 
J= 15.0, 1.5 Hz, =CHCOO) 3.71 (3H, s, CH3O) 2.49-2.42 (1H, m, CHCH3) 1.06 (6H, d, 
J= 6.7 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 167.6 (COOCH3) 155.9 
(CHCHCOO) 118.3 (CHCOO) 51.5 (OCH3) 31.0 (CHCH3) 21.3 (CH3CH). 
(E,E)-Methyl hexa-2,4-dienoate (103c)
63 
MeO2C  
A solution of chlorotrimethylsilane (12 mL, 2M) was added dropwise to a solution of 
sorbic acid (1.12 g, 10.0 mmol) in dry methanol (10 mL) via a cannula. The mixture 
was stirred for 16 h, then evaporated. The resulting pale yellow oil was purified by 
flash chromatography (30% ethyl acetate/hexane) to give 103c (1.05 g, 99%) as a 
colourless oil, Rf 0.71 (30% ethyl acetate/hexane); IR νmax 2951 (C-H), 1715 (ester 
C=O), 1644 (C=C), 1434, 1329, 1242, 1137, 996 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.33-7.15 (1H, m, CH=CHCOO) 6.19-6.06 (2H, m, =CHCH3 + CH=CHCH3) 5.76 (1H, 
d, J= 15.4 Hz, =CHCOO) 3.85 (3H, s, CH3O) 1.84 (3H, d, J= 5.3 Hz, CH3CH). 
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(E)-Methyl 3-cyclohexylprop-2-enoate (103d)
65 
OMe
O
 
Cyclohexanecarboxaldehyde (2 mL, 16.5 mmol) was added to a solution of 
carbomethoxymethylene triphenylphosphorane (6.07 g, 18.2 mmol) in toluene (40 mL). 
The mixture was heated under reflux for 16 h and then quenched with water (20 mL), 
extracted with diethyl ether (2 x 20 mL), dried (MgSO4), and evaporated. Hexane (20 
mL) was added and the solid was filtered off. The filtrate was evaporated to give 103d 
(2.03 g, 73%) as a pale yellow oil, IR νmax 2924 (C-H), 1721 (ester C=O), 1652 
(alkenyl C=C), 1447, 1312, 1167, 982, 721, 541 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
6.92 (1H, dd, J= 15.8, 6.8 Hz, CH=CHCOO) 5.76 (1H, dd, J= 15.8, 1.4 Hz, =CHCOO) 
3.73 (3H, s, CH3O) 2.14-2.12 (1H, m, 1'-cyclohexyl-CH) 1.76-1.73 (5H, m, 
cyclohexyl-CH2) 1.30-1.12 (5H, m, cyclohexyl-CH2);
 13
C NMR (500 MHz, CDCl3) δ 
167.7 (COOCH3) 154.7 (CHCHCOO) 118.5 (CHCOO) 51.5 (OCH3) 40.5 
(1'-cyclohexyl-C) 31.7 (2'- and 6'-cyclohexyl-C) 26.0 (3'- and 5'-cyclohexyl-C) 25.8 
(4'-cyclohexyl-C). 
(E)-Methyl 3-(pyridin-3-yl)propenoate (103f)
66 
OMe
O
N 1
2
3
4
5
6
7
 
To 3-pyridinecarboxaldehyde (1.5 mL, 16.0 mmol) in saturated sodium hydrogen 
carbonate solution (32 mL) was added triphenylphosphine (6.30 g, 24.0 mmol) and 
methyl bromoacetate (2.4 mL, 26.0 mmol). The mixture was stirred for 24 h at room 
temperature. The mixture was then filtered and the filtrate was extracted with diethyl 
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ether (2 x 30 mL), washed with brine (15 mL), dried (MgSO4) and evaporated. The 
resulting oil was purified by flash chromatography (40% ethyl acetate/hexane) to give 
103f (0.84 g, 32%) as an orange oil; Rf 0.20 (30% ethyl acetate/hexane); IR νmax 2950 
(C-H), 1713 (ester C=O), 1638 (alkenyl C=C), 1435, 1119, 805, 720, 541 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 8.73 (1H, s, C1H) 8.57 (1H, d, J= 4.5 Hz, C5H) 7.82 (1H, d, 
J= 7.9 Hz, C3H) 7.70 (1H, d, J= 19.8 Hz, C6H) 7.33-7..26 (1H, m, C4H) 6.53 (1H, d, 
J= 19.8 Hz, C7H) 3.81 (3H, s, OCH3);
 13
C NMR (500 MHz, CDCl3) δ 166.8 (COOCH3) 
152.1 (C1) 149.1 (C5) 141.2 (C6) 134.3 (C3) 130.2 (C2) 123.8 (C7) 120.1 (C4) 52.0 
(CH3O). 
(R)-Methyl 3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})butanoate (106a)
 
N
CO2Me
Ph
 
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(2.15 g, 13.3 mmol) in anhydrous THF (18 mL), n-butyllithium (1.6 M in hexanes, 8.0 
mL, 12.9 mmol), and methyl but-2-enoate (0.83 g, 8.30 mmol) in anhydrous THF (9 
mL) gave a pale yellow oil that was purified by flash chromatography (15% ethyl 
acetate/hexane) to give 106a (1.85 g, 85%) as a pale yellow oil, Rf 0.40 (15% ethyl 
acetate/hexane); [α]21D = +18.7 (c 0.75, CHCl3); IR νmax 2970 (C-H), 1737 (ester C=O), 
1463, 1295, 1200, 700; 
1
H NMR (500 MHz, CDCl3) δ 7.37-7.20 (5H, m, Ph) 5.87-5.82 
(1H, m, =CHCH2N) 5.15 (1H, dd, J= 17.2, 10.4 Hz, CH2=CHCH2N) 5.04 (1H, dd, J= 
17.2, 4.6 Hz, CH2=CHCH2N) 3.97 (1H, q, J= 6.8 Hz, CHPh) 3.56 (3H, s, OCH3) 
3.51-3.47 (1H, m, CHCH2CO2CH3) 3.18 (2H, d, J= 6.3 Hz, CH2N) 2.40 (1H, dd, J= 
14.2, 7.0 Hz, CH2CO2CH3) 2.19 (1H, dd, J= 14.2, 7.5 Hz, CH2CO2CH3) 1.37 (3H, d, 
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J= 6.8 Hz, CH3CHPh) 1.07 (3H, d, J= 6.7 Hz, CH3CHCH2);
 13
C NMR (500 MHz, 
CDCl3) δ 172.9 (COOCH3) 145.2 (ArC) 139.2 (CHCH2N) 128.1 (ArC) 127.6 (ArC) 
126.8 (ArC) 115.6 (CH2CHCH2N) 57.7 (CHPh) 51.4 (CHCH2COO) 50.6 (CH2N) 48.6 
(OCH3) 40.4 (CH2COO) 18.8 (CH3CHN) 17.5 (CH3CHN). 
(R)-Methyl 4-methyl-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})pentanoate 
(106b)
7 
N
CO2Me
Ph
 
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(2.22 g, 13.7 mmol) in anhydrous THF (28 mL), n-butyllithium (2.5 M in hexanes, 5.3 
mL, 13.3 mmol), and methyl 4-methylpent-2-enoate (1.10 g, 8.58 mmol) in anhydrous 
THF (22 mL) gave a pale yellow oil that was purified by flash chromatography (12% 
ethyl acetate/hexane) to give 106b (1.70 g, 69%) as a pale yellow oil, Rf 0.75 (30% 
ethyl acetate/hexane); [α]21D = +18.00 (c 5.00, CHCl3); IR νmax 2969 (C-H), 1736 (ester 
C=O), 1452, 1195, 1158, 914, 701; 
1
H NMR (500 MHz, CDCl3) δ 7.31-7.21 (5H, m, 
Ph) 5.96-5.85 (1H, m, =CHCH2N) 5.22-5.17 (1H, m, CH2=CHCH2N) 5.08-5.06 (1H, 
m, CH2=CHCH2N) 3.91 (1H, q, J= 7.1 Hz, CHPh) 3.58 (3H, s, OCH3) 3.20-3.17 (1H, 
m, CHCH2CO2CH3) 3.09-3.06 (2H, m, CH2N) 2.11 (1H, dd, J= 15.6, 7.8 Hz, 
CH2CO2CH3) 2.02 (1H, dd, J= 15.6, 4.0 Hz, CH2CO2CH3) 1.70-1.67 (1H, m, 
CH(CH3)2) 1.43 (3H, d, J= 7.1 Hz, CH3CHPh) 0.98 (3H, d, J= 6.7 Hz, (CH3)2CHCH) 
0.81 (3H, d, J= 6.7 Hz, (CH3)2CHCH);
 13
C NMR (500 MHz, CDCl3) δ 174.0 
(COOCH3) 143.9 (ArC) 139.2 (CHCH2N) 128.3 (ArC) 127.9 (ArC) 126.8 (ArC) 115.4 
(CH2CHCH2N) 59.8 (CHCH2COO) 58.9 (CHPh) 51.4 (CH2N) 49.7 (OCH3) 35.0 
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(CH2COO) 32.8 (CH(CH3)2) 21.0 ((CH3)2CH) 20.9 ((CH3)2CH) 19.8 (CH3CHN); m/z 
(Cl+) 290 (40%, M+H
+
) 246 (100%, M+H
+
-C3H7) 105 (30%, C9H9
+
); HRMS 
C18H28NO2 calcd. 290.2120, found 290.2123. 
(R)-Methyl 3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})hex-4-enoate (106c)
61 
Ph N
CO2Me 
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(3.00 g, 18.6 mmol) in anhydrous THF (15 mL), n-butyllithium (1.6 M in hexanes, 
11.3 mL, 18.0 mmol), and (E,E)-methyl hexa-2,4-dienoate (1.47 g, 11.6 mmol) in 
anhydrous THF (15 mL) gave a pale yellow oil that was purified by flash 
chromatography (10% ethyl acetate/hexane) to give 106c (2.61 g, 78%) as a pale 
yellow oil, Rf 0.79 (30% ethyl acetate/hexane); [α]
21
D = +3.4 (c 2.95, CHCl3) (lit.
61
 
opposite enantiomer [α]13D = -2.4 c 1.00, CHCl3); IR νmax 2970 (C-H), 1736 (ester 
C=O), 1436 , 1172, 993, 876, 699 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.35-7.17 (5H, 
m, Ph) 5.85-5.72 (1H, m, =CHCH2N) 5.53-5.49 (2H, m, CH=CHCHN + =CHCHN) 
5.12-5.00 (2H, m, CH2=CHCH2N) 4.02 (1H, q, J= 6.8 Hz, CHPh) 3.88-3.81 (1H, m, 
CHCH2CO2CH3) 3.56 (3H, s, OCH3) 3.16-3.09 (2H, m, CH2N) 2.51 (1H, dd, J= 14.3, 
5.8 Hz, CH2CO2CH3) 2.34 (1H, dd, J= 14.3, 7.5 Hz, CH2CO2CH3) 1.69 (3H, d, J= 4.6 
Hz, CH3CH=CH) 1.35 (3H, d, J= 6.8 Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 
172.5 (COOCH3) 145.2 (ArC) 138.8 (CHCH2N) 130.6 (CHCHN) 128.0 (ArC) 127.6 
(ArC) 127.1 (ArC) 126.5 (CHCHCHN) 115.7 (CH2CHCH2N) 56.9 (CHPh) 56.8 
(CHCH2COO) 51.4 (CH2N) 49.6 (OCH3) 38.9 (CH2COO) 18.1 (CH3CHN) 18.0 
(CH3CHCHCHN). 
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(R)-Methyl 3-cyclohexyl-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})propanoate 
(106d)
 
N
CO2Me
Ph
 
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(2.76 g, 17.1 mmol) in anhydrous THF (34 mL), n-butyllithium (2.5 M in hexanes, 6.6 
mL, 16.6 mmol), and methyl 3-cyclohexylpropenoate (1.80 g, 10.7 mmol) in 
anhydrous THF (27 mL) gave a pale yellow oil that was purified by flash 
chromatography (12% ethyl acetate/hexane) to give 106d (2.40 g, 68%) as a pale 
yellow oil, Rf 0.87 (30% ethyl acetate/hexane); [α]
25
D = +11.0 (c 6.69, CHCl3); IR νmax 
2923 (C-H), 1735 (ester C=O), 1449, 1171, 1156, 914, 701; 
1
H NMR (500 MHz, 
CDCl3) δ 7.30-7.19 (5H, m, Ph) 5.86-5.84 (1H, m, =CHCH2N) 5.21-5.17 (1H, m, 
CH2=CHCH2N) 5.08-5.06 (1H, m, CH2=CHCH2N) 3.90 (1H, q, J= 7.0 Hz, CHPh) 
3.57 (3H, s, OCH3) 3.17-3.12 (2H, m, CHCH2CO2CH3 + CH2N) 3.07-3.05 (1H, m, 
CH2N) 2.17-2.08 (2H, m, CH2CO2CH3 + 1'-cyclohexyl-CH) 2.00 (1H, dd, J= 15.7, 3.7 
Hz, CH2CO2CH3) 1.57-1.42 (4H, m, cyclohexyl-CH2) 1.39 (3H, d, J= 7.0 Hz, 
CH3CHPh) 1.17-1.12 (4H, m, cyclohexyl-CH2) 0.88-0.76 (2H, m, 4'-cyclohexyl-CH);
 
13
C NMR (500 MHz, CDCl3) δ 174.0 (COOCH3) 143.9 (ArC) 139.2 (CHCH2N) 128.3 
(ArC) 127.9 (ArC) 126.8 (ArC) 115.4 (CH2CHCH2N) 58.8 (CHPh) 51.4 (OCH3) 49.8 
(CH2N) 42.7 (CHCH2COO) 34.7 (CH2COO) 31.1 (1'-cyclohexyl-C) 30.2 
(4'-cyclohexyl-C) 27.0 (2'- and 6'-cyclohexyl-C) 26.6 (3'- and 5'-cyclohexyl-C) 21.0 
(CH3CHPh); m/z (Cl+) 330 (20%, M+H
+
) 246 (100%, M-C7H11
+
); HRMS C21H32NO2 
calcd. 330.2433, found 330.2439. 
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(R)-Methyl 3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})-3-phenylpropanoate 
(106e)
 
Ph N
CO2Me
Ph  
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(1.59 g, 9.86 mmol) in anhydrous THF (20 mL), n-butyllithium (2.5 M in hexanes, 3.8 
mL, 9.56 mmol), and methyl trans-cinnamate (1.00 g, 6.17 mmol) in anhydrous THF 
(16 mL) gave a pale yellow oil that was purified by flash chromatography (10% ethyl 
acetate/hexane) to give 106e (1.80 g, 90%) as a pale yellow oil, Rf 0.50 (15% ethyl 
acetate/hexane); [α]21D = +1.5 (c 4.10, CHCl3); IR νmax 2973 (C-H), 1736 (ester C=O), 
1451, 1167, 914, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.55-7.33 (10H, m, Ph) 
5.85-5.72 (1H, m, =CHCH2N) 5.17 (1H, ddd, J= 17.2, 8.6, 1.4 Hz, CH2=CHCH2N) 
5.08 (1H, ddd, J= 17.2, 10.1, 1.4 Hz, CH2=CHCH2N) 4.55-4.52 (1H, m, 
CHCH2CO2CH3) 4.08 (1H, q, J= 6.7 Hz, CHCH3) 3.57 (3H, s, OCH3) 3.22-3.18 (2H, 
m, CH2N) 2.91 (1H, dd, J= 14.6, 5.6 Hz, CH2CO2CH3) 2.69 (1H, dd, J= 14.6, 8.3 Hz, 
CH2CO2CH3) 1.18 (3H, d, J= 6.7 Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 
172.5 (COOCH3) 144.9 (ArC) 141.5 (ArC) 138.8 (CHCH2N) 128.4 (ArC) 128.1 (ArC) 
127.7 (ArC) 127.5 (ArC) 127.3 (ArC) 126.7 (ArC) 116.0 (CH2CHCH2N) 58.9 (CHCH3) 
56.3 (CHCH2COO) 51.5 (CH2N) 49.8 (OCH3) 38.0 (CH2COO) 16.6 (CH3CHN); m/z 
(Cl+) 324 (100%, M+H
+
); HRMS C12H25NO2 calcd. 324.1964, found 324.1958.). 
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(R)-Methyl 
3-(pyridin-3-yl)-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino}propanoate (106f)
 
N
CO2Me
Ph
N  
Following general procedure 4, reaction of (S)-(1-phenylethyl)(prop-2-enyl)amine 
(0.95 g, 4.09 mmol) in anhydrous THF (10 mL), n-butyllithium (2.5 M in hexanes, 1.9 
mL, 4.75 mmol), and methyl 3-(pyridin-3-yl)propenoate (0.50 g, 3.06 mmol) in 
anhydrous THF (5 mL) gave a pale yellow oil that was purified by flash 
chromatography (50% ethyl acetate/hexane) to give 106f (0.52 g, 48%) as a yellow oil, 
Rf 0.65 (75% ethyl acetate/hexane); [α]
21
D = -0.6 (c 1.70, CHCl3); IR νmax 2972 (C-H), 
1735 (ester C=O), 1434, 1202, 1167, 1024, 701; 
1
H NMR (500 MHz, CDCl3) δ 8.61 
(1H, s, aryl) 8.51-8.49 (1H, m, aryl) 7.67 (1H, d, J= 7.9 Hz, aryl) 7.37-7.22 (6H, m, 
aryl + Ph) 5.80-5.75 (1H, m, =CHCH2N) 5.16 (2H, ddd, J= 17.2, 4.8, 1.5 Hz, 
CH2=CHCH2N) 5.07 (2H, ddd, J= 17.2, 10.2, 1.5 Hz, CH2=CHCH2N) 4.55-4.52 (1H, 
m, CHCH2CO2CH3) 4.02 (1H, q, J= 6.8 Hz, CHPh) 3.55 (3H, s, OCH3) 3.19-3.13 (2H, 
m, CH2N) 2.81 (1H, dd, J=15.2, 6.0 Hz, CH2CO2CH3) 2.67 (1H, dd, J=15.2, 9.0 Hz, 
CH2CO2CH3) 1.23 (3H, d, J= 6.8 Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 
172.0 (COOCH3) 149.7 (ArC) 148.6 (ArC) 144.2 (ArC) 138.2 (ArC) 137.2 (ArC) 
135.3 (CHCH2N) 128.3 (ArC) 127.5 (ArC) 127.0 (ArC) 123.3 (ArC) 116.4 
(CH2CHCH2N) 56.9 (CHPh) 56.6 (OCH3) 51.7 (CHCH2COO) 49.8 (CH2N) 36.7 
(CH2COO) 17.6 (CH3CHN). 
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 (R)-Methyl 3-{[(1S)-1-phenylethyl]amino}butanoate (107a)
 
NH
CO2Me
Ph
 
Following general procedure 5, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})butanoate (1.00 g, 3.83 mmol), and 
Wilkinson’s catalyst (180 mg, 0.19 mmol) in acetonitrile/water (20 mL) gave a pale 
yellow oil that was purified by flash chromatography (15% ethyl acetate/hexane) to 
give 107a (0.73 g, 87%) as a pale brown oil, Rf 0.25 (30% ethyl acetate/hexane); [α]
21
D 
= -22.5 (c 1.29, CHCl3); IR νmax 2960 (N-H), 2923 (C-H), 1731 (ester C=O), 1436, 
1192, 1119, 699, 540; 
1
H NMR (500 MHz, CDCl3) δ 7.69-7.22 (5H, m, Ph) 3.87 (1H, q, 
J= 6.6 Hz, CHCH3) 3.66 (3H, s, OCH3) 3.02-2.97 (1H, m, CHCH2CO2CH3) 2.48-2.44 
(1H, m, CH2CO2CH3) 2.39-2.35 (1H, m, CH2CO2CH3) 1.68 (1H, br s, NH) 1.33 (3H, d, 
J= 6.6 Hz, CH3CHPh) 1.06 (3H, d, J= 6.7 Hz, CH3CHCH2);
 13
C NMR (500 MHz, 
CDCl3) δ 172.8 (COOCH3) 132.0 (ArC) 128.6 (ArC) 127.0 (CHCH2N) 126.6 (ArC) 
55.3 (CHCH3) 51.5 (OCH3) 47.8 (CHCH2COO) 40.6 (CH2COO) 24.6 (CH3CHCH2) 
21.5 (CH3CHAr). 
(R)-Methyl 4-methyl-3-[(1S)-1-phenylethylamino]pentanoate (107b)
 
NH
CO2Me
Ph
 
Following general procedure 5, reaction of (R)-methyl 
4-methyl-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})pentanoate (1.50 g, 5.18 mmol), 
and Wilkinson’s catalyst (0.24 g, 0.26 mmol) in acetonitrile/water (30 mL) gave a pale 
yellow oil that was purified by flash chromatography (18% ethyl acetate/hexane) to 
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give 107b (0.77 g, 59%) as a pale yellow oil, Rf 0.66 (30% ethyl acetate/hexane); 
[α]21D = -48.1 (c 2.35, CHCl3); IR νmax 2957 (C-H), 1733 (ester C=O), 1436, 1265, 
1168, 761, 701; 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.20 (5H, m, Ph) 3.86-3.81 (1H, m, 
CHCH2CO2CH3) 3.67 (3H, s, OCH3) 2.65 (1H, q, J= 6.3 Hz, CHPh) 2.45 (1H, dd, J= 
14.6, 9.0 Hz, CH2CO2CH3) 2.37 (1H, dd, J= 14.6, 5.5 Hz, CH2CO2CH3) 1.70-1.64 (1H, 
m, CH(CH3)2) 1.31 (3H, d, J= 6.3 Hz, CH3CHPh) 0.87 (3H, d, J= 6.9 Hz, CH3CHCH) 
0.80 (3H, d, J= 6.8 Hz, CH3CHCH);
 13
C NMR (500 MHz, CDCl3) δ 173.5 (COOCH3) 
128.3 (ArC) 126.9 (ArC) 57.6 (CHCH2COO) 55.5 (CHPh) 51.5 (OCH3) 35.9 
(CH2COO) 31.4 (CH(CH3)2) 24.9 (CH3CHN) 18.6 ((CH3)2CHCH) 18.5 
((CH3)2CHCH); m/z (Cl+) 250 (100%, M+H
+
) 206 (53%, M+H
+
-(CH3)2CH) 133 (8%, 
PhCHNCO+H
+
) 105 (47%, PhCHCH3
+
); HRMS C15H24NO2 calcd. 250.1807, found 
250.1805. 
(R)-Methyl 3-{[(1S)-1-phenylethyl]amino}hex-4-enoate (107c)
67 
Ph NH
CO2Me 
Following general procedure 5, reaction of (R)-methyl 3-{[(1S)-1-phenylethyl] 
(prop-2-enyl)amino})hex-4-enoate (5.10 g, 17.8 mmol), and Wilkinson’s catalyst (0.82 
g, 0.89 mmol) in acetonitrile/water (120 mL) gave a pale yellow oil that was purified 
by flash chromatography (10% ethyl acetate/hexane) to give 107c (3.69 g, 84%) as a 
pale yellow oil, Rf 0.70 (30% ethyl acetate/hexane); [α]
21
D = -38.9 (c 0.72, CHCl3); IR 
νmax 3061 (N-H), 2965 (C-H), 1734 (ester C=O), 1626, 1419, 1261, 1241 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 7.57-7.04 (5H, m, Ph) 5.59-5.51 (1H, m, CH=CHCHN) 
5.31-5.22 (1H, m, =CHCHN) 3.83 (1H, q, J= 6.5 Hz, CHPh) 3.66 (3H, s, OCH3) 
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3.51-3.44 (1H, m, CHCH2CO2CH3) 2.52-2.46 (2H, m, CH2CO2CH3) 1.63 (3H, dd, J= 
6.5, 1.4 Hz, CH3CH=CH) 1.31 (3H, d, J= 6.5 Hz, CH3CHPh);
 13
C NMR (500 MHz, 
CDCl3) δ 172.5 (COOCH3) 146.2 (ArC) 132.7 (ArC) 128.5 (ArC) 127.1 (CHCHCHN) 
126.9 (CHCHNH) 126.7 (ArC) 54.9 (CHPh) 54.7 (CHCH2COO) 51.5 (OCH3) 40.5 
(CH2COO) 23.3 (CH3CHN) 17.8 (CH3CHCHCHN). 
(R)-Methyl 3-cyclohexyl-3-[(1S)-1-phenylethyl]amino]propanoate (107d)
 
NH
CO2Me
Ph
 
Following general procedure 5, reaction of (R)-methyl 
3-cyclohexyl-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})propanoate (1.86 g, 5.65 
mmol), and Wilkinson’s catalyst (0.30 g, 0.32 mmol) in acetonitrile/water (35 mL) 
gave a pale yellow oil that was purified by flash chromatography (12% ethyl 
acetate/hexane) to give 107d (0.79 g, 53%) as a yellow oil, Rf 0.72 (30% ethyl 
acetate/hexane); [α]25D = -35.2 (c 1.90, CHCl3); IR νmax 2985 (N-H), 2922 (C-H), 1732 
(ester C=O), 1448, 1191, 1167, 760, 700; 
1
H NMR (500 MHz, CDCl3) δ 7.35-7.20 (5H, 
m, Ph) 3.87-3.71 (1H, m, CHCH2CO2CH3) 3.67 (3H, s, OCH3) 2.63 (1H, q, J= 5.9 Hz, 
CHPh) 2.49 (1H, dd, J= 14.7, 5.5 Hz, CH2CO2CH3) 2.37 (1H, dd, J= 14.7, 6.3 Hz, 
CH2CO2CH3) 1.79-1.62 (5H, m, 1'-cyclohexyl-CH + cyclohexyl-CH2) 1.31 (3H, d, J= 
5.9 Hz, CH3CHPh) 1.17-1.08 (4H, m, cyclohexyl-CH2) 0.96-0.86 (2H, m, 
4'-cyclohexyl-CH);
 13
C NMR (500 MHz, CDCl3) δ 173.5 (COOCH3) 128.3 (ArC) 
127.0 (ArC) 126.9 (ArC) 57.0 (CHN) 55.5 (CHPh) 51.5 (OCH3) 41.8 (CH2COO) 35.9 
(1'-cyclohexyl-C) 29.3 (4'-cyclohexyl-C) 29.1 (2'- and 6'-cyclohexyl-C) 26.6 (3'- and 
5'-cyclohexyl-C) 26.5 (CH3CHPh); m/z (Cl+) 290 (100%, M+H
+
); HRMS C18H28NO2 
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calcd. 290.2120, found 290.2112. 
(R)-Methyl 3-{[(1S)-1-phenylethyl]amino}-3-phenylpropanoate (107e)
 
Ph NH
CO2Me
Ph  
Following general procedure 5, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl](prop-2-enyl)amino})-3-phenylpropanoate (0.50 g, 1.55 mmol), 
and Wilkinson’s catalyst (72 mg, 0.08 mmol) in acetonitrile/water (10 mL) gave a pale 
yellow oil that was purified by flash chromatography (20% ethyl acetate/hexane) to 
give 107e (0.33 g, 76%) as a pale yellow oil, Rf 0.52 (30% ethyl acetate/hexane); [α]
21
D 
= -13.5 (c 7.47, CHCl3) (lit.
90
 [α]20D = -16.3 c 1.00, CHCl3); IR νmax 3050 (N-H), 2964 
(C-H), 1732 (ester C=O), 1451, 1080, 761, 588 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.33-7.21 (10H, m, Ph) 4.23-4.20 (1H, m, CHCH2CO2CH3) 3.66 (1H, q, J= 6.6 Hz, 
CHCH3) 3.62 (3H, s, OCH3) 2.79-2.75 (1H, m, CH2CO2CH3) 2.70-2.66 (1H, m, 
CH2CO2CH3) 1.85 (1H, br s, NH) 1.23 (3H, d, J= 6.6 Hz, CH3CHPh);
 13
C NMR (500 
MHz, CDCl3) δ 172.2 (COOCH3) 128.6 (ArC) 128.5 (ArC) 127.5 (CHCH2N) 127.1 
(ArC) 126.7 (ArC) 56.9 (CHCH3) 54.8 (OCH3) 51.6 (CHCH2COO) 42.5 (CH2COO) 
22.2 (CH3CHN); m/z (Cl+) 284 (100%, M+H
+
); HRMS C18H21NO2 calcd. 284.1651, 
found 284.1638. 
(R)-Methyl 3-(pyridin-3-yl)-3-{[(1S)-1-phenylethyl]amino}propanoate (107f)
70 
NH
CO2Me
Ph
N  
To a stirred solution of (R)-methyl 
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3-(pyridin-3-yl)-3-{[(1S)-1-phenylethyl](prop-2-enyl)amino}propanoate (0.54 g, 1.51 
mmol) in anhydrous dichloromethane (80 mL) at 30 
o
C under nitrogen, 
tetrakis(triphenylphosphine)palladium(0) (0.16 g, 0.01 mmol) and dimethylbarbituric 
acid (0.73 g, 2.98 mmol) was added. The solution was stirred at 30 
o
C for a further 3 h. 
The reaction mixture was washed with saturated sodium carbonate solution (2 x 10 mL) 
and the organic layer was dried (MgSO4), and evaporated. The resulting orange oil was 
purified by flash chromatography (60% ethyl acetate/hexane) to give 107f (0.41 g, 
96%) as an orange oil, Rf 0.33 (75% ethyl acetate/hexane); IR νmax 2982 (N-H), 2921 
(C-H), 1732 (ester C=O), 1435, 1202, 701; 
1
H NMR (500 MHz, CDCl3) δ 8.47 (1H, s, 
aryl) 8.42-8.38 (1H, m, aryl) 7.66-7.64 (1H, m, aryl) 7.43-7.14 (6H, m, aryl + Ph) 4.17 
(1H, dd, J=7.5, 6.3 Hz, CHCH2CO2CH3) 3.65 (1H, q, J= 6.4 Hz, CHPh) 3.58 (3H, s, 
OCH3) 2.75 (1H, dd, J=15.5, 7.5 Hz, CH2CO2CH3) 2.63 (1H, dd, J=15.5, 6.3 Hz, 
CH2CO2CH3) 2.25 (1H, br s, NH) 1.33 (3H, d, J= 6.4 Hz, CH3CHPh);
 13
C NMR (500 
MHz, CDCl3) δ 171.7 (COOCH3) 149.3 (ArC) 148.8 (ArC) 145.4 (ArC) 138.2 (ArC) 
133.7 (ArC) 132.0 (ArC) 132.0 (ArC) 128.9 (ArC) 128.5 (ArC) 127.1 (ArC) 123.5 
(ArC) 55.4 (CHPh) 54.9 (OCH3) 51.7 (CHCH2COO) 41.8 (CH2COO) 22.9 (CH3CHN); 
m/z (Cl+) 285 (100%, M+H
+
); HRMS C17H21N2O2 calcd. 285.1603, found 285.1637. 
(R)-Methyl 3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}butanoate 
(108a)
 
N
CO2Me
OMe
O O
Ph
 
Following general procedure 2b, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl]amino}butanoate (0.30 g, 1.36 mmol), triethylamine (0.22 mL, 
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1.63 mmol), and methyl 3-chloro-3-oxopropanoate (0.16 mL, 1.49 mmol) in 
dichloromethane (6 mL) gave a pale yellow oil that was purified by flash 
chromatography (50% ethyl acetate/hexane) to give 108a (0.25 g, 58%) as a colourless 
oil, Rf 0.60 (75% ethyl acetate/hexane); [α]
21
D = -2.5 (c 0.80, CHCl3); IR νmax 2952 
(C-H), 1736 (ester C=O), 1646 (amide C=O), 1438, 1331, 1201, 702 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.38-7.22 (5H, m, Ph) 4.95 (1H, q, J= 6.8 Hz, CHCH3) 3.78 (3H, 
s, OCH3) 3.60 (3H, s, OCH3) 3.46 (2H, s, CH2CON) 3.12-3.06 (1H, m, CHCH3) 
2.45-2.40 (1H, m, CH2CHN) 2.10-2.06 (1H, m, CH2CHN) 1.66 (3H, d, J= 6.8 Hz, 
CH3CHPh) 1.43 (3H, d, J= 6.7 Hz, CH3CHCH2);
 13
C NMR (500 MHz, CDCl3) δ 172.3 
(COOCH3) 168.3 (COOCH3) 165.6 (CONH) 139.0 (ArC) 128.3 (ArC) 128.1 (ArC) 
127.3 (ArC) 56.9 (OCH3) 52.6 (OCH3) 51.4 (CH2N) 48.6 (CH2CHCH3) 42.9 (CHCH3) 
39.1 (CH2CONH) 18.7 (CH3CHAr) 17.3 (CH3CHCH2); m/z (Cl+) 321 (5%, M+H
+
) 
220 (85%, M+H
+
-COCH2COOCH3
+
) 105 (100%, C8H9
+
); HRMS C17H23NO5 calcd. 
321.1576, found 321.1571. 
(R)-Methyl 
3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}-4-methylpentanoate 
(108b)
 
N
CO2Me
OMe
O O
Ph
 
Following general procedure 2b, reaction of (R)-methyl 
4-methyl-3-[(1S)-1-phenylethylamino]pentanoate (0.25 g, 1.00 mmol), triethylamine 
(0.18 mL, 1.30 mmol), and methyl 3-chloro-3-oxopropanoate (0.13 mL, 1.20 mmol) in 
dichloromethane (4 mL) gave a pale yellow oil that was purified by flash 
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chromatography (50% ethyl acetate/hexane) to give 108b (0.18 g, 50%) as a pale 
yellow oil, Rf 0.75 (75% ethyl acetate/hexane); [α]
21
D = +74.3 (c 0.35, CHCl3); IR νmax 
2953 (C-H), 1738 (ester C=O), 1647 (amide C=O), 1437, 1327, 1165 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) (presence of rotamers) δ 7.35-7.22 (5H, m, Ph) 5.01-4.98 (1H, m, 
CHCH2CO2CH3) 4.30-4.28 (1H, m, CHCH2CO2CH3) 3.95 (1H, d, J= 15.7 Hz, 
CH2CON) 3.79 (3H, s, OCH3) 3.78 (3H, s, OCH3) 3.72 (1H, d, J= 15.2 Hz, CH2CON) 
3.68 (1H, d, J= 15.7 Hz, CH2CON) 3.60 (1H, d, J= 15.2 Hz, CH2CON) 3.46 (3H, s, 
OCH3) 3.36 (3H, s, OCH3) 3.33-3.22 (1H, m, CHCH3) 2.72 (1H, dd, J= 18.0, 6.9 Hz, 
CH2CHN) 2.58-2.42 (3H, m, CHCHN + CH2CHN) 2.24 (2H, dd, J= 18.0, 2.5 Hz, 
CH2CHN) 2.04 (1H, m, CHCHN) 1.88 (3H, d, J= 7.0 Hz, CH3CHPh) 1.65 (3H, d, J= 
7.0 Hz, CH3CHPh) 1.11 (3H, d, J= 6.7 Hz, (CH3)2CH) 0.99 (3H, d, J= 6.7 Hz, 
(CH3)2CH) 0.92 (3H, d, J= 6.8 Hz, (CH3)2CH) 0.81 (3H, d, J= 6.8 Hz, (CH3)2CH);
 13
C 
NMR (500 MHz, CDCl3) δ 172.7 (COOCH3) 171.9 (COOCH3) 168.6 (COOCH3) 
168.4 (COOCH3) 167.6 (CON) 165.9 (CON) 139.2 (ArC) 128.8 (ArC) 128.3 (ArC) 
127.9 (ArC) 127.7 (ArC) 126.8 (ArC) 126.6 (ArC) 62.3 (CHCH3) 58.3 (CHCH3) 56.6 
(CHCH2CO2CH3) 55.6 (CHCH2CO2CH3) 52.6 (OCH3) 52.4 (OCH3) 51.9 (OCH3) 51.4 
(OCH3) 43.0 (CH2CON) 42.8 (CH2CON) 39.6 (CH2CHN) 35.9 (CH2CHN) 31.2 
(CH(CH3)2) 30.9 (CH(CH3)2) 21.4 (CH3CH) 21.2 (CH3CH) 20.7 ((CH3)2CH) 20.1 
((CH3)2CH) 19.9 ((CH3)2CH) 18.3 ((CH3)2CH); m/z (Cl+) 372 (100%, M+Na
+
); 
HRMS C19H27NO5Na calcd. 372.1787, found 372.1783. 
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(R)-Methyl 3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}hex-4-enoate 
(108c)
 
Ph N
CO2Me
OMe
O O
 
Following general procedure 2b, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl]amino}hex-4-enoate (1.20 g, 4.85 mmol), triethylamine (0.80 
mL, 5.82 mmol), and methyl 3-chloro-3-oxopropanoate (0.57 mL, 5.33 mmol) in 
dichloromethane (25 mL) gave a pale yellow oil that was purified by flash 
chromatography (30% ethyl acetate/hexane) to give 108c (1.58 g, 94%) as a colourless 
oil, Rf 0.17 (30% ethyl acetate/hexane); [α]
21
D = +5.5 (c 1.82, CHCl3); IR νmax 3030 
(N-H), 2952 (C-H), 1733 (ester C=O), 1641 (ketone C=O), 1434, 1246, 1202 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 7.38-7.21 (5H, m, Ph) 5.97-5.89 (1H, m, CHCH=CHCH3) 
5.65-5.56 (2H, m, CH=CHCHN + =CHCHN) 5.04 (1H, q, J= 6.7 Hz, CHPh) 3.78 (3H, 
s, OCH3) 3.51 (2H, s, CH2CON) 3.45 (3H, s, OCH3) 1.74 (2H, d, J= 4.9 Hz, 
CH2CO2CH3) 1.64 (3H, d, J= 6.7 Hz, CH3CHPh) 1.58 (3H, m, CH3CHCH); m/z (Cl+) 
370 (100%, M
+
), 311 (2%, M
+
-CO2CH3); HRMS C19H25NO5Na calcd. 370.1630, found 
370.1626. 
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(R)-Methyl 
3-cyclohexyl-3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}propanoate 
(108d)
 
N
CO2Me
OMe
O O
Ph
 
Following general procedure 2b, reaction of (R)-methyl 
3-cyclohexyl-3-[(1S)-1-phenylethyl]amino]propanoate
 
(0.25 g, 0.86 mmol), 
triethylamine (0.16 mL, 1.12 mmol), and methyl 3-chloro-3-oxopropanoate (0.11 mL, 
1.04 mmol) in dichloromethane (4 mL) gave a pale yellow oil that was purified by 
flash chromatography (50% ethyl acetate/hexane) to give 108d (0.22 g, 66%) as a pale 
yellow oil, Rf 0.75 (75% ethyl acetate/hexane); [α]
25
D = +22.5 (c 1.00, CHCl3); IR νmax 
2925 (C-H), 1737 (ester C=O), 1648 (amide C=O), 1437, 1167 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) (presence of rotamers) δ 7.32-7.16 (5H, m, Ph) 4.99-4.95 (1H, m, 
CHCH2CO2CH3) 4.30-4.28 (1H, m, CHCH2CO2CH3) 3.77 (3H, s, OCH3) 3.76 (3H, s, 
OCH3) 3.65 (1H, s, CH2CON) 3.60 (1H, s, CH2CON) 3.45 (3H, s, OCH3) 3.33 (3H, s, 
OCH3) 2.72 (1H, d, J= 7.0 Hz, CHCH3) 2.46 (1H, d, J= 7.0 Hz, CHCH3) 2.45-2.32 (2H, 
m, CH2CHN) 2.22-2.18 (2H, m, CH2CHN) 1.85-1.83 (3H, d, J= 7.0 Hz, CH3CHPh) 
1.73-1.61 (8H, m, CH3CHPh + cyclohexyl-CH) 1.29-0.82 (6H, m, cyclohexyl-CH);
 13
C 
NMR (500 MHz, CDCl3) δ 173.5 (COOCH3) 172.7 (COOCH3) 168.7 (COOCH3) 
168.4 (COOCH3) 167.6 (CON) 165.8 (CON) 142.6 (ArC) 139.3 (ArC) 128.7 (ArC) 
128.3 (ArC) 128.2 (ArC) 127.9 (ArC) 126.9 (ArC) 126.8 (ArC) 61.4 (CHCH3) 57.2 
(CHCH3) 57.0 (CHCH2CO2CH3) 55.5 (CHCH2CO2CH3) 52.5 (OCH3) 51.5 (OCH3) 
51.3 (OCH3) 50.0 (OCH3) 43.0 (CH2CON) 42.8 (CH2CON) 41.8 (CH2CHN) 40.8 
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(CH2CHN) 35.9 (cyclohexyl-C) 31.5 (cyclohexyl-C) 30.6 (cyclohexyl-C) 30.1 
(cyclohexyl-C) 29.2 (cyclohexyl-C) 29.1 (cyclohexyl-C) 26.6 (cyclohexyl-C) 26.5 
(cyclohexyl-C) 26.4 (cyclohexyl-C) 26.4 (cyclohexyl-C) 26.1 (cyclohexyl-C) 26.1 
(cyclohexyl-C) 25.0 (CH3CH) 21.2 (CH3CH); m/z (Cl+) 412 (100%, M+Na
+
); HRMS 
C22H31NO5Na calcd. 412.2100, found 412.2115. 
(R)-Methyl 
3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}-3-phenylpropanoate 
(108e)
 
Ph N
CO2Me
Ph
OMe
O O
 
Following general procedure 2b, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl]amino}-3-phenylpropanoate (4.16 g, 14.7 mmol), triethylamine 
(2.73 mL, 19.1 mmol), and methyl 3-chloro-3-oxopropanoate (1.9 mL, 17.6 mmol) in 
dichloromethane (45 mL) gave a pale yellow oil that was purified by flash 
chromatography (35% ethyl acetate/hexane) to give 108e (4.48 g, 80%) as a colourless 
oil, Rf 0.50 (50% ethyl acetate/hexane); [α]
21
D = +25.0 (c 1.56, CHCl3); IR νmax 2951 
(C-H), 1735 (ester C=O), 1647 (amide C=O), 1435, 1330, 1161, 700 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) (presence of rotamers) δ 7.37-7.17 (10H, m, Ph) 5.32 (1H, m, 
CHCH2CO2CH3) 5.26-5.22 (1H, m, CHCH2CO2CH3) 4.98 (1H, q, J= 6.1 Hz, CHCH3) 
3.71 (3H, s, OCH3) 3.56 (2H, s, CH2CON) 3.51 (3H, s, OCH3) 3.36-3.31 (2H, m, 
CH2CHN) 2.98-2.94 (1H, m, CH2CHN) 2.73-2.65 (1H, m, CH2CHN) 1.25 (3H, J= 6.1 
Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 171.9 (COOCH3) 171.1 (COOCH3) 
168.4 (COOCH3) 168.2 (COOCH3) 167.2 (CON) 166.5 (CON) 141.4 (ArC) 140.4 
Chapter 1 
121 
 
(ArC) 139.9 (ArC) 139.0 (ArC) 129.1 (ArC) 129.0 (ArC) 128.6 (ArC) 128.5 (ArC) 
128.2 (ArC) 128.0 (ArC) 127.4 (ArC) 127.2 (ArC) 127.0 (ArC) 126.6 (ArC) 126.5 
(ArC) 56.8 (CHCH3) 56.4 (CHCH3) 55.2 (CHCH2CO2CH3) 54.7 (CHCH2CO2CH3) 
52.6 (OCH3) 52.5 (OCH3) 52.1 (OCH3) 51.8 (OCH3) 43.0 (CH2CON) 40.8 (CH2CON) 
38.9 (CH2CHN) 38.3 (CH2CHN) 18.6 (CH3CH); m/z (Cl+) 384 (100%, M+H
+
); 
HRMS C22H26NO5Na calcd. 384.1811, found 384.1803. 
(R)-Methyl 
3-(pyridin-3-yl)-3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}propano
ate (108f)
 
N
CO2Me
OMe
O O
Ph
N  
Following general procedure 2b, reaction of (R)-methyl 
3-(pyridin-3-yl)-3-{[(1S)-1-phenylethyl]amino}propanoate
 
(0.16 g, 0.56 mmol), 
triethylamine (0.11 mL, 0.73 mmol), and methyl 3-chloro-3-oxopropanoate (0.07 mL, 
0.67 mmol) in dichloromethane (3 mL) gave a pale yellow oil that was purified by 
flash chromatography (50% ethyl acetate/hexane) to give 108f (0.16 g, 75%) as a 
colourless oil, Rf 0.12 (75% ethyl acetate/hexane); [α]
21
D = +15.0 (c 1.00, CHCl3); IR 
νmax 2952 (C-H), 1735 (ester C=O), 1648 (amide C=O), 1496, 1436, 1165, 702 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (presence of rotamers) δ 8.57 (1H, s, aryl) 8.44-8.37 (1H, 
m, aryl) 7.82 (1H, d, J= 7.3 Hz, aryl) 7.66-7.62 (1H, m, aryl) 7.45-7.17 (5H, m, aryl) 
5.08 (1H, q, J= 6.5 Hz, CHCH3) 4.86 (1H, dd, J= 7.7, 5.6 Hz, CHCH2CO2CH3) 3.74 
(3H, s, OCH3) 3.58 (2H, s, CH2CON) 3.43 (3H, s, OCH3) 2.74-2.69 (2H, m, CH2CHN) 
2.48 (2H, dd, J= 17.1, 7.7 Hz, CH2CHN) 2.27 (2H, dd, J= 17.1, 5,6 Hz, CH2CHN) 
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1.60 (3H, d, J= 6.5 Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 171.6 (COOCH3) 
168.1 (COOCH3) 166.2 (CON) 149.0 (ArC) 148.5 (ArC) 136.1 (ArC) 135.7 (ArC) 
132.1 (ArC) 132.0 (ArC) 129.1 (ArC) 128.8 (ArC) 128.4 (ArC) 127.2 (ArC) 123.3 
(ArC) 57.3 (CHCH3) 53.3 (CHCH2CO2CH3) 52.6 (OCH3) 51.8 (OCH3) 42.7 (CH2CON) 
38.7 (CH2CHN) 18.4 (CH3CH); m/z (Cl+) 385 (100%, M+H
+
) 279 (55%, 
M+H
+
-PhCHCH3); HRMS C21H25N2O5 calcd. 385.1764, found 385.1761. 
3-Methoxy-1-[(1S)-phenylethyl]-(6R)-propenylpiperidine-2,4-dione sodium salt 
(109c)
 
NPh
O
ONa
1 2
3
4
5
6
7
8
9
10
11
CO2Me
12 13
 
To a stirred solution of (R)-methyl 
3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}hex-4-enoate (1.58 g, 4.60 
mmol) in methanol (6 mL) at room temperature under nitrogen, sodium methoxide in 
methanol (2.3 mL, 5.0 mmol, 2.14 M) was added. The mixture was then heated under 
reflux for 1 h. The mixture was allowed to cool to room temperature, then diluted with 
diethyl ether and filtered to give 109c (1.46 g, 95%) as white microprisms, mp 203-207 
o
C; IR νmax 3064 (O-H), 2974 (C-H), 1660 (amide C=O), 1521, 1435, 1134, 1087, 733, 
698 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.35-7.22 (5H, m, Ph) 6.04 (1H, q, J= 7.2 Hz, 
C10H) 5.68-5.64 (1H, m, C7H) 5.56-5.51 (1H, m, C8H) 3.66 (3H, s, OCH3) 3.61-3.59 
(1H, m, C6H) 2.33 (1H, dd, J= 15.7, 6.2 Hz, C5H) 2.18 (1H, dd, J= 15.7, 2.4 Hz, C5H) 
1.61 (3H, d, J= 6.3 Hz, C9H) 1.49 (3H, d, J= 7.2 Hz, C11H);
 13
C NMR (500 MHz, 
CDCl3) δ 188.1 (C4) 170.8 (C12) 170.7 (C2) 144.1 (ArC) 132.7 (C7) 129.4 (ArC) 128.2 
(ArC) 128.2 (C8) 127.3 (ArC) 96.4 (C3) 51.8 (C13) 51.4 (C10) 50.4 (C5) 43.4 (C6) 17.8 
Chapter 1 
123 
 
(C9) 17.3 (C11); HRMS C18H21NO4Na calcd. 338.1368, found 338.1360. 
3-Methoxy-1-[(1S)-phenylethyl]-(6R)-phenylpiperidine-2,4-dione sodium salt 
(109e) 
NPh
O
ONa
1 2
3
4
5
6
7
8
CO2Me
9 10
Ph  
To a stirred solution of (R)-methyl 
3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}-3-phenylpropanoate (0.13 g, 
0.34 mmol) in methanol (0.7 mL) at room temperature under nitrogen, sodium 
methoxide in methanol (0.2 mL, 0.38 mmol, 1.97 M) was added. The mixture was then 
heated under reflux for 1 h. The mixture was allowed to cool to room temperature, then 
diluted with diethyl ether and filtered to give 109e (0.12 g, 97%) as white microprisms, 
mp 230 
o
C (decomposed); IR νmax 3220 (O-H), 2972 (C-H), 1671 (amide C=O), 1650 
(C=C), 1589, 1529, 1438, 1110, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.14 
(10H, m, Ph) 6.21 (1H, q, J= 7.2 Hz, C7H) 4.33 (1H, dd, J= 6.9, 1.3 Hz, C6H) 3.67 (3H, 
s, OCH3) 2.64 (1H, dd, J= 15.7, 6.9 Hz, C5H) 2.15 (1H, dd, J= 15.7, 1.3 Hz, C5H) 1.24 
(3H, d, J= 7.2 Hz, C8H);
 13
C NMR (500 MHz, CDCl3) δ 186.6 (C4) 171.8 (C9) 170.6 
(C2) 144.1 (ArC) 143.9 (ArC) 129.5 (ArC) 129.2 (ArC) 128.3 (ArC) 128.1 (ArC) 127.9 
(ArC) 127.7 (ArC) 97.5 (C3) 53.6 (C10) 51.4 (C7) 50.5 (C5) 44.9 (C6) 17.0 (C8). 
(6R)-Methyl-1-[(1S)-phenylethyl]piperidine-2,4-dione (110a)
 
NPh
O
O
1 2 3
4
5
6
7
8
9  
Following general procedure 3, reaction of 
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3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}butanoate (0.23 g, 0.70 
mmol), and sodium methoxide in methanol (0.7 mL, 1.40 mmol, 2.00 M) in methanol 
(5 mL) gave 110a (0.16 g, 97%) as a pale yellow oil, [α]21D = -198.1 (c 3.09, CHCl3); 
IR νmax 2975 (C-H), 1730 (ester C=O), 1642 (amide C=O), 1439, 1280, 1181, 701 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.36-7.25 (5H, m, Ph) 6.10 (1H, q, J= 6.9 Hz, C7H) 
3.60-3.50 (1H, m, C6H) 3.41-3.29 (2H, m, C3H) 2.24 (1H, dd, J= 16.5, 8.6 Hz, C5H) 
2.17 (1H, dd, J= 16.5, 5.0 Hz, C5H) 1.59 (3H, d, J= 6.9 Hz, C8H) 1.25 (3H, d, J= 6.7 
Hz, C9H);
 13
C NMR (500 MHz, CDCl3) δ 204.6 (C4) 166.2 (C2) 140.0 (ArC) 128.8 
(ArC) 128.1 (ArC) 127.2 (ArC) 50.9 (C5) 47.4 (C7) 46.5 (C3) 45.1 (C6) 22.7 (C8) 16.9 
(C9); m/z (Cl+) 232 (100%, M+H
+
), 105 (35%, PhCHCH3
+
); HRMS C14H18NO2 calcd. 
232.1338, found 232.1334. 
(6R)-Isopropyl-1-[(1S)-phenylethyl]piperidine-2,4-dione (110b)
 
NPh
O
O
1 2
3
4
5
6
7
8
9
10
10  
Following general procedure 3, reaction of 
3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}-4-methylpentanoate (0.15 g, 
0.47 mmol), and sodium methoxide in methanol (0.5 mL, 1.00 mmol, 2.00 M) in 
methanol (3 mL) gave 110b (0.12 g, 95%) as a pale yellow oil, [α]21D = -177.9 (c 1.31, 
CHCl3); IR νmax 2968 (C-H), 1726 (ester C=O), 1644 (amide C=O), 1443, 1319, 1170, 
702 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.37-7.26 (5H, m, Ph) 6.07 (1H, q, J= 7.1 Hz, 
C7H) 3.42 (1H, d, J= 21.3 Hz, C3H) 3.20 (1H, d, J= 21.3 Hz, C3H) 3.17-3.15 (1H, m, 
C6H) 2.53-2.50 (1H, dd, J= 16.7, 5.0 Hz, C5H) 2.02-1.96 (2H, m, C5H + C9H) 1.65 (3H, 
d, J= 7.1 Hz, C8H) 0.90 (3H, d, J= 6.9 Hz, C10H) 0.84 (3H, d, J= 6.9 Hz, C10H);
 13
C 
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NMR (500 MHz, CDCl3) δ 208.2 (C4) 170.2 (C2) 142.5 (ArC) 131.5 (ArC) 130.7 (ArC) 
130.2 (ArC) 58.3 (C7) 55.4 (C6) 50.1 (C3) 43.7 (C5) 35.9 (C9) 22.9 (C8) 20.4 (C10) 20.2 
(C10); m/z (El+) 259 (100%, M
+
), 216 (99%, M
+
-(CH3)2CH), 147 (5%, 
PhCH(CH3)NCO
+
), 132 (8%, PhCHNCO
+
) 105 (75%, PhCHCH3
+
), 77 (40%, Ph
+
); 
HRMS C16H21NO2 calcd. 259.1572, found 259.1575. 
1-[(1S)-Phenylethyl]-(6R)-propenylpiperidine-2,4-dione (110c)
 
NPh
O
O
1 2 3
4
5
6
7
8
9
10
11
 
3-Methoxy-1-[(1S)-phenylethyl]-(6R)-phenylpiperidine-2,4-dione sodium salt (1.00 g, 
2.96 mmol) was added to aqueous 5% hydrochloric acid (30 mL). The mixture was 
heated under reflux for 1 h. The mixture was allowed to cool to room temperature and 
extracted with dichloromethane (2 x 30 mL). The combined organic layers were dried 
(MgSO4) and evaporated to give 110c (0.56 g, 74%) as a pale yellow oil, [α]
21
D = 
-203.8 (c 2.08, CHCl3); IR νmax 3060 (N-H), 2938 (C-H), 1726 (amide C=O), 1650 
(ketone C=O), 1438, 1268, 1206 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.52-7.26 (5H, m, 
Ph) 6.14 (1H, q, J= 7.2 Hz, C10H) 5.55 (1H, dtq, J= 18.0, 6.2, 1.4 Hz, C7H) 5.41 (1H, 
dq, J= 18.0, 1.7 Hz, C8H) 3.93-3.90 (1H, m, C6H) 3.41-3.24 (2H, m, C3H) 2.42 (1H, dd, 
J= 17.0, 2.1 Hz, C5H) 2.16 (1H, dd, J= 17.0, 5.1 Hz, C5H) 1.68 (3H, dd, J= 6.2, 1.7 Hz, 
C9H) 1.54 (3H, d, J= 7.2 Hz, C11H);
 13
C NMR (300 MHz, CDCl3) δ 204.1 (C4) 166.6 
(C2) 139.9 (ArC) 129.8 (C7) 128.7 (C8) 128.0 (ArC) 127.9 (ArC) 127.3 (ArC) 51.1 
(CHPh) 50.2 (C5) 48.4 (C3) 44.9 (C6) 17.7 (C11) 16.5 (C9); m/z (Cl+) 257 (70%, M
+
), 
147 (5%, PhCH(CH3)NCO
+
), 132 (15%, PhCHNCO
+
) 105 (39%, PhCHCH3
+
), 77 
(15%, Ph
+
); HRMS C16H19NO2 calcd. 257.1416, found 257.1428. 
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(6R)-Cyclohexyl-1-[(1S)-phenylethyl]piperidine-2,4-dione (110d)
 
NPh
O
O
1
2
3
4
5
6
7
8
 
Following general procedure 3, reaction of (R)-methyl 
3-cyclohexyl-3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}propanoate 
(0.22 g, 0.57 mmol), and sodium methoxide in methanol (0.6 mL, 1.20 mmol, 2.00 M) 
in methanol (3 mL) gave 110d (0.13 g, 76%) as a colourless oil, [α]25D = -133.1 (c 3.40, 
CHCl3); IR νmax 2926 (C-H), 1726 (ester C=O), 1640 (amide C=O), 1444, 1317, 1172, 
762, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.46-7.25 (5H, m, Ph) 6.03 (1H, q, J= 
7.2 Hz, C7H) 3.38 (1H, d, J= 21.2 Hz, C3H) 3.26 (1H, d, J= 21.2 Hz, C3H) 3.14-3.12 
(1H, m, C6H) 2.49 (1H, dd, J= 16.7, 3.6 Hz, C5H) 1.95 (1H, dd, J= 16.7, 6.5 Hz, C5H) 
1.76-1.72 (2H, m, cyclohexyl-CH2) 1.61 (3H, d, J= 7.2 Hz, C8H) 1.59-1.47 (3H, m, 
cyclohexyl-CH2) 1.14-0.80 (6H, m, cyclohexyl-CH);
 13
C NMR (500 MHz, CDCl3) δ 
205.6 (C4) 169.5 (C2) 139.9 (ArC) 128.8 (ArC) 128.0 (ArC) 127.5 (ArC) 55.2 (C7) 
52.8 (C6) 47.7 (C3) 43.6 (C5) 41.7 (1'-cyclohexyl-C) 30.7 (4'-cyclohexyl-C) 28.6 (2'- 
cyclohexyl-C) 26.6 (6'-cyclohexyl-C) 26.4 (3'- cyclohexyl-C) 26.0 (5'-cyclohexyl-C)  
17.6 (C8) ; m/z (Cl+) 300 (100%, M+H
+
); HRMS C19H26NO2 calcd. 300.1964, found 
300.1953. 
1-[(1S)-Phenylethyl]-(6R)-phenylpiperidine-2,4-dione (110e)
 
NPh
O
OPh
1 2 3
4
5
6
7
8
 
3-Methoxy-1-[(1S)-phenylethyl]-(6R)-phenylpiperidine-2,4-dione sodium salt (0.10 g, 
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0.28 mmol) was added to aqueous 5% hydrochloric acid (5 mL). The mixture was 
heated under reflux for 1 h. The mixture was allowed to cool to room temperature and 
extracted with dichloromethane (2 x 5 mL). The combined organic layers were dried 
(MgSO4) and evaporated. The resulting pale yellow oil was purified by flash 
chromatography (50% ethyl acetate/hexane) to give 110e (69 mg, 85%) as pale yellow 
microprisms, mp 104-107 
o
C; Rf 0.42 (50% ethyl acetate/hexane); [α]
21
D = +103.4 (c 
2.95, CHCl3) (lit.
61
 opposite enantiomer [α]13D = -107.7 c 1.04, CHCl3); IR νmax 2923 
(C-H), 1730 (ester C=O), 1648 (amide C=O), 1453, 1323, 1207, 755, 700 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.39-7.11 (10H, m, Ph) 6.31 (1H, q, J= 7.2 Hz, C7H) 4.65 
(1H, dd, J= 6.1, 2.2 Hz, C6H) 3.39 (2H, s, C3H) 2.68 (1H, dd, J= 16.4, 2.2 Hz, C5H) 
2.51 (1H, dd, J= 16.4, 6.1 Hz, C5H) 1.35 (3H, d, J= 7.2 Hz, C8H);
 13
C NMR (500 MHz, 
CDCl3) δ 203.2 (C4) 167.4 (C2) 140.0 (ArC) 140.0 (ArC) 129.2 (ArC) 128.9 (ArC) 
128.1 (ArC) 128.0 (ArC) 127.5 (ArC) 125.7 (ArC) 53.0 (C5) 51.6 (C7) 48.8 (C3) 47.9 
(C6) 16.4 (C8); m/z (El+) 293 (100%, M
+
), 105 (35%, PhCHCH3
+
), 77 (10%, Ph
+
); 
HRMS C19H19NO2 calcd. 293.1416, found 293.1413. 
(6R)-Pyridin-3-yl-1-[(1S)-phenylethyl]piperidine-2,4-dione (110f)
 
NPh
O
O
N
1
2
3
4
5
6
7
8
 
Following general procedure 3, reaction of (R)-methyl 
3-(pyridin-3-yl)-3-{(2-methoxycarbonylacetyl)[(1S)-1-phenylethyl]amino}propanoate 
(0.25 g, 0.65 mmol), and sodium methoxide in methanol (0.65 mL, 1.30 mmol, 2.00 M) 
in methanol (3 mL) gave 110f (0.19 g, 99%) as a brown oil, [α]25D = -84.7 (c 1.00, 
CHCl3); IR νmax 2977 (C-H), 1730 (ester C=O), 1642 (amide C=O), 1414, 1206, 747, 
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697, 540 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.57 (1H, d, J= 4.5 Hz, aryl) 8.48 (1H, s, 
aryl) 7.67-7.63 (1H, m, aryl) 7.53-7.26 (6H, m, aryl + Ph) 6.31 (1H, q, J= 7.2 Hz, C7H) 
4.66 (1H, dd, J= 6.0, 1.8 Hz, C6H) 3.46 (1H, d, J= 20.6 Hz, C3H) 3.35 (1H, d, J= 20.6 
Hz, C3H) 2.66 (1H, dd, J= 16.4, 1.8 Hz, C5H) 2.56 (1H, dd, J= 16.4, 6.0 Hz, C5H) 1.34 
(3H, d, J= 7.2 Hz, C8H);
 13
C NMR (500 MHz, CDCl3) δ 202.1 (C4) 167.1 (C2) 149.6 
(ArC) 147.6 (ArC) 139.5 (ArC) 135.7 (ArC) 133.2 (ArC) 132.2 (ArC) 129.1 (ArC) 
128.6 (ArC) 128.3 (ArC) 127.4 (ArC) 123.8 (ArC) 51.6 (C5) 51.1 (C7) 48.6 (C3) 47.7 
(C6) 16.6 (C8); m/z (El+) 294 (15%, M
+
); HRMS C18H18N2O2 calcd. 294.1368, found 
294.1366. 
(6R)-Isopropylpiperidine-2,4-dione (111a)
 
HN
O
O
1 2
3
4
5
6
7
8
8  
To a stirred solution of (6R)-isopropyl-1-[(1S)-phenylethyl]piperidine-2,4-dione (76 
mg, 0.29 mmol) in toluene (2 mL) at room temperature under nitrogen, 
methanesulfonic acid (0.02 mL, 0.26 mmol) was added. The mixture was then heated 
under reflux for 3 h. The mixture was allowed to cool to room temperature and 
evaporated. The resulting pale yellow oil was purified by flash chromatography (ethyl 
acetate) to give 111a (22 mg, 48%) as a pale yellow oil, Rf 0.20 (ethyl acetate); [α]
21
D = 
+30.6 (c 0.49, CHCl3) (lit.
22
 [α]13D = +35.3 c 1.00, MeOH); IR νmax 3212 (N-H), 2922 
(C-H), 1722 (ester C=O), 1665 (amide C=O), 1464, 1347 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.05 (1H, br s, NH) 3.50-3.48 (1H, m, C6H) 3.28 (2H, s, C3H) 2.63 (1H, dd, 
J= 16.1, 4.4 Hz, C5H) 2.45 (1H, dd, J= 16.1, 9.1 Hz, C5H) 1.85-1.81 (1H, m, C7H) 
1.01-0.95 (6H, m, C8H);
 13
C NMR (500 MHz, CDCl3) δ 203.5 (C4) 170.2 (C2) 54.3 (C6) 
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47.2 (C3) 41.6 (C5) 32.5 (C7) 18.2 (C8) 17.9 (C8). 
(6R)-Cyclohexylpiperidine-2,4-dione (111c)
 
HN
O
O
1 2
3
4
5
6
 
To a stirred solution of (6R)-cyclohexyl-1-[(1S)-phenylethyl]piperidine-2,4-dione 
 
(0.14 g, 0.47 mmol) in toluene (3 mL) at room temperature under nitrogen, 
methanesulfonic acid (0.04 mL, 0.61 mmol) was added. The mixture was then heated 
under reflux for 5 h. The mixture was allowed to cool to room temperature and 
evaporated. The resulting pale yellow oil was purified by flash chromatography (ethyl 
acetate) to give 111c (38 mg, 42%) as yellow microprisms, mp 125-127 
o
C; Rf 0.24 
(ethyl acetate); [α]21D = +14.2 (c 1.26, MeOH); IR νmax 3223 (N-H), 2925 (C-H), 1724 
(ester C=O), 1665 (amide C=O), 1449, 1337, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.10 (1H, br s, NH) 3.66-3.45 (1H, m, C6H) 3.25 (2H, s, C3H) 2.61 (1H, dd, J= 16.1, 
4.8 Hz, C5H) 2.50 (1H, dd, J= 16.1, 8.1 Hz, C5H) 1.80-1.74 (3H, m, cyclohexyl-CH) 
1.70-1.69 (2H, m, cyclohexyl-CH) 1.52-1.64 (1H, m, cyclohexyl-CH) 1.25-1.14 (3H, 
m, cyclohexyl-CH) 1.02-0.98 (2H, m, cyclohexyl-CH);
 13
C NMR (500 MHz, CDCl3) δ 
203.9 (C4) 169.4 (C2) 53.6 (C6) 47.3 (C3) 42.4 (C5) 41.7 (1'-cyclohexyl-C) 28.8 
(4'-cyclohexyl-C) 28.5 (2'-cyclohexyl-C) 26.1 (6'-cyclohexyl-C) 25.9 (3'-cyclohexyl-C) 
25.9 (5'-cyclohexyl-C); m/z (El+) 195 (2%, M
+
) 112 (100%, M
+
-cyclohexyl) 83 (5%, 
cyclohexyl
+
); HRMS C11H17NO2 calcd. 195.1259, found 195.1255. 
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(6R)-Phenylpiperidine-2,4-dione (111e)
71 
HN
O
OPh
1 2 3
4
5
6
 
To a stirred solution of 1-[(1S)-phenylethyl]-(6R)-phenylpiperidine-2,4-dione (1.00 g, 
3.41 mmol) in toluene (15 mL) at room temperature under nitrogen, methanesulfonic 
acid (0.23 mL, 3.07 mmol) was added. The mixture was then heated under reflux for 3 
h. The mixture was allowed to cool to room temperature and evaporated. The resulting 
pale yellow oil was purified by flash chromatography (90% ethyl acetate/hexane) to 
give 111e (0.36 g, 56%) as white microprisms, mp 163-166 
o
C (lit.
23
 166-168 
o
C); Rf 
0.20 (ethyl acetate); [α]25D = +119.1 (c 1.00, CHCl3) (lit.
23
 [α]20D = +123.4 c 0.35, 
CHCl3); IR νmax 3185 (N-H), 2899 (C-H), 1716 (ester C=O), 1665 (amide C=O), 1409, 
1369, 1329, 701, 660 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.43-7.21 (5H, m, Ph) 7.13 
(1H, br s, NH) 4.80-4.77 (1H, m, C6H) 3.33 (2H, s, C3H) 2.85 (1H, dd, J= 16.1, 4.5 Hz, 
C5H) 2.73 (1H, dd, J= 16.1, 8.9 Hz, C5H);
 13
C NMR (500 MHz, CDCl3) δ 202.5 (C4) 
169.2 (C2) 139.4 (ArC) 129.4 (ArC) 128.9 (ArC) 126.1 (ArC) 52.9 (C5) 47.3 (C3) 47.0 
(C6); m/z (El+) 189 (100%, M
+
); HRMS C11H11NO2 calcd. 189.0790, found 189.0787. 
3,3-Dimethyl-1-[(1S)-phenylethyl]-(6R)-propenylpiperidine-2,4-dione (112)
 
NPh
O
O
1 2
3
4
5
6
7
8
9
10
11
12
13
 
To 1-[(1S)-phenylethyl]-(6R)-propenylpiperidine-2,4-dione (0.13 g, 0.51 mmol) in 
ethanol (2 mL) was added potassium carbonate (0.21 g, 1.52 mmol) and iodomethane 
(0.1 ml, 1.52 mmol). The mixture was stirred at 40 
o
C for 16 h. The solution was 
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filtered and the filtrate was evaporated. Chloroform (5 mL) was added and the solution 
was filtered again. After evaporation, the resulting yellow oil was purified by flash 
chromatography (15% ethyl acetate/hexane) to give 112 (0.11 g, 76%) as a colourless 
oil, [α]21D = -142.9 (c 0.35, CHCl3); IR νmax 2923 (C-H), 1724 (amide C=O), 1640 
(ketone C=O), 1429, 1185, 701 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.36-7.24 (5H, m, 
Ph) 6.07 (1H, q, J= 6.5 Hz, C10H) 5.50-5.43 (1H, m, C7H) 5.29-5.22 (1H, m, C8H) 
3.83-3.81 (1H, m, C6H) 2.65 (1H, dd, J= 13.8, 5.7 Hz, C5H) 2.30 (1H, dd, J= 13.8, 2.5, 
C5H) 1.63 (3H, d, J= 6.5 Hz, C11H) 1.51 (3H, dd, J= 7.2, 1.8 Hz, C9H) 1.39 (3H, d, J= 
1.9 Hz, C12H) 1.35 (3H, d, J= 1.9 Hz, C13H);
 13
C NMR (300 MHz, CDCl3) δ 209.2 (C4) 
174.0 (C2) 140.5 (ArC) 131.1 (C7) 128.7 (C8) 128.3 (ArC) 127.7 (ArC) 127.3 (ArC) 
52.4 (CHPh) 52.1 (C5) 50.6 (C3) 44.4 (C6) 26.5 (C12) 21.7 (C13) 17.6 (C11) 16.8 (C9). 
Methyl 3-[(1-phenylethyl)propionylamino]hex-4-enoate (113)
 
N
CO2Me
O
Ph
 
To a stirred solution of (R)-methyl 3-{[(1S)-1-phenylethyl]amino}hex-4-enoate (0.10 g, 
0.42 mmol) in dichloromethane (1.5 mL) at 0 
o
C under nitrogen, triethylamine (0.01 
mL, 0.62 mmol) and 1-chloro-1-oxopropane (0.05 mL, 0.52 mmol) was added. The 
mixture was then allowed to warm to room temperature and stirred for 1 h. The 
mixture was diluted with dichloromethane (5 mL) and washed with saturated aqueous 
sodium hydrogen carbonate (3 mL). The aqueous layer was extracted with 
dichloromethane (2 x 3 mL) and the combined organic layers were dried (MgSO4) and 
evaporated. The resulting pale yellow oil was purified by flash chromatography (30% 
ethyl acetate/hexane) to give 113 (0.09 g, 74%) as a colourless oil, Rf 0.72 (75% ethyl 
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acetate/hexane); 
1
H NMR (500 MHz, CDCl3) δ 7.29-7.23 (5H, m, Ph) 5.92-5.87 (1H, 
m, CHCH=CHCH3) 5.54-5.50 (2H, m, CH=CHCHN + =CHCHN) 5.06 (1H, q, J= 6.7 
Hz, CHPh) 3.98-3.94 (1H, m, CH2CON) 3.51 (3H, s, OCH3) 3.12-3.09 (1H, m, 
CH2CON) 2.50-2.38 (2H, m, CH2CO2CH3) 1.58-1.57 (6H, m, CH3CH=CH + 
CH3CHPh) 1.14-1.11 (3H, m, CH3CH2CO);
 13
C NMR (500 MHz, CDCl3) δ 173.2 
(COOCH3) 172.0 (CONH) 140.1 (ArC) 130.1 (ArC) 128.7 (ArC) 128.3 (CHCHCHN) 
127.6 (CHCHNH) 127.2 (ArC) 55.6 (OCH3) 54.6 (CHPh) 51.3 (CHCH2COO) 38.7 
(CH2COO) 28.0 (CH2CON) 18.0 (CH3CHPh) 17.6 (CH3CHCHCHN) 9.6 
(CH3CH2CON). 
(4R,6R)-4-Hydroxy-6-phenylpiperidine-2-one (116)
 
HN
O
OHPh
1 2 3
4
5
6
 
To a stirred solution of (6R)-phenylpiperidine-2,4-dione (0.19 g, 0.98 mmol) in 
anhydrous dichloromethane (2 mL) at 0 
o
C under nitrogen, zinc borohydride (2.0 mL, 
1.37 M, 2.74 mmol) was added. The mixture was then stirred at room temperature for 
20 h. Water (5 mL) was then added to the mixture. The mixture was extracted with 
ethyl acetate (2 x 10 mL). The combined organic layers were dried (MgSO4) and 
evaporated. The residue was then recrystallised from isopropanol/hexane to give 116 
(0.08 g, 43%) as white microprisms, mp 206-210 
o
C (lit.
91
 213 
o
C) ; Rf 0.36 (10% 
methanol/50% ethyl acetate/40% chloroform); [α]25D = +53.3 (c 1.20, MeOH) (lit.
91
 
[α]20D = +52.3 c 0.88, MeOH); IR νmax 3269 (O-H), 2896 (C-H), 1648 (amide C=O), 
1319, 1069, 761, 699 cm
-1
; 
1
H NMR (500 MHz, CD3OD) δ 7.38-7.28 (5H, m, Ph) 4.51 
(1H, dd, J= 11.6, 4.3 Hz, C6H) 4.12-4.10 (1H, m, C4H) 2.71 (1H, ddd, J= 17.1, 5.6, 2.3 
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Hz, C3H) 2.33-2.26 (2H, m, C3H + C5H) 1.62 (1H, ddd, J= 15.6, 11.6, 10.8 Hz, C5H);
 
13
C NMR (500 MHz, CD3OD) δ 174.1 (C2) 143.5 (ArC) 129.8 (ArC) 129.0 (ArC) 
127.4 (ArC) 65.6 (C4) 56.2 (C5) 42.7 (C6) 41.4 (C3); m/z (Cl+) 192 (100%, M+H
+
); 
HRMS C11H14NO2 calcd. 192.1025, found 192.1028. 
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CHAPTER 2 
 
Synthesis of Codeine and Piperidin-4-ones 
 
2.1 Introduction 
Codeine, also called 3-methylmorphine, is an analgesic opium alkaloid that has long 
been used to alleviate pain and relieve coughing. Codeine has attracted the interest of 
synthetic chemists due to its compact pentacyclic structure; it contains a phenyl ring (A 
ring), two unsaturated cyclohexane rings (B and C rings), a piperidine ring (D ring), 
and a dihydrofuran ring (E ring). Since the first total synthesis of codeine reported by 
Gates
1
 in 1956, various syntheses have been described by several groups
2–7
 in the last 
fifty years. However, most syntheses are long and of little commercial use; of the 
racemic syntheses, only Magnus’ and Rice’s are practical.8,9 
NMe
HO H
MeO
O
H
(-)-Codeine
NMe
HO H
HO
O
H
A
E
D
C
B
(-)-Morphine  
Figure 2.1 Structure of (-)-morphine and (-)-codeine  
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2.1.1 Conversion of 2,3-Disubstituted Piperidin-4-ones into 
Benzomorphans by the Grewe Cyclisation 
The benzomorphan ring system (Scheme 2.1) is a substructure in morphine, codeine 
and related alkaloids and thus has important pharmacological properties.
10
 The 
benzomorphan ring is mostly synthesized by Grewe cyclisation of a benzene ring onto 
an alcohol at C-6, thereby forming the 6,7-bond (Scheme 2.1). 2,3-Disubstituted 
piperidin-4-ones 124 would be key for the syntheses of opium alkaloids such as 
codeine, which requires assembly of the demanding 2,3,4-trisubstitued piperidine ring 
(D ring, Figure 2.1). Reduction of piperidin-4-ones 124 followed by Grewe cyclisation 
would afford the benzomorphan system; with a suitable 2-substituent, the cyclohexenol 
ring (C ring) could be assembled. However, syntheses of 2,3-disubstituted 
piperidin-4-ones are not routine and involve many steps, few being enantioselective. 
The groups of Meyers,
11
 Marazano,
12
 and Comins,
10 
have addressed that but their 
strategies have not been advanced beyond the synthesis of alkyl-substituted 
benzomorphans. Thus, it was of interest to develop a general route to 2,3-disubstituted 
piperidin-4-ones 124. 
NMe NMe
R
H
R
H
Benzomorphans
11
6
7
2
1
Scheme 2.1 A Grewe cyclisation to benzomorphans
O
(i) NaBH4
(ii) HBr
124
 
Comins
10
 prepared the benzomorphan 127 from 125 which has the trans-configuration 
(Scheme 2.2, eq (i)) suggesting that direct cyclisation of the tertiary carbocation is not 
the correct mechanism for Grewe cyclisation, since only the equatorial methyl group at 
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C-11 was found in the product 127. It is proposed that the tetrasubstituted alkene 126, 
as in eq (i), is formed first and then trans-diaxial protonation-cyclisation undergoes to 
give the product 125 with solely equatorial C-11 methyl group (Scheme 2.2). Therefore, 
it is believed that both cis- and trans-2,3-disubstituted piperidin-4-ones would undergo 
Grewe cyclisations, and thus afford benzomorphans. 
NMe
H
OH
Me
48% HBr
Comins10
NMe
H
+
NMe
H+
NR
H+
rapid R=Me
81%
85% H3PO4
140-145 oC
6 h Marazano12
NR
(i) (ii)
Scheme 2.2 Proposed mechanism for Grewe cyclisations
125 126 127
11
128
 
2.1.2 Comins' Asymmetric Synthesis of Benzomorphans 
In 1999, Comins described an asymmetric synthesis of benzomorphans (Scheme 2.3).
10
 
Asymmetric alkylation of 4-methoxy-3-(triisopropylsilyl)pyridine with benzylic 
Grignard reagents was induced by the addition of the chiral auxiliary to afford 
dihydropyridones 130 (Scheme 2.3). After the removal of the chiral auxiliary and 
triisopropylsilyl group, methylation using LiHMDS and then olefinic reduction using 
L-selectride were performed to give 2,3-disubstituted piperidin-4-ones 133. 
Methylation of the ketone and then reduction of the N-protective group gave 
4-hydroxypiperidines 135 which were ready for a Grewe cyclisation to afford 
enantiopure benzomorphans 136. However, only a methyl group was introduced at 
C-11 and so assembly of the complete structure of codeine or other opium alkaloids 
using this route was not addressed. 
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N
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Me OH N
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(I) R'CO2Cl, -42 
oC
(ii) BnMgCl, -78 oC
(iii) 10% HCl, RT
R'= (+)-trans-2-(α-cumyl)cyclohexyl
(i) NaOMe/MeOH 
    reflux
(ii) 10% HCl, RT
(i) n-BuLi, -78 oC
(ii) PhOCOCl
(iii) LiHMDS, -78 oC
(iv) MeI
L-Selectride
THF, -78 oC
MeCeCl2
-78 oC
LiAlH4
reflux
48% HBr
heat
130a R=H, 86%, de 92%
130b R=OMe, 89%, de 90%
136a R=H, 81% 
136b R=OMe, 70%
134a R=H, 77% 
134b R=OMe, 87%
135a R=H, 95% 
135b R=OMe, 90%
133a R=H, 94% 
133b R=OMe, 92%
132a R=H, 85% 
132b R=OMe, 83%
131a R=H, 89% 
131b R=OMe, 88%
Scheme 2.3 Comins' asymmetric synthesis of benzomorphans 13610
two isomers 3.75:2
 
2.1.3 Grewe's Total Synthesis of Tetrahydrodeoxycodeine 
In 1949, Grewe reported the total synthesis of the tetrahydrodeoxycodeine 141 
(Scheme 2.4).
13
 137 was first treated with 48% HBr in acetic acid at room temperature 
for 24 hours; zinc dust was then added to the mixture and stirred at 25-30 
o
C for 2 
hours to give 138 in 85% yield. N-Methylation of 138 by heating with methyl iodide at 
100 
o
C for 3 hours afforded 139 which was then hydrogenated over platinum to give 
140 in 87% over two steps. Grewe cyclisation was performed by bubbling hydrogen 
chloride gas through a solution of 140 in concentrated sulfuric acid at 120 
o
C for 10 
hours to give the tetrahydrodeoxycodeine 141 in 7% yield. Although the yield of 141 
was quite low, this synthesis showed the potential of a Grewe cyclisation to synthesize 
codeine and benzomorphans. 
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     85%
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Scheme 2.4 Synthesis of the tetrahydrodeoxycodeine 141 via a Grewe cyclisation
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2.1.4 Key Steps in Gates' Total Synthesis of Codeine 
In 1956, the first total synthesis of (-)-codeine was described by Gates, and involved 
resolution.
1
 Diels-Alder addition of 142 with 1,3-butadiene was used to constuct the 
cyclohexene ring (C ring). Reductive cyclisation of 143 using copper chromite under 
hydrogen afforded the keto lactam 146 (construction of piperidine ring D, Scheme 2.5).   
HO
OH
MeO
O
MeO
O
CN
MeO
OH
MeO
O
CN
MeO
O
MeO
O
NH
MeO
O
MeO
O
NH
MeO
NH
MeO
O
O
H H H
Heat H2, 130 
oC
142
146145144
143
Scheme 2.5 Formation of the tetracyclic intermediate 146
CuCr2O4
Chapman 
rearrangement
 
Through a series of reactions shown in Scheme 2.6, the keto lactam 146 was converted 
into the β-dihydrothebainone 147. However, since β-dihydrothebainone 147 had the 
inappropriate trans-configuration, epimerisation was required, and was achieved 
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through the preparation of the α,β-unsaturated hydrazone 148 which was hydrolysed to 
give cis-fused 1-bromodihydrothebainone (149). Dibromination of 149 (2 equivalents 
of bromine) afforded the α-bromo ketone that under the basic conditions underwent 
cyclisation to the dihydrofuran E ring and hence 150. After the hydrolysis of the 
hydrazone under acidic conditions to give the corresponding enone, treatment with 
lithium aluminium hydride reduced the ketone and debrominated the aromatic ring, 
affording (-)-codeine. This total synthesis involves 31 steps and requires resolution to 
generate enantiopure (-)-codeine. 
150149
Scheme 2.6 Gates' total synthesis
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2.1.5 Key Steps in Rice's Formal Synthesis of (±)-Codeine 
In 1980, Rice described the shortest formal synthesis of (±)-codeine (Scheme 2.7), at 
that time.
14
 The key step is the Grewe cyclisation of 151 to give the morphinan 152. A 
series of reactions including N-deprotection, debromination, dihydrofuran E ring 
formation (bromination and displacement), and N-methylation of 152 were performed 
to give the dihydrocodeinone 153 which was converted into (±)-codeine in five steps. 
The overall yield of the synthesis of (±)-153 was 29%. 
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Dihydrocodeinone
153
MeO
NMe
O
O
H
MeO
NCHO
O
HO
H
Br
NCHO
MeO
OH
Br
152151
    CF2SO3H
(i) MeOH, HCl
     then NH3, H2O, i-PrOH
(ii) H2, Pd/C, HOAc, HCHO
(iii) Br2, HOAc
(iv) NaOH, CHCl3
(v) H2, HOAc, HCHO
Scheme 2.7 Synthesis of dihydrocodeinone 153 via a Grewe cyclisation
O
NH4F, HF
 
2.1.6 Outline of Overman's Formal Synthesis of Codeine 
In 1993, Overman described the formal synthesis of (-)-codeine which employed an 
enantioselective catechol borane reduction as a source of asymmetric induction.
3
 In the 
presence of zinc iodide, reaction of the amine 154 with the arylacetaldehyde 155 gave 
the iminium intermediate 156 which underwent an iminium-allylsilane cyclisation to 
give the octahydroisoquinoline 157 in excellent ee (formation of piperidine D ring, 
Scheme 2.8). The second key step was the intramolecular Heck reaction of 157 which 
gave the morphinan 158. After the formation of dihydrofuran E ring (by epoxidation
15
 
and subsequent intramolecular displacement), oxidation of the alcohol, and 
hydrogenolysis of the N-DBS group, the dihydrocodeinone 153 was obtained. The 
most characteristic feature of this synthesis is the use of an intramolecular Heck 
reaction to construct the cyclohexene B ring instead of a Grewe cyclisation. 
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OBn
I
CHO
NDBS
I
H
OBn
OMe
MeO
NDBS
BnO
H
Dihydrocodeinone
153
MeO
NMe
O
O
H
DBS=
158
155
154
157
N
Ar
H
PhMe2Si
DBS
156
ZnI2, EtOH
E/Z 20:1
(i) BF3.OEt2, EtSH
(ii) ArCO3H, campSO3H
(iii) TPAP, NMO
(iv) H2, Pd(OH)2, HCHO
Scheme 2.8 Synthesis of the dihydrocodeinone 153 via an intramolecular Heck reaction
Pd(CF3CO2)2(PPh3)2
PMP, PhMe, 120 oC
 
The mechanism of the Heck reaction is shown in Scheme 2.9. The first step is the 
oxidative addition of palladium(0) to the R
1
-X bond. The second step is the syn 
addition of the palladium complexes to alkenes. C-C bond rotation permits a 
syn-β-hydride elminiation, resulting in (E)-alkenes. Reductive elimination regenerates 
the palladium(0) compound and the cycle continues. 
Pd(CF3CO2)2(PPh3)2
Pd(PPh3)2 R
1X
R1Pd(PPh3)2X
-2 CF3CO2
-
Oxidative addition
R2
Alkene insertion
Pd(PPh3)2X
H
R2
H
R1
H
Pd(PPh3)2X
H
R2
R1
H
H
C-C Bond rotation
R1
R2
syn β-Hydride elimination
HPd(PPh3)2X
Base
Reductive elimination
Base.HX
Scheme 2.9 Mechanism of the Heck reaction  
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Other total syntheses of codeine by different strategies have been reported; for example, 
Parker (2006) described a tandem radical cyclisation that constructed both the 
dihydrofuran E ring and the cyclohexene B ring; the piperidine D ring was formed by a 
reductive hydroamination.
5
 The source of asymmetric induction was a catechol borane 
reduction, as in Overman's synthesis.
3
 Metz's racemic synthesis (2011) employed a 
nitrone cycloaddition followed by an Eschenmoser–Claisen rearrangement to construct 
the cyclohexene B ring and the piperidine D ring.
7
 However, no asymmetric synthesis 
of (-)-codeine of commercial application has yet been described. 
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2.2 Results and Discussion 
2.2.1 Retrosynthetic Analysis of Codeine 
The retrosynthetic plan to codeine is shown in Scheme 2.1. The allylic alcohol unit of 
codeine would be converted from a ketone of 159 via selenoxide elimination-ketone 
reduction following White's synthesis.
4
 A bromine atom would be introduced to the 
aryl ring to define the location for a Grewe cyclisation to occur; debromination would 
occur concurrently with the ketone reduction by treating 159 with lithium aluminium 
hydride to afford codeine.
4
  
Disconnection of the dihydrofuran ring of 159 would give 160; a bromine would be 
added to the alpha carbon of the ketone (marked in diagram) of 160 as a leaving group 
which would then be displaced by the hydroxy group of the aryl ring (after 
TBS-deprotection using TBAF) to form the pentacyclic structure of 159 (similar 
strategy as Metz's synthesis).
7
  
A Grewe cyclisation
16
 of 162 was planned for assembling the cyclohexane B ring of 
160. By treating 162 with acid, C=C bond isomerisation would occur to give the 
β,γ-unsaturated ketone (161); Grewe cyclisation would then take place to give 160 in 
the presence of acid. 
162 would be derived from the piperidin-4-one 163 via a Robinson annulation; while 
163 itself would be prepared from the 5,6-dihydro-4-pyridone 164 via N-methylation 
and C=C reduction. A Dieckmann cyclisation
17
 would be employed to make 164 from 
the diester 165; while 165 would be prepared by an electrophilic substitution of the 
β-keto ester 166 and the β-amino ester 167. 
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Scheme 2.10 Retrosynthetic analysis of codeine
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2.2.2 Synthesis of the 5,6-Dihydro-4-pyridone 172a by a 
Dieckmann Cyclisation 
The synthesis of codeine started with the preparation of the β-keto ester 166a. This 
could be done by an acylation of 2,2-dimethyl-1,3-dioxane-4,6-dione (Meldrum's acid) 
with subsequent heating.
18
 For the fully-substituted aromatic ring of codeine, the aryl 
group of the β-keto ester 166a should contain functionality appropriate to the desired 
3-hydroxy and 4-methoxy groups (Scheme 2.11). In our studies, the β-keto ester 166b 
with an unsubstituted phenyl group was prepared first to test the feasibility of first few 
steps. Once the route to benzomorphans was developed, the β-keto ester 166 with a 
substituted aryl group would be used to synthezise codeine. 
Meldrum's acid was acylated with phenylacetyl chloride using pyridine to give an 
adduct which was then heated under reflux in ethanol to afford the β-keto ester 166b in 
72% (Scheme 2.11); and the mechanism is shown in Scheme 2.12. Pyridine 
deprotonates the alpha carbon of the esters of the Meldrum's acid to give an enolate 
which attacks the acid chloride to form the adduct 168. On heating, 168 decomposed to 
give the electrophilic ketene. Ethanol acts as the nucleophile, attacking the ketene to 
afford an enolate which is converted into the β-keto ester after tautomerization. 
(i) Meldrum's acid (1 eq)
    pyridine (2.5 eq)
    DCM, 0 oC-RT, 1.5 h
Cl
Ph
O
(ii) EtOH, reflux, 3 h, 72%
EtO
Ph
OO
Scheme 2.11 Synthesis of the β-keto ester 166b
166b
EtO
OO
166a
OH
OMe
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Scheme 2.12 Mechanism of acylation using Meldrum's acid
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Amination of the β-keto ester 166b with β-alanine ethyl ester by heating under reflux 
in benzene with the azeotropic removal of water afforded the diester 171a in 42% yield 
(Scheme 2.13).
19
 Since the yield was not satisfactory and the reaction time was long (3 
days), another route to the diester 171a was sought.  
The β-keto ester 166b was condensed with ammonium acetate to give the enamino 
ester 169a in 90% yield (procedure modified from Karg's synthesis).
20
 β-Alanine ethyl 
ester (170) then displaced the amine group to afford the diester 171a in 93% yield as 
described by Becker (Scheme 2.13).
17
 The yield was excellent because the by-product 
ammonium chloride is precipitated from ethanol, thereby shifting the equilibrium to 
the right. Only the cis-isomer of 171a was obtained because there is hydrogen bonding 
between the ester and the amine in this conformation (Scheme 2.13).
21
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AcOH, PhMe
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EtO
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Scheme 2.13 Synthesis of the diester 171a
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Several attempts at Dieckmann cyclisations of the diethyl ester 171a were made but the 
5,6-dihydro-4-pyridone 172a was isolated in low yield (Table 2.1). Cyclisation using 
sodium hydride gave a poor yield (27%, Scheme 2.14). In our studies, the Dieckmann 
cyclisation proceeded much better with high concentrations of reactants. Although the 
yield was better (56%) when sodium methoxide was used, incomplete 
trans-esterification occurred. Pure sodium ethoxide solution could not be obtained in 
high concentration while more dilute solution (0.6 M) was not efficient (25% yield). 
Accordingly, ethoxide ion was generated by adding tert-butoxide to ethanol. Potassium 
tert-butoxide was not efficient (28%) while sodium tert-butoxide provided a moderate 
yield of 172a (50%). These studies show that the counter ion participates in the 
reaction and that sodium facilitates the cyclisation.  
In order to achieve a higher yield of 5,6-dihydro-4-pyridones, synthesis of the methyl 
ester analog 172b was attempted since Becker had reported that in 84% yield using 
sodium methoxide.
17
 The yields of the β-keto ester 166c, the enamino ester 169b, and 
the diester 171b were similar to those of the ethyl analogs (78%, 97%, and 93% 
respectively, Scheme 2.14). Dieckmann cyclisation of the dimethyl ester 171b using 
sodium methoxide gave the 5,6-dihydro-4-pyridone 172b in 72% yield, much higher 
than that using other reagents. In other syntheses, the aryl group is often introduced by 
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metalation which is not so convenient on a large scale; whereas our route is suitable for 
a large scale synthesis, since this does not involve the use of any air-sensitive reagents. 
Scheme 2.14 Dieckmann cyclisations to 5,6-dihydro-4-pyridones
172a
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1 h, 27%
NH
Ph
CO2Et
O
NaH (1.5 eq)
Ph
NH
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MeO
Ph
NH2O
169b
MeO
Ph
OO
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MeO2C
NH2.HCl
(1.3 eq) Ph
NH
171b
MeO2C
MeO2C
172b
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1 h, 72%
NH
Ph
CO2Me
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(ii)
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Substrate Reaction conditions Product
Table 2.1 Dieckmann cyclisations of enamino esters
NaH (1.5 eq)
 THF, reflux, 1h
Na (1.3 eq), MeOH
reflux, overnight
Na (1.3 eq), EtOH
reflux, overnight
KOt-Bu (2 eq), EtOH
reflux, overnight
NaOt-Bu (2 eq), EtOH
reflux, overnight
172a, 27%
mixture of 172b, and 
172a,  ~8:1, 56%
172a, 25%
172a, 28%
172a, 50%
171a
171a
171a
171a
172b
Na (1.3 eq), MeOH
reflux, overnight
172b, 72%
NH
Ph
CO2Et
O
NH
Ph
CO2Me
O
Entry
1
2
3
4
5
6
Ph
NH
171a
EtO2C
EtO2C
Ph
NH
171b
MeO2C
MeO2C
 
2.2.3 Reduction of the 5,6-Dihydro-4-pyridone 172b to the 
Piperidin-4-one 174 
N-Methylation of the 5,6-dihydro-4-pyridone 172b using methyl iodide and potassium 
carbonate proceeded in 68% yield. The methylated product 173 was reduced by 
sodium borohydride but ketone reduction, instead of the desired C=C bond reduction, 
took place to give the unwanted 4-hydroxy-1,4,5,6-tetrahydro-4H-pyridine 175 in 82% 
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yield (Scheme 2.15). Diisobutylaluminium hydride was also employed but ketone 
reduction occurred again.
22
 
173
NMe
Ph
CO2Me
O
172b
NH
Ph
CO2Me
O
174
NMe
Ph
CO2Me
O
MeI (5 eq)
K2CO3 (5 eq)
DMF, 60 oC
16 h, 68%
NaBH4 (1.1 eq)
MeOH, -15 oC
1 h, 82%
175
NMe
Ph
CO2Me
HO
NOT
Scheme 2.15 Reduction of the 5,6-dihydro-4-pyridone 173  
Comins has shown that similar 5,6-dihydro-4-pyridones were reduced by L-selectride 
to give piperidin-4-ones, once the amino group was deactivated by a phenoxycarbonyl 
group;
23
 the electron-withdrawing nature of the deactivating group makes the C=C 
bond more electrophilic, so that it is attacked by hydride. Accordingly, the amino group 
of 172b was deactivated by reacting with n-butyllithium and phenylchloroformate to 
give 176a (82%). However, L-selectride reduced the ketone instead of the C=C bond to 
give the undesired 4-hydroxy-5,6-dihydro-4H-pyridine 177 in 60% yield (Scheme 
2.16). Undesired reduction of the ketone also occurred when sodium borohydride in 
methanol was employed (91%). 
A literature survey revealed that Schultz and co-workers had reduced the C=C bond in 
a protected dihydropyridones related to 176a using sodium borohydride in an aprotic 
solvent at low temperature; they reported that ketone reduction took place 
predominantly at room temperature while olefinic reduction was the major reaction at 
-15 
o
C.
 24
 Once the C=C bond was reduced, further ketone reduction was suppressed by 
adding benzaldehyde to quench the remaining sodium borohydride prior to acidic 
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workup.
24
 In our hands, it was found that the C=C bond of the 5,6-dihydro-4-pyridone 
176a was selectively reduced to afford the desired piperidin-4-one 178a in 80% yield. 
If required, the deactivating N-phenoxycarbonyl group would be reduced into the 
desired N-methyl group by lithium aluminium hydride at the last step concurrently 
with the ketone reduction to afford codeine (Scheme 2.16). 
Scheme 2.16 Reduction of the 5,6-dihydro-4-pyridone 176a
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2.2.4 Robinson Annulation of the Piperidin-4-one 178a 
Rodriguez reported that the anionic resin Dowex 66 promoted Michael addition of 
cyclic β–keto esters with methyl vinyl ketone.25 In our hands, by employing the anionic 
resin, the Michael adduct 179 was prepared from 178a in 99% yield (Scheme 2.17). 
When the reaction was scaled up to gram scale, the yield dropped to 70%. Claisen 
condensation of the Michael adduct 179 using sodium hydroxide gave the cyclised 
product 180 in 80% yield as a 3:1 mixture of diastereoisomers. The major isomer of 
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180 would be cis-isomer so that both bulky groups are equatorial. 
178a
NCO2Ph
Ph
CO2Me
O
180
NCO2Ph
Ph
179
NCO2Ph
Ph
O
MeO2C
O
MVK (2.2 eq)
Dowex 66, MeOH
reflux, 120 h, 99%
NaOH (6 eq)
MeOH, H2O
RT, 48 h, 80%
Scheme 2.17 Robinson annulation of the piperidin-4-one 178a
O
~3:1 mixture of 
diastereoisomers
 
Christoffers developed an asymmetric copper-catalyzed Michael addition of a related 
N-protected 3-methoxycarbonylpiperidin-4-one with methyl vinyl ketone using 
L-valine diethylamide (182) as the chiral auxiliary (Scheme 2.18).
26
 It would be useful 
if this can be applied to synthesize enantiopure (-)-codeine.  
N
O
CO2Me
Boc
NEt2
Oi-Pr
H2N
N
NH
CO2Me
Boc
i-Pr
Et2N O O
N
O
Boc
CO2Me
O
181
182
183
184
Scheme 2.18 L-Valine derivative-induced asymmetric Michael reaction26
cat. HCl, molecular sieves
82%
(i)
(ii) HCl, 74%
Cu(OAc)2.H2O
 
The mechanism of metal-catalyzed Michael reaction was proposed by Christoffers and 
is shown in Scheme 2.19.
27,28
 The metal would form complexes 186 with β-keto esters 
185. By ligand exchange, methyl vinyl ketone would coordinate at a vacant site of 
metal to form 187. The function of the metal catalyst is to bring two reactants close to 
each other and to activate methyl vinyl ketone by the Lewis acidity of the metal. Once 
the Michael reaction has occurred, the adducts 189 leave the metal and other β-keto 
esters 185 would form complexes with the metal again.
27,28
 With the presence of the 
chiral auxiliary, methyl vinyl ketone would coordinate to the metal at the opposite side 
of the bulky isopropyl group of the auxiliary to give the enantiopure adduct 184.   
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Scheme 2.19 Proposed mechanism of metal-catalyzed Michael reaction 
Amination of the piperidin-4-one 178a with L-valine diethylamide 182 was attempted 
following the Christoffers' procedure
26
 but a complex mixture resulted and no desired 
product 190 could be isolated (Scheme 2.20). Amination of the piperidin-4-one 178a 
with benzylamine gave the enamine 191 in 86% yield but the enamine 190 could not 
be prepared under the same conditions. Since there is difficulty in making the enamine 
190, the asymmetric Michael reaction was abandoned and the cyclohex-2-enone ring 
of 180 was cyclised by the original route involving the use of the anionic resin Dowex 
66. 
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178a
NCO2Ph
Ph
CO2Me
O
(2S,3R)-179
NCO2Ph
Ph
O
MeO2C
O
Scheme 2.20 Attempted amination with the chiral auxiliary 182
190
NCO2Ph
Ph
CO2Me
N
H
i-Pr
Et2N O
NEt2
Oi-Pr
H2N
182  (1 eq)
HCl, sieves
PhMe, 50 oC
16 h
191
NCO2Ph
Ph
CO2Me
N
HAcOH, PhMe
70 oC, 2 h, 86%
Bn
BnNH2 (1 eq)
 
2.2.5 Attempted Grewe Cyclisation to Give the Benzomorphan 
194 
It was proposed to prepare the benzormorphan 194 from 180 by treatment with acid, 
during which it was hoped that the olefinic bond of 180 would isomerise to give the 
β,γ-unsaturated ketone 193, an ideal substrate for a Grewe cyclisation that would afford 
the benzomorphan 194 (Scheme 2.21). 
NCO2Ph
O
H
Ph
180
NCO2Ph
O
H
Ph
192
-H+
NCO2Ph
HO
H+
+
193
NCO2PhO
H
194
H+
Scheme 2.21 Proposed Grewe cyclisation to the benzomorphan 194  
However, a Grewe cyclisation using 80% sulphuric acid with heating under reflux was 
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attempted but decomposition occurred. Other acids such as hydrochloric acid were 
employed but none gave the desired product. Wang reported that β,γ-unsaturated 
ketones underwent Grewe cyclisation whereas α,β-unsaturated ketone such as 180 did 
not.
29 
It is because under acidic conditions, the equilibrium shifts towards the 
α,β-unsaturated ketone 180 and almost no β,γ-unsaturated ketone 193 is formed 
(Scheme 2.22).
9,14,29
 Thus, an effective way to convert the α,β-unsaturated ketone 180 
into a β,γ-unsaturated ketone is needed for the benzomorphan synthesis. However, 
further investigation was not undertaken due to time limitation. 
NCO2Ph
O
H
Ph
180
80% H2SO4
150 oC, reflux
16 h
NCO2PhO
H
194
NCO2Ph
O
H
Ph
180
NCO2Ph
O
Ph
193
H+
Scheme 2.22 Attempted Grewe cyclisation  
2.2.6 Modified Synthetic Plan for Codeine 
One possible solution would be the conversion of the α,β-unsaturated ketone 180 into 
the halohydrin 195 which would be a potential substrate for Grewe cyclisation. When 
the halohydrin 195 was treated with acid, dehydration would take place to form the 
β,γ-unsaturated ketone 196 (Scheme 2.23, eq i). The formation of the unwanted 
α,β-unsaturated ketone would be avoided since the olefinic bond formed would be 
thermodynamically less stable due to the presence of the electron-withdrawing 
bromine. Grewe cyclisation of 196 could occur to afford the benzormorphan 197. 
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Moreover, the bromine atom would be ideally located for the construction of the 
dihydrofuran ring by intramolecular etherification (Scheme 2.23, eq ii).  
Scheme 2.23 Proposed Grewe cyclisation of the halohydrin 195
NCO2Ph
O
Ph
180
NCO2PhO
H
197
NCO2Ph
O
Ph
195
OH
Br
Br
NBS
H2O, THF
80% H2SO4
NCO2Ph
O
Ph
196
Br
NCO2PhO
H
TBSO
MeO Br
NCO2PhO
H
MeO Br
O
H
198199
Br
TBAF
(i)
(ii)
 
If the benzormorphan 197 can be prepared from the halohydrin 195, it is believed that 
codeine can be synthesized by this route because the formation of the dihydrofuran 
ring of 198 is related to that of the Metz's synthesis;
7
 while the final selenoxide 
elimination-reduction sequence giving codeine is close to White's synthesis (Scheme 
2.24).
4
 This route would be 12-13 steps, much shorter than most of the total syntheses 
of codeine (usually over 20 steps). An enantioselective synthesis of codeine would also 
be feasible if an asymmetric Michael addition of 202 could be developed. 
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Scheme 2.24 New retrosynthetic plan for codeine
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2.2.7 Attempted Synthesis of 2,3-Disubstituted Piperidin-4-ones 
Since 2,3-disubstitued piperidin-4-ones could be key compounds for the synthesis of 
benzomorphans and opium alkaloids as discussed in the Section 2.1.1, it was of interest 
to develop a general route which does not involve many steps. In Section 2.2.3, the 
2-benzyl 3-methoxycarbonylpiperidin-4-one 178a was prepared as an intermediate in 
the synthesis of codeine. Therefore, synthesis of different 2,3-disubstituted 
piperidin-4-ones 208 using a related route was attempted (Scheme 2.25). The same 
strategy was applied for the preparation of 3-methoxycarbonylpiperidin-4-ones 178 
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from β-keto esters 166. Alkylation of 178 with alkyl halides following decarboxylation 
would afford 2,3-disubstituted piperidin-4-ones 208. This would be a powerful route 
since different 2,3-disubstituted piperidin-4-ones could be prepared from simple 
starting materials such as β-keto esters 166 and β-alanine methyl ester only. 
Scheme 2.25 Proposed route to 2,3-disubstituted piperidin-4-ones 208
178
172171166
MeO2C
O
NCO2Ph
R1
MeO2C
O
NH
R1
NH
R1
CO2Me
CO2Me
NH2
O
R1
CO2Me
169
NH2
R1
CO2Me
207
MeO2C
O
NCO2Ph
R1
R2
208
R2
O
NCO2Ph
R1
NH4OAc
NaOMe
1. PhOCOCl
2. NaBH4, THF
    pyridine
R2X
K2CO3
wet DMSO
150 oC
NaCl
MeO2C
 
Two β-keto esters 166 (R1 being a methyl and a benzyl) were employed to see whether 
2,3-disubstituted piperidin-4-ones 208 could be made by the proposed route (Scheme 
2.26). Amination of the β-keto ester 166c with ammonium acetate gave the enamine 
169b in 97% yield;
20
 while amination of the β-keto ester 166d with ammonium 
hydroxide gave the enamine 169c in 35% yield (procedure modified from Hansen's 
synthesis).
30
 Displacement of enamines 169 with β-alanine methyl ester afforded 
diesters 171 in excellent yields which were then cyclised by sodium methoxide to give 
5,6-dihydro-4-pyridones 172 (82% and 74% respectively).
17
 N-Protection of 
5,6-dihydro-4-pyridones 172 using phenylchloroformate proceeded well (82% and 
74%, procedure modified from Comins' synthesis).
23
 Olefinic reduction using sodium 
borohydride in anhydrous THF at -15 
o
C afforded 3-methoxycarbonylpiperidin-4-ones 
178 in good yields (procedure modified from Schultz's synthesis).
24
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172b: 82%
172c: 74%
171b: 93%
171c: 88%
MeO2C
O
NH
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NH
R1
CO2Me
NH2
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CO2Me
NaOMe (1.2 eq)
 (1.3 eq)
CO2Me
NH2
MeOH, reflux, 3 h
.HCl
MeOH, reflux, 1 h
178a: 80%
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MeO2C
O
NCO2Ph
R1
PhOCOCl (1.3 eq) NaBH4 (1.2 eq)
176a: 82%
176b: 74%
MeO2C
O
NCO2Ph
R1n-BuLi (1.1 eq)
THF, -78 oC, 1 h
THF, pyridine,
-15 oC, 0.5 h
Scheme 2.26 Synthesis of piperidin-4-ones 178
MeO2C
166c: R1= Bn
166d: R1= Me
O
R1
CO2Me
NH4OAc, PhMe
reflux, 6 h
or NH4OH, MeOH
reflux, 16 h
169b: 97%
169c: 35%
 
With 3-methoxycarbonylpiperidin-4-ones 178 in hand, 3-substitution could be 
attempted using alkyl halides and potassium carbonate (Scheme 2.27). Methylation 
using methyl iodide gave excellent yields (around 90% for both substrates, Scheme 
2.27); while allylation using allyl bromide proceeded well (around 70% for both 
substrates). If removal of the methoxycarbonyl group of 207 can be achieved, different 
2,3-disubstituted piperidin-4-ones 208 can be made by this route. 
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178
MeO2C
O
NCO2Ph
R1
207
MeO2C
O
NCO2Ph
R1
R2
R2X (2 eq)
K2CO3 (2 eq)
acetone, reflux, 16 h
 
Cpd R1 R2X yield (%) 
178a Bn Methyl iodide 89 
178a Bn Allyl bromide 74 
178b Me Methyl iodide 88 
178b Me Allyl bromide 70 
Scheme 2.27 Alkylations of piperidin-4-ones 178 
Krapcho decarboxylation of 207 using lithium chloride in wet DMSO was attempted 
but no reaction took place.
31
 Decarboxylation under neutral conditions by heating 
under reflux in acetonitrile was also tried but not successful.
32
 Various reagents 
including hydrochloric acid, TFA,
33
 and sodium hydroxide were investigated but none 
were effective (Scheme 2.28). In view of these surprising difficulties encountered, this 
route to 2,3-disubstituted piperidin-4-ones 208 was abandoned. 
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207
MeO2C
O
NCO2Ph
R1
R2
208
R2
O
NCO2Ph
R1
 
Entry Conditions 
1 LiCl (1.1 eq), H2O (2 eq), DMSO, reflux, 4 h  
2 MeCN, 1% H2O, reflux, 3 h 
3 5% HCl, water, reflux, 3 h 
4 TFA, PhMe, MeOH, reflux, 4 h 
5 NaOH, MeOH, H2O, RT, 2 d 
Scheme 2.28 Attempted decarboxylation of the piperidin-4-ones 207 
2.2.8 Future Work 
Hohenlohe-Oeringen described a one-pot synthesis of the piperidin-4-one 209, which 
is closely related to 202, using Nazarov’s reagent (ethyl 3-oxo-4-pentenoate) via a 
tandem Mannich aza-Michael cyclisation, achieved in 29% (scheme 2.29).
34
 With the 
advent of asymmetric Mannich reactions, it is possible to make piperidin-4-ones 
enantioselectively.
35,36
 Chiral
 
imines, β-keto esters, or catalysts could be potential 
reagents for such enantioselective condensations. If the important intermediate 202 
could be synthesized asymmetrically in one step by this tandem Mannich aza-Michael 
cyclisation, the synthetic route of (-)-codeine would be greatly shortened. 
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Scheme 2.29 A one-pot enantioselective synthesis of the piperidin-4-one 
209 via a tandem Mannich aza-Michael cyclisation
209
 
The mechanism of a tandem Mannich aza-Michael cyclisation is shown in Scheme 
2.30. Methylamine reacts with the aldehyde to give an iminium ion via an electrophilic 
substitution. The enol form of ethyl 3-oxo-4-pentenoate attacks the iminium ion to 
afford an adduct. An intramolecular Michael addition undergoes to afford the 
piperidin-4-one 209. 
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Scheme 2.30 Mechanism of tandem Mannich aza-Michael cyclisation
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2.3 Conclusions  
The main objective was to develop a synthetic route to codeine with a relatively short 
path; the retrosynthetic plan is shown in Scheme 2.24. The bicyclic compound 180 was 
prepared by a Robinson annulation from the piperidin-4-one 178a. The original plan 
was to make the benzomorphan 194 by treating 180 with acid (Scheme 2.31). However, 
C=C bond isomerisation of 197 did not occur to give the β,γ-unsaturated ketone 193 
under acidic conditions; thus, no Grewe cyclisation to afford the benzomorphan 194 
could be attempted. Owing to time limitations, further investigation was not 
undertaken. 
It was proposed that the halohydrin 195 would undergo a Grewe cyclisation to give the 
benzomorphan 197 under acidic conditions. The formation of the unwanted 
α,β-unsaturated ketone is avoided since the olefinic bond formed would be 
thermodynamically less stable due to the presence of the electron-withdrawing 
bromine (Scheme 2.31). If this happens, it is very likely that codeine can be 
synthesized by this route because the remaining steps have similar strategies as White's 
and Metz's syntheses.
4,7
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Scheme 2.31 Proposed Grewe cyclisation to benzomorphan 197
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Synthesis of 2,3-disubstituted piperidin-4-ones 208 from β-keto esters 168 using a 
related route was attempted (Scheme 2.26). Although different 2,3-disubstituted 
3-methoxycarbonylpiperidin-4-ones 207 were prepared, there was difficulty with the 
removal of the methoxycarbonyl group and therefore, this route was abandoned. 
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2.4 Experimental  
Ethyl 3-oxo-4-phenylbutanoate (166b) 
Ph
OEt
O O  
To a stirred solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (14.4 g, 0.100 mol) in 
dichloromethane (60 mL) at 0 °C, pyridine (20 mL, 0.247 mol) was added over 10 min. 
A solution of phenylacetyl chloride (13.3 mL, 0.100 mol) in dichloromethane (140 mL) 
was added over 30 min and the mixture was stirred at 0 °C for 30 min. The mixture 
was then allowed to warm to room temperature and stirred for a further 1 h. The 
solution was diluted with dichloromethane (200 mL), washed with water (4 x 300 mL), 
dried (MgSO4), and evaporated. The orange solid was dissolved in ethanol (200 mL) 
and the solution was heated under reflux for 3 h. The solution was then evaporated to 
give an orange oil that was purified by flash chromatography (30% ethyl 
acetate/hexane) to give 166b (14.9 g, 72%) as a pale yellow oil, Rf 0.69 (30% ethyl 
acetate/hexane); IR νmax 2985 (C-H), 1743 (ketone C=O), 1717 (ester C=O), 1265, 
1025, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.37-7.09 (5H, m, Ph) 4.20 (2H, q, J= 
7.2 Hz, OCH2) 3.83 (2H, s, CH2Ar) 3.45 (2H, s, CH2CO2CH2) 1.26 (3H, t, J= 7.2 Hz, 
CH3CH2O). Spectroscopic data were consistent with reported values in the literature.
37
 
Methyl 3-oxo-1-phenylbutanoate (166c)
18 
Ph
OMe
O O  
To a stirred solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (6.20 g, 43.1 mmol) in 
dichloromethane (30 mL) at 0 °C, pyridine (9 mL, 111 mmol) was added over 5 min. A 
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solution of phenylacetyl chloride (5.73 mL, 43.1 mmol) in dichloromethane (70 mL) 
was added over 10 min and the mixture was stirred at 0 °C for 30 min. The mixture 
was then allowed to warm to room temperature and stirred for a further 1 h. The 
solution was diluted with dichloromethane (100 mL), washed with water (4 x 150 mL), 
dried (MgSO4), and evaporated to give an orange solid which was dissolved in 
methanol (150 mL) and the solution was heated under reflux for 3 h. The solution was 
then evaporated. The resulting orange oil was purified by flash chromatography (30% 
ethyl acetate/hexane) to give 166c (6.41 g, 78%) as a pale yellow oil, Rf 0.8 (30% ethyl 
acetate/hexane); IR νmax 2954 (C-H), 1744 (ketone C=O), 1715 (ester C=O), 1436, 
1260, 1201 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.60-7.19 (5H, m, Ph) 3.82 (2H, s, 
CH2Ar) 3.71 (3H, s, OCH3) 3.46 (2H, s, CH2CO2CH3).  
Ethyl 3-amino-4-phenylbut-2-enoate (169a)
20 
EtO
H2N
Ph
O
  
Ethyl 3-oxo-1-phenylbutanoate (11.8 g, 57.0 mmol), ammonium acetate (20.0 g, 0.259 
mol), and acetic acid (5 mL) were dissolved in dry toluene (150 mL). The solution was 
heated under reflux for 6 h with the azeotropic removal of water. The mixture was 
allowed to cool to room temperature, then washed with saturated aqueous sodium 
hydrogen carbonate (30 mL), dried (Na2SO4), and evaporated to give 169a (10.5 g, 
90%) as a pale orange oil, Rf 0.79 (30% ethyl acetate/hexane); IR νmax 3437 (N-H), 
3332 (N-H), 2979 (C-H), 1717 (ester C=O), 1663 (C=C), 1613, 1265, 1153, 1039, 698 
cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.49-7.22 (5H, m, Ph) 4.64 (1H, s, CHCOO) 4.12 
(2H, q, J= 7.2 Hz, CH2CH3) 3.46 (2H, s, CH2Ar) 1.26 (3H, t, J= 7.2 Hz, CH3CH2O). 
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Methyl 3-amino-4-phenylbut-2-enoate (169b)
20 
MeO
H2N
Ph
O
 
Methyl 3-oxo-1-phenylbutanoate (4.00 g, 20.8 mmol), ammonium acetate (8.02 g, 
0.104 mol), and acetic acid (2 mL) were dissolved in dry toluene (70 mL). The solution 
was heated under reflux for 6 h with the azeotropic removal of water. The mixture was 
allowed to cool to room temperature, then washed with saturated aqueous sodium 
hydrogen carbonate (15 mL), dried (Na2SO4), and evaporated to give 169b (3.85 g, 
97%) as a pale orange gum, Rf 0.45 (30% ethyl acetate/hexane); IR νmax 3449 (N-H), 
3333 (N-H), 2947 (C-H), 1716 (ester C=O), 1665 (C=C), 1613, 1449, 1266, 1156, 
1030, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.36-7.22 (5H, m, Ph) 4.65 (1H, s, 
CHCOO) 3.65 (3H, s, OCH3) 3.47 (2H, s, CH2Ar).  
Methyl 3-iminobutanoate (169c) 
OMe
NH O
 
To a solution of methyl 3-oxobutanoate (2.00 g, 17.4 mmol) in methanol (8 mL) was 
added 0.880 ammonia solution (2 mL, 70 mmol) dropwise. The mixture was heated 
under reflux for 16 h. The mixture was allowed to cool to room temperature and 
evaporated. The resulting solution was extracted with chloroform (3 x 10 mL). The 
combined organic layers were evaporated to give 169c (0.70 g, 35%) as white 
microprisms, mp 76-79 °C (lit.
38
 mp
 
81-83 °C); Rf 0.72 (50% ethyl acetate/hexane); IR 
νmax 3319 (N-H), 2953 (C-H), 1735 (ester C=O), 1436, 1201, 1174, 703 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.92 (1H, br s, NH) 4.52 (2H, s, CH2CO2CH3) 3.63 (3H, s, OCH3) 
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1.90 (3H, s, CH3CNH); 
13
C NMR (500 MHz, CDCl3) δ 170.6 (COOCH3) 159.9 (CNH) 
83.8 (CH2CO2Me) 50.2 (OCH3) 22.4 (CH3CNH). Spectroscopic data were consistent 
with reported values in the literature.
38
 
Ethyl 3-aminopropanoate hydrochloride (170)
37 
H2N
CO2Et.HCl
 
To a stirred solution of β-alanine (17.8 g, 0.200 mol) in ethanol (50 mL) in a salt-ice 
bath, thionyl chloride (32.8 g, 0.275 mol) was added dropwise via an addition funnel. 
The resulting solution was stirred for 2 d at room temperature. Acetone (50 mL) was 
added and the solution was left to crystallize. Filtration, washing with acetone and then 
with diethyl ether gave 206 (29.0 g, 94%) as white microprisms, mp 58-59 °C (lit.
39
 mp
 
58 °C); IR νmax 3402 (N-H), 2981 (C-H), 1722 (ester C=O), 1614, 1378, 1212, 1021 
cm
-1
. 
Ethyl 3-(2-ethoxycarbonylethyl)amino-4-phenylbut-2-enoate (171a)
17 
Ph
NH
EtO2C
EtO2C  
To ethyl 3-amino-4-phenylbut-2-enoate (4.50 g, 21.9 mmol) in ethanol (5 mL) was 
added ethyl 3-aminopropanoate hydrochloride (4.33 g, 28.2 mmol). The mixture was 
heated under reflux for 3 h, then allowed to cool to room temperature and diluted with 
diethyl ether (10 mL). The solution was filtered and the filtrate was evaporated to give 
171a (6.05 g, 93%) as an orange oil, Rf 0.79 (30% ethyl acetate/hexane); IR νmax 3445 
(N-H), 2980 (C-H), 1729 (ester C=O), 1650 (C=C), 1599, 1373, 1181, 700 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 8.71 (1H, br d, J= 6.6 Hz, NH) 7.33-7.19 (5H, m, Ph) 4.49 
(1H, s, CHCOO) 4.18-4.05 (4H, m, 2 x CH2OOC) 3.57 (2H, s, CH2Ar) 3.39 (2H, q, J= 
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6.6 Hz, CH2NH) 2.35 (2H, t, J= 6.6 Hz, CH2COO) 1.27-1.19 (6H, m, 2 x CH3CH2). 
Methyl 3-(2-methoxycarbonylethyl)amino-4-phenylbut-2-enoate (171b)
17 
Ph
NH
MeO2C
MeO2C  
To methyl 3-amino-4-phenylbut-2-enoate (4.50 g, 23.5 mmol) in methanol (5 mL) was 
added methyl 3-aminopropanoate hydrochloride (3.94 g, 28.2 mmol) and the solution 
was heated under reflux for 3 h. The mixture was allowed to cool to room temperature 
and diluted with diethyl ether (10 mL). The solution was filtered and the filtrate was 
evaporated to give 171b (6.05 g, 93%,) as an orange oil, Rf 0.56 (30% ethyl 
acetate/hexane); IR νmax 3345 (N-H), 2951 (C-H), 1734 (ester C=O), 1653 (C=C), 1598, 
1435, 1246, 1165, 729, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.70 (1H, br d, J= 6.6 
Hz, NH) 7.33-7.22 (5H, m, Ph) 4.51 (1H, s, =CHCOO) 3.68 (3H, s, OCH3) 3.64 (3H, s, 
OCH3) 3.57 (2H, s, CH2Ar) 3.39 (2H, q, J= 6.6 Hz, CH2NH) 2.36 (2H, t, J= 6.6 Hz, 
CH2COO). 
Methyl 3-(2-methoxycarbonylethyl)aminobut-2-enoate (171c)
17 
NH
MeO2C
MeO2C  
To methyl 3-aminobut-2-enoate (2.00 g, 17.4 mmol) in methanol (3 mL) was added 
methyl 3-aminopropanoate hydrochloride (2.80 g, 20.9 mmol) and the solution was 
heated under reflux for 3 h. The mixture was allowed to cool to room temperature and 
diluted with diethyl ether (8 mL). The solution was filtered and the filtrate was 
evaporated. The pale yellow oil was purified by flash chromatography (20% ethyl 
acetate/hexane) to give 171c (3.06 g, 88%,) as a colourless oil, Rf 0.30 (30% ethyl 
acetate/hexane); IR νmax 3346 (N-H), 2952 (C-H), 1734 (ester C=O), 1651 (C=C), 1599, 
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1436, 1166, 1047, 783, 701 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.61 (1H, br d, J= 6.7 
Hz, NH) 4.43 (1H, s, CHCOO) 3.68 (3H, s, OCH3) 3.58 (3H, s, OCH3) 3.48 (2H, q, J= 
6.7 Hz, CH2NH) 2.54 (2H, t, J= 6.7 Hz, CH2COO) 1.90 (3H, s, CH3CH); 
13
C NMR 
(500 MHz, CDCl3) δ 171.8 (COOCH3) 170.8 (COOCH3) 161.4 (=CNH) 82.8 
(CH=CNH) 52.0 (OCH3) 50.1 (OCH3) 38.6 (CH2NH) 35.3 (CH2COO) 19.3 
(CH3CNH). 
2-Benzyl-5,6-dihydro-3-(methoxycarbonyl)-4-pyridone (172b)
17 
HN
Ph
CO2Me
O
 
To methyl 3-(2-methoxycarbonylethyl)amino-4-phenylbut-2-enoate (9.57 g, 34.5 mmol) 
in methanol (7 mL) was added sodium methoxide in methanol (17.8 mL, 38.0 mmol, 
2.14 M) and the solution was heated under reflux for 6 h under nitrogen. The mixture 
was allowed to cool to room temperature and evaporated. The resulting brown residue 
was purified by flash chromatography (5% ethanol/ethyl acetate) to give 172b (6.05 g, 
72%) as white microprisms, mp 116-117 
o
C (lit.
17 
mp 116-118 
o
C); Rf 0.13 (ethyl 
acetate); IR νmax 3239 (N-H), 2855 (C-H), 1691 (ketone C=O), 1616, 1452, 1288, 1218 
cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.39-7.22 (5H, m, Ph) 5.69 (1H, br d, J= 2.8 Hz, 
NH) 4.08 (2H, s, CH2Ar) 3.76 (3H, s, OCH3) 3.49 (2H, td, J= 7.6, 2.8 Hz, CH2NH) 
2.47 (2H, t, J= 7.6 Hz, CH2CO);
 13
C NMR (300 MHz, CDCl3) δ 188.7 (COCH2) 168.2 
(COOCH3) 167.2 (=CNH) 135.2 (ArC) 129.5 (ArC) 129.4 (ArC) 129.0 (ArC) 128.9 
(ArC) 127.5 (ArC) 103.2 (=CCO) 51.3 (CH3O) 40.6 (CH2CO) 39.5 (CH2NH) 35.5 
(CH2Ph); m/z (Cl+) 268 (90%, M
+
); HRMS C14H15NO3Na calcd. 268.0950, found 
268.0960.  
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5,6-dihydro-3-(methoxycarbonyl)-2-methyl-4-pyridone (172c)
17 
HN
CO2Me
O
 
To methyl 3-(2-methoxycarbonylethyl)aminobut-2-enoate (6.00 g, 29.8 mmol) in 
methanol (1.0 mL) was added sodium methoxide in methanol (20.4 mL, 32.8 mmol, 
1.61 M) and the solution was heated under reflux for 6 h under nitrogen. The mixture 
was allowed to cool to room temperature and evaporated to give a brown residue 
which was purified by flash chromatography (10% ethanol/chloroform) to give 172c 
(2.90 g, 58%) as white microprisms, mp 128-130 
o
C (lit.
17 
mp 142-154 
o
C); Rf 0.35 
(15% ethanol/chloroform); IR νmax 3246 (N-H), 2947 (C-H), 1710 (ketone C=O), 1683 
(ester C=O), 1569, 1390, 1218, 1169, 1110, 534 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.19 (1H, br s, NH) 3.67 (3H, s, OCH3) 3.54 (2H, t, J= 7.2 Hz, CH2NH) 2.42 (2H, t, J= 
7.2 Hz, CH2CO) 2.35 (3H, s, CH3CNH);
 13
C NMR (500 MHz, CDCl3) δ 189.1 
(COCH2) 168.9 (COOCH3) 167.3 (=CNH) 101.8 (=CCO) 50.9 (CH3O) 40.3 (CH2CO) 
35.6 (CH2NH) 22.0 (CH3CNH); m/z (Cl+) 170 (100%, M+H
+
) 138 (60%, M
+
-OCH3); 
HRMS C8H11NO3 calcd. 170.0817, found 170.0813.  
2-Benzyl-5,6-dihydro-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-4-pyridone 
(176a)
 
N
Ph
CO2Me
O
O
OPh
 
To 2-benzyl-5,6-dihydro-3-(methoxycarbonyl)-4-pyridone (0.30 g, 1.22 mmol) in THF 
(9.4 mL) was added n-butyllithium (1.6 M in hexanes, 0.84 mL) dropwise at -78 
o
C 
under nitrogen and the mixture was stirred for 20 min. Phenyl chloroformate (0.2 mL, 
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1.59 mmol) was added to the mixture which was then stirred for 1 h at -78 
o
C. The 
mixture was quenched by addition of saturated aqueous sodium hydrogen carbonate (3 
mL), after allowing to warm to room temperature, water (3 mL) was added. The 
mixture was extracted with diethyl ether (4 x 3 mL) and the combined organic layers 
were washed with brine (1.5 mL), dried (MgSO4), and evaporated to give 176a (0.32 g, 
82%) as white microprisms, mp 109-112 
o
C; Rf 0.76 (50% ethyl acetate/hexane); IR 
νmax 2951 (C-H), 1723 (ketone C=O), 1671 (ester C=O), 1591, 1581, 1296, 1254 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.38-7.22 (8H, m, Ph) 6.86-6.83 (2H, m, Ph) 4.24 (2H, s, 
CH2Ar) 4.15 (2H, t, J= 6.5 Hz, CH2N) 3.88 (3H, s, OCH3) 2.73 (2H, t, J= 6.5 Hz, 
CH2CO);
 13
C NMR (300 MHz, CDCl3) δ 190.6 (COCH2) 166.4 (COOCH3) 157.3 
(CON) 151.3 (CCH2) 150.1 (ArC) 136.0 (ArC) 129.6 (ArC) 128.9 (ArC) 128.8 (ArC) 
127.3 (ArC) 126.4 (ArC) 122.6 (CCO) 121.2 (ArC) 52.8 (CH3O) 47.2 (CH2CO) 38.4 
(CH2N) 37.3 (CH2Ar); m/z (Cl+) 388 (40%, M
+
); HRMS C21H19NO5Na calcd. 
388.1161, found 388.1146.   
5,6-Dihydro-3-(methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)-4-pyridone 
(176b)
 
N
CO2Me
O
O
OPh
 
To 5,6-dihydro-3-(methoxycarbonyl)-2-methyl-4-pyridone (1.00 g, 5.91 mmol) in THF 
(120 mL) was added n-butyllithium (2.5 M in hexanes, 2.6 mL, 6.50 mmol) dropwise 
at -78 
o
C under nitrogen and the mixture was stirred for 20 min. Phenyl chloroformate 
(1.0 mL, 7.68 mmol) was added to the mixture which was then stirred for 1 h at -78 
o
C. 
The mixture was quenched by addition of saturated aqueous sodium hydrogen 
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carbonate (15 mL), after allowing to warm to room temperature, water (15 mL) was 
added. The mixture was extracted with diethyl ether (4 x 15 mL) and the combined 
organic layers were washed with brine (7 mL), dried (MgSO4), and evaporated to give 
176b (1.26 g, 74%) as a pale yellow microprism, mp 152-155 
o
C; Rf 0.56 (50% ethyl 
acetate/hexane); IR νmax 2952 (C-H), 1723 (ketone C=O), 1667 (ester C=O), 1587, 
1348, 1249, 1189, 1154, 751 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.40 (2H, dd, J= 7.8, 
7.1 Hz, Ph) 7.26 (1H, t, J= 7.1 Hz, Ph) 7.13 (2H, d, J= 7.8 Hz, Ph) 4.22 (2H, t, J= 6.5 
Hz, CH2N) 3.82 (3H, s, OCH3) 2.63 (2H, t, J= 6.5 Hz, CH2CO) 2.42 (3H, s, CH3CN);
 
13
C NMR (500 MHz, CDCl3) δ 190.0 (COCH2) 166.6 (COOCH3) 156.2 (ArC) 151.7 
(CON) 150.3 (CCH3) 129.5 (ArC) 126.5 (ArC) 121.3 (ArC) 120.8 (CCO) 52.7 (CH3O) 
46.3 (CH2CO) 36.8 (CH2N) 21.1 (CH3C); m/z (Cl+) 290 (100%, M+H
+
) 258 (24%, 
M
+
-OCH3); HRMS C15H15NO5 calcd. 290.1028, found 290.1026.   
2-Benzyl-4-hydroxy-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-1,4,5,6-tetrahydro
-4H-pyridine (177)
 
N
Ph
CO2Me
OH
O
OPh
 
(a) Using L-selectride: To 
2-benzyl-5,6-dihydro-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-4-pyridone (0.31 g, 
0.85 mmol) in THF (8.8 mL) was added borontrifluoride diethyletherate (0.24 mL, 
1.95 mmol) dropwise at -78 
o
C under nitrogen and the mixture was stirred for 1 h. 
L-selectride (0.84 mL, 0.85 mmol) was added to the mixture which was then stirred for 
2 h at -15 
o
C. The mixture was quenched by adding saturated aqueous sodium 
hydrogen carbonate (30 mL). The mixture was allowed to warm to room temperature, 
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then extracted with diethyl ether (3 x 20 mL). The combined organic layers were 
washed with brine (3.5 mL), dried (MgSO4), and evaporated. The resulting yellow oil 
was purified by flash chromatography (30% ethyl acetate/hexane) to give 177 (0.19 g, 
60%) as white microprisms, mp 117-119 
o
C; Rf 0.62 (50% ethyl acetate/hexane); IR 
νmax 2948 (C-H), 1735 (ester C=O), 1676 (ester C=O), 1607, 1430, 1282, 1251 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.36-7.18 (8H, m, Ph) 6.48-6.46 (2H, m, Ph) 4.63 (1H, 
d, J= 4.6 Hz, CHOH) 4.60 (1H, d, J= 16.0 Hz, CH2Ar) 4.46 (1H, d, J= 16.0 Hz, CH2Ar) 
4.15 (1H, dt, J= 11.0, 3.0 Hz, CH2N) 3.80 (3H, s, OCH3) 3.39 (1H, dt, J= 13.0, 3.0 Hz, 
CH2N) 2.12-1.97 (2H, m, CH2CHOH); 
13
C NMR (300 MHz, CDCl3) δ 169.1 
(COOCH3) 152.0 (ArC) 150.5 (CON) 149.9 (ArC) 138.4 (CCH2Ar) 129.4 (ArC) 128.5 
(ArC) 128.4 (ArC) 126.4 (ArC) 125.9 (ArC) 121.4 (ArC) 119.6 (CCO2CH3) 63.0 
(CHOH) 52.1 (CH2CHOH) 42.5 (CH2Ar) 36.7 (CH2N) 31.1 (CH3OOC); m/z (Cl+) 390 
(40%, M
+
); HRMS C21H21NO5Na calcd. 390.1317, found 390.1320. 
(b) Using sodium borohydride: To 
2-benzyl-5,6-dihydro-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-4-pyridone (1.00 g, 
2.70 mmol) in methanol (16 mL) was added sodium borohydride (0.13 g, 3.30 mmol) 
at 0 
o
C and the mixture was stirred for 1 h. The mixture was quenched by adding water 
(10 mL), then allowed to warm to room temperature and then was extracted with 
dichloromethane (3 x 20 mL). The combined organic layers were dried (MgSO4), and 
evaporated to give a residue that was purified by flash chromatography (30% ethyl 
acetate/hexane) to give 177 (0.91 g, 91%) as white microprisms with mp and 
spectroscopic data as above. 
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2-Benzyl-3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-one (178a)
 
N
Ph
CO2Me
O
O
OPh
N
Ph
CO2Me
OH
O
OPh=
2 3
4
56
7
 
To 2-benzyl-5,6-dihydro-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-4-pyridone (0.30 
g, 0.82 mmol) in THF-pyridine (6.5 mL, 10:1) was added sodium borohydride (0.04 g, 
0.98 mmol) at -15 
o
C under nitrogen; the mixture was stirred for 0.5 h at -15 
o
C. 
Benzaldehyde (0.66 mL, 6.6 mmol) was then added and the mixture was stirred for 10 
min at room temperature. After cooling to -78 
o
C, a mixture of hydrochloric acid (0.9 
mL, 10 M) and ethanol (1.6 mL) was added and the mixture was stirred for 5 min at 
-78 
o
C and 10 min at room temperature. Water (5 mL) was then added and the mixture 
was extracted with dichloromethane (3 x 10 mL), dried (MgSO4), and evaporated. The 
resulting orange oil was purified by flash chromatography (25% ethyl acetate/hexane) 
to give 178a (0.24 g, 80%) as white microprisms, mp 137-139 
o
C; Rf 0.67 (50% ethyl 
acetate/hexane); IR νmax 1714 (ester C=O), 1657 (ester C=O), 1618, 1422, 1260, 1236 
cm
-1
; 
1
H NMR (300 MHz, CDCl3) (presence of rotamers) δ 7.38-7.07 (8H, m, Ph) 6.77 
(2H, d, J= 7.5 Hz, Ph) 5.32-5.25 (1H, m, C2H) 4.33 (1H, dd, J= 13.9, 7.2 Hz, C6H) 
3.81 (3H, s, OCH3) 3.44-3.34 (1H, m, C3H) 3.19-3.13 (1H, m, C7H) 2.86-2.78 (1H, m, 
C2H) 2.87-2.60 (1H, m, C3H) 2.37-2.30 (1H, m, C7H); 
13
C NMR (300 MHz, CDCl3) δ 
171.5 (COOCH3) 171.2 (COOCH3) 171.1 (C4) 170.8 (C4) 153.5 (CON) 153.3 (CON) 
151.3 (ArC) 151.0 (ArC) 138.6 (ArC) 138.0 (ArC) 129.5 (ArC) 129.4 (ArC) 129.4 
(ArC) 129.2 (ArC) 129.0 (ArC) 128.6 (ArC) 128.3 (ArC) 127.7 (ArC) 127.0 (ArC) 
126.7 (ArC) 126.6 (ArC) 125.3 (ArC) 121.7 (ArC) 121.6 (ArC) 100.5 (C5) 100.5 (C5) 
52.2 (OCH3) 52.0 (OCH3) 51.9 (C6) 51.0 (C6) 40.2 (C2) 40.0 (C2) 36.9 (C7) 35.5 (C7) 
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28.8 (C3) 28.6 (C3); m/z (Cl+) 368 (8%, M
+
) 276 (95%, M
+
-ArCH2); HRMS 
C21H21NO5Na calcd. 368.1495, found 368.1498. 
3-(Methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)piperidin-4-one (178b)
 
N
CO2Me
O
O
OPh
N
CO2Me
OH
O
OPh=
2 3
4
56
7
 
To 5,6-dihydro-3-(methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)-4-pyridone (0.20 
g, 0.69 mmol) in THF-pyridine (5.5 mL, 10:1) was added sodium borohydride (0.03 g, 
0.82 mmol) at -15 
o
C under nitrogen; the mixture was stirred for 0.5 h at -15 
o
C. 
Benzaldehyde (0.28 mL, 2.8 mmol) was then added to the mixture and subsequently 
stirred for 10 min at room temperature. After cooling to -78 
o
C, a mixture of  
hydrochloric acid (0.9 mL, 10 M) and ethanol (1.6 mL) was added and the mixture was 
stirred for 5 min at -78 
o
C and 10 min at room temperature. Water (5 mL) was then 
added and the mixture was extracted with dichloromethane (3 x 10 mL), dried 
(MgSO4), and evaporated. The resulting orange oil was purified by flash 
chromatography (25% ethyl acetate/hexane) to give 178b (0.15 g, 76%) as a colourless 
oil, Rf 0.76 (50% ethyl acetate/hexane); IR νmax 3300 (O-H), 2960 (C-H), 1718 (ester 
C=O), 1660 (C=C), 1419, 1303, 1200, 746 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
(presence of rotamers) δ 7.38-7.11 (5H, m, Ph) 5.14 (1H, q, J= 6.4 Hz, C6H) 5.08 (1H, 
q, J= 6.4 Hz, C6H) 4.33-4.27 (1H, m, C2H) 3.81 (3H, s, OCH3) 3.79 (3H, s, OCH3) 
3.38 (1H, td, J= 7.9, 3.4 Hz, C2H) 3.23 (1H, td, J= 7.9, 1.5 Hz, C2H) 2.67-2.62 (2H, m, 
C3H) 2.34-2.29 (2H, m, C3H) 1.43 (3H, d, J= 6.4 Hz, C7H) 1.37 (3H, d, J= 6.4 Hz, 
C7H); 
13
C NMR (500 MHz, CDCl3) δ 171.3 (COOCH3) 171.2 (COOCH3) 170.8 (C4) 
170.1 (C4) 153.4 (CON) 152.9 (CON) 151.3 (ArC) 129.1 (ArC) 129.1 (ArC) 125.7 
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(ArC) 125.4 (ArC) 121.9 (ArC) 121.8 (ArC) 101.6 (C5) 101.0 (C5) 51.8 (OCH3) 51.5 
(OCH3) 46.4 (C2) 46.0 (C2) 36.2 (C6) 35.5 (C6) 29.1 (C3) 28.7 (C3) 19.4 (C7) 19.3 (C7). 
2-Benzyl-3-(methoxycarbonyl)-3-(3-oxobutyl)-1-(phenoxycarbonyl)piperidin-4-on
e (179)
 
N
Ph
O
O
OPh CO2Me
O
1 2
3
4
5
6
7
8  
To 2-benzyl-3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-one (0.20 g, 0.35 
mmol) in methanol (5.0 mL) was added Dowex 66 anionic resin (0.40 g) and methyl 
vinyl ketone (0.10 ml, 0.82 mmol). The mixture was heated under reflux for 5 d. The 
solution was filtered and the filtrate was evaporated to give a yellow oil which was 
purified by flash chromatography (20% ethyl acetate/hexane) to give 179 (0.23 g, 99%) 
as white microprisms, mp 71-73 
o
C; Rf 0.27 (50% ethyl acetate/hexane); IR νmax 2953 
(C-H), 1754 (ketone C=O), 1711 (ester C=O), 1410, 1267, 1199, 735, 700 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) (3:1 mixture of diastereomers) δ 7.30-7.20 (8H, m, Ph) 6.46 
(2H, d, J= 8.2 Hz, Ph) 5.29-5.27 (1H, m, C4H) 3.86 (3H, s, OCH3) 3.82 (3H, s, OCH3) 
3.58-3.54 (1H, m, C1H) 3.21-3.18 (1H, m, C1H) 2.61-1.81 (8H, m, C2H + C5H + C6H + 
C7H) 1.42 (3H, s, C8H) 1.29 (3H, s, C8H); 
13
C NMR (500 MHz, CDCl3) δ 206.1 
(COCH3) 205.6 (COCH3) 171.1 (COOCH3) 154.0 (CON) 150.6 (ArC) 137.5 (ArC) 
129.4 (ArC) 129.2 (ArC) 126.9 (ArC) 125.7 (ArC) 121.6 (ArC) 121.4 (ArC) 64.9 (C3) 
60.7 (C4) 59.0 (C1) 52.8 (OCH3) 42.5 (C2) 34.6 (C7) 34.2 (C5) 32.6 (C6) 27.9 (C8); m/z 
(Cl+) 438 (100%, M+H
+
) 346 (80%, M
+
-ArCH2); HRMS C25H28NO6Na calcd. 
438.1917, found 438.1911. 
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1-Benzyl-6-oxo-2-(phenoxycarbonyl)-3,4,6,7,8,8a-hexahydro-1H-isoquinoline 
(180) 
N
Ph
O
OPh O
1 2
3
4
56
7
8
9
 
To 2-benzyl-3-(methoxycarbonyl)-3-(3-oxobutyl)-1-(phenoxycarbonyl)piperidin-4-one 
(0.20 g, 0.45 mmol) in methanol/water (6 mL, 2:1) was added sodium hydroxide (0.12 
g, 2.70 mmol). The mixture was stirred at room temperature for 48 h. The solution was 
neutralized by aqueous 5% hydrochloric acid, extracted into dichloromethane (3 x 10 
mL), and the combined organic layers were dried (MgSO4), and evaporated to give 180 
(0.13 g, 80%) as a brown gum; IR νmax 2959 (C-H), 1700 (ketone C=O), 1652 (amide 
C=O), 1423, 1201, 748, 699 cm
-1
; 
1
H NMR (300 MHz, CDCl3) (3:1 mixture of 
diastereomers) δ 7.35-7.08 (8H, m, Ph) 6.92-6.37 (2H, m, Ph) 5.29 (1H, s, C4H) 
4.16-4.13 (1H, m, C8H) 3.73-3.57 (2H, m, C5H) 3.16-3.12 (1H, m, C7H) 2.48-2.13 (6H, 
m, C1H + C2H + C9H) 1.79-1.76 (1H, m C6H) 1.61-1.58 (1H, m, C6H); 
13
C NMR (500 
MHz, CDCl3) δ 207.1 (COCH3) 154.6 (C3) 151.0 (CON) 150.6 (ArC) 138.5 (ArC) 
129.3 (ArC) 129.1 (ArC) 128.4 (ArC) 126.8 (ArC) 121.5 (ArC) 121.4 (ArC) 115.4 (C4) 
60.3 (C8) 54.0 (C1) 38.0 (C5) 35.7 (C7) 34.8 (C9) 33.5 (C2) 29.9 (C6); m/z (Cl+) 362 
(100%, M
+
); HRMS C25H28NO6Na calcd. 362.1751, found 362.1755. 
tert-Butyl (1-diethylcarbamoyl-2-methylpropyl)carbamate (210)
40
  
N
H
CONEt2(H3C)3CO
O
 
To valine (0.59 g, 5.00 mmol) in methanol/water (30 mL, 1:1) was added tert-butyl 
dicarbonate (1.09 g, 5.00 mmol) and sodium carbonate (0.53 g, 5.10 mmol) and the 
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mixture was stirred for 16 h at room temperature. The solution was evaporated and the 
residue was acidified by citric acid. The mixture was extracted with dichloromethane 
(3 x 20 mL), dried (MgSO4), and evaporated to give N-Boc valine (0.86 g, 80%) as 
white microprisms. It was used directly for the next step without further purification. 
To N-Boc valine (0.86 g, 4.00 mmol) in dichloromethane (4.5 mL) was added 
dicyclohexylcarbodiimide (DCC) (0.94 g, 4.60 mmol) in small portions at 0 
o
C. 
Diethylamide (0.58 g, 7.90 mmol) in dichloromethane (1.5 mL) was added to the 
mixture which was then stirred at room temperature for 16 h. The solution was filtered 
and the filtrate was evaporated. The resulting yellow oil was purified by flash 
chromatography (20% ethyl acetate/hexane) to give 210 (0.58 g, 43%) as a colourless 
oil; Rf 0.42 (50% methyl tert-butyl ether/hexane); IR νmax 3035 (N-H), 2971 (C-H), 
1703 (ester C=O), 1634 (amide C=O), 1453, 1365, 1247, 1171, 1016 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) δ 5.25 (1H, br d, J= 9.4 Hz, NH) 4.39-4.34 (1H, m, CHNH) 
3.64-3.11 (4H, m, CH2CH3 x2) 1.95-1.89 (1H, m, CHCH3) 1.42 (9H, s, CH3CO x3) 
1.22 (3H, t, J= 7.2 Hz, CH3CH2) 1.11 (3H, t, J= 7.2 Hz, CH3CH2) 0.94 (3H, d, J= 6.9 
Hz, CH3CH) 0.91 (3H, d, J= 6.9 Hz, CH3CH); m/z (El+) 272 (5%, M
+
) 116 (100%, 
BocNH
+
); HRMS C14H28N3O2 calcd. 272.2094, found 272.2097. 
(1-Diethylcarbamoyl-2-methylpropyl)carbamic acid (182)
40
  
H2N CONEt2 
To tert-butyl (1-diethylcarbamoyl-2-methylpropyl)carbamate (0.58 g, 2.10 mmol) in 
dichloromethane (5 mL) was added trifloroacetic acid (TFA) (0.70 mL, 9.00 mmol) 
and the mixture was stirred for 24 h at 30 
o
C. The mixture was cooled to 0 
o
C and 
neutralized with 10% aqueous potassium hydroxide. The mixture was extracted with 
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dichloromethane (3 x 5 mL), dried (MgSO4), and the combined organic layers were 
evaporated to give 182 (0.28 g, 78%) as a colourless oil; Rf 0.71 (75% methyl 
tert-butyl methyl ether/hexane); 
1
H NMR (300 MHz, CDCl3) δ 7.94 (2H, br s, NH2) 
4.28-4.32 (1H, m, CHNH2) 3.61-3.21 (4H, m, CH2CH3 x2) 2.21-2.14 (1H, m, CHCH3) 
1.23 (3H, t, J= 7.2 Hz, CH3CH2) 1.14 (3H, t, J= 7.4 Hz, CH3CH2) 1.04 (3H, d, J= 6.9 
Hz, CH3CH) 0.97 (3H, d, J= 6.0 Hz, CH3CH). 
2-Benzyl-4-benzylamino-5,6-dihydro-2H-3-(methoxycarbonyl)-1-(phenoxycarbon
yl)pyridine (191) 
N
Ph
CO2Me
NH
O
OPh
2 3
4
56
7
Ph
8
 
To 2-benzyl-5,6-dihydro-3-(methoxycarbonyl)-1-(phenoxycarbonyl)-4-pyridone (0.20 
g, 0.55 mmol) in toluene (3.0 mL) was added benzylamine (0.06 mL, 0.55 
mmol).Acetic acid (3 drops) was added and the mixture was heated to 70 
o
C for 2 h. 
Saturated aqueous sodium hydrogen carbonate (3 mL) was then added and the mixture 
was extracted with dichloromethane (3 x 5 mL), dried (MgSO4), and evaporated. The 
resulting yellow oil was purified by flash chromatography (25% ethyl acetate/hexane) 
to give 191 (0.22 g, 86%) as a colourless viscous oil, Rf 0.62 (50% ethyl 
acetate/hexane); IR νmax 3335 (N-H), 3027 (C-H), 1713 (ester C=O), 1655 (C=C), 1595, 
1425, 1202, 746, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) (presence of rotamers) δ 
7.35-7.12 (13H, m, Ph) 6.74 (2H, d, J= 7.4 Hz, Ph) 5.41-5.37 (1H, m, C2H) 4.45-4.41 
(2H, m, C8H) 4.41-3.93 (1H, m, C6H) 3.81 (3H, s, OCH3) 3.43-3.38 (1H, m, C3H) 
3.25-3.20 (1H, m, C7H) 2.88-2.80 (1H, m, C2H) 2.55-2.52 (1H, m, C3H) 2.44-2.39 (1H, 
m, C7H); m/z (Cl+) 457 (65%, M
+
) 365 (100%, M
+
-C7H7); HRMS C28H29N4O2 calcd. 
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457.2127, found 457.2135. 
General procedure for alkylation of 207 
To 3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-ones 207 (1.0 equiv) in 
acetone was added potassium carbonate (2.0 equiv) and alkyl halides (2.0 equiv). The 
mixture was heated under reflux for 16 h. The solution was filtered and the filtrate was 
evaporated. Chloroform was added and the solution was filtered again. The filtrate was 
then evaporated. 
2-Benzyl-3-(methoxycarbonyl)-3-methyl-1-(phenoxycarbonyl)piperidin-4-one 
(207a)
 
N
Ph
O
O
OPh CO2Me
1 2
3
4
5
6
7
 
Following general procedure, reaction of 
2-benzyl-3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-one (0.80 g, 2.18 
mmol), potassium carbonate (0.60 g, 4.36 mmol), and iodomethane (0.3 ml, 4.36 mmol) 
in acetonitrile (7 mL) gave a yellow oil that was purified by flash chromatography 
(25% ethyl acetate/hexane) to give 207a (0.74 g, 89%) as a pale yellow oil, Rf 0.25 
(30% ethyl acetate/hexane); IR νmax 2951 (C-H), 1734 (ketone C=O), 1707 (ester C=O), 
1411, 1191, 941, 734, 689 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (presence of rotamers) δ 
7.35-7.13 (8H, m, Ph) 6.80-6.60 (2H, m, Ph) 5.01 (1H, dd, J= 11.9, 3.5 Hz, C5H) 
4.42-4.38 (1H, m, C1H) 3.82 (3H, s, OCH3) 3.75 (3H, s, OCH3) 3.64-3.60 (1H, m, C1H) 
3.22-3.18 (1H, m, C2H) 2.93-2.85 (2H, m, C6H) 2.65-2.62 (1H, m, C2H) 1.72 (3H, s, 
C7H) 1.64 (3H, s, C7H); 
13
C NMR (500 MHz, CDCl3) δ 205.2 (C3) 204.9 (C3) 171.2 
(COOCH3) 171.1 (COOCH3) 154.2 (CON) 150.8 (CON) 137.2 (ArC) 136.8 (ArC) 
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129.3 (ArC) 129.1 (ArC) 128.8 (ArC) 128.5 (ArC) 127.1 (ArC) 126.9 (ArC) 125.6 
(ArC) 125.5 (ArC) 121.7 (ArC) 121.5 (ArC) 60.7 (C4) 60.5 (C4) 52.6 (OCH3) 39.5 (C5) 
38.7 (C5) 36.9 (C1) 36.5 (C1) 36.2 (C2) 35.7 (C2) 22.7 (C6) 22.3 (C6) 21.1 (C7) 20.9 (C7); 
m/z (Cl+) 382 (100%, M+H
+
); HRMS C22H24NO5 calcd. 382.1654, found 382.1655. 
3-Allyl-2-benzyl-3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-one (207b)
 
N
Ph
O
O
OPh CO2Me
1 2
3
4
5
6 7
8
9  
Following general procedure, reaction of 
2-benzyl-3-(methoxycarbonyl)-1-(phenoxycarbonyl)piperidin-4-one (0.50 g, 1.36 
mmol), potassium carbonate (0.38 g, 2.72 mmol), and allyl bromide (0.45 ml, 4.08 
mmol) in acetonitrile (5 mL) gave a solid that was purified by flash chromatography 
(22% ethyl acetate/hexane) to give 207b (0.41 g, 74%) as a milky gum, Rf 0.26 (30% 
ethyl acetate/hexane); IR νmax 2955 (C-H), 1742 (ketone C=O), 1707 (ester C=O), 1407, 
1189, 973, 736, 689 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (presence of rotamers) δ 
7.33-7.23 (8H, m, Ph) 6.79-6.55 (2H, m, Ph) 5.82-5.66 (1H, m, C8H) 5.22-5.12 (3H, m, 
C9H + C5H) 4.52-4.43 (1H, m, C1H) 3.81 (3H, s, OCH3) 3.76 (3H, s, OCH3) 3.71-3.61 
(1H, m, C1H) 3.24-3.22 (1H, m, C2H) 3.05-3.04 (1H, m, C7H) 2.85-2.77 (3H, m, C7H 
+ C6H) 2.57-2.532 (1H, m, C2H) 1.72 (3H, s, C7H) 1.64 (3H, s, C7H); 
13
C NMR (300 
MHz, CDCl3) δ 203.2 (C3) 203.2 (C3) 169.7 (COOCH3) 169.5 (COOCH3) 154.1 (CON) 
154.0 (CON) 151.2 (ArC) 150.7 (ArC) 137.2 (C8) 136.9 (C8) 131.6 (ArC) 131.2 (ArC) 
129.2(ArC) 128.8 (ArC) 128.4 (ArC) 127.0 (ArC) 126.9 (ArC) 125.6 (ArC) 125.5 
(ArC) 121.4 (ArC) 120.2 (C9) 120.0 (C9) 65.1 (C4) 59.9 (C5) 58.7 (C5) 52.4 (OCH3) 
39.8 (C1) 39.6 (C1) 38.8 (C2) 37.8 (C6) 37.2 (C6) 35.4 (C7) 34.9 (C7); m/z (Cl+) 408 
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(100%, M+H
+
); HRMS C24H26NO5 calcd. 408.1811, found 408.1813. 
3-(Methoxycarbonyl)-2,3-dimethyl-1-(phenoxycarbonyl)piperidin-4-one (207c)
 
N O
O
OPh CO2Me
1 2
3
4
5
6
7  
Following general procedure, reaction of 
3-(methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)piperidin-4-one (0.20 g, 0.69 
mmol), potassium carbonate (0.19 g, 1.37 mmol), and iodomethane (0.1 ml, 1.37 mmol) 
in acetonitrile (2 mL) gave a yellow oil that was purified by flash chromatography 
(35% ethyl acetate/hexane) to give 207c (0.18 g, 88%) as a colourless oil, Rf 0.35 (30% 
ethyl acetate/hexane); 
1
H NMR (300 MHz, CDCl3) δ 7.41-7.10 (5H, m, Ph) 4.70 (1H, 
q, J= 6.5 Hz, C5H) 4.36-4.01 (1H, m, C1H) 3.69 (3H, s, OCH3) 3.69-3.68 (1H, m, C1H) 
2.87-2.76 (1H, m, C2H) 2.66-2.61 (1H, m, C2H) 1.61 (3H, s, C7H) 1.45 (3H, d, J= 6.5 
Hz, C6H); 
13
C NMR (300 MHz, CDCl3) δ 205.1 (C3) 170.8 (COOCH3) 153.8 (CON) 
151.0 (ArC) 129.4 (ArC) 125.7 (ArC) 121.6 (ArC) 60.6 (C4) 56.1 (OCH3) 52.4 (C5) 
39.1 (C1) 36.9 (C2) 21.8 (C6) 17.2 (C7). 
3-Allyl-3-(methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)piperidin-4-one 
(207d)
 
N O
O
OPh CO2Me
1 2
3
4
5
6
7
8
9  
Following general procedure, reaction of 
3-(methoxycarbonyl)-2-methyl-1-(phenoxycarbonyl)piperidin-4-one (0.20 g, 0.69 
Chapter 2 
192 
 
mmol), potassium carbonate (0.19 g, 1.37 mmol), and allyl bromide (0.15 ml, 1.37 
mmol) in acetonitrile (2 mL) gave a yellow oil that was purified by flash 
chromatography (35% ethyl acetate/hexane) to give 207d (0.168 g, 70%) as a 
colourless oil, Rf 0.32 (30% ethyl acetate/hexane); IR νmax 2952 (C-H), 1735 (ketone 
C=O), 1710 (ester C=O), 1414, 1200, 751 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.63-7.09 (5H, m, Ph) 5.72-5.65 (1H, m, C8H) 5.17-5.09 (2H, m, C9H) 4.77 (1H, q, J= 
6.9 Hz, C5H) 4.37-4.31 (1H, m, C1H) 3.73 (3H, s, OCH3) 3.67-3.50 (1H, m, C1H) 
2.93-2.92 (1H, m, C2H) 2.79-2.65 (2H, m, C7H) 2.54-2.48 (1H, m, C2H) 1.40 (3H, d, 
J= 6.9 Hz, C6H); 
13
C NMR (300 MHz, CDCl3) δ 203.4 (C3) 169.6 (COOCH3) 153.7 
(CON) 151.0 (ArC) 131.6 (C8) 129.4 (ArC) 125.7 (ArC) 121.6 (ArC) 119.8 (C9) 65.0 
(C4) 54.0 (OCH3) 52.3 (C5) 39.3 (C1) 39.0 (C2) 37.6 (C7) 16.7 (C6); m/z (Cl+) 332 
(100%, M+H
+
); HRMS C18H22NO5 calcd. 332.1498, found 332.1487. 
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CHAPTER 3 
 
Synthesis of Substituted Pyrrolidin-3-ones and Related 
Ring Systems 
 
3.1 Introduction 
The pyrrolidine ring, whether present as a single ring or as a part of a fused ring system, 
is commonly found in pharmaceutically active compounds and natural compounds 
including alkaloids.
1–8
 Oxopyrrolidines are also found in some alkaloids; 
pyrrolidin-2-ones being the most abundant.
9–11
 In contrast, pyrrolidin-3-ones are much 
less common; however, they are sometimes found in alkaloids.
12–16
 Some 
pyrrolidin-3-one derivatives are used as potent HIV protease inhibitors;
17,18
 while 
others are key intermediates for making agonists for metabotropic glutamate 
receptors,
19
  inhibitors of tripeptidylpeptidase II,
20
 androgen receptor antagonists,
21
 
and GABA uptake inhibitors.
22
 Furthermore, pyrrolidin-3-ones are precusors for the 
synthesis of pyrrolidin-3-ol-containing natural compounds like preussin and 
bulgecinine;
23
 or quinocarcin
24
 and stemofoline
25
 in which pyrrolidin-3-ol acts as a part 
of a fused ring system. Although this area has significant potential for drug 
development, there are few methods of synthesizing pyrrolidin-3-ones. Therefore, 
developing synthetic routes to pyrrolidin-3-ones would be useful for exploiting this 
area. 
Chapter 3 
197 
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NMeO
H
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H
(-)-Slaframine  
Figure 3.1 Some pyrrolidin-3-one- and pyrrolidin-3-ol-based alkaloids  
3.1.1 Approaches to 1,2-Dihydropyrrol-3-ones 
1,2-Dihydropyrrol-3-ones, also named pyrrolinones, are present in pharmaceutically 
active compounds as a peptidomimetic scaffold.
26–29
 Moreover, 
1,2-dihydropyrrol-3-one derivatives are key intermediates for the synthesis of 
pyrrolidin-3-one- and pyrrolidin-3-ol-containing natural compounds. However, there 
are few papers
29,30
 describing the synthesis of this ring system and general routes to 
1,2-dihydropyrrol-3-ones are not well developed. 
N
N
O
O
HRR
R
O
H
H
 Pyrrolinone scaffold  
Figure 3.2 1,2-Dihydropyrrol-3-ones as part of a peptidomimetic scaffold
26
  
In 2009, Gouault reported a gold-catalysed cyclisation of α-amino-ynones to give 
enantiopure 1,2-dihydropyrrol-3-ones (Scheme 3.1).
30
 Gold was chosen because of its 
ability to coordinate and activate C-C mutiple bonds through its Lewis acidity.
30
 
Enantiopure α-amino-ynones were prepared from α-amino acids (chiral pool synthesis). 
Gouault also showed that the 1,2-dihydropyrrol-3-one 212 could be converted into the 
pyrrolidin-3-one 213 and then into the pyrrolidin-3-ol 214 in excellent ee.
30
 In 2013, 
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Lamaty employed PtCl2 as the catalyst and was able to do this reaction in a more 
environmentally-friendly way.
29
  
O
Ph
NHBoc
iPr N
Ph
O
iPr
Boc
N
Ph
O
iPr
Boc
N
Ph
HO
iPr
Boc
Au2O3 
(10 mol%)
THF, 60 oC
1.5 h, 95%
H2, Pd/C
MeOH, RT
16 h, 88%
NaBH4
EtOH, RT
2 h, 100%
211 212
213 214
Scheme 3.1 A gold-catalyzed approach to the 1,2-dihydropyrrol-3-one 21230 
Although it seems that Dieckmann cyclisation of enamino esters 21 to afford 
1,2-dihydropyrrol-3-ones 22 is feasible and convenient, to our knowledge the only 
attempt is by Cambon
31
 who in 1990 reported that 21 did not undergo a Dieckmann 
cyclisation by the treatment of sodium in xylene to give 1,2-dihydropyrrol-3-ones 22 
(refers to Section 1.1.3). Since little is known about the potential of this Dieckmann 
cyclisation to give 1,2-dihydropyrrol-3-ones 22, it would be of interest to investigate 
its feasibility using different substrates and conditions. 
N
MeO2C
CO2Me
21 22
base
Scheme 3.2 Dieckmann cyclisation to 1,2-dihydropyrrol-3-ones 22
N
O
R2
R3
R4
CO2Me
R4R2
R3
R1 R1
 
3.1.2 Approaches to Pyrrolidin-3-ones 
In 1922, Ruzicka and Seidel attempted to prepare pyrrolidin-3-ones via a 
Dieckmann-like cyclisation by heating diesters under reflux with sodium in xylene but 
they could not characterise the product.
32
 In 1956, Kuhn and Osswald developed a 
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one-pot aza-Michael addition-Dieckmann cyclisation of the N-protected glycine ethyl 
ester 215 with β-substituted acrylates 216 using sodium in benzene to give N-protected 
pyrrolidin-3-ones 217 (Scheme 3.3).
33
 They were able to prepare the pyrrolidin-3-one 
hydrochloride and the pyrrolidin-3-ol, which were first described in 1957, using this 
method.
34
 
N
CO2Et
R
CO2Et
O
CO2Et
R
CO2Et
NH
EtO2C
+
Na
Scheme 3.3 Michael addition-Dieckmann cyclisation to pyrrolidin-3-ones 21733
215 216 217
PhH
 
In 1987, Padwa reported a radical rearrangement of the 5-exomethyleneisoxazolidine 
derivative 218 to prepare the pyrrolidin-3-one 220.
35
 Since C
4
 (marked in diagram, 
Scheme 3.4) is fully substituted, rearrangement of 218 by 1,3-hydrogen shift is 
prohibited.
35
 By heating, N-O bond breaks and the nitrogen radical attacks the C=C 
bond to form the pyrrolidin-3-one 220. 
O
N
CH3
H
CH3
Ph
H3C
H3CO2C
N
O
Ph
H3C
H3CO2C
N
O
CH3
Ph
H3C
H3CO2C
CH3
H
H3C
CH3
218 219 220
Scheme 3.4 Rearrangement of the 5-exomethyleneisoxazolidine derivative 22035
heat
4
 
In 1984, Taylor described a Diels-Alder route to the pyrrolidin-3-one 225 (Scheme 
3.5).
36
 Diels-Alder addition of the methyl 4-nitrosobenzoate 221 with 
2-methoxy-1,3-butadiene gave the 3,6-dihydro-2H-1,2-oxazine 222 which was 
converted into tetrahydro-2H-1,2-oxazin-4-one 223 in the presence of acid. The N-O 
bond of 223 was cleaved by hydrogenation, and subsequent dehydrative ring closure 
afforded the pyrrolidin-3-one 225. Despite these advances, scaleable routes to 
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pyrrolidin-3-ones with different substitutions are in demand. 
Scheme 3.5 A Diels-Alder route to the pyrrolidin-3-one 22536
221 222
225
NO
CO2CH3
N
CO2CH3
O
H3CO
N
CO2CH3
O
O
NH
CO2CH3
OH
O
N
CO2CH3
O
H3CO
HCl
H2, Pd/C
Pyridine
TsCl
224
223
 
3.1.3 Enantiocontrolled Strategies to Pyrrolidin-3-ones 
Enantioselective syntheses of pyrrolidin-3-ones are useful for drug development but 
only a few have been reported. Costa employed the chiral acrylate 226 derived from 
D-(+)-mannitol to induce asymmetric Michael addition to give the enantiopure β-keto 
ester 227 (Scheme 3.6).
1
 Dieckmann cyclisation of the diester 228 afforded the 
pyrrolidin-3-one derivative 229 in a single enantiomer. Using a similar approach, Li 
used a diester derived from a chiral β-amino ester to prepare enantiopure 
N-benzyl-5-methylpyrrolidin-3-one by a Dieckmann cyclisation.
37
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Scheme 3.6 Preparation of the enantiopure pyrrolidin-3-one 229 
from D-(+)-mannitol derivatives1
226
229228
227
 
Kraus prepared the chiral tetramic acid 231 by the treatment of Boc-L-phenylalanine 
with Meldrum's acid.
18
 After subsequent reduction and oxidation, enantiopure 
(2S)-2-benzyl-1-(tert-butyloxycarbonyl)pyrrolidin-3-one (234) was synthesized 
(Scheme 3.7). 
Ph OH
O
NH
Boc
N
Boc
O
OH
Ph
N
Boc
O
OH
Ph
N
Boc
OH
Ph
N
Boc
O
Ph
(i) Meldrum's acid
(ii) EtOAc, reflux
NaBH4
BH3-DMS TPAP
NMO
234233
232231
230
Scheme 3.7 Preparation of the enantiopure pyrrolidin-3-one 234 from 
Boc-L-phenylalanine18  
Yuan prepared enantiopure oxophosphonates 235 by the treatment of Ellman's 
sulfinylimines with 2-oxophosphonates (Scheme 3.8).
38
 Oxophosphonates 235 were 
converted into 1-diazo derivatives 237 which were then cyclised by N-H insertion. The 
cyclised products 238 were subjected to Horner-Wadsworth-Emmons olefination to 
give 5,5-disubstituted 2-benzylidenepyrrolidin-3-ones 239. Yang also reported the 
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synthesis of enantiopure 5-substituted pyrrolidin-3-ones by an N-H insertion approach 
with the use of chiral N-Boc-amino acids.
39
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Scheme 3.8 Preparation of the enantiopure pyrrolidin-3-one 239 via an N-H insertion38 
In 2002, Quirion prepared enantiopure 4-substituted pyrrolidin-3-ones 245 via a 
diastereoselective alkylation using Enders’ chiral hydrazone protocol (Scheme 3.9).24 
This approach afforded 245 in high regioselectivity and acceptable diastereoselectivity; 
the bulkier the R is, the higher the regioselectivity due to the steric hindrance between 
R and PG in minor products 244.  
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Scheme 3.9 Regio- and diastereoselective alkylation of hydrazones 
241 to give enantiopure pyrrolidin-3-ones 24524
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3.1.4 Mode of Cyclisation of Diesters to Pyrrolidin-3-ones  
When the diester 246 is treated with a base, Dieckmann cyclisation could in principle 
ocurr at both sides to afford the 4-ethoxycarbonylpyrrolidin-3-one 247 and the 
2-ethoxycarbonylpyrrolidin-3-one 248 as products. Rapoport demonstrated that the 
4-ethoxycarbonylpyrrolidin-3-one 247, being the thermodynamic product, was the only 
product when the reaction was performed at high temperature; while at low 
temperature, the 2-ethoxycarbonylpyrrolidin-3-one 248, being the kinetic product, was   
identified together with 247 (Scheme 3.10).
40
 Other groups were also able to isolate the 
kinetic products using the same approach.
41–43
 The 4-ethoxycarbonylpyrrolidin-3-one 
247 is the thermodynamic product because there is no steric hindrance between the 
alkoxy group and the N-protecting group; while the 2-ethoxycarbonylpyrrolidin-3-one 
248 is the kinetic product since the glycine-type methylene is more acidic than the 
propionic methylene due to the inductive effect of the N-ethoxycarbonyl group.
40
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Scheme 3.10 Mode of cyclisation of the diester 246  
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3.2 Results and Discussion 
3.2.1 Attempted Synthesis of 1,2-Dihydropyrrol-3-ones 
In Section 2.2.7, 2-substituted piperidin-4-ones were efficiently prepared by a 
Dieckmann cyclisation approach. It was of interest to see if this synthetic strategy 
could be applied to make the five-membered-ring counterpart, i.e. 
1,2-dihydropyrrol-3-one derivatives, especially to have various substituents at the 2- 
and/or 5-positions. 
The proposed route, shown in Scheme 3.11, began with β-keto esters 166. Amination 
of β-keto esters 166 using ammonium acetate gave enamines 169 which were coupled 
with amino esters 249 to give diesters 250. Dieckmann cyclisation of diesters 250 
using sodium methoxide and subsequent decarboxylation gave the desired 
1,2-dihydropyrrol-3-ones 252. Depending on β-keto esters 166 and amino esters 249 
used, it was hoped that 1,2-dihydropyrrol-3-ones 252 with various 2- and 
5-substitutions could be made in a few steps. 
Scheme 3.11 Proposed route to 1,2-dihydropyrrol-3-ones 252
R1 OMe
O O
R1
CO2Me
NH2
R1
HN CO2Me
R2
H2N CO2Me
R2
HN
R2
CO2Me
O
R1
HN
R2
O
R1
NH4OAc
reflux reflux
NaOMe
reflux
MeCN, H2O
reflux
166
249
169
250 251 252
CO2Me
 
Amino esters 249 were made from their corresponding amino acids 253 using the 
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traditional thionyl chloride-activated esterification, except for the alanine-derived 
amino ester 253b which was commercially-avaliable.
44,45
 The yields were good to 
excellent (75-97%, Scheme 3.12). Five different amino esters 249 were prepared to 
investigate the limitations of the proposed route. First, whether this route was feasible 
or not was tested using the glycine amino ester 253a (R=H). Then, monosubstituted 
amino esters 253b (R= methyl), 253c (R= isopropyl), and 253d (R= benzyl) were used 
to find out if dihydropyrrol-3-ones with bulky R groups could be synthesized by this 
route. Finally, the disubstituted amino ester 253e (R=gem-dimethyl) was employed to 
see if 2,2-disubstituted 1,2-dihydropyrrol-3-ones could be synthesized. 
H2N CO2Me.HCl
R
H2N CO2H
R
SOCl2
MeOH
249253  
Cpd R yield (%) 
253a H 90 
253c i-Propyl 78 
253d Benzyl 97 
253e gem-Dimethyl 75 
Scheme 3.12 Synthesis of amino esters 249 HCl salt 
The enamine 169b was made from the β-keto ester 166c by amination in 97% yield.46 
The amine group of the enamine 169b was then displaced by amino esters 249 to 
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afford diesters 250 (Scheme 3.13).
47
 This was a very good reaction for monosubstituted 
amino esters 253a-d (87-93% yields). However, no reaction of the gem-dimethyl 
animo ester 253e with the enamine 169b was observed, suggesting that steric 
hindrance from the gem-dimethyl groups was too large for displacement to occur. 
Bn
CO2Me
NH2
H2N CO2Me.HCl
R
MeOH, reflux, 3 h
249
169b
Bn
HN CO2Me
R
250
(1.3 eq)
CO2Me
 
Cpd R yield (%) 
253a H 87 
253b Methyl 87 
253c i-Propyl 93 
253d Benzyl 90 
253e gem-Dimethyl 0 
Scheme 3.13 Synthesis of diesters 250 
Cyclisations of diesters 250 by a Dieckmann cyclisation to form 
1,2-dihydropyrrol-3-ones 251 were attempted but none of them were successful 
(Scheme 3.14). When diesters 250 were heated under reflux with sodium methoxide in 
methanol, a hydrolysis reaction took place instead of a Dieckmann cyclisation and the 
precusor 168b was isolated as the single product in over 80% yield. Other bases 
Chapter 3 
207 
 
including sodium hydride and poatssium tert-butoxide were used but were also 
ineffective. 
Scheme 3.14 Attempted synthesis of 1,2-dihydropyrrol-3-ones 4
Bn
HN CO2Me
R
HN
R
CO2Me
O
Bn
NaOMe (1.3 eq)
MeOH, reflux, 1 h
250 251
Bn OMe
O O
168b
NOT
CO2Me
 
The ester groups of the diester 250a were changed in the hope that a Dieckmann 
cyclisation would take place with these substrates. It is because it was found in Section 
2.2.2 that Dieckmann cyclisation affording 5,6-dihydro-4-pyridones was affected by 
the type of ester groups involved. The mixed diester 255 and ethyl diester 256 were 
prepared by the same approach in excellent yields (Scheme 3.15). However, hydrolysis 
reaction occurred again to give β-keto esters 168 as the products. 
Bn
CO2Me
NH2
H2N CO2Et.HCl
MeOH, reflux, 3 h, 92%
254
170b
Bn
HN CO2Et
255
(1.3 eq)
Bn
CO2Et
NH2
H2N CO2Et.HCl
MeOH, reflux, 3 h, 91%
254
170a
Bn
HN CO2Et
256
(1.3 eq)
NaOMe (1.3 eq)
MeOH, reflux, 1 h
88%
Bn OMe
O O
168b
NaOMe (1.3 eq)
MeOH, reflux, 1 h
84%
Bn OEt
O O
168a
Scheme 3.15 Attempted synthesis of 1,2-dihydropyrrol-3-ones 252 with ethyl esters
CO2Me
CO2Et
 
From the above result, it was suspected that hydrolysis reaction was facilitated by the 
benzyl group of diesters 250 so cyclisation of the diester 257 was attempted (Scheme 
3.16). The diester 257 was prepared from the imine 170c by a substitution in 91% yield. 
When the diester 257 was treated with sodium methoxide, hydrolysis also occurred, 
affording the β-keto ester 168c in 85% yield. Since the problem of hydrolysis reaction 
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could not be solved, focus was changed to cyclise a related ring system by a SN2 
substitution reaction.  
Me
CO2Me
NH
H2N CO2Me.HCl
MeOH, reflux, 3 h, 91%
253a
170c
Me
HN CO2Me
257
(1.3 eq) NaOMe (1.3 eq)
MeOH, reflux, 1 h
85%
Me OMe
O O
168c
Scheme 3.16 Attempted synthesis of 2-methyl-1,2-dihydropyrrol-3-ones 252
CO2Me
 
3.2.2 Attempted Synthesis of 1,2-Dihydropyrroles 
Owing to the difficulty of making 1,2-dihydropyrrol-3-ones 252 by a Dieckmann 
cyclisation, diesters 250 were replaced by bromo esters 260 in the hope that esters 260 
would cyclise in the presence of a base by a SN2 substitution reaction. The proposed 
route is shown in Scheme 3.17. Amino alcohols 258 were prepared from the 
corresponding amino acids by reduction and were coupled with enamines 168 to give 
hydroxy esters 259. By an Appel reaction
48
 with tetrabromomethane, bromo esters 260 
were formed. Bromo esters 260 were then treated with a base to afford 
4-methoxycarbonyl-1,2-dihydropyrroles 261 by a SN2 substitution reaction. 
Decarboxylation would then give the desired 2,5-disubstituted 1,2-dihydropyrroles 
262. 
Scheme 3.17 Poposed route to 1,2-dihydropyrroles 262
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HN
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The mechanism of the Appel reaction is shown in Scheme 3.18. The 
triphenylphosphine attacks the bromine atom of the tetrabromomethane to form the 
electrophilic phosphonium cation which undergoes nucleophilic displacement by an 
alcohol. The adduct is electrophilic and it is ready for the SN2 displacement reaction by 
the bromide because Ph3P=O is a very good leaving group. 
Ph3P
Br
Br
Br
Br
CBr3
R OH
Ph3P Br
R O
PPh3
Proton transfers Br
R Br
Ph3P O
+
Scheme 3.18 Mechanism of the Appel reaction
CHBr3
 
Phenylalanine was reduced by sodium borohydride to give the amino alcohol 258a in 
83% yield (Scheme 3.19).
49
 It was then coupled with the enamine 168b to give the 
hydroxy ester 259a in 65% yield. However, when the latter was treated with 
triphenylphosphine and tetrabromomethane at room temperature for 1 hour, a complex 
mixture was obtained and no desired bromo ester 260a was isolated, perphaps beacuse 
the bromo ester 260a is very reactive, leading to side reactions. Owing to these 
difficulties, this route was abandoned and the synthesis of a related ring system using 
the synthetic route of piperidin-2,4-diones (Section 1.2.3) was investigated. 
Bn
CO2Me
NH2
168b
Et2O, RT, 1 h
H2N
Bn
OH
(1.2 eq)
Bn
HN
259a
Bn
OH
CBr4 (2 eq)
PPh3 (2 eq)
Bn
HN
260a
Bn
Br
Scheme 3.19 Attempted substitution of an alcohol with a bromide
258a
MeOH, reflux
3 h, 65%
CO2Me CO2Me
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3.2.3 Synthesis of Pyrrolidin-3-ones via a Dieckmann 
Cyclisation 
5,6-Disubstituted piperidin-2,4-diones were made successfully in Section 1.2.3 via a 
Dieckmann cyclisation starting from β-keto esters 168. It was hoped that 
pyrrolidin-3-ones with various substituents at position-5 could also be prepared by this 
strategy. The proposed route is shown in Scheme 3.20. Amination of β-keto esters 168 
with ammonium acetate afforded enamines 170 which were coupled with the amino 
ester 253a to give diesters 250. The diesters 250 were reduced by sodium 
triacetoxyborohydride.
50
 Dieckmann cyclisation of diesters 263 and subsequent 
decarboxylation would give the desired pyrrolidin-3-ones 265. 
Scheme 3.20 Proposed route to pyrrolidin-3-ones 265
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NH4OAc
reflux reflux
NaOMe
reflux reflux
168
253a
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R
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5-Phenylpyrrolidin-3-one (265a) was the first target since 6-phenylpiperidin-2,4-dione 
(65e) was prepared in good yield by a closely-related synthetic route in Section 1.2.3. 
The intermediate diester 263d could be prepared from acetophenone or 
β-phenylalanine methyl ester (Scheme 3.21). Acetophenone was converted into its 
enolate by sodium hydride and was then reacted with dimethyl carbonate to give the 
β-keto ester 166e in 92% yield.51 Amination gave the enamine 169e in 62% which was 
coupled with the amino ester 253a to give the diester 250f. Reduction of 250f using 
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sodium triacetoxyborohydride gave the diester 263d in 40% over two steps. 
Another feasible route to the diester 263d is the displacement reaction of 
β-phenylalanine methyl ester with methyl bromoacetate in the presence of potassium 
carbonate. Since the yield was excellent (91%) and the diester 263d could be prepared 
in one step, this route was used to make 263d in grams quantities. 
Scheme 3.21 Synthesis of the diester 263d by 2 routes
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The diester 263d was then heated under reflux with sodium methoxide in methanol for 
1 hour. However, instead of a Dieckmann cyclisation, a reverse-Michael reaction took 
place to give the α,β-unsaturated ester 266 in 62% yield. Potassium tert-butoxide and 
sodium hydride were employed but both of them also gave the unwanted product 266 
(Scheme 3.22). 
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HN
CO2Me
O
Ph
base
Ph
HN
CO2Me
CO2Me
263d
Ph
CO2Me
266
NOT
264a
 
Entry Conditions 
1 NaOMe (1.2 eq), MeOH, reflux, 1 h 
2 t-BuOK (1.2 eq), PhMe, reflux, 1 h 
3 NaH (1.3 eq), THF, reflux, 1 h 
Scheme 3.22 Attempted cyclisation of the diester 263d 
The N-methyl diester 267 was prepared in the hope that no reverse-Michael reaction 
would occur since the nitrogen is fully substituted. The diester 263d was methylated 
using potassium carbonate and methyl iodide in moderate yield (52%). The resulting 
N-methyl diester 267 was heated under reflux with potassium tert-butoxide in toluene 
for 2 hours; however, a reverse-Michael reaction took place again to give the 
α,β-unsaturated ester 266 in 52% yield (Scheme 3.23). 
MeN
CO2Me
O
Ph
t-BuOK (1.3 eq)
268
Ph
MeN
CO2Me
CO2Me
267
Ph
CO2Me
266
NOT
PhMe, reflux
 2 h, 52%
Scheme 3.23 Attempted cyclisation of the N-methyl diester 267
Ph
HN
CO2Me
CO2Me
263d
MeI (5 eq)
K2CO3 (5 eq)
MeCN, 5 h
RT, 52%
 
It was suspected that the phenyl group of the diester 263d facilitates the 
reverse-Michael reaction so the diester 263c with a benzyl group was prepared. The 
diester 263c was synthesized by a sodium triacetoxyborohydride reduction of the 
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diester 250a in 92% yield. The diester 263c was treated with potassium tert-butoxide 
but again reverse-Michael reaction occurred to give the α,β-unsaturated ester 269 in 
52% yield (Scheme 3.24). 
Bn
HN
CO2Me
CO2Me
250a
HN
CO2Me
O
Bn
265b
Bn
HN
CO2Me
CO2Me
263c
Bn
CO2Me
269
NOT
MeCN, 0 oC
4 h, 92%
t-BuOK (1.3 eq)
PhMe, reflux
 2 h, 28%
NaBH(OAc)3
 (3.9 eq)
Scheme 3.24 Attempted cyclisation of the diester 263c  
The deactivating Boc group was then added to the diester 263c in the hope of 
preventing the undesired reverse-Michael reaction. The Boc group could be easily 
added by treating the diester 263c with di-tert-butyl dicarbonate in 72% yield. 
However, when the N-Boc diester 270 was heated with potassium tert-butoxide for 40 
minutes, a complex mixture resulted and no desired product could be isolated (Scheme 
3.25). 
A literature search for the synthesis of pyrrolidin-3-ones via a Dieckmann cyclisation 
revealed only one patent that described such an approach. In that patent, the N-benzyl 
diester was cyclised by treating with 1M potassium tert-butoxide solution in toluene at 
room temperature for 16 hours.
52
 Since 1-benzyl-5-methylpyrrolidin-3-one (274a) was 
the only pyrrolidin-3-one described in that patent, the scope was evaluated by using the 
same conditions to prepare the N-benzyl diester 272c; which was via a displacement 
reaction of the diester 263c and benzyl bromide using potassium carbonate in 70% 
yield. A trace amount of lithium iodide was added to generate benzyl iodide which is a 
better substrate for a SN2 reaction because iodide is a better leaving group. The 
N-benzyl diester 272c was then reacted with 1M potassium tert-butoxide solution at 
room temperature. The Dieckmann cyclisation took place and after decarboxylation, 
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the desired pyrrolidin-3-one 274c was isolated in 65% over two steps (Scheme 3.25). 
1M Potassium tert-butoxide solution was also an important factor for a clean 
Dieckmann cyclisation; when potassium tert-butoxide powder was used instead, the 
reaction was not complete after 3 days and the pyrrolidin-3-one 274c was isolated in 
only 38%. 
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271
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t-BuOK (1.3 eq)
PhMe, reflux
 40 min
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CO2Me
CO2Me
272c
Bn
HN
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CO2Me
263c
BnN
O
Bn
274c
BnBr (1.1 eq)
K2CO3 (2 eq)
LiI, MeCN, 55 oC
16 h, 70%
1. t-BuOK (1.3 eq)
PhMe, RT, 16 h
2. 5% H2SO4
    reflux, 2 h, 65%
Scheme 3.25 Dieckmann cyclisation of N-protected diesters  
Since the presence of a N-benzyl group is vital for a satisfied Dieckmann cyclisation, 
the benzyl amino ester 275a was prepared so as to shorten the synthetic route (Scheme 
3.26). The para-methoxybenzyl amino ester 275b was also prepared because if a para-
methoxybenzyl group can block the reverse-Michael reaction, this can then be 
removed easily in later step by cerium(IV) ammonium nitrate (CAN). 
The amino esters 275a and 275b were prepared by displacement of methyl 
bromoacetate with the corresponding amines in the presence of diisopropylethylamine. 
The yields were moderate (76% and 51% respectively, Scheme 3.26). However, when 
they were heated under reflux with the enamine 170b in methanol for 3 hours, no 
displacement took place and a complex mixture was resulted, perphaps because the 
secondary amines are too bulky for a displacement reaction to take place. Therefore, 
the original synthetic route was used to make other pyrrolidin-3-ones 274. 
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Scheme 3.26 Attempted synthesis of N-protected enamines
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From the above result, a general route to pyrrolidin-3-ones 274 was generated (Scheme 
3.27). The 5-benzyl pyrrolidin-3-one 274c had already been prepared by this route 
(Scheme 3.25). Synthesis of four more different pyrrolidin-3-ones were attempted in 
order to outline the scope and limitations of this route. Two of them possess a 5-alkyl 
substitution (methyl and propyl) and a third has a 5-phenyl group. The fourth, 
5-(3-pyridyl)pyrrolidin-3-one, possesses the same skeleton as the alkaloid nicotine. 
Scheme 3.27 General route to pyrrolidin-4-ones 274
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Since the 5-methylpyrrolidin-3-one 274a is the only known N-benzylpyrrolidin-3-one, 
it was prepared by our synthetic route so that the formation of such ring could be 
confirmed by comparing the spectroscopic data with the literature values. Reduction of 
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the enamine 257 gave the diester 263a in 75% yield. N-Benzylation of the diester 263a 
proceeded in good yield. The diester 272a was then cyclised and decarboxylated to 
give the 5-methylpyrrolidin-3-one 274a in 62% yield (Scheme 3.28).
52
 Since the 
spectroscopic data for 274a matched with the literature values, synthesis of other 
pyrrolidin-3-ones 274 was attempted. 
Scheme 3.28 Synthesis of the pyrrolidin-3-one 274a
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263a
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Me
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LiI, MeCN, 55 oC
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1. t-BuOK (1.3 eq)
PhMe, RT, 16 h
2. 5% H2SO4
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For the preparation of 5-propylpyrrolidin-3-one, the β-keto ester 168e was prepared by 
a Weiler dianion alkylation and was coupled with ammonium acetate to give the 
enamine 170d in 35% over two steps (Scheme 3.29). Displacement with the amino 
ester 253a gave the diester 250e in 79% and reduction with sodium 
triacetoxyborohydride proceeded in excellent yield. N-Benzylation proceeded in 70% 
yield and a subsequent Dieckmann cyclisation gave the 
4-(methoxycarbonyl)pyrrolidin-3-one 273b in 60% yield. However, decarboxylation of 
273b using 5% sulfuric acid gave a complex mixture. Since the diester 272b was 
consumed, Krapcho decarboxylation was not tried here although it was found to be an 
effective decarboxylation method for such ring system later on. 
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Scheme 3.29 Attempted synthesis of the pyrrolidin-3-one 274b
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Synthesis of the 5-phenylpyrrolidin-3-one 274d was attempted using the general route 
(Scheme 3.30). Treatment of the diester 263d with benzyl bromide gave the benzyl 
diester 272d in 61% yield which underwent a Dieckmann cyclisation in 91% yield to 
give the cyclised product 273d which was decarboxylated using 5% sulfuric acid to 
give the 5-phenylpyrrolidin-3-one 274d in 81% yield. Since the yield of cyclisation 
was very good, grams of 274d were prepared for the investigation of the reactivity of 
pyrrolidin-3-ones in Section 3.2.4. 
Ph
HN
CO2Me
CO2Me
263d
Ph
BnN
CO2Me
CO2Me
272d
BnBr (1.1 eq)
K2CO3 (2 eq)
LiI, MeCN, 55 oC
16 h, 61%
Scheme 3.30 Synthesis of the pyrrolidin-3-one 274d
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The final attempted to be synthesized was a 5-(3-pyridyl)pyrrolidin-3-one. It was of 
interest because it shares the same structure with nicotine. The diester 263e was 
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prepared from the β-amino ester 68f by a displacement reaction in 33% yield (Scheme 
3.31). However, when the diester 263e was treated with benzyl bromide and potassium 
carbonate, a complex mixture resulted, probably because the pyridine ring interacted 
with benzyl bromide to afford unwanted side products. The benzyl diester 272e was 
prepared by a reductive amination of benzaldehyde and the diester 263e in 26% yield 
(by a modification of Ley's synthesis).
53
 However, when the diester 263e was treated 
with 1M potassium tert-butoxide solution at room temperature for 16 hours, side 
reactions took place to give a complex mixture. Since the pyridine ring was too 
reactive, synthesis of the 5-(3-pyridyl)pyrrolidin-3-one 274e was abandoned. 
HN
CO2Me
CO2Me
263e
BnN
CO2Me
CO2Me
272e
Scheme 3.31 Attempted synthesis of the 4-(methoxycarbonyl)pyrrolidin-3-one 273e
BnN
O
273e
t-BuOK (1.3 eq)
PhMe, RT, 16 h
CO2Me
N
N N
NH2
CO2Me
68f
N
Methyl bromoacetate (1 eq)
K2CO3 (3.9 eq), MeCN
RT, 5 h, 33%
PhCHO (5.5 eq)
NaBH(OAc)3 (3 eq)
MgSO4, DCM
RT, 16 h, 26%
MeN
(-)-Nicotine
N
BnN
O
274e
N
 
To sum up, the synthesis of five different 5-substituted pyrrolidin-3-ones using the 
general route was attempted. Dieckmann cyclisation using 1M potassium tert-butoxide 
solution gave four different 5-substituted 4-(methoxycarbonyl)pyrrolidin-3-ones in 
60-91% yields except the 5-(3-pyridyl)pyrrolidin-3-one 273e. Three of them could be 
decarboxylated using 5% sulfuric acid (62-81% yields) but not the 
5-propylpyrrolidin-3-one 273b. It is believed that a Krapcho decarboxylation of 273b 
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could have been successful but it was not attempted owing to the lack of the starting 
materials. The 5-phenylpyrrolidin-3-one 274d would be used to investigate the 
reactivity of pyrrolidin-3-ones which will be discussed in the next section. 
3.2.4 Methylation, Reduction, and Deprotection of 
Pyrrolidin-3-ones  
By the general route shown in Scheme 3.27, pyrrolidin-3-ones with various 
5-substitutions were synthesized. Our next objective was the addition of another 
substituent to the 4-position. It was proposed that alkylation of 
4-(methoxycarbonyl)pyrrolidin-3-ones 273 with alkyl halide and subsequent 
decarboxylation would give 5,6-disubstituted pyrrolidin-3-ones. 
The tradition methylation procedure using potassium carbonate as a base was first 
applied to the 4-(methoxycarbonyl)pyrrolidin-3-one 273d; heating the mixture at 55 
o
C 
in acetone for 16 hours gave the methylated product 278 in 32% yield. However, 
modification of the method sued by Prof. Philip Page
54
, using TBAF as a base and 
stirring at room temperature in THF for 24 hours, gave 278 in much higher yield (69%, 
Scheme 3.32). 
BnN
O
Ph
273d
CO2Me
BnN
O
Ph
278
CO2Me
Me
MeI (2 eq)
K2CO3 (2 eq)
acetone, 55 oC
16 h, 32%
BnN
O
Ph
273d
CO2Me
BnN
O
Ph
278
CO2Me
Me
MeI (2 eq)
TBAF (1.2 eq)
THF, RT
24 h, 69%
Scheme 3.32 Methylation of the 4-(methoxycarbonyl)pyrrolidin-3-one 273d 
Decarboxylation of 4-(methoxycarbonyl)-4-methylpyrrolidin-3-one 278 by heating 
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under reflux in 1% water/acetonitrile for 3 hours was attempted but no reaction took 
place (Scheme 3.33). Then a Krapcho decarboxylation (modified from Hashizume's 
synthesis
55
) was employed by heating 278 with lithium iodide at 150 
o
C in DMF for 2 
hours; this gave the desired trans-4-methylpyrrolidin-3-one 279 in 54% yield. 
BnN
O
Ph
278
CO2Me
Me
BnN
O
Ph
279
Me
MeCN, 1% H2O
reflux, 3 h
BnN
O
Ph
278
CO2Me
Me
BnN
O
Ph
279
Me
LiI (0.5 eq), DMF
150 oC, 2 h, 54%
Scheme 3.33 Decarboxylation of the 4-(methoxycarbonyl)-4-methylpyrrolidin-3-one 278 
Since 4,5-disubstituted pyrrolidin-3-ones had been successfully prepared, the next 
ojective was the synthesis of 2,5-disubstituted pyrrolidin-3-ones. Giles reported that 
2-substituted pyrrolidin-3-ones 283 could be made from 
4-(ethoxycarbonyl)pyrrolidin-3-ones 280 (Scheme 3.34).
56
 By treating 280 with 2 
equivalents of lithium diisopropylamine (LDA), the dianion 281 was formed, in the 
presence of dimethylpropyleneurea (DMPU) as a co-solvent.
56
 Giles had showed that 
alkylation of dianions of type 281 occurred at the 2-position since that enolate was 
more reactive.
56
 After decarboxylation, 2-substituted pyrrolidin-3-ones 283 were 
synthesized. It was hoped that this strategy could be applied to make 2,5-disubstituted 
pyrrolidin-3-ones. 
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N
O
280
CO2Et
EtO2C LDA (2 eq)
DMPU, THF
-78 oC
N
OLi
281
EtO2C
EtO
OLi
RX
N
O
282
CO2Et
EtO2C
R
N
O
283
EtO2C
R
NaCl, wet DMSO
130 oC
Scheme 3.34 Giles' alkylation of 4-(ethoxycarbonyl)pyrrolidin-3-ones 28056 
When the 4-(methoxycarbonyl)pyrrolidin-3-one 278 was treated with 2 equivalents of 
LDA using the Giles' method, no reaction took place and 278 was recovered (Scheme 
3.35). It was suspected that the system was not anhydrous enough to form the highly 
reactive dianion. Extra attention was paid to make sure everthing was anhydrous but 
the problem could not be solved. Due to the difficulty of generating the dianion, 
synthesis of 2,5-disubstituted pyrrolidin-3-ones was abandoned. 
BnN
O
Ph
278
CO2Me
BnN
O
Ph
284
CO2Me
LDA (2.5 eq)
MeI (1 eq)
DMPU, THF
 -78 oC, 1 h
Scheme 3.35 Attempted methylation of the 4-(methoxycarbonyl)pyrrolidin-3-
one 278 using 2 equivalents of LDA  
Reduction of pyrrolidin-3-ones to give 5-substituted pyrrolidin-3-ols was also of 
interest. Sodium triacetoxyborohydride
57
 was employed to reduce the pyrrolidin-3-one 
274d but no reduction of 274d was observed after 20 hours (Scheme 3.36). Then the 
more reactive sodium borohydride was used which reduced the pyrrolidin-3-one 274d 
to the pyrrolidin-3-ol 285 in 55% yield, as a 5:1 mixture of (E)- and (Z)- 
diastereoisomers. The major isomer would be the (Z)-isomer so that the steric 
hindrance is minimized. 
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BnN
O
Ph
274d
BnN
OH
Ph
285
NaBH(OAc)3 (2.8 eq)
AcOH, DCM
RT, 20 h
BnN
O
Ph
274d
BnN
OH
Ph
285
NaBH4 (1.2 eq)
MeOH, 0 oC
1 h, 55%
5:1 mixture of diastereoisomers
Scheme 3.36 Reduction of the pyrrolidin-3-one 274d  
The final objective was the removal of benzyl group to give N-unsubstituted 
pyrrolidin-3-ones. Traditional hydrogenation deprotection was attempted using 
palladium on activated carbon and hydrogen gas. However, no change was observed by 
TLC after stirring for 3 days. A few drops of acetic acid were added to the reaction 
mixture to facilitate hydrogenation. A complex mixture had formed after 1 day 
(Scheme 3.36), perhaps because after removal of the benzyl group the N-unsubstituted 
pyrrolidin-3-one 265a was unstable and was decomposed even under mild acidic 
conditions. Due to time limitations, further attempts to remove the benzyl group were 
abandoned. 
BnN
O
Ph
274d
HN
O
Ph
265a
H2, Pd/C
AcOH,EtOH
RT, 24 h
Scheme 3.36 Deprotection of the pyrrolidin-3-one 274d 
3.2.5 Enantioselective Synthesis of Pyrrolidin-3-ones  
In Section 1.2.4, enantiopure piperidin-2,4-diones were prepared with the use of a 
chiral auxiliary. It was desired to extend this methodology to the synthesis of 
enantiopure pyrrolidin-3-ones. The proposed route is shown in Scheme 3.37. 
Aza-Michael addition of the chiral amino ester 287 to α,β-unsaturated esters 286 would 
give diesters 288. Dieckmann cyclisation followed by decarboxylation would afford 
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enantiopure piperidin-2,4-diones 290.  
Scheme 3.37 Proposed route to enantiopure pyrrolidin-3-ones 290
N
CO2Me
O
R
N
O
R
t-BuOK
reflux
289
290
N
H
CO2Me
286
5% H2SO4
R
N
CO2Me
CO2Me
288
n-BuLi
R
CO2Me
Ph
Ph
Ph Ph
287
 
The chiral amino ester 287 was prepared in 32% yield by a displacement reaction of 
methyl bromoacetate with (S)-1-phenylethylamine using triethylamine.
58
 However, 
when the chiral amino ester 287 was treated with the α,β-unsaturated ester 103a and 
n-butyllithium at -78 
o
C, a complex mixture resulted and no desired diester 288a could 
be isolated (Scheme 3.38). Presumably the strong base n-butyllithium had reacted at 
the ester group of amino ester 287 giving various side products. Therefore, the 
proposed route needed to be modified to prevent such interactions. 
N
H
CO2Me
103a
N
CO2Me
CO2Me
288a
CO2Me
Ph
Ph
287    (1.6 eq)
Scheme 3.38 Attempted aza-Michael reaction to the diester 288a
n-BuLi (1.55 eq)
THF, -78 oC, 2 h
 
The modified route to enantiopure pyrrolidin-3-ones 290 is shown in Scheme 3.39. The 
first two steps were in common with the enantioselective synthesis of 
piperidin-2,4-diones (Scheme 1.42). Diesters 288 were made from amines 107 by 
reaction with methyl bromoacetate. The desired pyrrolidin-3-ones 290 were then 
formed by a Dieckmann cyclisation followed by a decarboxylation. 
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Scheme 3.39 Modified route to enantiopure pyrrolidin-3-ones 290
N
CO2Me
O
R
N
O
R
t-BuOK
reflux
289
290
5% H2SO4
R
N
CO2Me
CO2Me
288
Ph
Ph Ph
R
NH
CO2Me
107
Ph
Methyl bromoacetate
CO2Me
n-BuLi
Wilkinson's
catalyst
105 106
103R
N
H
Ph
R
N
CO2Me
Ph
 
To examine the feasibility of this synthetic route, synthesis of five enantiopure 
5-substituted pyrrolidin-3-ones 290 was attempted; three had an aliphatic chain 
(methyl, isopropyl, and propenyl) and two had a ring (cyclohexyl and phenyl). Amines 
107 were prepared as in Section 1.2.4, using Wilkinson's catalyst.
59
 Amines 107 were 
then alkylated with methyl bromoacetate to give diesters 288 in moderate to excellent 
yields (51-96%, Scheme 3.40). 
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R
N
CO2Me
CO2Me
288
Ph
R
NH
CO2Me
107
Ph Methyl bromoacetate
(1 eq)
Na2CO3 (2 eq)
MeCN, reflux, 1 d
 
Cpd R yield (%) 
107a Me 96 
107b i-Pr 56 
107c (E)-CH=CHMe 84 
107d Cyclohexyl 51 
107e Ph 58 
Scheme 3.40 Synthesis of diesters 288 
Dieckmann cyclisations of diesters 288 were attempted using 1M potassium 
tert-butoxide solution in THF at room temperature (Scheme 3.41). After 
decarboxylation, the enantiopure 5-methylpyrrolidin-3-one 290a was isolated in 40% 
yield over two steps. However, treating diesters 288b (R= isopropyl), 288c (R= 
propenyl), and 288d (R= cyclohexyl) with potassium tert-butoxide gave complex 
mixtures. Dieckmann cyclisation of the diester 288e gave the enantiopure 
4-(methoxycarbonyl)-5-phenylpyrrolidin-3-one 289a in 55% yield. However, 
decarboxylation of 289a using 5% sulfuric acid gave the 5-phenylpyrrolidin-3-one 
290b as a 3:1 mixture of diastereoisomers in 28% yield over two steps. Krapcho 
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decarboxylation of 289a by heating with lithium iodide in DMF at 150 
o
C for 1 hour 
gave 290b as a 1:1 mixture of diastereoisomers. Because of time limitations, synthesis 
of further enantiopure pyrrolidin-3-ones 290 could not be carried out. 
R
N
CO2Me
CO2Me
288
Ph N
O
R
290
Ph
1. t-BuOK (1.3 eq)
THF, RT, 24 h
2. 5% H2SO4
reflux, 2 h
 
Cpd R yield (%) 
288a Me 40 
288b i-Pr 0 (decomposed) 
288c (E)-CH=CHMe 0 (decomposed) 
288d Cyclohexyl 0 (decomposed) 
288e Ph 28 (mixture of diastereoisomers) 
Scheme 3.41 Synthesis of pyrrolidin-3-ones 288 
3.2.6 Future Work 
2,5-Disubstituted pyrrolidin-3-ones 294 could not be prepared by using the dianion 
procedure (Scheme 3.35). Therefore, another route was proposed (Scheme 3.42) in 
which the 5-substituents were supplied from amino esters 249. The presence of the R
2
 
group in diesters 291 may facilitate the Dieckmann cyclisation since a bulky group 
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constrains the bond rotation of 291 and brings the ester close to the enolate.  
Scheme 3.42 Proposed route to 2,5-disubstituted pyrrolidin-3-ones 294
BnN
CO2Me
O
R1
BnN
O
R1
t-BuOK
reflux
293 294
R1
HN
CO2Me
CO2Me
291
5% H2SO4
R1
BnN
CO2Me
CO2Me
292
BnBr
K2CO3
R1
CO2Me
NH2
H2N CO2Me
R2
249
170
R1
HN CO2Me
R2
NaBH(OAc)3
250
R2
R2 R
2 R2
CO2Me
 
For the enantioselective synthesis of pyrrolidin-3-ones, the presence of the auxiliary, 
instead of a N-benzyl group, hindered the ring formation and only enantiopure 
5-methylpyrrolidin-3-one 290a could be prepared (Scheme 3.41). Thus, the solution 
would be that diesters 288 have their auxiliary removed by hydrogenation and are 
reprotected by a benzyl group prior to a Dieckmann cyclisation. 
Scheme 3.43 Modified route to enantiopure pyrrolidin-3-ones 298
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3.3 Conclusions  
The synthesis of 1,2-dihydropyrrolidin-3-ones was attempted (Scheme 3.11) 
employing the same strategy used to make piperidin-4-ones (Section 2.2.7) but a 
hydrolysis reaction, rather than a Dieckmann cyclisation, occurred to give β-keto esters 
168. Then diesters 250 were replaced by bromo esters 260 and it was hoped that 
1,2-dihydropyrroles 262 could be made by a SN2 substitution reaction (Scheme 3.17). 
However, the bromo esters 260 could not be prepared from hydroxy esters 259 so this 
route was abandoned. 
Pyrrolidin-3-ones 274 were prepared by the protocol used to make piperidin-2,4-diones 
(Section 1.2.3). Dieckmann cyclisation using 1M potassium tert-butoxide solution at 
room temperature afforded the 4-(methoxycarbonyl)pyrrolidin-3-ones 273 (Scheme 
3.27). The 4,5-disubstituted pyrrolidin-3-one 279 and the 5-substituted pyrrolidin-3-ol 
285 were prepared but the N-benzyl could not be removed.  
Enantioselective synthesis of pyrrolidin-3-ones 290 was attempted (Scheme 3.39) by 
asymmetric induction using the Davies' chiral auxiliary. The enantiopure 
5-methylpyrrolidin-3-one 290a was prepared by this route, but other diesters 288 
decomposed when treated with potassium tert-butoxide.  
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3.4 Experimental  
Methyl aminoethanoate hydrochloride (253a)
60 
H2N CO2Me.HCl 
To a stirred solution of glycine (2.00 g, 26.0 mmol) in methanol (40 mL) in a salt-ice 
bath, thionyl chloride (1.2 mL, 28.0 mmol) was added dropwise via an addition funnel. 
The resulting solution was heated under reflux for 30 min. Diethyl ether (40 mL) was 
added and the solution was left to crystallize. The microprisms were filtered, washed 
with diethyl ether to give 253a (2.94 g, 90%) as white microprisms, mp 170-172 °C 
(lit.
60
 mp
 
177 °C); IR νmax 3389 (N-H), 2952 (C-H), 1739 (ester C=O), 1612, 1512, 
1437, 1247, 1178, 1033 cm
-1
; 
1
H NMR (500 MHz, CD3OD) δ 3.85 (3H, s, OCH3) 3.83 
(2H, s, CH2NH2);
 13
C NMR (500 MHz, CDCl3) δ 169.0 (COOCH3) 53.5 (OCH3) 41.0 
(CH2NH2). 
Methyl 2-amino-3-methylbutanoate hydrochloride (253c)
45
 
H2N CO2Me.HCl 
To a stirred solution of valine (2.00 g, 17.1 mmol) in methanol (20 mL) in a salt-ice 
bath, thionyl chloride (3.7 mL, 50.2 mmol) was added dropwise via an addition funnel. 
The resulting solution was stirred at room temperature for 16 h. Diethyl ether (20 mL) 
was added and the solution was left to crystallize. The microprisms were filtered, 
washed with diethyl ether to give 253c (2.23 g, 78%) as white microprisms, 
1
H NMR 
(500 MHz, CD3OD) δ 3.93 (1H, d, J= 4.7 Hz, CHNH2) 3.84 (3H, s, OCH3) 2.32-2.25 
(1H, m, CHCH3) 1.07 (3H, d, J= 5.2 Hz, CH3CHCH3) 1.06 (3H, d, J= 5.1 Hz, 
CH3CHCH3);
 13
C NMR (500 MHz, CDCl3) δ 170.4 (COOCH3) 59.4 (CHNH2) 53.5 
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(OCH3) 31.0 (CHCH3) 18.4 (CH3CH) 18.2 (CH3CH). 
Methyl 2-amino-3-phenylpropanoate hydrochloride (253d)
61 
H2N CO2Me.HCl
Ph
 
To a stirred solution of 2-amino-3-phenylpropionic acid (3.00 g, 18.1 mmol) in 
methanol (16 mL) in a salt-ice bath, thionyl chloride (1.5 mL, 20.0 mmol) was added 
dropwise via an addition funnel. The resulting solution was heated under reflux for 2 h. 
Diethyl ether (30 mL) was added and the solution was left to crystallize. The 
microprisms were filtered, washed with diethyl ether to give 253d (3.70 g, 97%) as 
white microprisms, mp 156-157 °C (lit.
61 
158-160 °C); IR νmax 3457 (N-H), 2847 (C-H), 
1745 (ester C=O), 1497, 1240, 701 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.74 (2H, br s, 
NH2) 7.33-7.26 (5H, m, Ph) 4.40 (1H, s, CHNH2) 3.69 (3H, s, OCH3) 3.47-3.32 (2H, m, 
CH2Ar);
 13
C NMR (500 MHz, CD4OD) δ 170.5 (COOCH3) 135.3 (ArC) 130.4 (ArC) 
130.2 (ArC) 129.0 (ArC) 55.2 (CHNH2) 53.6 (OCH3) 47.4 (CH2Ar). 
Methyl 2-amino-2-methylpropanoate hydrochloride
 
(253e)
44 
H2N CO2Me.HCl 
To a stirred solution of aminoisobutyric acid (2.00 g, 17.1 mmol) in methanol (20 mL) 
in a salt-ice bath, thionyl chloride (1.5 mL, 20.0 mmol) was added dropwise via an 
addition funnel. The resulting solution was stirred for 4 h at 55 
o
C and stirred overnight 
at room temperature. Diethyl ether (30 mL) was added and the solution was left to 
crystallize. The microprisms were filtered, washed with diethyl ether to give 253e 
(2.30 g, 75%) as white microprisms, mp 182-183 °C (lit.
62 
182-183 °C); IR νmax 3368 
(N-H), 2922 (C-H), 1741 (ester C=O), 1634, 1521, 1322, 1197, 875 cm
-1
; 
1
H NMR 
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(300 MHz, CDCl3) δ 8.97 (2H, br s, NH2) 3.86 (3H, s, OCH3) 1.73 (6H, s, CH3CCH3). 
General procedure for enamino esters 250 
To enamino esters 250 (1.0 equiv) in methanol was added amino esters (1.1 equiv) and 
the solution was heated under reflux for 3 h. The mixture was allowed to cool to room 
temperature, then diluted with diethyl ether. The solution was filtered and the filtrate 
was evaporated. 
Methyl 3-(1-methoxycarbonylmethyl)amino-4-phenylbut-2-enoate (250a) 
Bn
HN CO2Me
CO2Me 
Following general procedure, reaction of methyl 3-amino-4-phenylbut-2-enoate (1.00 g, 
5.20 mmol) and methyl aminoethanoate hydrochloride (0.79 g, 6.30 mmol) in 
methanol (1.1 mL) gave 250a (1.45 g, 87%) as a milky gum, Rf 0.24 (30% ethyl 
acetate/hexane); IR νmax 3340 (N-H), 2954 (C-H), 1745 (ester C=O), 1656 (C=C), 1605, 
1436, 1209 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.87 (1H, br d, J= 6.1 Hz, NH) 
7.34-7.21 (5H, m, Ph) 4.62 (1H, s, =CHCOO) 3.87 (2H, d, J= 6.1 Hz, CH2NH) 3.69 
(3H, s, OCH3) 3.67 (3H, s, OCH3) 3.51 (2H, s, CH2Ar). 
Methyl 3-( 1-methoxycarbonylethyl)amino-4-phenylbut-2-enoate (250b) 
Bn
HN CO2Me
CO2Me 
Following general procedure, reaction of methyl 3-amino-4-phenylbut-2-enoate (0.80 g, 
4.18 mmol) and methyl 2-aminopropanoate hydrochloride (0.70 g, 5.02 mmol) in 
methanol (1 mL) gave 250b (1.01 g, 87%) as an orange oil, Rf 0.72 (50% ethyl 
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acetate/hexane); IR νmax 3245 (N-H), 2950 (C-H), 1741 (ester C=O), 1657 (C=C), 1598, 
1452, 1251, 1146, 729 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.79 (1H, br d, J= 8.6 Hz, 
NH) 7.33-6.91 (5H, m, Ph) 4.57 (1H, s, CH=CNH) 4.17-4.12 (1H, m, CHNH) 3.66 
(3H, s, OCH3) 3.64 (3H, s, OCH3) 3.50 (2H, s, CH2CNH) 1.34 (3H, d, J= 7.4 Hz, 
CH3CHCOO);
 13
C NMR (500 MHz, CDCl3) δ 173.2 (COOCH3) 170.7 (COOCH3) 
161.4 (=CNH) 136.0 (ArC) 129.1 (ArC) 128.6 (ArC) 127.0 (ArC) 86.1 (=CCO) 52.3 
(CH2N) 51.2 (CH3O) 50.2 (CH3O) 39.1 (CH2Ar) 19.5 (CH3CH); m/z (Cl+) 278 (100%, 
M+H
+
); HRMS C15H20NO4 calcd. 278.1392, found 238.1371. 
Methyl 3-(1-methoxycarbonyl-2-methylpropyl)amino-4-phenylbut-2-enoate (250c) 
Bn
HN CO2Me
CO2Me 
Following general procedure, reaction of methyl 3-amino-4-phenylbut-2-enoate (0.50 g, 
2.61 mmol) and methyl 2-amino-3-methylbutanoate hydrochloride (0.57 g, 3.40 mmol) 
in methanol (0.6 mL) gave 250c (0.74 g, 93%) as yellow microprisms, mp 48-50 °C; Rf 
0.76 (50% ethyl acetate/hexane); IR νmax 3247 (N-H), 2964 (C-H), 1741 (ester C=O), 
1657 (C=C), 1609, 1248, 1146, 698 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.90 (1H, br d, 
J= 10.0 Hz, NH) 7.35-7.14 (5H, m, Ph) 4.60 (1H, s, CH=CNH) 3.84 (1H, dd, J= 10.0, 
5.5 Hz, CHNH) 3.69 (3H, s, OCH3) 3.61 (3H, s, OCH3) 3.47 (2H, s, CH2CNH) 
2.10-1.99 (1H, m, CHCHCOO) 0.86 (3H, d, J= 6.9 Hz, CH3CHCH3) 0.82 (3H, d, J= 
6.9 Hz, CH3CHCH3);
 13
C NMR (500 MHz, CDCl3) δ 172.4 (COOCH3) 170.9 
(COOCH3) 162.0 (=CNH) 136.1 (ArC) 129.0 (ArC) 128.6 (ArC) 127.0 (ArC) 86.0 
(=CCO) 61.2 (CH2N) 52.0 (CH3O) 50.3 (CH3O) 39.3 (CH2Ar) 31.6 (CHCH3) 19.1 
(CH3CH) 17.7 (CH3CH); m/z (Cl+) 306 (100%, M+H
+
); HRMS C17H24NO4 calcd. 
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306.1705, found 306.1693. 
Methyl 3-(1-methoxycarbonyl-2-phenylethyl)amino-4-phenylbut-2-enoate (250d)
 
Bn
HN CO2Me
Bn
CO2Me 
Following general procedure, reaction of methyl 3-amino-4-phenylbut-2-enoate (0.80 g, 
4.18 mmol) and methyl 2-amino-3-phenylpropanoate hydrochloride (1.08 g, 5.02 
mmol) in methanol (1 mL) gave 250d (1.21 g, 90%) as orange microprisms, mp 59-63 
°C; Rf 0.42 (30% ethyl acetate/hexane); IR νmax 3256 (N-H), 2949 (C-H), 1743 (ester 
C=O), 1657 (C=C), 1609, 1493, 1249, 1164, 1123, 729, 696 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 8.95 (1H, br d, J= 9.9 Hz, NH) 7.26-6.83 (10H, m, Ph) 4.50 (1H, s, 
CH=CNH) 4.24 (1H, ddd, J= 9.9, 8.5, 5.3 Hz, CHNH) 3.69 (3H, s, OCH3) 3.61 (3H, s, 
OCH3) 3.27 (2H, s, CH2CNH) 3.03 (1H, dd, J= 13.6, 5.3 Hz, CH2CHCOO) 2.81 (1H, 
dd, J= 13.6, 8.5 Hz, CH2CHCOO);
 13
C NMR (500 MHz, CDCl3) δ 172.0 (COOCH3) 
170.7 (COOCH3) 161.3 (=CNH) 136.3 (ArC) 135.9 (ArC) 129.6 (ArC) 129.2 (ArC) 
129.0 (ArC) 128.6 (ArC) 127.1 (ArC) 127.0 (ArC) 86.1 (=CCO) 57.5 (CHN) 52.4 
(CH3O) 50.3 (CH3O) 40.2 (CH2Ar) 39.0 (CH2Ar); m/z (Cl+) 354 (100%, M+H
+
); 
HRMS C21H24NO4 calcd. 354.1705, found 354.1718. 
Methyl 3-(ethoxycarbonylmethyl)amino-4-phenylbut-2-enoate (255)
 
Bn
HN CO2Et
CO2Me 
Following general procedure, reaction of methyl 3-amino-4-phenylbut-2-enoate (1.30 g, 
6.80 mmol) and ethyl aminoethanoate hydrochloride (1.33 g, 9.50 mmol) in methanol 
(1.5 mL) gave 255 (1.73 g, 92%) as white microprisms, mp 88-91 
o
C; Rf 0.86 (ethyl 
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acetate); IR νmax 3296 (N-H) 2944 (C-H), 1743 (ester C=O), 1655 (ester C=O), 1595, 
1413 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.88 (1H, br d, J= 3.6 Hz, NH) 7.32-7.21 
(5H, m, Ph) 4.60 (1H, s, =CHCOO) 4.16 (2H, q, J= 4.2 Hz, CH2OOC) 3.85 (2H, d, J= 
3.6 Hz, CH2NH) 3.66 (3H, s, OCH3) 3.51 (2H, s, CH2Ar) 1.25 (3H, t, J= 4.2 Hz, 
CH3CH2);
 13
C NMR (300 MHz, CDCl3) δ 170.7 (COOCH2) 169.7 (COOCH3) 161.6 
(=CNH) 135.8 (ArC) 129.2 (ArC) 128.6 (ArC) 127.0 (ArC) 86.0 (=CCO) 61.5 (CH2N) 
50.3 (CH2O) 44.7 (CH3O) 39.1 (CH2Ar) 14.1 (CH3CH2); m/z (Cl+) 278 (100%, M
+
); 
HRMS C15H20NO4Na calcd. 278.1392, found 238.1406.  
Ethyl 3-(ethoxycarbonylmethyl)amino-4-phenylbut-2-enoate (256)
 
HN
CO2Et
Ph
CO2Et
 
Following general procedure, reaction of ethyl 3-amino-4-phenylbut-2-enoate (0.20 g, 
1.00 mmol) and ethyl aminoethanoate hydrochloride (0.18 g, 1.30 mmol) in methanol 
(0.3 mL) gave 256 (0.26 g, 91%) as a yellow oil; Rf 0.57 (30% ethyl acetate/hexane); 
IR νmax 3222 (N-H), 2923 (C-H), 1741 (ester C=O), 1660 (C=C), 1518, 1435, 1359, 
1198, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.89 (1H, br d, J= 6.0 Hz, NH) 
7.33-7.22 (5H, m, Ph) 4.60 (1H, s, =CHCOO) 4.20-4.11 (4H, m, CH2CH3 x2) 3.85 (2H, 
d, J= 6.0 Hz, CH2NH) 3.51 (2H, s, CH2Ar) 0.89-0.84 (6H, m, CH3CH2 x2). 
Methyl 3-(methoxycarbonylmethyl)aminobut-2-enoate (257)
 
CO2MeHN
CO2Me 
Following general procedure, reaction of methyl 3-iminobutanoate (0.50 g, 4.34 mmol) 
and methyl aminoethanoate hydrochloride (0.71 g, 5.65 mmol) in methanol (0.8 mL) 
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gave 257 (0.74 g, 91%) as an orange oil, Rf 0.46 (30% ethyl acetate/hexane); 
1
H NMR 
(300 MHz, CDCl3) δ 8.81 (1H, br d, J= 6.3 Hz, NH) 4.58 (1H, s, CH=CNH) 4.00 (2H, 
d, J= 6.3 Hz, CH2NH) 3.80 (3H, s, OCH3) 3.64 (3H, s, OCH3) 1.89 (3H, s, CH3CNH); 
13
C NMR (500 MHz, CDCl3) δ 170.7 (COOCH3) 170.3 (COOCH3) 160.6 (=CNH) 
84.4 (=CHCO2Me) 52.5 (OCH3) 50.2 (OCH3) 44.7 (CH2NH) 19.3 (CH3CNH); m/z 
(Cl+) 188 (100%, M+H
+
) 156 (55%, M
+
-OCH3); HRMS C8H14N4O calcd. 188.0923, 
found 188.0925. 
2-Amino-3-phenylpropan-1-ol (258a)
49 
H2N
Ph
OH
 
To a two-neck flask fitted with a condenser, phenylalanine (2.48 g, 15.0 mmol) was 
dissolved in dry THF (40 mL). Sodium borohydride (1.36 g, 36.1 mmol) was added to 
the mixture and it was cooled to 0 
o
C. Iodine (3.80 g, 15.0 mmol) dissolved in dry THF 
(10 mL) was added via a dropping funnel over 30 min. The resulting solution was 
heated under reflux for 16 h. The mixture was allowed to cool to room temperature and 
methanol was added slowly until the solution became clear. The mixture was stirred for 
30 min and evaporated. The resulting white paste was dissolved in 20% potassium 
hydroxide (30 mL) and was stirred for 4 h. The mixture was extracted with 
dichloromethane (3 x 30 mL) and the combined organic layers were washed with brine 
(15 mL), dried (Na2SO4), and evaporated to give a white solid which was recrystalised 
from toluene to give 258a (1.89 g, 83%) as white microprisms, mp 89-91 
o
C (lit.
49 
90-92 °C); 
1
H NMR (500 MHz, CDCl3) δ 7.32-7.18 (5H, m, Ph) 3.64 (1H, dd, J= 10.7, 
3.8 Hz, CH2OH) 3.39 (1H, dd, J= 10.7, 7.2 Hz, CH2OH) 3.14-3.09 (1H, m, CHN) 2.79 
(1H, dd, J= 13.5, 5.2 Hz, CH2Ph) 2.53 (1H, dd, J= 13.5, 8.7 Hz, CH2Ph) 2.02 (3H, br s, 
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NH2 and OH);
 13
C NMR (500 MHz, CDCl3) δ 138.8 (ArC) 129.3 (ArC) 128.7 (ArC) 
126.5 (ArC) 66.3(CH2OH) 54.3 (CHN) 40.9 (CH2Ar). 
Methyl 3-(1-benzyl-2-hydroxyethyl)amino-4-phenylbut-2-enoate (259a)
 
Bn
HN
Bn
CO2Me
OH
 
To methyl 3-amino-4-phenylbut-2-enoate (0.20 g, 1.04 mmol) in methanol (0.4 mL) 
was added 2-amino-3-phenylpropan-1-ol (0.19 g, 1.25 mmol) and the solution was 
heated under reflux for 3 h. The mixture was allowed to cool to room temperature and 
evaporated. The resulting oil was purified by flash chromatography (10% ethyl 
acetate/hexane) to give 259a (0.22 g, 65%) as a colourless oil, Rf 0.22 (30% ethyl 
acetate/hexane); 
1
H NMR (300 MHz, CDCl3) δ 8.76 (1H, br d, J= 10.4 Hz, NH) 
7.32-7.01 (10H, m, Ph) 4.50 (1H, s, CH=CNH) 3.71-3.55 (1H, m, CHNH) 3.66 (3H, s, 
OCH3) 3.55-3.45 (2H, m, CH2OH) 3.36 (2H, d, J= 16.0 Hz, CH2CNH) 3.21 (2H, d, J= 
16.0 Hz, CH2CNH) 2.95 (1H, br s, OH) 2.80 (1H, dd, J= 13.4, 6.0 Hz, CH2CHCH2OH) 
2.62 (1H, dd, J= 13.4, 7.8 Hz, CH2CHCH2OH);
 13
C NMR (500 MHz, CDCl3) δ 171.3 
(COCH2) 169.5 (CCH) 138.1 (ArC) 136.6 (ArC) 129.3 (ArC) 128.9 (ArC) 128.8 (ArC) 
126.9 (ArC) 126.6 (ArC) 84.1 (CHCOO) 65.1 (CH2OH) 56.6 (CHN) 50.3 (OCH3) 39.5 
(CH2Ar) 39.2 (CH2Ar). 
Methyl 3-oxo-3-phenylpropanoate (166e)
51 
Ph OMe
O O
 
To a solution of sodium hydride (60% dispersion in mineral oil, 1.00 g, 25.7 mmol) in 
THF (15 mL) was added a solution of acetophenone (1.5 mL, 12.8 mmol) in THF (1 
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mL) dropwise. The mixture was stirred for 30 min at room temperature, then dimethyl 
carbonate (6 mL, 70.2 mmol) was added dropwise. The mixture was stirred for 20 min 
at room temperature and was heated under reflux for 4 h. The mixture was allowed to 
cool to room temperature and 3M acetic acid was added until all solids dissolved. The 
aqueous layer was extracted with diethyl ether (3 x 10 mL). The combined organic 
layers were washed with saturated aqueous sodium hydrogen carbonate (10 mL) and 
then brine (10 mL), dried (MgSO4), and evaporated to give 166e (2.10 g, 92%) as an 
orange oil, 
1
H NMR (300 MHz, CDCl3) δ 7.96-7.42 (5H, m, Ph) 5.68 (s, from enol) 
4.02 (2H, s, CH2CO2CH3) 3.80 (d, J= 5.6 Hz, from enol) 3.76 (3H, s, OCH3);
 13
C NMR 
(500 MHz, CDCl3) δ 192.6 (COCH2) 168.1 (COOCH3) 133.9 (ArC) 128.9 (ArC) 128.8 
(ArC) 126.1 (ArC) 52.6 (OCH3) 45.7 (CH2CO). 
(E)-Methyl 3-aminohex-2-enoate (169d)
63 
Pr OMe
NH2 O
 
To a stirred solution of sodium hydride (0.82 g, 20.4 mmol, 60% in mineral oil, washed 
with petroleum ether and THF) in THF (30 mL) at 0 °C, methyl acetoacetate (2 mL, 
18.6 mmol) was added dropwise. The mixture was cooled to -20 °C after stirring at 0 
°C for 10 min. n-Butyllithium (8.2 mL, 20.4 mmol, 2.5 M) was added over 10 min and 
the mixture was stirred at -20 °C for 5 min. Bromoethane (1.4 mL, 93.1 mmol) was 
added dropwise and the mixture was stirred at room temperature for 3 h. The mixture 
was then poured to saturated ammonium chloride solution (100 mL), extracted with 
dithyl ether (3 x 100 mL), dried (MgSO4), and evaporated. The orange solid was 
dissolved in toluene (70 mL). Ammonium acetate (7.16 g, 92.8 mmol) and a few drops 
of acetic acid were added. The mixture was heated under reflux for 3 h with the 
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azeotropic removal of water. The mixture was allowed to cool to room temperature, 
then diluted with ethyl acetate (50 mL), washed with saturated aqueous sodium 
hydrogen carbonate (15 mL), dried (Na2SO4), and evaporated to give β-enamino ester 
as a pale orange oil. The resulting oil was purified by flash chromatography (20% ethyl 
acetate/hexane) to give 169d (0.96 g, 36%) as a yellow oil, Rf 0.45 (30% ethyl 
acetate/hexane); IR νmax 3453 (N-H), 3335 (N-H), 2962 (C-H), 1713 (ester C=O), 1666 
(alkenyl C=C), 1437, 1265, 1159, 1042, 788 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 4.54 
(1H, s, CHCOOCH3) 3.64 (3H, s, OCH3) 2.10 (2H, t, J= 7.4 Hz, CH2CH2CH3) 
1.61-1.55 (2H, m, CH2CH3) 0.94 (3H, t, J= 7.4 Hz, CH3CH2). Spectroscopic data were 
consistent with reported calues in the literature.
63
 
Methyl 3-amino-3-phenylpropenoate (169e)
64 
Ph OMe
NH2 O
 
To a solution of methyl 3-oxo-3-phenylpropanoate (0.50 g, 2.80 mmol) in methanol (5 
mL) was added ammonium acetate (1.50 g, 14.0 mmol). The mixture was heated under 
reflux for 16 h. The mixture was allowed to cool to room temperature and water (5 mL) 
was added. The mixture was extracted with dichloromethane (3 x 5 mL). The 
combined organic layers were dried (Na2SO4), evaporated to give 169e (0.31 g, 62%)  
as an orange oil, 
1
H NMR (300 MHz, CDCl3) δ 7.56-7.52 (2H, m, Ph) 7.43-7.26 (3H, 
m, Ph) 4.97 (1H, s, CHCO2CH3) 3.69 (3H, s, OCH3). 
Methyl 3-(methoxycarbonylmethylamino)hex-2-enoate (250e)
 
HN
CO2MePr
CO2Me
 
To methyl 3-aminohex-2-enoate (0.48 g, 3.31 mmol) in methanol (0.5 mL) was added 
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methyl 2-aminoethanoate hydrochloride (0.50 g, 3.98 mmol) and the solution was 
heated under reflux for 3 h. The mixture was allowed to cool to room temperature and 
diluted with diethyl ether (5 mL). The solution was filtered and the filtrate was 
evaporated to give 250e (0.56 g, 79%,) as a yellow oil, 
1
H NMR (500 MHz, CDCl3) δ 
8.85 (1H, br d, J= 6.2 Hz, NH) 4.58 (1H, s, CHCOO) 3.99 (2H, d, J= 6.2 Hz, CH2COO) 
3.77 (3H, s, OCH3) 3.64 (3H, s, OCH3) 2.10 (2H, t, J= 10.5 Hz, CH2CH2CH3) 1.53 (2H, 
tq, J= 10.5, 7.5 Hz, CH2CH3) 0.98 (3H, t, J= 7.5 Hz, CH3CH2); 
13
C NMR (500 MHz, 
CDCl3) δ 171.0 (COOCH3) 170.3 (COOCH3) 164.2 (CNH) 83.5 (CHCOO) 52.5 
(CH3O) 50.2  (CH3O) 44.4 (CH2Ar) 34.2 (CH2CH2CH3) 21.0 (CH2CH3) 13.8 
(CH3CH2). 
Methyl 3-(methoxycarbonylmethylamino)butanoate (263a)
50 
HN
CO2Me
CO2Me
 
To sodium triacetoxyborohydride (0.68 g, 3.21 mmol) in glacial acetic acid (1.8 mL) 
was added methyl 3-(methoxycarbonylmethylamino)but-2-enoate (0.20 g, 1.07 mmol)  
in acetonitrile (1.8 mL) in one portion at 0 
o
C. The mixture was stirred for 4 h at 0 
o
C. 
The mixture was evaporated and the residue was then diluted with dichloromethane 
(10 mL), washed with saturated sodium carbonate solution (2 x 5 mL), dried (MgSO4) 
and evaporated to give 263a (0.15 g, 75%) as a brown oil, Rf 0.10 (75% ethyl 
acetate/hexane); IR νmax 3350 (N-H), 2954 (C-H), 1730 (ester C=O), 1435, 1195, 1004, 
768 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 3.75 (3H, s, OCH3) 3.69 (3H, s, OCH3) 3.45 
(2H, d, J= 5.4 Hz, CH2NH) 3.15-3.12 (1H, m, CHNH) 2.48 (1H, dd, J= 15.4, 6.7 Hz, 
CH2CHCH3) 2.37 (1H, dd, J= 15.4, 6.2 Hz, CH2CHCH3) 1.89 (1H, br d, J= 5.4 Hz, 
NH) 1.11 (3H, d, J= 6.5 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 172.6 (COOCH3) 
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172.5 (COOCH3) 52.0 (CH3O) 51.7 (CH3O) 50.1 (CH2Ar) 48.3 (CHN) 41.3 
(CH2CHCH3) 20.3 (CH3CH).  
Methyl 3-(methoxycarbonylmethylamino)hexanoate (263b)
 
HN
CO2MePr
CO2Me
 
To sodium triacetoxyborohydride (1.64 g, 7.74 mmol) in glacial acetic acid (4.4 mL) 
was added methyl 3-(methoxycarbonylmethylamino)hex-2-enoate (0.56 g, 2.58 mmol)  
in acetonitrile (4.4 mL) in one portion at 0 
o
C. The mixture was stirred for 4 h at 0 
o
C. 
The mixture was evaporated and the residue was then diluted with dichloromethane 
(30 mL), washed with saturated sodium carbonate solution (2 x 10 mL) ,dried (MgSO4) 
and evaporated to give 263b (0.53 g, 95%,) as a pale yellow oil, IR νmax 3350 (N-H), 
2956 (C-H), 1732 (ester C=O), 1435, 1199, 1172, 1012, 734 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 3.72 (3H, s, OCH3) 3.68 (3H, s, OCH3) 3.43 (2H, s, CH2NH) 3.15-3.12 (1H, 
m, CHNH) 2.40 (2H, d, J= 5.1 Hz, CH2CHCH2CH2CH3) 2.07 (1H, br s, NH) 1.47-1.35 
(4H, m, CH2CH2CH3 + CH2CH3) 0.90 (3H, t, J= 5.4 Hz, CH3CH2);
 13
C NMR (500 
MHz, CDCl3) δ 172.9 (COOCH3) 172.8 (COOCH3) 54.4 (CH2NH) 51.9 (CH3O) 51.6 
(CH3O) 48.3 (CHN) 39.2 (CH2CHCH2CH2CH3) 36.7 (CH2CH2CH3) 18.9 (CH2CH3) 
14.2 (CH3CH2).  
Methyl 3-(methoxycarbonylmethylamino)-4-phenylbutanoate (263c)
 
HN
CO2MeBn
CO2Me
 
To sodium triacetoxyborohydride (2.20 g, 10.35 mmol) in glacial acetic acid (5.8 mL) 
was added methyl 3-(methoxocarbonylmethylamino)-4-phenylbut-2-enoate (0.91 g, 
3.45 mmol) in acetonitrile (5.8 mL) in one portion at 0 
o
C. The mixture was stirred for 
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4 h at 0 
o
C. The mixture was evaporated and the residue was then diluted with 
dichloromethane (30 mL), washed with saturated sodium carbonate solution (2 x 15 
mL), dried (MgSO4) and evaporated to give 263c (0.84 g, 92%) as a brown oil, IR νmax 
3350 (N-H), 2952 (C-H), 1731 (ester C=O), 1435, 1199, 1148, 748, 701 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 7.46-7.19 (5H, m, Ph) 3.70 (3H, s, OCH3) 3.67 (3H, s, OCH3) 
3.46 (2H, s, CH2NH) 3.29 (1H, ddd, J= 7.1, 6.2, 5.7 Hz, CHNH) 2.85 (1H, dd, J= 13.5, 
6.2 Hz, CH2CHN) 2.75 (1H, dd, J= 13.5, 7.1 Hz, CH2CHN) 2.43 (2H, d, J= 5.7 Hz, 
CH2Ph) 2.09 (1H, br s, NH);
 13
C NMR (500 MHz, CDCl3) δ 172.6 (COOCH3) 172.5 
(COOCH3) 138.1 (ArC) 129.4 (ArC) 128.6 (ArC) 126.7 (ArC) 56.1 (CH2N) 52.0 
(CH3O) 51.7 (CH3O) 48.5 (CHN) 40.8 (CH2Ar) 38.6 (CH2CHCH2Ar).  
Methyl 3-(methoxycarbonylmethylamino)-3-phenylpropanoate (263d)
 
HN
CO2Me
CO2Me
Ph  
To a stirred solution of methyl 3-amino-3-phenylpropanoate (10.52 g, 98.9 mmol) in 
acetonitrile (260 mL), methyl bromoacetate (7.56 g, 98.9 mmol) and potassium 
carbonate (26.30 g, 138.2 mmol) were added. The mixture was stirred for 5 h at room 
temperature and was then diluted with ethyl acetate (300 mL), washed with water (2 x 
150 mL) and brine (2 x 30 mL), dried (MgSO4), and evaporated to give an oil that was 
purified by flash chromatography (50% ethyl acetate/hexane) to give 263d (11.19 g, 
91%) as a colourless oil, Rf 0.67 (50% ethyl acetate/hexane); IR νmax 3350 (N-H), 2952 
(C-H), 1735 (ester C=O), 1453, 1199, 1167, 763, 702 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
δ 7.51 (1H, br s, NH) 7.37-7.25 (5H, m, Ph) 4.10 (1H, dd, J= 8.5, 5.3 Hz, ArCH) 3.67 
(3H, s, OCH3) 3.65 (3H, s, OCH3) 3.27 (1H, d, J= 17.4 Hz, CH2NH) 3.21 (1H, d, J= 
17.4 Hz, CH2NH) 2.76 (1H, dd, J= 15.6, 8.5 Hz, CH2CH) 2.64 (1H, dd, J= 15.6, 5.3 
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Hz, CH2CH);
 13
C NMR (500 MHz, CDCl3) δ 172.6 (COOCH3) 172.0 (COOCH3) 141.6 
(ArC) 128.7 (ArC) 127.8 (ArC) 127.2 (ArC) 59.1 (CHNH) 51.8 (CH3O) 51.8 (CH3O) 
48.5 (CH2NH) 42.7 (CH2CH); HRMS C13H17NO4 calcd. 252.1236, found 252.1230. 
Methyl 3-(methoxycarbonylmethylamino)-3-(pyridin-3-yl)propanoate (263e)
 
HN
CO2Me
CO2Me
N  
To a stirred solution of methyl 3-amino-3-(pyridin-3-yl)propanoate (0.60 g, 2.38 mmol) 
in acetonitrile (15 mL), methyl bromoacetate (0.37 g, 2.38 mmol) and potassium 
carbonate (1.61 g, 11.66 mmol) were added. The mixture was stirred for 5 h at room 
temperature and was then diluted with ethyl acetate (10 mL), washed with water (2 x 5 
mL) and brine (2 x 3 mL), dried (MgSO4), and evaporated. The resulting oil was 
purified by flash chromatography (1% methanol/chloroform) to give 263e (0.20 g, 33%) 
as a yellow oil, Rf 0.14 (3% methanol/chloroform); IR νmax 3332 (N-H), 2953 (C-H), 
1730 (ester C=O), 1433, 1199, 1164, 715 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.57-8.51 (2H, m, aryl) 7.71-7.69 (1H, m, aryl) 7.28-7.26 (1H, m, aryl) 4.16 (1H, dd, 
J= 8.2, 5.7 Hz, CHAr) 3.67 (3H, s, OCH3) 3.65 (3H, s, OCH3) 3.26 (1H, d, J= 17.4 Hz, 
CH2NH) 3.19 (1H, d, J= 17.4 Hz, CH2NH) 2.77 (1H, dd, J= 15.7, 8.2 Hz, CH2CHN) 
2.63 (1H, dd, J= 15.7, 5.7 Hz, CH2CHN);
 13
C NMR (500 MHz, CDCl3) δ 172.4 
(COOCH3) 171.4 (COOCH3) 149.4 (ArC) 149.4 (ArC) 137.2 (ArC) 134.8 (ArC) 123.7 
(ArC) 56.8 (CHNH) 52.3 (CH3O) 51.9 (CH3O) 48.4 (CH2NH) 42.4 (CH2CH). 
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Methyl 3-(methoxycarbonylmethylmethylamino)-3-phenylpropanoate (267)
 
MeN
CO2Me
CO2Me
Ph  
To a stirred solution of methyl 3-(methoxycarbonylmethylamino)-3-phenylpropanoate 
(0.40 g, 1.57 mmol) in acetonitrile (10 mL), methyl iodide (0.50 ml, 7.85 mmol) and 
potassium carbonate (1.08 g, 7.85 mmol) were added. The mixture was stirred for 5 h 
at room temperature and was then diluted with ethyl acetate (10 mL), washed with 
water (2 x 5 mL) and brine (2 x 3 mL), dried (MgSO4), and evaporated. The resulting 
oil was purified by flash chromatography (12% ethyl acetate/hexane) to give 267 (0.22 
g, 52%) as a colorless oil, Rf 0.15 (15% ethyl acetate/hexane); 
1
H NMR (500 MHz, 
CDCl3) δ 7.34-7.24 (5H, m, Ph) 4.23 (1H, dd, J= 8.3, 6.7 Hz, ArCH) 3.67 (3H, s, 
OCH3) 3.58 (3H, s, OCH3) 3.28 (1H, d, J= 16.6 Hz, CH2NH) 3.11 (1H, d, J= 16.6 Hz, 
CH2NH) 2.99 (1H, dd, J= 14.9, 6.7 Hz, CH2CH) 2.73 (1H, dd, J= 14.9, 8.3 Hz, CH2CH) 
2.34 (3H, s, NCH3);
 13
C NMR (500 MHz, CDCl3) δ 171.9 (COOCH3) 171.5 (COOCH3) 
138.8 (ArC) 128.4 (ArC) 128.3 (ArC) 127.8 (ArC) 64.2 (NCH3) 55.6 (CHN) 51.7 
(CH3O) 51.6 (CH3O) 39.3 (CH2NH) 38.5 (CH2CH); HRMS C14H19NO4 calcd. 
265.1314, found 265.1302. 
Methyl 
3-[(tert-butoxycarbonyl)(methoxycarbonylmethyl)amino]-4-phenylbutanoate 
(270)
 
N
CO2MeBn
CO2Me
Boc
 
To methyl 3-(methoxycarbonylmethylamino)-4-phenylbutanoate (0.20 g, 0.75 mmol) 
in dichloromethane (2 mL) was added di-tert-butyl dicarbonate (0.18 mL, 0.83 mmol). 
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The mixture was stirred for 16 h at room temperature. The mixture was evaporated and 
the residue was then diluted with water (3 mL), acidied with 1M hydrochloric acid to 
pH 4, and washed with ethyl acetate (2 x 6 mL). The aqueous phase was then 
neutralized by saturated sodium hydrogen carbonate solution, extracted with ethyl 
acetate (2 x 6 mL), washed with water (2 x 3 mL), dried (MgSO4) and evaporated. The 
resulting oil was purified by flash chromatography (10% ethyl acetate/hexane) to give 
270 (0.20 g, 72%) as a colourless oil, Rf 0.75 (30% ethyl acetate/hexane);
 1
H NMR 
(500 MHz, CDCl3) δ 7.26-7.13 (5H, m, Ph) 4.34-4.28 (1H, m, CHNH) 3.77 (3H, s, 
OCH3) 3.65 (3H, s, OCH3) 3.60 (2H, s, CH2NH) 3.06-2.93 (1H, m, CH2Ph) 2.87-2.79 
(2H, m, CH2Ph + CH2CHN) 2.60-2.55 (1H, m, CH2CHN) 1.38 (4H, s, (CH3)3C) 1.35 
(5H, s, (CH3)3C);
 13
C NMR (500 MHz, CDCl3) δ 172.2 (COOCH3) 171.9 (COOCH3) 
170.7 (COOCH3) 170.7 (COOCH3) 155.1 (CON) 154.3 (CON) 138.4 (ArC) 129.4 
(ArC) 129.2 (ArC) 129.0 (ArC) 128.6 (ArC) 126.6 (ArC) 126.5 (ArC) 80.2 (C(CH3)3) 
80.4 (C(CH3)3) 57.3 (CH2N) 52.0 (CH3O) 51.9 (CH3O) 51.7 (CH3O) 51.7 (CH3O) 48.9 
(CHN) 39.6 (CH2Ar) 38.7 (CH2Ar) 38.1 (CH2CHCH2Ar) 37.3 (CH2CHCH2Ar) 28.4 
((CH3)3C) 28.2 ((CH3)3C); m/z (Cl+) 366 (10%, M+H
+
) 266 (100%, 
M+H
+
-CO2C(CH3)3); HRMS C19H27NO6 calcd. 366.1917, found 366.1917. 
General procedure for benzylation 
To diesters 272 (1.0 equiv) in acetonitrile was added potassium carbonate (2.0 equiv), 
lithium iodide (catalytic amount) and benzyl bromide (1.1 equiv). The mixture was 
stirred for 16 h at 55 
o
C. The mixture was then evaporated and redissolved in 
dicholomethane. The mixture was washed with water and the organic layer was dried 
(MgSO4) and evaporated. 
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Methyl 3-(benzylmethoxycarbonylmethylamino)butanoate (272a)
 
N
CO2Me
CO2Me
Bn
 
Following general procedure, reaction of methyl 
3-(methoxycarbonylmethylamino)butanoate (1.00 g, 5.30 mmol), potassium carbonate 
(1.46 g, 10.6 mmol), lithium iodide (50 mg), and benzyl bromide (0.69 mL, 5.81 mmol) 
in acetonitrile (100 mL) gave an oil that was purified by flash chromatography (20% 
ethyl acetate/hexane) to give 272a (1.13 g, 77%) as a yellow oil; Rf 0.66 (30% ethyl 
acetate/hexane); IR νmax 2952 (C-H), 1734 (ester C=O), 1436, 1197, 1004, 744, 699 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.17 (5H, m, Ph) 3.75 (2H, s, CH2Ar) 3.62 
(3H, s, OCH3) 3.59 (3H, s, OCH3) 3.39-3.34 (1H, m, CHN) 3.25 (2H, s, CH2NCH2Ar) 
2.59 (1H, dd, J= 14.4, 5.9 Hz, CH2CHCH3) 2.26 (1H, dd, J= 14.4, 7.3 Hz, CH2CHCH3) 
1.09 (3H, d, J= 6.7 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 172.7 (COOCH3) 
172.6 (COOCH3) 139.2 (ArC) 128.8 (ArC) 128.3 (ArC) 127.0 (ArC) 54.1 (CH2Ar) 
53.6 (CH2NCH2Ar) 51.7 (CHN) 51.6 (CH3O) 51.5 (CH3O) 39.5 (CH2CHCH3) 15.8 
(CH3CH). 
Methyl 3-(benzylmethoxycarbonylmethylamino)hexanoate (272b)
 
N
CO2MePr
CO2Me
Bn
 
Following general procedure, reaction of methyl 
3-(methoxycarbonylmethylamino)hexanoate (0.30 g, 1.38 mmol), potassium carbonate 
(0.38 g, 2.72 mmol), lithium iodide (10 mg), and benzyl bromide (0.18 mL, 1.52 mmol) 
in acetonitrile (25 mL) gave an oil that was purified by flash chromatography (15% 
ethyl acetate/hexane) to give 272b (0.30 g, 70%) as a yellow oil; Rf 0.60 (30% ethyl 
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acetate/hexane); IR νmax 2954 (C-H), 1734 (ester C=O), 1436, 1195, 1175, 699 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.38-7.21 (5H, m, Ph) 3.87 (1H, d, J= 13.7 Hz, CH2Ar) 
3.72 (1H, d, J= 13.7 Hz, CH2Ar) 3.67 (3H, s, OCH3) 3.63 (3H, s, OCH3) 3.28 (2H, s, 
CH2NCH2Ar) 3.21-3.19 (1H, m, CHN) 2.62 (1H, dd, J= 14.5, 6.7 Hz, 
CH2CHCH2CH2CH3) 2.29 (1H, dd, J= 14.5, 7.3 Hz, CH2CHCH2CH2CH3) 1.60-1.57 
(2H, m, CH2CH2CH3) 1.33-1.28 (2H, m, CH2CH3) 0.87 (3H, t, J= 7.3 Hz, CH3CH2);
 
13
C NMR (500 MHz, CDCl3) δ 173.1 (COOCH3) 172.6 (COOCH3) 139.2 (ArC) 129.0 
(ArC) 128.2 (ArC) 127.1 (ArC) 58.1 (CH2Ar) 54.3 (CH2NCH2Ar) 51.6 (CHN) 51.5 
(CH3O) 51.2 (CH3O) 36.5 (CH2CHCH2CH2CH3) 34.2 (CH2CH2CH3) 19.9 (CH2CH3) 
14.1 (CH3CH2). 
Methyl 3-(benzylmethoxycarbonylmethylamino)-4-phenylbutanoate (272c)
 
N
CO2MeBn
CO2Me
Bn
 
Following general procedure, reaction of methyl 
3-(methoxycarbonylmethylamino)-4-phenylbutanoate (0.25 g, 0.94 mmol), potassium 
carbonate (0.26 g, 1.88 mmol), lithium iodide (10 mg), and benzyl bromide (0.12 mL, 
1.03 mmol) in acetonitrile (18 mL) gave an oil that was purified by flash 
chromatography (20% ethyl acetate/hexane) to give 272c (0.23 g, 70%) as a yellow oil; 
Rf 0.87 (50% ethyl acetate/hexane); IR νmax 2950 (C-H), 1731 (ester C=O), 1435, 1198, 
1151, 1028, 734, 697 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.40-7.15 (10H, m, Ph) 3.90 
(1H, d, J= 13.9 Hz, CH2NCH2COO) 3.82 (1H, d, J= 13.9 Hz, CH2NCH2COO) 3.64 
(3H, s, OCH3) 3.60 (3H, s, OCH3) 3.59-3.48 (1H, m, CHN) 3.43 (1H, d, J= 12.8 Hz, 
CH2NCH2Ar) 3.37 (1H, d, J= 12.8 Hz, CH2NCH2Ar) 3.07 (1H, m, CH2CHCH2COO) 
2.60-2.52 (2H, m, CH2CHCH2COO + CH2CHCH2Ar) 2.34 (1H, dd, J= 14.7 Hz, 6.0 
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Hz, CH2CHCH2Ar);
 13
C NMR (500 MHz, CDCl3) δ 172.6 (COOCH3) 172.6 (COOCH3) 
139.2 (ArC) 139.1 (ArC) 129.3 (ArC) 128.9 (ArC) 128.5 (ArC) 128.2 (ArC) 127.2 
(ArC) 126.3 (ArC) 60.5 (CH2Ar) 54.4 (CH2NCH2Ar) 51.6 (CHN) 51.4 (CH3O) 37.6 
(CH2CHCH2COO) 37.0 (CH2CHCH2Ar). 
Methyl 3-(benzylmethoxycarbonylmethylamino)-3-phenylpropanoate (272d)
 
N
CO2MePh
CO2Me
Bn
 
Following general procedure, reaction of methyl 
3-(methoxycarbonylmethylamino)-3-phenylpropanoate (1.93 g, 7.67 mmol), potassium 
carbonate (2.12 g, 15.3 mmol), lithium iodide (82 mg), and benzyl bromide (0.82 mL, 
8.43 mmol) in acetonitrile (110 mL) gave an oil that was purified by flash 
chromatography (20% ethyl acetate/hexane) to give 272d (1.59 g, 61%) as pale yellow 
microprisms and also methyl 3-(methoxycarbonylmethylamino)-3-phenylpropanoate 
(0.80 g), mp 45-47 
o
C; Rf 0.50 (30% ethyl acetate/hexane); IR νmax 2950 (C-H), 1732 
(ester C=O), 1434, 1195, 1167, 1081, 735, 697 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.39-7.23 (10H, m, Ph) 4.47 (1H, dd, J= 8.1, 7.3 Hz, CHN) 3.83 (1H, d, J= 14.5 Hz, 
CH2NCH2COO) 3.62 (3H, s, OCH3) 3.60 (3H, s, OCH3) 3.59 (1H, d, J= 14.5 Hz, 
CH2NCH2COO) 3.38 (1H, d, J= 17.1 Hz, CH2NCH2Ar) 3.16 (1H, d, J= 17.1 Hz, 
CH2NCH2Ar) 3.05 (2H, dd, J= 14.1, 7.3 Hz, CH2CHAr) 2.75 (1H, dd, J= 14.1, 8.1 Hz, 
CH2CHAr);
 13
C NMR (500 MHz, CDCl3) δ 172.1 (COOCH3) 172.0 (COOCH3) 139.1 
(ArC) 139.0 (ArC) 129.1 (ArC) 128.9 (ArC) 128.4 (ArC) 128.3 (ArC) 127.7 (ArC) 
127.2 (ArC) 61.6 (CH2Ar) 54.8 (CH2NCH2Ar) 51.7 (CHN) 51.5 (CH3O) 51.1 (CH3O) 
37.9 (CH2CHCH2COO); m/z (Cl+) 342 (100%, M+H
+
); HRMS C20H23NO4 calcd. 
342.1705, found 342.1709.   
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Methyl 3-(benzylmethoxycarbonylmethylamino)-3-(pyridin-3-yl)propanoate 
(272e)
 
N
CO2Me
CO2Me
N
Bn
 
To a stirred solution of methyl 
3-(methoxycarbonylmethylamino)-3-(pyridin-3-yl)propanoate (0.11 g, 0.45 mmol) in 
dichloromethane (6 mL), benzaldehyde (0.28 ml, 2.71 mmol) and MgSO4 (20 mg) was 
added. The mixture was stirred for 5 min at room temperature. Sodium 
triacetoxyborohydride (0.29 g, 1.36 mmol) was then added and the mixture was stirred 
for 16 h. The mixture was diluted with dichloromethane (20 mL), washed with 
saturated sodium carbonate solution (2 x 5 mL), dried (MgSO4), and evaporated. The 
resulting oil was purified by flash chromatography (22% ethyl acetate/hexane) to give 
272e (0.04 g, 26%) as a yellow oil, Rf 0.48 (30% ethyl acetate/hexane); IR νmax 2952 
(C-H), 1731 (ester C=O), 1433, 1199, 1025, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.63-8.55 (2H, m, aryl) 7.80 (1H, d, J= 7.8 Hz, aryl) 7.35-7.22 (6H, m, aryl + Ph) 4.53 
(1H, dd, J= 8.6, 6.6 Hz, CHAr) 3.78 (2H, s, CH2Ar) 3.62 (3H, s, OCH3) 3.60 (3H, s, 
OCH3) 3.38 (1H, d, J= 17.3 Hz, CH2NCH2Ar) 3.18 (1H, d, J= 17.3 Hz, CH2NCH2Ar) 
3.07 (1H, dd, J= 15.0, 6.6 Hz, CH2CHN) 2.78 (1H, dd, J= 15.0, 8.6 Hz, CH2CHN);
 13
C 
NMR (500 MHz, CDCl3) δ 171.8 (COOCH3) 171.4 (COOCH3) 148.9 (ArC) 148.3 
(ArC) 138.3 (ArC) 136.6 (ArC) 135.8 (ArC) 128.9 (ArC) 128.3 (ArC) 127.5 (ArC) 
123.7 (ArC) 59.3 (CHN) 54.7 (CH2Ar) 52.0 (CH3O) 51.7 (CH3O) 50.9 (CH2NHCH2Ar) 
36.7 (CH2CH). 
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Methyl 1-benzyl-4-methoxy-5-propylpyrrolidin-3-one (273b) 
N
Bn O
CO2MePr  
To methyl 3-(benzylmethoxycarbonylmethylamino)hexanoate (0.19 g, 0.61 mmol) in 
toluene (2 mL) was added potassium tert-butoxide (0.8 mL, 1M solution in THF) at 0 
o
C. The mixture was stirred for 16 h at room temperature under nitrogen. The mixture 
was diluted with dichloromethane (10 mL), washed with hydrochloric acid (2 mL, 1M), 
dried (MgSO4), and evaporated to give 273b (0.10 g, 60%) as an yellow oil, Rf 0.83 
(30% ethyl acetate/hexane); 
1
H NMR (500 MHz, CDCl3) δ 7.37-7.22 (5H, m, Ph) 4.24 
(1H, d, J= 13.1 Hz, CH2CO) 3.76 (3H, s, OCH3) 3.35-3.23 (4H, m, 
CH2CO+CH2Ar+CHCOO+CHN) 2.79 (1H, d, J= 17.7 Hz, CH2Ar) 1.90-1.89 (2H, m, 
CH2CH2CH3) 1.41-1.33 (2H, m, CH2CH3) 0.97 (3H, t, J= 7.3 Hz, CH3CH2);
 13
C NMR 
(500 MHz, CDCl3) δ 206.2 (COCH2N) 168.5 (COOCH3) 137.7 (ArC) 128.6 (ArC) 
128.5 (ArC) 127.0 (ArC) 65.0 (CH2CO) 61.6 (CHCOO) 60.5 (CH2Ar) 57.4 (CH3O) 
52.7 (CHN) 34.1 (CH2CH2CH3) 18.1 (CH2CH3) 14.5 (CH3CH2). 
Methyl 1-benzyl-4-methoxy-5-phenylpyrrolidin-3-one (273d) 
N
Bn O
CO2MePh  
To methyl 3-(benzylmethoxycarbonylmethylamino)-3-phenylpropanoate (0.44 g, 1.28 
mmol) in toluene (4.5 mL) was added potassium tert-butoxide (1.7 mL, 1M solution in 
THF) at 0 
o
C. The mixture was stirred for 16 h at room temperature under nitrogen.  
The mixture was acidified with hydrochloric acid (3 mL, 1M), neutralized by sodium 
carbonate to around pH 6, extracted with ethyl acetate (10 mL), dried (MgSO4), and 
evaporated to give 273d (0.36 g, 91%) as an orange oil, IR νmax 3318 (O-H), 2951 
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(C-H), 1664 (ester C=O), 1603 (alkenyl C=C), 1436, 1204, 1110, 732, 696 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.61-7.27 (10H, m, Ph) 4.31 (1H, d, J= 10.5 Hz, 
CHCHCOO) 4.00 (1H, d, J= 13.1 Hz, CH2Ar) 3.71 (3H, s, OCH3) 3.57 (1H, d, J= 17.9 
Hz, CH2CO) 3.49 (1H, d, J= 10.5 Hz, CHCOO) 3.20 (1H, d, J= 13.1 Hz, CH2Ar) 2.93 
(1H, d, J= 17.9 Hz, CH2CO);
 13
C NMR (500 MHz, CDCl3) δ 204.9 (COCH2N) 167.3 
(COOCH3) 139.1 (ArC) 137.5 (ArC) 129.1 (ArC) 129.0 (ArC) 128.6 (ArC) 128.2 (ArC) 
128.0 (ArC) 127.7 (ArC) 69.4 (CHCOO) 64.1 (CH2CO) 61.0 (CH2Ar) 57.2 (CH3O) 
52.7 (CHCHCOO); m/z (Cl+) 310 (100%, M+H
+
); HRMS C19H20NO3 calcd. 310.1443, 
found 310.1444. 
1-Benzyl-5-methylpyrrolidin-3-one (274a)
52
 
N
Bn O
 
To methyl 3-(benzylmethoxycarbonylmethylamino)butanoate (0.46 g, 1.63 mmol) in 
toluene (6 mL) was added potassium tert-butoxide (2.2 mL, 1M solution in THF) at 0 
o
C. The mixture was stirred for 16 h at room temperature under nitrogen. The mixture 
was diluted with dichloromethane (30 mL), washed with hydrochloric acid (6 mL, 1M), 
dried (MgSO4), and evaporated. The resulting oil was added to 5% sulfuric acid 
solution (5 mL) and the mixture was heated under reflux for 2 h. The mixture was then 
neutralized with saturated sodium carbonate solution, extracted with ethyl acetate, 
dried (MgSO4), and evaporated. The resulting oil was purified by flash 
chromatography (10% ethyl acetate/hexane) to give 274a (0.19 g, 62%) as a yellow oil, 
Rf 0.47 (30% ethyl acetate/hexane); IR νmax 2924 (C-H), 1699 (ketone C=O), 1640, 
1495, 1452, 1352, 733, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.48-7.26 (5H, m, Ph) 
4.16 (1H, d, J= 11.6 Hz, CH2NCH2Ar) 3.30-3.22 (2H, m, CH2NCH2Ar + CH2Ar) 
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3.01-2.95 (1H, m, CHCH3) 2.65 (1H, d, J= 17.4 Hz, CH2Ar) 2.50 (1H, dd, J= 18.3, 6.1 
Hz, CH2CHN) 2.15 (1H, dd, J= 18.3, 9.9 Hz, CH2CHN) 1.35 (3H, d, J= 6.1 Hz, 
CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 213.4 (COCH2N) 138.0 (ArC) 128.8 (ArC) 
128.5 (ArC) 127.4 (ArC) 61.9 (CH2NCH2Ar) 57.3 (CH2CHN) 57.2 (CH2Ar) 46.1 
(CHN) 18.4 (CH3CH). 
1,5-Dibenzylpyrrolidin-3-one (274c) 
N
Bn O
Bn  
Methyl 3-(benzylmethoxycarbonylmethylamino)-4-phenylbutanoate (0.41 g, 1.16 
mmol) in toluene (4.5 mL) was added potassium tert-butoxide (1.5 mL, 1M solution in 
THF) at 0 
o
C. The mixture was stirred for 16 h at room temperature under nitrogen.  
The mixture was acidified with hydrochloric acid (3 mL, 1M), neutralized by sodium 
carbonate to around pH 6, extracted with ethyl acetate (10 mL), dried (MgSO4), and 
evaporated. The residue was added to aqueous 5% sulfuric acid (5 mL) and the mixture 
was heated under reflux for 2 h. The mixture was then neutralized with saturated 
sodium carbonate solution, extracted with ethyl acetate, dried (MgSO4), and 
evaporated. The resulting oil was purified by flash chromatography (18% ethyl 
acetate/hexane) to give 274c (0.20 g, 65%) as a yellow oil, Rf 0.33 (15% ethyl 
acetate/hexane); IR νmax 2923 (C-H), 1700 (ketone C=O), 1452, 1203, 1076, 735, 698 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.31-7.20 (10H, m, Ph) 4.38 (1H, d, J= 13.1 Hz, 
CH2NCH2Ar) 3.42 (1H, d, J= 13.1 Hz, CH2NCH2Ar) 3.33-3.28 (2H, m, CH2NCH2CO 
+  CH2CHCH2CO) 3.21-3.18 (1H, m, CHN) 2.77-2.69 (2H, m, CH2NCH2CO + 
CH2CHCH2CO) 2.30 (1H, dd, J= 18.3, 6.3 Hz, CH2CHCH2Ar) 2.21 (1H, dd, J= 18.3, 
9.5 Hz, CH2CHCH2Ar);
 13
C NMR (500 MHz, CDCl3) δ 212.9 (COCH2N) 138.2 (ArC) 
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137.9 (ArC) 129.3 (ArC) 129.1 (ArC) 128.6 (ArC) 128.6 (ArC) 127.5 (ArC) 126.6 
(ArC) 63.2 (CH2NCH2Ar) 62.0 (CH2NCH2CO) 57.8 (CHN) 43.6 (CH2CHN) 39.2 
(CH2CHCH2CO); m/z (Cl+) 266 (100%, M+H
+
); HRMS C18H20NO calcd. 266.1545, 
found 266.1545.     
1-Benzyl-5-phenylpyrrolidin-3-one (274d) 
N
Bn O
Ph  
Methyl 1-benzyl-4-methoxy-5-phenylpyrrolidin-3-one (0.31 g, 1.00 mmol) was added 
to aqueous 5% sulfuric acid (5 mL) and the mixture was heated under reflux for 1 h. 
After allowing to cool, the mixture was then neutralized with saturated sodium 
carbonate solution, extracted with ethyl acetate, dried (MgSO4), and evaporated. The 
resulting oil was purified by flash chromatography (12% ethyl acetate/hexane) to give 
274d (0.20 g, 81%) as an yellow oil, Rf 0.38 (15% ethyl acetate/hexane); IR νmax 2952 
(C-H), 1712 (ketone C=O), 1668, 1451, 1203, 764, 698 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.56-7.23 (10H, m, Ph) 3.99 (1H, d, J= 13.2 Hz, CH2NCH2Ar) 3.90-3.87 (1H, 
m, CHN) 3.48 (1H, d, J= 13.2 Hz, CH2Ar) 3.19 (1H, d, J= 13.2 Hz, CH2NCH2Ar) 
2.78-2.72 (2H, m, CH2Ar + CH2CHN) 2.47 (1H, dd, J= 18.2, 10.6 Hz, CH2CHN);
 13
C 
NMR (500 MHz, CDCl3) δ 212.4 (COCH2N) 140.9 (ArC) 137.9 (ArC) 129.3 (ArC) 
129.01 (ArC) 128.6 (ArC) 128.5 (ArC) 127.6 (ArC) 127.4 (ArC) 66.9 (CH2NCH2Ar) 
61.6 (CH2NCH2CO) 57.6 (CHN) 48.2 (CH2CHN); m/z (Cl+) 252 (100%, M+H
+
); 
HRMS C17H18NO calcd. 252.1388, found 252.1387.   
 
 
Chapter 3 
253 
 
Methyl benzylaminoethanoate (275a)
 
N
H
CO2MePh  
To a mixture of benzylamine (1.0 mL, 9.20 mmol) and diethylpropylamine (6.4 mL, 
36.6 mmol) in acetonitrile (70 mL) was added methyl bromoacetate (1.40 g, 9.20 mmol) 
at 0 
o
C. The mixture was stirred for 4 h at room temperature. The mixture was then 
washed with water (30 mL) and the aqueous phase was extracted with dichloromethane 
(2 x 30 mL), dried (MgSO4) and evaporated. The resulting oil was purified by flash 
chromatography (30% ethyl acetate/hexane) to give 275a (1.24 g, 76%) as a yellow oil; 
Rf 0.22 (30% ethyl acetate/hexane); IR νmax 3340 (N-H), 2951 (C-H), 1738 (ester C=O), 
1667, 1435, 1199, 738, 698 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.33-7.23 (5H, m, Ph) 
3.81 (2H, s, CH2Ar) 3.73 (3H, s, OCH3) 3.43 (2H, s, CH2COO) 1.96 (1H, br s, NH);
 
13
C NMR (500 MHz, CDCl3) δ 172.9 (COOCH3) 139.5 (ArC) 128.5 (ArC) 128.3 (ArC) 
127.3 (ArC) 53.4 (CH3O) 51.8 (CH2Ar) 50.0 (CH2COO). 
Methyl 4-methoxybenzylaminoethanoate (275b)
 
N
H
CO2Me
MeO  
To a mixture of 4-methoxyphenylethylamine (2.00 g, 14.6 mmol) and triethylamine 
(2.1 mL, 14.6 mmol) in dichloromethane (7 mL) was added methyl bromoacetate (1.40 
g, 14.6 mmol) at 0 
o
C. The mixture was stirred for 3 h at room temperature. The 
mixture was then washed with water (2 x 5 mL), dried (MgSO4) and evaporated. The 
resulting oil was purified by flash chromatography (50% ethyl acetate/hexane) to give 
275b (1.57 g, 51%) as a colourless oil; Rf 0.18 (30% ethyl acetate/hexane); IR νmax 
2951 (C-H), 1737 (ester C=O), 1611, 1510, 1243, 1173, 1031, 815, 733, 520 cm
-1
; 
1
H 
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NMR (500 MHz, CDCl3) δ 7.25 (2H, d, J= 10.1 Hz, Ph) 6.90 (2H, d, J= 10.1 Hz, Ph) 
3.79 (3H, s, ArOCH3) 3.76 (2H, s, CH2Ar) 3.72 (3H, s, OCH3) 3.45 (2H, s, CH2COO) 
1.75 (1H, br s, NH). 
Methyl 1-benzyl-4-methyl-4-methoxy-5-phenylpyrrolidin-3-one (278) 
N
O
CO2Me
Ph
Ph
Me  
To methyl 1-benzyl-4-methoxy-5-phenylpyrrolidin-3-one (0.17 g, 0.54 mmol) in THF 
(3 mL) was added tetrabutylammonium fluoride (0.65 mL, 1M in THF) and methyl 
iodide (0.07 mL, 1.09 mmol). The mixture was stirred for 24 h at room temperature 
under nitrogen. The mixture was neutralized with 1M hydrochloic acid, extracted by 
chloroform, filtered and evaporated. The resulting oil was purified by flash 
chromatography (12% ethyl acetate/hexane) to give 278 (0.12 g, 69%) as a yellow oil, 
Rf 0.22 (15% ethyl acetate/hexane); IR νmax 2924 (C-H), 1762 (ketone C=O), 1736 
(ester C=O), 1453, 1237, 1203, 1077, 755, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) (5:1 
mixture of diasteriomers) δ 7.55-7.26 (10H, m, Ph) 4.13 (1H, d, J= 13.8 Hz, CH2Ar) 
4.06 (1H, d, J= 13.8 Hz, CH2Ar) 3.88 (1H, s, CHAr) 3.75 (1H, s, CHAr) 3.50 (3H, s, 
OCH3) 3.48 (3H, s, OCH3) 3.20 (1H, d, J= 13.8 Hz, CH2CO) 2.99 (1H, d, J= 18.0 Hz, 
CH2CO) 2.87 (1H, d, J= 18.0 Hz, CH2CO) 1.40 (3H, s, CH3C) 1.09 (3H, s, CH3C);
 13
C 
NMR (500 MHz, CDCl3) δ 210.6 (COCH2N) 209.5 (COCH2N) 170.9 (COOCH3) 
169.8 (COOCH3) 137.8 (ArC) 137.5 (ArC) 136.7 (ArC) 136.0 (ArC) 128.8 (ArC) 
128.7 (ArC) 128.6 (ArC) 128.6 (ArC) 128.6 (ArC) 128.5 (ArC) 128.5 (ArC) 128.4 
(ArC) 128.3 (ArC) 127.5 (ArC) 127.4 (ArC) 127.3 (ArC) 73.2 (CCH3) 70.4 (CCH3) 
61.8 (CH2CO) 61.5 (CH2CO) 60.7 (CH2Ar) 60.5 (CH2Ar) 58.1 (CHAr) 57.4 (CHAr) 
52.8 (CH3O) 52.1 (CH3O) 17.3 (CH3C) 15.5 (CH3C); m/z (Cl+) 324 (100%, M+H
+
); 
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HRMS C20H22NO3 calcd. 324.1600, found 324.1598.   
1-Benzyl-4-methyl-5-phenylpyrrolidin-3-one (279) 
N
Bn O
Ph  
To methyl 1-benzyl-4-methyl-4-methoxy-5-phenylpyrrolidin-3-one (0.13 g, 0.39 mmol) 
in DMF (3 mL) was added lithium iodide (0.27 g, 0.20 mmol). The mixture was stirred 
for 2 h at 150 
o
C under nitrogen. The mixture was diluted with water (8 mL), extracted 
with ethyl acetate (4 x 8 mL), washed with brine (8 mL), dried (MgSO4), and 
evaporated. The resulting oil was purified by flash chromatography (12% ethyl 
acetate/hexane) to give 279 (56 mg, 54%) as an orange oil, Rf 0.72 (15% ethyl 
acetate/hexane); 
1
H NMR (500 MHz, CDCl3) δ 7.70-7.26 (10H, m, Ph) 3.98 (1H, d, J= 
13.2 Hz, CH2CO) 3.55 (1H, d, J= 17.8 Hz, CH2Ar) 3.34 (1H, d, J= 6.2 Hz, CHAr) 3.12 
(1H, d, J= 13.2 Hz, CH2CO) 2.73 (1H, d, J= 17.8 Hz, CH2Ar) 2.26 (1H, qt, J= 7.1, 6.2 
Hz, CHCH3) 1.04 (3H, d, J= 7.1 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 214.7 
(COCH2N) 140.4 (ArC) 138.0 (ArC) 128.9 (ArC) 128.7 (ArC) 128.5 (ArC) 128.4 (ArC) 
127.6 (ArC) 127.3 (ArC) 74.6 (CH2CO) 60.9 (CH2Ar) 57.7 (CHCH3) 53.2 (CHAr) 
10.5 (CH3CH); m/z (Cl+) 266 (100%, M+H
+
); HRMS C18H20NO calcd. 266.1545, 
found 266.1540. 
1-Benzyl-4-hydroxy-2-phenylpyrrolidine (285) 
N
Bn OH
Ph  
To 1-benzyl-5-phenylpyrrolidin-3-one (0.20 g, 0.80 mmol) in methanol (3 mL), 
sodium borohydride (0.03 g, 0.80 mmol) was added at 0 
o
C and the mixture was stirred 
for 1 h at 0 
o
C. The mixture was diluted with water (5 mL), acidified by aqueous 1% 
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hydrochloric acid to around pH 9, extracted with ethyl acetate (3 x 5 mL), dried 
(MgSO4), and evaporated. The resulting oil was purified by flash chromatography 
(30% ethyl acetate/hexane) to give 285 (0.11 g, 55%) as an orange oil, Rf 0.56 (50% 
ethyl acetate/hexane); IR νmax 3365 (O-H), 2935 (C-H), 1601, 1452, 1169, 757, 697 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) (5:1 mixture of diastereoisomers) δ 7.62-7.21 (10H, 
m, Ph) 4.28-4.25 (1H, m, CHOH) 3.89 (1H, d, J= 13.2 Hz, CH2Ar) 3.38 (1H, dd, J= 
8.4, 4.9 Hz, CHN) 3.08-3.04 (2H, m, CH2Ar + CH2NCH2Ar) 2.69-2.63 (1H, m, 
CH2NCH2Ar) 2.35 (1H, dd, J= 10.4, 4.9 Hz, CH2CHAr) 2.05 (1H, br s, OH) 1.76 (1H, 
dd, J= 10.4, 8.4 Hz, CH2CHAr);
 13
C NMR (500 MHz, CDCl3) δ 142.7 (ArC) 138.7 
(ArC) 128.8 (ArC) 128.8 (ArC) 128.4 (ArC) 128.3 (ArC) 127.6 (ArC) 127.4 (ArC) 
70.2 (CH2CHAr) 68.4 (CH2OH) 62.2 (CH2Ar) 57.2 (CHN) 46.0 (CHAr); m/z (Cl+) 
253 (10%, M
+
) 176 (25%, M
+
-Ph) 162 (10%, M
+
-PhCH2) 91 (100%, PhCH2
+
) 77 (10%, 
Ph
+
); HRMS C17H19NO calcd. 253.1467, found 253.1462.   
(S)-Methyl 1-phenylethylaminoethanoate (287)
58 
N
H
CO2MePh
 
To a mixture of (S)-1-phenylethylamine (1.00 g, 8.3 mmol) and triethylamine (1.2 mL, 
8.3 mmol) in dichloromethane (4 mL) was added methyl bromoacetate (0.80 g, 8.3 
mmol) at 0 
o
C. The mixture was stirred for 3 h at 20 
o
C then washed with water (2 x 3 
mL), dried (MgSO4) and evaporated to give kc0 40 (0.51 g, 32%) as a pale yellow oil, 
[α]21D = -64.2 (c 6.20, CHCl3); IR νmax 3005 (N-H), 2955 (C-H), 1736 (ester C=O), 
1435, 1199, 761, 700; 
1
H NMR (500 MHz, CDCl3) δ 7.35-7.24 (5H, m, Ph) 3.79 (1H, 
q, J= 6.6 Hz, CHAr) 3.69 (3H, s, OCH3) 3.30 (2H, d, J= 17.4 Hz, CH2COO) 3.24 (2H, 
d, J= 17.4 Hz, CH2COO) 1.89 (1H, br s, NH) 1.38 (3H, d, J= 6.6 Hz, CH3CH);
 13
C 
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NMR (500 MHz, CDCl3) δ 173.1 (COOCH3) 144.7 (ArC) 128.6 (ArC) 127.3 (ArC) 
126.8 (ArC) 57.8 (CH3O) 51.8 (CHAr) 48.8 (CH2COO) 24.3 (CH3CH).  
General procedure for diesters 288 
To a stirred solution of β-amino esters 288 (1.0 equiv) in acetonitrile at room 
temperature, sodium carbonate (2.0 equiv) and methyl bromoacetate (1.0 equiv) were 
added. The mixture was then heated under reflux for 16 h. The mixture was allowed to 
cool to room temperature and diluted with diethyl ether. The mixture was then washed 
with water, dried (MgSO4) and evaporated.  
(R)-Methyl 3-{methoxycarbonylmethyl-[(1S)-1-phenylethyl]amino}butanoate 
(288a)
 
N
CO2Me
CO2MePh
 
Following general procedure, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl]amino}butanoate (0.50 g, 2.36 mmol), sodium carbonate (0.50 
g, 4.72 mmol), and methyl bromoacetate (0.25 ml, 2.60 mmol) in acetonitrile (6 mL) 
gave a pale yellow oil that was purified by flash chromatography (10% ethyl 
acetate/hexane) to give 288a (0.66 g, 96%) as a pale yellow oil, Rf 0.52 (30% ethyl 
acetate/hexane); [α]21D = +5.6 (c 10.2, CHCl3); IR νmax 2971 (C-H), 1731 (ester C=O), 
1435, 1194, 1160, 701; 
1
H NMR (500 MHz, CDCl3) δ 7.37-7.20 (5H, m, Ph) 4.08 (1H, 
q, J= 6.7 Hz, CHCH3) 3.64 (3H, s, OCH3) 3.62 (3H, s, OCH3) 3.54-3.48 (1H, m, 
CHCH2CO2CH3) 3.35 (2H, s, CH2N) 2.54 (1H, dd, J= 14.6, 6.2 Hz, CH2CH) 2.18 (1H, 
dd, J= 14.6, 7.9 Hz, CH2CH) 1.33 (3H, d, J= 5.3 Hz, CH3CHCH2) 1.05 (3H, d, J= 6.7 
Hz, CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 173.9 (COOCH3) 172.7 (COOCH3) 
Chapter 3 
258 
 
145.2 (ArC) 128.3 (ArC) 127.6 (ArC) 127.0 (ArC) 59.6 (CHCH3) 51.6 (OCH3) 51.5 
(OCH3) 51.2 (CH2N) 47.6 (CHCH2COO) 39.6 (CH2CHCH3) 20.7 (CH3CHCH2) 17.4 
(CH3CHAr). 
(R)-Methyl 
3-{methoxycarbonylmethyl-4-methyl-[(1S)-1-phenylethyl]amino}pentanoate 
(288b)
 
N
CO2Me
Ph CO2Me
 
Following general procedure, reaction of (R)-methyl 
4-methyl-3-[(1S)-1-phenylethylamino]pentanoate (0.46 g, 1.85 mmol), sodium 
carbonate (0.40 g, 3.69 mmol), and methyl bromoacetate (0.22 ml, 2.03 mmol) in 
acetonitrile (5 mL) gave a pale yellow oil that was purified by flash chromatography 
(2% ethyl acetate/chloroform) to give 288b (0.33 g, 56%) as a pale yellow oil, Rf 0.66 
(2% ethyl acetate/chloroform); [α]21D = +15.2 (c 0.33, CHCl3); IR νmax 2954 (C-H), 
1736 (ester C=O), 1436, 1196, 1171, 703; 
1
H NMR (500 MHz, CDCl3) δ 7.42-7.18 
(5H, m, Ph) 3.94 (1H, q, J= 6.6 Hz, CHPh) 3.65 (3H, s, OCH3) 3.59 (3H, s, OCH3) 
3.35 (2H, s, CH2N) 2.91-2.87 (1H, m, CHCH2CO2CH3) 2.32 (1H, dd, J= 15.5, 4.4 Hz, 
CH2CO2CH3) 2.21 (1H, dd, J= 15.5, 6.9 Hz, CH2CO2CH3) 1.66-1.62 (1H, m, 
CH(CH3)2) 1.33 (3H, d, J= 6.6 Hz, CH3CHPh) 0.95 (3H, d, J= 6.9 Hz, CH3CHCH) 
0.74 (3H, d, J= 6.9 Hz, CH3CHCH);
 13
C NMR (500 MHz, CDCl3) δ 173.9 (COOCH3) 
173.6 (COOCH3) 144.7 (ArC) 128.3 (ArC) 128.1 (ArC) 127.1 (ArC) 60.6 
(CHCH2COO) 60.3 (CHAr) 51.6 (OCH3) 51.5 (OCH3) 48.4 (CH2N) 34.7 (CH2CHN) 
32.7 (CH(CH3)2) 21.2 (CH3CHN) 20.8 ((CH3)2CHCH) 19.7 ((CH3)2CHCH). 
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(R)-Methyl 3-{methoxycarbonylmethyl-[(1S)-1-phenylethyl]amino}hex-4-enoate 
(288c)
 
N
CO2Me
Ph CO2Me
 
Following general procedure, reaction of (R)-methyl 
3-{[(1S)-1-phenylethyl]amino}hex-4-enoate (0.20 g, 0.81 mmol), sodium carbonate 
(0.17 g, 1.62 mmol), and methyl bromoacetate (0.09 ml, 0.89 mmol) in acetonitrile (3 
mL) gave a pale yellow oil that was purified by flash chromatography (20% ethyl 
acetate/hexane) to give 288c (0.22 g, 84%) as a pale yellow oil, Rf 0.67 (30% ethyl 
acetate/hexane); [α]21D = +5.3 (c 1.33, CHCl3); IR νmax 2952 (C-H), 1737 (ester C=O), 
1436, 1195, 1173, 702; 
1
H NMR (500 MHz, CDCl3) δ 7.53-7.20 (5H, m, Ph) 5.59-5.54 
(1H, m, CH=CHCH3) 5.45-5.42 (1H, m, CH=CHCHN) 4.11 (1H, q, J= 6.7 Hz, CHCH3) 
3.89-3.88 (1H, m, CHCH2CO2CH3) 3.62 (3H, s, OCH3) 3.60 (3H, s, OCH3) 3.31 (2H, s, 
CH2N) 2.62 (1H, dd, J= 14.6, 6.3 Hz, CH2CO2CH3) 2.37 (1H, dd, J= 14.6, 8.4 Hz, 
CH2CO2CH3) 1.68 (3H, d, J= 2.3 Hz, CH3CHCH) 1.36 (3H, d, J= 6.7 Hz, CH3CHPh);
 
13
C NMR (500 MHz, CDCl3) δ 173.7 (COOCH3) 172.3 (COOCH3) 144.9 (ArC) 129.7 
(ArC) 128.3 (ArC) 127.7 (ArC) 127.7 (=CHCHN) 127.0 (CH=CHCHN) 59.2 (CHCH3) 
57.4 (CH2N) 51.6 (OCH3) 51.5 (OCH3) 48.5 (CHCH2COO) 37.7 (CH2CHN) 19.8 
(CH3CH=CH) 18.1 (CH3CHAr). 
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(R)-Methyl 
3-cyclohexyl-3-{methoxycarbonylmethyl-[(1S)-1-phenylethyl]amino}propanoate 
(288d)
 
N
CO2Me
Ph CO2Me
 
Following general procedure, reaction of (R)-methyl 
3-cyclohexyl-3-[(1S)-1-phenylethyl]amino]propanoate (0.42 g, 1.45 mmol), sodium 
carbonate (0.32 g, 2.90 mmol), and methyl bromoacetate (0.17 ml, 1.59 mmol) in 
acetonitrile (5 mL) gave a pale yellow oil that was purified by flash chromatography 
(2% ethyl acetate/chloroform) to give 288d (0.26 g, 51%) as a pale yellow oil, Rf 0.70 
(2% ethyl acetate/chloroform); [α]25D = +11.7 (c 1.00, CHCl3); IR νmax 2923 (C-H), 
1734 (ester C=O), 1434, 1193, 1169, 702; 
1
H NMR (500 MHz, CDCl3) δ 7.48-7.19 
(5H, m, Ph) 3.94 (1H, q, J= 6.8 Hz, CHPh) 3.66 (3H, s, OCH3) 3.59 (3H, s, OCH3) 
3.35 (2H, s, CH2N) 2.95-2.92 (1H, m, CHCH2CO2CH3) 2.31 (1H, dd, J= 15.6, 4.1 Hz, 
CH2CO2CH3) 2.21 (1H, dd, J= 15.6, 7.3 Hz, CH2CO2CH3) 1.67-1.44 (5H, m, 
1'-cyclohexyl-CH + cyclohexyl-CH2) 1.34 (3H, d, J= 6.8 Hz, CH3CHPh) 1.30-1.04 
(4H, m, cyclohexyl-CH2) 0.76-0.71 (2H, m, 4'-cyclohexyl-CH);
 13
C NMR (500 MHz, 
CDCl3) δ 173.9 (COOCH3) 173.7 (COOCH3) 144.8 (ArC) 128.5 (ArC) 128.4 (ArC) 
127.1 (ArC) 60.9 (CHCH2COO) 60.3 (CHPh) 51.5 (OCH3) 51.4 (OCH3) 48.4 (CH2N) 
42.4 (CH2CHN) 34.5 (1'-cyclohexyl-C) 30.7 (4'-cyclohexyl-C) 30.0 (2'- cyclohexyl-C) 
26.6 (6'-cyclohexyl-C) 26.5 (3'- cyclohexyl-C) 26.5 (5'-cyclohexyl-C) 21.3 (CH3CHPh); 
m/z (Cl+) 362 (100%, M+H
+
); HRMS C21H32NO4 calcd. 362.2331, found 362.2322. 
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(R)-Methyl 
3-{methoxycarbonylmethyl-3-phenyl-[(1S)-1-phenylethyl]amino}propanoate 
(288e)
 
N
CO2Me
Ph
Ph CO2Me
 
Following general procedure, reaction of (R)-methyl 
3-phenyl-{[(1S)-1-phenylethyl]amino}propanoate (0.70 g, 2.47 mmol), sodium 
carbonate (0.54 g, 4.94 mmol), and methyl bromoacetate (0.29 ml, 2.70 mmol) in 
acetonitrile (9 mL) gave a pale yellow oil that was purified by flash chromatography 
(20% ethyl acetate/hexane) to give 288e (0.50 g, 58%) as a colourless oil, Rf 0.62 (30% 
ethyl acetate/hexane); [α]21D = -10.0 (c 2.91, CHCl3); IR νmax 2950 (C-H), 1733 (ester 
C=O), 1435, 1196, 1169, 761, 700; 
1
H NMR (500 MHz, CDCl3) δ 7.58-7.25 (10H, m, 
Ph) 4.51 (1H, dd, J= 9.2, 5.6 Hz, CHCH2CO2CH3) 4.11 (1H, q, J= 6.7 Hz, CHCH3) 
3.59 (3H, s, OCH3) 3.55 (3H, s, OCH3) 3.32 (2H, s, CH2N) 2.95 (1H, dd, J= 15.0, 5.6 
Hz, CH2CO2CH3) 2.73 (1H, dd, J= 15.0, 9.2 Hz, CH2CO2CH3) 1.33 (3H, d, J= 6.7 Hz, 
CH3CHPh);
 13
C NMR (500 MHz, CDCl3) δ 173.6 (COOCH3) 172.2 (COOCH3) 144.4 
(ArC) 141.0 (ArC) 128.4 (ArC) 128.3 (ArC) 128.0 (ArC) 127.7 (ArC) 127.5 (ArC) 
127.1 (ArC) 59.9 (CHCH3) 58.3 (CHCH2COO) 51.6 (OCH3) 51.6 (OCH3) 48.2 (CH2N) 
37.2 (CH2CHN) 17.8 (CH3CHAr). 
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(5R, 4S)-Methyl 4-methoxy-5-phenyl-[(1S)-1-phenylethyl]pyrrolidin-3-one (289a) 
N
O
CO2MePh
Ph
 
To (R)-methyl 
3-{methoxycarbonylmethyl-3-phenyl-[(1S)-1-phenylethyl]amino}propanoate (0.32 g, 
0.91 mmol) in toluene (3 mL) was added potassium tert-butoxide (1.2 mL, 1M solution 
in THF) at 0 
o
C. The mixture was stirred for 16 h at room temperature under nitrogen.  
The mixture was acidified with hydrochloric acid (2 mL, 1M), neutralized by sodium 
carbonate to around pH 6, extracted with ethyl acetate (10 mL). The combined organic 
extracts were dried (MgSO4), and evaporated to give 289a (0.16 g, 55%) as a yellow 
oil, Rf 0.58 (30% ethyl acetate/hexane); [α]
21
D = -13.7 (c 1.53, CHCl3); IR νmax 2922 
(C-H), 1731 (ester C=O), 1669 (ketone C=O), 1453, 1263, 1336, 759, 699; 
1
H NMR 
(500 MHz, CDCl3) δ 7.58-7.24 (10H, m, Ph) 4.58 (1H, d, J= 10.1 Hz, CHCHCOO) 
4.02 (1H, q, J= 6.7 Hz, CHCH3) 3.68 (3H, s, OCH3) 3.48 (1H, d, J= 10.1 Hz, CHCOO) 
3.20 (2H, s, CH2N) 1.30 (3H, d, J= 6.7 Hz, CH3CH);
 13
C NMR (500 MHz, CDCl3) δ 
205.4 (COCH2N) 167.4 (COOCH3) 142.3 (ArC) 139.1 (ArC) 129.3 (ArC) 128.7 (ArC) 
128.3 (ArC) 128.0 (ArC) 127.6 (ArC) 127.2 (ArC) 66.1 (CHCOO) 64.3 (CH2CO) 53.7 
(CHCH3) 53.0 (CH3O) 52.6 (CHCHCOO) 8.6 (CH3CH); m/z (Cl+) 323 (55%, M+H
+
) 
105 (100%, C8H9
+
); HRMS C20H21NO3 calcd. 323.1521, found 323.1526.   
(5S)-5-Phenyl-[(1S)-1-phenylethyl]pyrrolidin-3-one (290a) 
N
O
Ph
 
(R)-Methyl 3-{methoxycarbonylmethyl-[(1S)-1-phenylethyl]amino}butanoate (0.30 g, 
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1.04 mmol) in toluene (3.5 mL) was added potassium tert-butoxide (1.4 mL, 1M 
solution in THF) at 0 
o
C. After stirring for 16 h at room temperature under nitrogen, the 
mixture was acidified with hydrochloric acid (3 mL, 1M), neutralized by sodium 
carbonate to around pH 6, extracted with ethyl acetate (10 mL), dried (MgSO4), and 
evaporated. The residue was added to aqueous 5% sulfuric acid (5 mL) and the mixture 
was heated under reflux for 2 h, then allowed to cool, and neutralized with saturated 
sodium carbonate solution. The mixture was extracted with ethyl acetate, dried 
(MgSO4), and evaporated. The resulting oil was purified by flash chromatography 
(15% ethyl acetate/hexane) to give 290a (85 mg, 40%) as a yellow oil, Rf 0.28 (15% 
ethyl acetate/hexane); [α]21D = +186.5 (c 0.52, CHCl3); IR νmax 2923 (C-H), 1654 
(ketone C=O), 1451, 1378, 1208, 761, 700; 
1
H NMR (500 MHz, CDCl3) δ 7.36-7.22 
(5H, m, Ph) 3.93 (1H, q, J= 6.7 Hz, CHAr) 3.56-3.52 (1H, m, CHCH2) 2.88 (2H, s, 
CH2N) 2.60 (1H, dd, J= 17.9, 6.4 Hz, CH2CH) 2.12 (1H, dd, J= 17.9, 6.0 Hz, CH2CH) 
1.38 (3H, d, J= 6.7 Hz, CH3CHAr) 1.20 (3H, d, J= 6.7 Hz, CH3CHCH2);
 13
C NMR 
(500 MHz, CDCl3) δ 214.6 (COCH2N) 144.2 (ArC) 128.3 (ArC) 127.1 (ArC) 125.6 
(ArC) 57.5 (CH2NCH2Ar) 56.3 (CH2NCH2CO) 53.2 (CHCH2) 46.6 (CH2CHN) 16.3 
(CH3CHAr) 16.1 (CH3CHCH2); m/z (Cl+) 204 (85%, M+H
+
) 105 (100%, C9H9
+
); 
HRMS C13H18NO calcd. 204.1388, found 204.1388.   
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